1	ARTICLES	NNS	O	article	_	0	SENT_1	[p1l91t81r244b102],

1	Tamoxifen	NN	MISC	tamoxifen	_	0	SENT_2	[p1l88t172r385b220],
2	and	CC	O	and	_	0	SENT_2	[p1l409t173r511b220],
3	risk	NN	O	risk	conj_and	1	SENT_2	[p1l537t172r642b220],
4	of	IN	O	of	_	0	SENT_2	[p1l664t172r719b220],
5	contralateral	JJ	O	contralateral	amod	7	SENT_2	[p1l738t173r1111b220],
6	breast	NN	O	breast	nn	7	SENT_2	[p1l1137t173r1319b220],
7	cancer	NN	O	cancer	prep_of	1	SENT_2	[p1l1342t184r1541b220],
8	in	IN	O	in	_	0	SENT_2	[p1l1563t172r1610b220],
9	BRCA1	NN	O	brca1	nn	13	SENT_2	[p1l1634t173r1838b220],
10	and	CC	O	and	_	0	SENT_2	[p1l1861t173r1963b220],
11	BRCA2	NN	O	brca2	conj_and	9	SENT_2	[p1l88t257r293b304],
12	mutation	NN	O	mutation	nn	13	SENT_2	[p1l317t256r574b304],
13	carriers	NNS	O	carrier	prep_in	7	SENT_2	[p1l598t256r838b304],
14	:	:	O	:	_	0	SENT_2	[p1l598t256r838b304],
15	a	DT	O	a	det	17	SENT_2	[p1l863t268r895b304],
16	case-control	JJ	O	case-control	amod	17	SENT_2	[p1l918t257r1275b304],
17	study	NN	O	study	dep	1	SENT_2	[p1l1299t257r1458b315],
18	Steven	NNP	PERSON	Steven	nn	22	SENT_2	[p1l87t374r193b401],
19	A	NNP	PERSON	A	nn	22	SENT_2	[p1l205t375r225b401],
20	Narod	NNP	PERSON	Narod	nn	22	SENT_2	[p1l238t375r339b406],
21	,	,	O	,	_	0	SENT_2	[p1l238t375r339b406],
22	Jean	NNP	PERSON	Jean	dep	17	SENT_2	[p1l351t373r589b401],
23	.	.	O	.	_	0	SENT_2	[p1l351t373r589b401],

1	—	NN	O	—	_	0	SENT_3	[p1l351t373r589b401],
2	.	.	O	.	_	0	SENT_3	[p1l351t373r589b401],

1	Sébastien	NNP	PERSON	Sébastien	nn	2	SENT_4	[p1l351t373r589b401],
2	Brunet	NNP	PERSON	Brunet	_	0	SENT_4	[p1l603t375r713b406],
3	,	,	O	,	_	0	SENT_4	[p1l603t375r713b406],
4	Parviz	NNP	PERSON	Parviz	nn	5	SENT_4	[p1l729t375r821b401],
5	Ghadirian	NNP	PERSON	Ghadirian	appos	2	SENT_4	[p1l833t374r991b406],
6	,	,	O	,	_	0	SENT_4	[p1l833t374r991b406],
7	Mark	NNP	PERSON	Mark	nn	8	SENT_4	[p1l1006t375r1086b401],
8	Robson	NNP	PERSON	Robson	appos	5	SENT_4	[p1l1098t375r1222b406],
9	,	,	O	,	_	0	SENT_4	[p1l1098t375r1222b406],
10	Ketil	NNP	PERSON	Ketil	nn	11	SENT_4	[p1l1237t375r1306b401],
11	Heimdal	NNP	PERSON	Heimdal	appos	5	SENT_4	[p1l1318t375r1453b406],
12	,	,	O	,	_	0	SENT_4	[p1l1318t375r1453b406],
13	Susan	NNP	PERSON	Susan	nn	15	SENT_4	[p1l1467t374r1564b401],
14	L	NNP	PERSON	L	nn	15	SENT_4	[p1l1578t375r1594b401],
15	Neuhausen	NNP	PERSON	Neuhausen	appos	5	SENT_4	[p1l1607t375r1793b406],
16	,	,	O	,	_	0	SENT_4	[p1l1607t375r1793b406],
17	Dominique	NNP	PERSON	Dominique	nn	18	SENT_4	[p1l88t425r256b457],
18	Stoppa	NNP	PERSON	Stoppa	appos	5	SENT_4	[p1l268t424r518b457],
19	.	.	O	.	_	0	SENT_4	[p1l268t424r518b457],

1	—	NN	O	—	_	0	SENT_5	[p1l268t424r518b457],
2	.	.	O	.	_	0	SENT_5	[p1l268t424r518b457],

1	Lyonnet	NNP	PERSON	Lyonnet	_	0	SENT_6	[p1l268t424r518b457],
2	,	,	O	,	_	0	SENT_6	[p1l268t424r518b457],
3	Caryn	NNP	PERSON	Caryn	nn	4	SENT_6	[p1l534t424r620b457],
4	Lerman	NNP	PERSON	Lerman	appos	1	SENT_6	[p1l634t425r760b456],
5	,	,	O	,	_	0	SENT_6	[p1l634t425r760b456],
6	Barbara	NNP	PERSON	Barbara	nn	7	SENT_6	[p1l775t425r899b451],
7	Pasini	NNP	PERSON	Pasini	appos	1	SENT_6	[p1l913t425r1012b456],
8	,	,	O	,	_	0	SENT_6	[p1l913t425r1012b456],
9	Patricia	NNP	PERSON	Patricia	nn	12	SENT_6	[p1l1027t425r1143b451],
10	de	IN	PERSON	de	amod	12	SENT_6	[p1l1156t425r1193b451],
11	Ios	NNP	PERSON	Ios	nn	12	SENT_6	[p1l1206t425r1248b451],
12	Rios	NNP	PERSON	Rios	appos	1	SENT_6	[p1l1262t425r1335b456],
13	,	,	O	,	_	0	SENT_6	[p1l1262t425r1335b456],
14	Barbara	NNP	PERSON	Barbara	nn	15	SENT_6	[p1l1350t425r1474b451],
15	Weber	NNP	PERSON	Weber	appos	1	SENT_6	[p1l1489t425r1594b456],
16	,	,	O	,	_	0	SENT_6	[p1l1489t425r1594b456],
17	Henry	NNP	PERSON	Henry	nn	18	SENT_6	[p1l1609t425r1701b457],
18	Lynch	NNP	PERSON	Lynch	appos	1	SENT_6	[p1l1712t425r1809b457],
19	,	,	O	,	_	0	SENT_6	[p1l1712t425r1809b457],
20	for	IN	O	for	_	0	SENT_6	[p1l1824t424r1867b451],
21	the	DT	O	the	det	24	SENT_6	[p1l1878t425r1926b451],
22	Hereditary	JJ	O	hereditary	amod	24	SENT_6	[p1l88t475r251b507],
23	Breast	NN	O	breast	nn	24	SENT_6	[p1l262t475r364b501],
24	Cancer	NN	O	cancer	prep_for	1	SENT_6	[p1l376t474r486b501],
25	Clinical	JJ	O	clinical	amod	27	SENT_6	[p1l497t474r608b501],
26	Study	NNP	O	Study	nn	27	SENT_6	[p1l619t474r709b507],
27	Group	NNP	O	Group	dep	1	SENT_6	[p1l720t474r833b507],
28	*	IN	O	*	amod	27	SENT_6	[p1l720t474r833b507],

1	Summary	NN	O	summary	_	0	SENT_7	[p1l8t629r430b713],

1	Background	NN	O	background	nn	2	SENT_8	[p1l11t828r430b898],
2	Women	NNS	O	woman	nsubj	10	SENT_8	[p1l456t828r710b885],
3	with	IN	O	with	_	0	SENT_8	[p1l738t828r872b885],
4	a	DT	O	a	det	5	SENT_8	[p1l902t841r939b885],
5	mutation	NN	O	mutation	prep_with	2	SENT_8	[p1l970t828r1267b885],
6	in	IN	O	in	_	0	SENT_8	[p1l1300t828r1351b884],
7	BRCA1	NN	O	brca1	prep_in	5	SENT_8	[p1l1382t829r1612b885],
8	or	CC	O	or	_	0	SENT_8	[p1l1641t841r1707b885],
9	BRCA2	NN	O	brca2	prep_in	5	SENT_8	[p1l1732t828r1963b885],
10	have	VBP	O	have	_	0	SENT_8	[p1l1993t828r2148b885],
11	a	DT	O	a	det	13	SENT_8	[p1l9t935r46b979],
12	high	JJ	O	high	amod	13	SENT_8	[p1l90t922r224b993],
13	risk	NN	O	risk	dobj	10	SENT_8	[p1l269t922r389b979],
14	of	IN	O	of	_	0	SENT_8	[p1l427t921r494b979],
15	developing	VBG	O	develop	amod	17	SENT_8	[p1l529t922r896b993],
16	breast	NN	O	breast	nn	17	SENT_8	[p1l935t922r1151b979],
17	cancer	NN	O	cancer	prep_of	13	SENT_8	[p1l1188t935r1418b979],
18	and	CC	O	and	_	0	SENT_8	[p1l1454t922r1576b979],
19	of	IN	O	of	conj_and	10	SENT_8	[p1l1618t921r1685b979],
20	contralateral	JJ	O	contralateral	amod	21	SENT_8	[p1l1719t922r2145b979],
21	cancer	NN	O	cancer	pobj	19	SENT_8	[p1l9t1031r238b1074],
22	after	IN	O	after	_	0	SENT_8	[p1l269t1016r427b1074],
23	the	DT	O	the	det	25	SENT_8	[p1l454t1017r562b1074],
24	initial	JJ	O	initial	amod	25	SENT_8	[p1l600t1017r775b1074],
25	diagnosis	NN	O	diagnosis	prep_after	19	SENT_8	[p1l812t1017r1138b1089],
26	of	IN	O	of	_	0	SENT_8	[p1l1173t1016r1239b1074],
27	breast	NN	O	breast	nn	28	SENT_8	[p1l1270t1017r1486b1074],
28	cancer	NN	O	cancer	prep_of	25	SENT_8	[p1l1516t1031r1762b1074],
29	.	.	O	.	_	0	SENT_8	[p1l1516t1031r1762b1074],

1	Tamoxifen	NN	MISC	tamoxifen	nsubj	2	SENT_9	[p1l1798t1016r2146b1074],
2	protects	VBZ	O	protect	_	0	SENT_9	[p1l13t1115r288b1182],
3	against	IN	O	against	_	0	SENT_9	[p1l335t1112r587b1184],
4	contralateral	JJ	O	contralateral	amod	6	SENT_9	[p1l631t1112r1057b1169],
5	breast	NN	O	breast	nn	6	SENT_9	[p1l1109t1112r1325b1169],
6	cancer	NN	O	cancer	prep_against	2	SENT_9	[p1l1369t1126r1598b1169],
7	in	IN	O	in	_	0	SENT_9	[p1l1645t1112r1696b1168],
8	the	DT	O	the	det	10	SENT_9	[p1l1742t1112r1850b1169],
9	general	JJ	O	general	amod	10	SENT_9	[p1l1896t1112r2145b1184],
10	population	NN	O	population	prep_in	6	SENT_9	[p1l13t1207r384b1276],
11	,	,	O	,	_	0	SENT_9	[p1l13t1207r384b1276],
12	but	CC	O	but	_	0	SENT_9	[p1l416t1207r522b1263],
13	whether	IN	O	whether	dep	15	SENT_9	[p1l545t1207r817b1263],
14	it	PRP	O	it	nsubj	15	SENT_9	[p1l844t1207r882b1263],
15	protects	VBZ	O	protect	ccomp	28	SENT_9	[p1l910t1210r1183b1276],
16	against	IN	O	against	_	0	SENT_9	[p1l1210t1207r1459b1277],
17	contralateral	JJ	O	contralateral	amod	19	SENT_9	[p1l1483t1207r1905b1263],
18	breast	NN	O	breast	nn	19	SENT_9	[p1l1937t1207r2151b1263],
19	cancer	NN	O	cancer	prep_against	15	SENT_9	[p1l9t1314r238b1358],
20	in	IN	O	in	_	0	SENT_9	[p1l267t1301r318b1357],
21	BRCA1	NN	O	brca1	prep_in	19	SENT_9	[p1l349t1301r579b1358],
22	or	CC	O	or	_	0	SENT_9	[p1l609t1314r675b1358],
23	BRCA2	NN	O	brca2	conj_or	21	SENT_9	[p1l701t1301r932b1358],
24	mutation	NN	O	mutation	nn	25	SENT_9	[p1l963t1301r1259b1358],
25	carriers	NNS	O	carrier	nsubjpass	28	SENT_9	[p1l1290t1301r1545b1358],
26	is	VBZ	O	be	auxpass	28	SENT_9	[p1l1577t1301r1628b1358],
27	not	RB	O	not	neg	28	SENT_9	[p1l1660t1304r1766b1358],
28	known	VBN	O	know	conj_but	2	SENT_9	[p1l1795t1301r2027b1358],
29	.	.	O	.	_	0	SENT_9	[p1l1795t1301r2027b1358],

1	Methods	NNS	O	method	nsubj	20	SENT_10	[p1l11t1490r301b1546],
2	We	PRP	O	we	nsubj	3	SENT_10	[p1l331t1490r431b1546],
3	compared	VBD	O	compare	rcmod	1	SENT_10	[p1l464t1490r783b1559],
4	209	CD	NUMBER	209	num	5	SENT_10	[p1l819t1489r949b1546],
5	women	NNS	O	woman	dobj	3	SENT_10	[p1l980t1503r1209b1546],
6	with	IN	O	with	_	0	SENT_10	[p1l1243t1490r1370b1546],
7	bilateral	JJ	O	bilateral	amod	9	SENT_10	[p1l1407t1490r1662b1546],
8	breast	NN	O	breast	nn	9	SENT_10	[p1l1699t1490r1905b1546],
9	cancer	NN	O	cancer	prep_with	3	SENT_10	[p1l1935t1503r2152b1546],
10	and	CC	O	and	_	0	SENT_10	[p1l9t1583r125b1640],
11	BRCA1	NN	O	brca1	nn	14	SENT_10	[p1l172t1583r391b1640],
12	or	CC	O	or	_	0	SENT_10	[p1l437t1596r500b1640],
13	BRCA2	NN	O	brca2	conj_or	11	SENT_10	[p1l541t1583r762b1640],
14	mutation	NN	O	mutation	conj_and	9	SENT_10	[p1l808t1583r1090b1640],
15	(	CD	NUMBER	(	num	19	SENT_10	[p1l1138t1583r1695b1652],
16	bilateral	JJ	O	bilateral	amod	19	SENT_10	[p1l1138t1583r1695b1652],
17	—	NN	O	—	nn	19	SENT_10	[p1l1138t1583r1695b1652],
18	disease	NN	O	disease	nn	19	SENT_10	[p1l1138t1583r1695b1652],
19	cases	NNS	O	case	dep	14	SENT_10	[p1l1740t1583r1973b1652],
20	)	VBP	O	)	_	0	SENT_10	[p1l1740t1583r1973b1652],
21	,	,	O	,	_	0	SENT_10	[p1l1740t1583r1973b1652],
22	with	IN	O	with	_	0	SENT_10	[p1l2019t1583r2146b1640],
23	384	CD	NUMBER	384	num	24	SENT_10	[p1l9t1676r141b1733],
24	women	NNS	O	woman	prep_with	20	SENT_10	[p1l198t1690r428b1733],
25	with	IN	O	with	_	0	SENT_10	[p1l488t1676r615b1733],
26	unilateral	JJ	O	unilateral	amod	27	SENT_10	[p1l680t1676r975b1733],
27	disease	NN	O	disease	prep_with	24	SENT_10	[p1l1038t1676r1292b1733],
28	and	CC	O	and	_	0	SENT_10	[p1l1353t1676r1468b1733],
29	BRCA1	NN	O	brca1	conj_and	27	SENT_10	[p1l1530t1677r1748b1733],
30	or	CC	O	or	_	0	SENT_10	[p1l1810t1690r1873b1733],
31	BRCA2	NN	O	brca2	nn	32	SENT_10	[p1l1929t1676r2150b1733],
32	mutation	NN	O	mutation	prep_with	20	SENT_10	[p1l11t1770r293b1826],
33	(	CD	NUMBER	(	num	34	SENT_10	[p1l324t1770r626b1839],
34	controls	NNS	O	control	dep	32	SENT_10	[p1l324t1770r626b1839],
35	)	RB	O	)	advmod	20	SENT_10	[p1l324t1770r626b1839],
36	in	IN	O	in	_	0	SENT_10	[p1l656t1770r705b1825],
37	a	DT	O	a	det	40	SENT_10	[p1l734t1783r769b1826],
38	matched	VBN	O	match	amod	40	SENT_10	[p1l800t1770r1076b1826],
39	case-control	JJ	O	case-control	amod	40	SENT_10	[p1l1105t1770r1495b1826],
40	study	NN	O	study	prep_in	20	SENT_10	[p1l1526t1770r1715b1840],
41	.	.	O	.	_	0	SENT_10	[p1l1526t1770r1715b1840],

1	Age	NNP	O	Age	nsubj	17	SENT_11	[p1l1745t1770r1862b1840],
2	and	CC	O	and	_	0	SENT_11	[p1l1890t1770r2006b1826],
3	age	NN	O	age	nsubj	17	SENT_11	[p1l2035t1778r2149b1840],
4	at	IN	O	at	_	0	SENT_11	[p1l9t1866r72b1920],
5	diagnosis	NN	O	diagnosis	prep_at	3	SENT_11	[p1l95t1863r405b1935],
6	of	IN	O	of	_	0	SENT_11	[p1l431t1862r494b1920],
7	breast	NN	O	breast	nn	10	SENT_11	[p1l516t1863r722b1920],
8	cancer	NN	O	cancer	nn	10	SENT_11	[p1l745t1877r962b1920],
9	(	NN	O	(	nn	10	SENT_11	[p1l985t1863r1185b1935],
10	range	NN	O	range	prep_of	5	SENT_11	[p1l985t1863r1185b1935],
11	24-74	CD	NUMBER	24-74	num	12	SENT_11	[p1l1212t1863r1426b1919],
12	years	NNS	NUMBER	year	tmod	5	SENT_11	[p1l1449t1863r1644b1934],
13	)	CD	NUMBER	)	dep	3	SENT_11	[p1l1449t1863r1644b1934],
14	were	VBD	O	be	cop	17	SENT_11	[p1l1668t1877r1821b1920],
15	much	RB	O	much	advmod	17	SENT_11	[p1l1849t1863r2020b1920],
16	the	DT	O	the	det	17	SENT_11	[p1l2045t1863r2148b1920],
17	same	JJ	O	same	_	0	SENT_11	[p1l10t1971r187b2014],
18	in	IN	O	in	_	0	SENT_11	[p1l228t1957r277b2013],
19	bilateral	JJ	O	bilateral	amod	22	SENT_11	[p1l319t1957r853b2014],
20	—	NN	O	—	nn	22	SENT_11	[p1l319t1957r853b2014],
21	disease	NN	O	disease	nn	22	SENT_11	[p1l319t1957r853b2014],
22	cases	NNS	O	case	prep_in	17	SENT_11	[p1l891t1971r1082b2014],
23	and	CC	O	and	_	0	SENT_11	[p1l1120t1957r1235b2014],
24	controls	NNS	O	control	prep_in	17	SENT_11	[p1l1276t1957r1553b2024],
25	,	,	O	,	_	0	SENT_11	[p1l1276t1957r1553b2024],
26	and	CC	O	and	_	0	SENT_11	[p1l1595t1957r1711b2014],
27	both	DT	O	both	det	28	SENT_11	[p1l1752t1957r1890b2014],
28	groups	NNS	O	group	nsubjpass	31	SENT_11	[p1l1928t1965r2148b2029],
29	had	VBD	O	have	aux	31	SENT_11	[p1l12t2051r125b2108],
30	been	VBN	O	be	auxpass	31	SENT_11	[p1l168t2051r322b2108],
31	followed	VBN	O	follow	conj_and	17	SENT_11	[p1l361t2050r628b2108],
32	up	RP	O	up	prt	31	SENT_11	[p1l671t2064r746b2121],
33	for	IN	O	for	_	0	SENT_11	[p1l783t2050r871b2108],
34	the	DT	O	the	det	36	SENT_11	[p1l904t2051r1007b2108],
35	same	JJ	O	same	amod	36	SENT_11	[p1l1047t2064r1224b2108],
36	time	NN	O	time	prep_for	31	SENT_11	[p1l1261t2051r1403b2108],
37	for	IN	O	for	_	0	SENT_11	[p1l1440t2050r1528b2108],
38	a	DT	DURATION	a	det	42	SENT_11	[p1l1564t2064r1598b2108],
39	second	JJ	DURATION	second	amod	42	SENT_11	[p1l1640t2051r1871b2108],
40	primary	JJ	O	primary	amod	42	SENT_11	[p1l1915t2051r2152b2122],
41	breast	NN	O	breast	nn	42	SENT_11	[p1l11t2145r216b2202],
42	cancer	NN	O	cancer	prep_for	36	SENT_11	[p1l254t2159r486b2202],
43	.	.	O	.	_	0	SENT_11	[p1l254t2159r486b2202],

1	History	NN	O	history	nsubjpass	10	SENT_12	[p1l534t2145r756b2216],
2	of	IN	O	of	_	0	SENT_12	[p1l793t2144r856b2202],
3	tamoxifen	NN	O	tamoxifen	nn	4	SENT_12	[p1l889t2144r1207b2202],
4	use	NN	O	use	prep_of	1	SENT_12	[p1l1251t2159r1365b2202],
5	for	IN	O	for	_	0	SENT_12	[p1l1403t2144r1491b2202],
6	first	JJ	ORDINAL	first	amod	8	SENT_12	[p1l1525t2144r1653b2202],
7	breast	NN	O	breast	nn	8	SENT_12	[p1l1692t2145r1897b2202],
8	cancer	NN	O	cancer	prep_for	4	SENT_12	[p1l1934t2159r2152b2202],
9	was	VBD	O	be	auxpass	10	SENT_12	[p1l7t2252r134b2296],
10	obtained	VBN	O	obtain	_	0	SENT_12	[p1l162t2239r442b2296],
11	by	IN	O	by	_	0	SENT_12	[p1l472t2239r541b2309],
12	interview	NN	O	interview	agent	10	SENT_12	[p1l569t2239r869b2305],
13	,	,	O	,	_	0	SENT_12	[p1l569t2239r869b2305],
14	or	CC	O	or	_	0	SENT_12	[p1l899t2252r963b2296],
15	by	IN	O	by	_	0	SENT_12	[p1l988t2239r1057b2309],
16	self-administered	JJ	O	self-administered	amod	17	SENT_12	[p1l1082t2239r1640b2296],
17	questionnaire	NN	O	questionnaire	conj_or	12	SENT_12	[p1l1670t2239r2133b2308],
18	.	.	O	.	_	0	SENT_12	[p1l1670t2239r2133b2308],

1	Findings	NNS	O	finding	nsubj	19	SENT_13	[p1l11t2427r301b2499],
2	The	DT	O	the	det	5	SENT_13	[p1l339t2428r461b2485],
3	multivariate	JJ	O	multivariate	amod	5	SENT_13	[p1l505t2428r900b2485],
4	odds	NNS	O	odds	nn	5	SENT_13	[p1l942t2428r1106b2485],
5	ratio	NN	O	ratio	nsubj	10	SENT_13	[p1l1150t2428r1296b2485],
6	for	IN	O	for	_	0	SENT_13	[p1l1335t2427r1427b2485],
7	contralateral	JJ	O	contralateral	amod	9	SENT_13	[p1l1464t2428r1890b2485],
8	breast	NN	O	breast	nn	9	SENT_13	[p1l1935t2428r2151b2485],
9	cancer	NN	O	cancer	prep_for	5	SENT_13	[p1l9t2535r238b2579],
10	associated	VBN	O	associate	rcmod	1	SENT_13	[p1l287t2522r659b2579],
11	with	IN	O	with	_	0	SENT_13	[p1l712t2522r846b2579],
12	tamoxifen	NN	O	tamoxifen	nn	13	SENT_13	[p1l898t2522r1233b2579],
13	use	NN	O	use	prep_with	10	SENT_13	[p1l1290t2535r1410b2579],
14	was	VBD	O	be	cop	19	SENT_13	[p1l1461t2535r1594b2579],
15	0-50	CD	PERCENT	0-50	num	19	SENT_13	[p1l1647t2522r1809b2579],
16	(	CD	PERCENT	(	number	17	SENT_13	[p1l1862t2522r2032b2592],
17	95	CD	PERCENT	95	dep	18	SENT_13	[p1l1862t2522r2032b2592],
18	%	NN	PERCENT	%	dep	19	SENT_13	[p1l1862t2522r2032b2592],
19	Cl	NN	O	cl	_	0	SENT_13	[p1l2084t2522r2145b2579],
20	O-28-0-89	NN	O	o-28-0-89	nn	21	SENT_13	[p1l10t2614r421b2685],
21	)	NN	O	)	dep	19	SENT_13	[p1l10t2614r421b2685],
22	.	.	O	.	_	0	SENT_13	[p1l10t2614r421b2685],

1	Tamoxifen	NN	O	tamoxifen	nsubj	2	SENT_14	[p1l454t2614r803b2672],
2	protected	VBD	O	protect	_	0	SENT_14	[p1l840t2615r1158b2685],
3	against	IN	O	against	_	0	SENT_14	[p1l1192t2615r1443b2686],
4	contralateral	JJ	O	contralateral	amod	6	SENT_14	[p1l1472t2615r1898b2672],
5	breast	NN	O	breast	nn	6	SENT_14	[p1l1935t2615r2151b2672],
6	cancer	NN	O	cancer	prep_against	2	SENT_14	[p1l9t2722r238b2766],
7	for	IN	O	for	_	0	SENT_14	[p1l262t2708r354b2766],
8	carriers	NNS	O	carrier	prep_for	6	SENT_14	[p1l380t2709r635b2766],
9	of	IN	O	of	_	0	SENT_14	[p1l665t2708r732b2766],
10	BRCA1	NN	O	brca1	nn	11	SENT_14	[p1l757t2709r987b2766],
11	mutations	NNS	O	mutation	prep_of	8	SENT_14	[p1l1019t2709r1360b2766],
12	(	VBP	O	(	dep	2	SENT_14	[p1l1390t2709r1578b2778],
13	odds	NNS	O	odds	dobj	12	SENT_14	[p1l1390t2709r1578b2778],
14	ratio	NN	O	ratio	nsubj	12	SENT_14	[p1l1610t2709r1757b2766],
15	0-38	CD	NUMBER	0-38	num	14	SENT_14	[p1l1788t2709r1969b2775],
16	,	,	O	,	_	0	SENT_14	[p1l1788t2709r1969b2775],
17	95	CD	PERCENT	95	num	18	SENT_14	[p1l2003t2709r2150b2766],
18	%	NN	PERCENT	%	appos	14	SENT_14	[p1l2003t2709r2150b2766],
19	Cl	NN	O	cl	nn	21	SENT_14	[p1l10t2802r71b2859],
20	O-19-0-74	NN	O	o-19-0-74	nn	21	SENT_14	[p1l120t2802r511b2872],
21	)	NN	O	)	dep	18	SENT_14	[p1l120t2802r511b2872],
22	and	CC	O	and	_	0	SENT_14	[p1l557t2802r678b2859],
23	for	IN	O	for	mark	28	SENT_14	[p1l724t2802r816b2859],
24	those	DT	O	those	nsubj	28	SENT_14	[p1l856t2802r1048b2859],
25	with	IN	O	with	_	0	SENT_14	[p1l1092t2802r1226b2859],
26	BRCA2	NN	O	brca2	nn	27	SENT_14	[p1l1274t2802r1504b2859],
27	mutations	NNS	O	mutation	prep_with	24	SENT_14	[p1l1554t2802r1894b2859],
28	(	VBP	O	(	conj_and	12	SENT_14	[p1l1941t2802r2145b2872],
29	O-63	NN	O	o-63	nn	32	SENT_14	[p1l1941t2802r2145b2872],
30	,	,	O	,	_	0	SENT_14	[p1l1941t2802r2145b2872],
31	O-20-1-50	NN	O	o-20-1-50	dep	32	SENT_14	[p1l10t2894r421b2965],
32	)	NN	O	)	dobj	28	SENT_14	[p1l10t2894r421b2965],
33	.	.	O	.	_	0	SENT_14	[p1l10t2894r421b2965],

1	In	IN	O	in	_	0	SENT_15	[p1l458t2895r510b2951],
2	women	NNS	O	woman	prep_in	17	SENT_15	[p1l540t2908r781b2952],
3	who	WP	O	who	nsubj	4	SENT_15	[p1l810t2895r946b2952],
4	used	VBD	O	use	rcmod	2	SENT_15	[p1l978t2895r1139b2952],
5	tamoxifen	NN	O	tamoxifen	dobj	4	SENT_15	[p1l1167t2894r1502b2952],
6	for	IN	O	for	_	0	SENT_15	[p1l1531t2894r1624b2952],
7	2-4	CD	NUMBER	2-4	num	8	SENT_15	[p1l1650t2894r1780b2951],
8	years	NNS	NUMBER	year	prep_for	4	SENT_15	[p1l1807t2908r2009b2966],
9	,	,	O	,	_	0	SENT_15	[p1l1807t2908r2009b2966],
10	the	DT	O	the	det	11	SENT_15	[p1l2040t2895r2148b2952],
11	risk	NN	O	risk	nsubjpass	17	SENT_15	[p1l12t2989r132b3046],
12	of	IN	O	of	_	0	SENT_15	[p1l175t2988r241b3046],
13	contralateral	JJ	O	contralateral	amod	15	SENT_15	[p1l280t2989r706b3046],
14	breast	NN	O	breast	nn	15	SENT_15	[p1l756t2989r972b3046],
15	cancer	NN	O	cancer	prep_of	11	SENT_15	[p1l1014t3003r1243b3046],
16	was	VBD	O	be	auxpass	17	SENT_15	[p1l1282t3003r1416b3046],
17	reduced	VBN	O	reduce	_	0	SENT_15	[p1l1464t2989r1732b3046],
18	by	IN	O	by	_	0	SENT_15	[p1l1781t2989r1853b3060],
19	75	CD	PERCENT	75	num	20	SENT_15	[p1l1897t2989r2060b3046],
20	%	NN	PERCENT	%	agent	17	SENT_15	[p1l1897t2989r2060b3046],
21	.	.	O	.	_	0	SENT_15	[p1l1897t2989r2060b3046],

1	A	DT	O	a	det	2	SENT_16	[p1l2107t2989r2151b3045],
2	reduction	NN	O	reduction	nsubjpass	10	SENT_16	[p1l12t3083r324b3140],
3	in	IN	O	in	_	0	SENT_16	[p1l369t3083r420b3139],
4	risk	NN	O	risk	prep_in	2	SENT_16	[p1l465t3083r585b3140],
5	of	IN	O	of	_	0	SENT_16	[p1l623t3083r689b3140],
6	contralateral	JJ	O	contralateral	amod	7	SENT_16	[p1l723t3083r1149b3140],
7	cancer	NN	O	cancer	prep_of	4	SENT_16	[p1l1192t3097r1421b3140],
8	was	VBD	O	be	auxpass	10	SENT_16	[p1l1455t3097r1589b3140],
9	also	RB	O	also	advmod	10	SENT_16	[p1l1629t3083r1769b3140],
10	seen	VBN	O	see	_	0	SENT_16	[p1l1810t3097r1972b3140],
11	with	IN	O	with	_	0	SENT_16	[p1l2012t3083r2146b3140],
12	oophorectomy	NN	O	oophorectomy	nn	14	SENT_16	[p1l10t3177r495b3248],
13	(	CD	NUMBER	(	num	14	SENT_16	[p1l556t3176r760b3247],
14	O-42	NN	O	o-42	prep_with	10	SENT_16	[p1l556t3176r760b3247],
15	,	,	O	,	_	0	SENT_16	[p1l556t3176r760b3247],
16	O-22-0-83	NN	O	o-22-0-83	nn	17	SENT_16	[p1l827t3176r1218b3247],
17	)	NN	O	)	prep_with	10	SENT_16	[p1l827t3176r1218b3247],
18	and	CC	O	and	_	0	SENT_16	[p1l1282t3177r1403b3234],
19	with	IN	O	with	prep_with	10	SENT_16	[p1l1466t3177r1601b3234],
20	chemotherapy	NN	O	chemotherapy	nn	22	SENT_16	[p1l1666t3177r2152b3248],
21	(	CD	NUMBER	(	num	22	SENT_16	[p1l10t3271r215b3340],
22	O-40	NN	O	o-40	pobj	19	SENT_16	[p1l10t3271r215b3340],
23	,	,	O	,	_	0	SENT_16	[p1l10t3271r215b3340],
24	O-26-0-60	NN	O	o-26-0-60	nn	25	SENT_16	[p1l247t3271r659b3340],
25	)	NN	O	)	conj_and	14	SENT_16	[p1l247t3271r659b3340],
26	.	.	O	.	_	0	SENT_16	[p1l247t3271r659b3340],

1	Interpretation	NNP	O	Interpretation	nn	3	SENT_17	[p1l11t3459r492b3529],
2	Tamoxifen	NN	O	tamoxifen	nn	3	SENT_17	[p1l519t3459r867b3516],
3	use	NN	O	use	nsubj	4	SENT_17	[p1l900t3473r1020b3516],
4	reduces	VBZ	O	reduce	_	0	SENT_17	[p1l1051t3460r1319b3516],
5	the	DT	O	the	det	6	SENT_17	[p1l1345t3460r1453b3516],
6	risk	NN	O	risk	dobj	4	SENT_17	[p1l1484t3460r1604b3516],
7	of	IN	O	of	_	0	SENT_17	[p1l1630t3459r1697b3516],
8	contralateral	JJ	O	contralateral	amod	10	SENT_17	[p1l1719t3460r2145b3516],
9	breast	NN	O	breast	nn	10	SENT_17	[p1l11t3553r227b3610],
10	cancer	NN	O	cancer	prep_of	6	SENT_17	[p1l273t3567r502b3610],
11	in	IN	O	in	_	0	SENT_17	[p1l549t3553r601b3609],
12	women	NNS	O	woman	prep_in	10	SENT_17	[p1l649t3567r891b3610],
13	with	IN	O	with	_	0	SENT_17	[p1l939t3553r1074b3610],
14	pathogenic	JJ	O	pathogenic	amod	15	SENT_17	[p1l1127t3553r1499b3625],
15	mutations	NNS	O	mutation	prep_with	12	SENT_17	[p1l1549t3553r1889b3610],
16	in	IN	O	in	_	0	SENT_17	[p1l1941t3553r1992b3609],
17	the	DT	O	the	det	21	SENT_17	[p1l2040t3553r2148b3610],
18	BRCA1	NN	O	brca1	nn	21	SENT_17	[p1l10t3648r240b3704],
19	or	CC	O	or	_	0	SENT_17	[p1l289t3661r355b3704],
20	BRCA2	NN	O	brca2	conj_or	18	SENT_17	[p1l400t3647r632b3704],
21	gene	NN	O	gene	prep_in	15	SENT_17	[p1l677t3655r862b3719],
22	.	.	O	.	_	0	SENT_17	[p1l677t3655r862b3719],

1	The	DT	O	the	det	3	SENT_18	[p1l912t3647r1034b3704],
2	protective	JJ	O	protective	amod	3	SENT_18	[p1l1086t3647r1417b3717],
3	effect	NN	O	effect	nsubj	7	SENT_18	[p1l1465t3647r1659b3704],
4	of	IN	O	of	_	0	SENT_18	[p1l1705t3647r1771b3704],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_18	[p1l1811t3647r2146b3704],
6	seems	VBZ	O	seem	cop	7	SENT_18	[p1l10t3755r238b3799],
7	independent	JJ	O	independent	_	0	SENT_18	[p1l270t3742r695b3812],
8	of	IN	O	of	_	0	SENT_18	[p1l721t3741r788b3799],
9	that	DT	O	that	prep_of	7	SENT_18	[p1l808t3742r945b3799],
10	of	IN	O	of	_	0	SENT_18	[p1l971t3741r1038b3799],
11	oophorectomy	NN	O	oophorectomy	prep_of	9	SENT_18	[p1l1061t3742r1563b3813],
12	.	.	O	.	_	0	SENT_18	[p1l1061t3742r1563b3813],

1	Lancet	NNP	O	Lancet	_	0	SENT_19	[p2l10t116r238b171],
2	2000	CD	DATE	2000	num	1	SENT_19	[p2l264t114r468b181],
3	;	:	O	;	_	0	SENT_19	[p2l264t114r468b181],
4	356	CD	NUMBER	356	num	6	SENT_19	[p2l499t114r661b171],
5	:	:	O	:	_	0	SENT_19	[p2l499t114r661b171],
6	1876-81	CD	NUMBER	1876-81	dep	1	SENT_19	[p2l695t114r1012b171],

1	*	NN	O	*	nn	2	SENT_20	[p2l14t353r337b404],
2	Members	NNS	O	member	nsubjpass	4	SENT_20	[p2l14t353r337b404],
3	are	VBP	O	be	auxpass	4	SENT_20	[p2l364t365r458b404],
4	listed	VBN	O	list	_	0	SENT_20	[p2l487t353r648b404],
5	on	IN	O	on	_	0	SENT_20	[p2l676t365r746b404],
6	page	NN	O	page	nn	8	SENT_20	[p2l776t360r919b416],
7	1880	NNP	DATE	1880	nn	8	SENT_20	[p2l948t352r1111b404],
8	Centre	NNP	ORGANIZATION	Centre	prep_on	4	SENT_20	[p2l9t449r218b500],
9	for	IN	ORGANIZATION	for	_	0	SENT_20	[p2l242t448r325b500],
10	Research	NNP	ORGANIZATION	Research	prep_for	8	SENT_20	[p2l350t449r640b500],
11	on	IN	ORGANIZATION	on	_	0	SENT_20	[p2l666t461r738b500],
12	Women	NNP	ORGANIZATION	Women	poss	14	SENT_20	[p2l763t449r1055b500],
13	’s	POS	ORGANIZATION	’s	_	0	SENT_20	[p2l763t449r1055b500],
14	Health	NNP	ORGANIZATION	Health	prep_on	4	SENT_20	[p2l1082t449r1302b510],
15	,	,	O	,	_	0	SENT_20	[p2l1082t449r1302b510],
16	Women	NNP	O	Women	poss	19	SENT_20	[p2l1328t449r1620b500],
17	’s	POS	O	’s	_	0	SENT_20	[p2l1328t449r1620b500],
18	College	NNP	O	College	nn	19	SENT_20	[p2l1645t449r1879b512],
19	Hospital	NNP	O	Hospital	appos	14	SENT_20	[p2l11t537r284b598],
20	,	,	O	,	_	0	SENT_20	[p2l11t537r284b598],
21	University	NNP	ORGANIZATION	University	appos	14	SENT_20	[p2l314t537r625b599],
22	of	IN	ORGANIZATION	of	_	0	SENT_20	[p2l648t537r708b587],
23	Toronto	NNP	ORGANIZATION	Toronto	prep_of	21	SENT_20	[p2l728t537r987b598],
24	,	,	O	,	_	0	SENT_20	[p2l728t537r987b598],
25	Toronto	NNP	LOCATION	Toronto	nn	27	SENT_20	[p2l1013t537r1272b598],
26	,	,	O	,	_	0	SENT_20	[p2l1013t537r1272b598],
27	Canada	NNP	LOCATION	Canada	appos	14	SENT_20	[p2l1300t537r1534b587],
28	(	CD	NUMBER	(	number	29	SENT_20	[p2l1560t537r1620b598],
29	8	CD	NUMBER	8	num	32	SENT_20	[p2l1560t537r1620b598],
30	A	DT	O	a	det	32	SENT_20	[p2l1644t537r1682b587],
31	Narod	NN	O	narod	nn	32	SENT_20	[p2l1709t537r1884b587],
32	MD	NN	O	md	dep	27	SENT_20	[p2l1914t550r2002b596],
33	,	,	O	,	_	0	SENT_20	[p2l1914t550r2002b596],
34	P	NN	O	p	appos	14	SENT_20	[p2l11t626r45b675],
35	de	FW	O	de	nn	36	SENT_20	[p2l70t625r141b675],
36	los	FW	O	los	dep	34	SENT_20	[p2l171t626r255b675],
37	Rios	NNP	ORGANIZATION	Rios	nn	39	SENT_20	[p2l285t625r412b675],
38	Msc	NNP	ORGANIZATION	Msc	nn	39	SENT_20	[p2l440t626r574b687],
39	)	NN	O	)	dep	34	SENT_20	[p2l440t626r574b687],
40	;	:	O	;	_	0	SENT_20	[p2l440t626r574b687],
41	CIinTrials	NNS	O	ciintrial	dep	34	SENT_20	[p2l602t625r893b675],
42	BioResearch	NNP	O	BioResearch	nn	48	SENT_20	[p2l921t625r1335b686],
43	,	,	O	,	_	0	SENT_20	[p2l921t625r1335b686],
44	Senneville	NNP	O	Senneville	appos	48	SENT_20	[p2l1361t625r1700b686],
45	,	,	O	,	_	0	SENT_20	[p2l1361t625r1700b686],
46	Canada	NNP	LOCATION	Canada	appos	48	SENT_20	[p2l1729t625r1963b675],
47	(	CD	NUMBER	(	num	48	SENT_20	[p2l10t713r114b775],
48	J	NNP	O	J	dep	41	SENT_20	[p2l10t713r114b775],
49	.	.	O	.	_	0	SENT_20	[p2l10t713r114b775],

1	—	NN	O	—	_	0	SENT_21	[p2l10t713r114b775],
2	.	.	O	.	_	0	SENT_21	[p2l10t713r114b775],

1	S	NN	O	s	dep	223	SENT_22	[p2l10t713r114b775],
2	Brunet	NNP	O	Brunet	dep	223	SENT_22	[p2l143t714r341b764],
3	Msc	NNP	O	Msc	dep	223	SENT_22	[p2l361t714r495b775],
4	)	NN	O	)	dep	223	SENT_22	[p2l361t714r495b775],
5	;	:	O	;	_	0	SENT_22	[p2l361t714r495b775],
6	Epidemiology	NNP	ORGANIZATION	Epidemiology	dep	223	SENT_22	[p2l525t713r940b775],
7	Research	NNP	ORGANIZATION	Research	dep	223	SENT_22	[p2l966t714r1257b764],
8	Unit	NNP	ORGANIZATION	Unit	dep	223	SENT_22	[p2l1285t713r1428b774],
9	,	,	O	,	_	0	SENT_22	[p2l1285t713r1428b774],
10	Centre	NNP	ORGANIZATION	Centre	dep	223	SENT_22	[p2l1456t713r1665b764],
11	Hopital	NNP	ORGANIZATION	Hopital	dep	223	SENT_22	[p2l1692t713r1910b775],
12	de	IN	ORGANIZATION	de	dep	223	SENT_22	[p2l1937t714r2010b764],
13	Université	NNP	ORGANIZATION	Université	dep	223	SENT_22	[p2l10t799r324b851],
14	de	IN	ORGANIZATION	de	dep	223	SENT_22	[p2l349t801r422b851],
15	Montreal	NNP	ORGANIZATION	Montreal	dep	223	SENT_22	[p2l449t801r747b861],
16	,	,	O	,	_	0	SENT_22	[p2l449t801r747b861],
17	Hotel-Dieu	NNP	O	Hotel-Dieu	dep	223	SENT_22	[p2l777t800r1117b861],
18	,	,	O	,	_	0	SENT_22	[p2l777t800r1117b861],
19	Montreal	NNP	LOCATION	Montreal	dep	223	SENT_22	[p2l1147t801r1445b861],
20	,	,	O	,	_	0	SENT_22	[p2l1147t801r1445b861],
21	Canada	NNP	LOCATION	Canada	dep	223	SENT_22	[p2l1473t800r1707b851],
22	(	CD	NUMBER	(	dep	223	SENT_22	[p2l10t890r66b951],
23	P	NN	O	p	dep	223	SENT_22	[p2l10t890r66b951],
24	Ghadirian	JJ	O	ghadirian	dep	223	SENT_22	[p2l92t890r379b940],
25	PhD	NN	O	phd	dep	223	SENT_22	[p2l408t890r535b951],
26	)	NN	O	)	dep	223	SENT_22	[p2l408t890r535b951],
27	;	:	O	;	_	0	SENT_22	[p2l408t890r535b951],
28	Department	NNP	ORGANIZATION	Department	dep	223	SENT_22	[p2l564t890r933b951],
29	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l958t889r1018b940],
30	Human	JJ	ORGANIZATION	human	dep	223	SENT_22	[p2l1041t890r1254b940],
31	Genetics	NNP	ORGANIZATION	Genetics	dep	223	SENT_22	[p2l1280t889r1557b940],
32	and	CC	ORGANIZATION	and	dep	223	SENT_22	[p2l1582t890r1693b940],
33	Medicine	NNP	ORGANIZATION	Medicine	dep	223	SENT_22	[p2l1721t889r2024b950],
34	,	,	O	,	_	0	SENT_22	[p2l1721t889r2024b950],
35	Memorial	NNP	O	Memorial	dep	223	SENT_22	[p2l11t977r300b1029],
36	Sloan-Kettering	NNP	O	Sloan-Kettering	dep	223	SENT_22	[p2l325t977r815b1041],
37	Cancer	NNP	O	Cancer	dep	223	SENT_22	[p2l837t978r1059b1029],
38	Center	NNP	O	Center	dep	223	SENT_22	[p2l1083t978r1310b1039],
39	,	,	O	,	_	0	SENT_22	[p2l1083t978r1310b1039],
40	New	NNP	LOCATION	New	dep	223	SENT_22	[p2l1340t978r1473b1029],
41	York	NNP	LOCATION	York	dep	223	SENT_22	[p2l1495t978r1656b1039],
42	,	,	O	,	_	0	SENT_22	[p2l1495t978r1656b1039],
43	NY	NNP	O	NY	dep	223	SENT_22	[p2l1686t978r1788b1039],
44	,	,	O	,	_	0	SENT_22	[p2l1686t978r1788b1039],
45	USA	NNP	LOCATION	USA	dep	223	SENT_22	[p2l1817t978r1948b1029],
46	(	CD	NUMBER	(	dep	223	SENT_22	[p2l10t1066r81b1127],
47	M	NN	O	m	dep	223	SENT_22	[p2l10t1066r81b1127],
48	Robson	NN	PERSON	robson	dep	223	SENT_22	[p2l113t1066r337b1116],
49	MD	NN	O	md	dep	223	SENT_22	[p2l367t1066r477b1127],
50	)	NN	O	)	dep	223	SENT_22	[p2l367t1066r477b1127],
51	;	:	O	;	_	0	SENT_22	[p2l367t1066r477b1127],
52	Unit	NN	O	unit	dep	223	SENT_22	[p2l507t1066r632b1116],
53	of	IN	O	of	dep	223	SENT_22	[p2l657t1066r717b1116],
54	Medical	JJ	ORGANIZATION	medical	dep	223	SENT_22	[p2l740t1066r985b1116],
55	Genetics	NNP	ORGANIZATION	Genetics	dep	223	SENT_22	[p2l1012t1066r1308b1127],
56	,	,	O	,	_	0	SENT_22	[p2l1012t1066r1308b1127],
57	Norwegian	NNP	O	Norwegian	dep	223	SENT_22	[p2l1337t1066r1665b1128],
58	Radium	NNP	ORGANIZATION	Radium	dep	223	SENT_22	[p2l1694t1066r1925b1116],
59	Hospital	NNP	ORGANIZATION	Hospital	dep	223	SENT_22	[p2l10t1154r284b1216],
60	,	,	O	,	_	0	SENT_22	[p2l10t1154r284b1216],
61	Oslo	NNP	LOCATION	Oslo	dep	223	SENT_22	[p2l312t1154r466b1215],
62	,	,	O	,	_	0	SENT_22	[p2l312t1154r466b1215],
63	Norway	NNP	LOCATION	Norway	dep	223	SENT_22	[p2l496t1155r726b1216],
64	(	CD	NUMBER	(	dep	223	SENT_22	[p2l750t1154r813b1216],
65	K	NNP	O	K	dep	223	SENT_22	[p2l750t1154r813b1216],
66	Heimdal	NNP	O	Heimdal	dep	223	SENT_22	[p2l839t1154r1082b1204],
67	MD	NNP	O	MD	dep	223	SENT_22	[p2l1112t1155r1224b1216],
68	)	NN	O	)	dep	223	SENT_22	[p2l1112t1155r1224b1216],
69	;	:	O	;	_	0	SENT_22	[p2l1112t1155r1224b1216],
70	Department	NNP	ORGANIZATION	Department	dep	223	SENT_22	[p2l1253t1155r1622b1216],
71	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l1647t1154r1707b1204],
72	Medical	NNP	ORGANIZATION	Medical	dep	223	SENT_22	[p2l1730t1154r1975b1204],
73	Informatics	NNP	ORGANIZATION	Informatics	dep	223	SENT_22	[p2l11t1242r382b1303],
74	,	,	O	,	_	0	SENT_22	[p2l11t1242r382b1303],
75	University	NNP	ORGANIZATION	University	dep	223	SENT_22	[p2l412t1242r722b1304],
76	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l746t1242r806b1293],
77	Utah	NNP	ORGANIZATION	Utah	dep	223	SENT_22	[p2l829t1243r992b1303],
78	,	,	O	,	_	0	SENT_22	[p2l829t1243r992b1303],
79	Salt	NNP	LOCATION	Salt	dep	223	SENT_22	[p2l1018t1242r1143b1293],
80	Lake	NNP	LOCATION	Lake	dep	223	SENT_22	[p2l1169t1243r1316b1292],
81	City	NNP	LOCATION	City	dep	223	SENT_22	[p2l1341t1242r1482b1304],
82	,	,	O	,	_	0	SENT_22	[p2l1341t1242r1482b1304],
83	UT	NNP	ORGANIZATION	UT	dep	223	SENT_22	[p2l1511t1243r1610b1303],
84	,	,	O	,	_	0	SENT_22	[p2l1511t1243r1610b1303],
85	USA	NNP	LOCATION	USA	dep	223	SENT_22	[p2l1639t1242r1769b1293],
86	(	CD	NUMBER	(	dep	223	SENT_22	[p2l10t1330r69b1392],
87	S	NN	PERSON	s	dep	223	SENT_22	[p2l10t1330r69b1392],
88	L	NN	PERSON	l	dep	223	SENT_22	[p2l99t1331r128b1380],
89	Neuhausen	NNP	PERSON	Neuhausen	dep	223	SENT_22	[p2l155t1331r497b1381],
90	PhD	NNP	O	PhD	dep	223	SENT_22	[p2l526t1331r652b1392],
91	)	NN	O	)	dep	223	SENT_22	[p2l526t1331r652b1392],
92	;	:	O	;	_	0	SENT_22	[p2l526t1331r652b1392],
93	lnstitut	NN	O	lnstitut	dep	223	SENT_22	[p2l683t1330r909b1381],
94	Curie	NNP	PERSON	Curie	dep	223	SENT_22	[p2l934t1330r1115b1391],
95	,	,	O	,	_	0	SENT_22	[p2l934t1330r1115b1391],
96	Paris	NNP	LOCATION	Paris	dep	223	SENT_22	[p2l1145t1330r1318b1391],
97	,	,	O	,	_	0	SENT_22	[p2l1145t1330r1318b1391],
98	France	NNP	LOCATION	France	dep	223	SENT_22	[p2l1347t1331r1557b1381],
99	(	NN	O	(	dep	223	SENT_22	[p2l10t1419r73b1481],
100	D	NN	O	d	dep	223	SENT_22	[p2l10t1419r73b1481],
101	Stoppa-Lyonnet	NN	O	stoppa-lyonnet	dep	223	SENT_22	[p2l99t1419r572b1482],
102	MD	NN	O	md	dep	223	SENT_22	[p2l598t1419r709b1481],
103	)	NN	O	)	dep	223	SENT_22	[p2l598t1419r709b1481],
104	;	:	O	;	_	0	SENT_22	[p2l598t1419r709b1481],
105	Lombardi	NNP	ORGANIZATION	Lombardi	dep	223	SENT_22	[p2l739t1418r1021b1469],
106	Cancer	NNP	ORGANIZATION	Cancer	dep	223	SENT_22	[p2l1047t1418r1269b1469],
107	Center	NNP	ORGANIZATION	Center	dep	223	SENT_22	[p2l1293t1418r1520b1480],
108	,	,	O	,	_	0	SENT_22	[p2l1293t1418r1520b1480],
109	Georgetown	NNP	ORGANIZATION	Georgetown	dep	223	SENT_22	[p2l1548t1418r1925b1481],
110	University	NNP	ORGANIZATION	University	dep	223	SENT_22	[p2l10t1507r321b1570],
111	Medical	NNP	ORGANIZATION	Medical	dep	223	SENT_22	[p2l347t1507r592b1559],
112	Center	NNP	ORGANIZATION	Center	dep	223	SENT_22	[p2l619t1508r846b1569],
113	,	,	O	,	_	0	SENT_22	[p2l619t1508r846b1569],
114	Washington	NNP	LOCATION	Washington	dep	223	SENT_22	[p2l873t1507r1245b1571],
115	DC	NNP	LOCATION	DC	dep	223	SENT_22	[p2l1273t1508r1379b1569],
116	,	,	O	,	_	0	SENT_22	[p2l1273t1508r1379b1569],
117	USA	NNP	LOCATION	USA	dep	223	SENT_22	[p2l1409t1508r1539b1559],
118	(	CD	NUMBER	(	dep	223	SENT_22	[p2l1564t1508r1623b1570],
119	C	NN	PERSON	c	dep	223	SENT_22	[p2l1564t1508r1623b1570],
120	Lerman	NNP	PERSON	Lerman	dep	223	SENT_22	[p2l1653t1508r1874b1559],
121	PhD	NNP	O	PhD	dep	223	SENT_22	[p2l1903t1508r2030b1570],
122	)	NN	O	)	dep	223	SENT_22	[p2l1903t1508r2030b1570],
123	;	:	O	;	_	0	SENT_22	[p2l1903t1508r2030b1570],
124	Istituto	NNP	ORGANIZATION	Istituto	dep	223	SENT_22	[p2l11t1596r238b1646],
125	Nazionale	NNP	ORGANIZATION	Nazionale	dep	223	SENT_22	[p2l265t1596r564b1646],
126	Tumori	NNP	ORGANIZATION	Tumori	dep	223	SENT_22	[p2l588t1596r819b1657],
127	,	,	O	,	_	0	SENT_22	[p2l588t1596r819b1657],
128	Milan	NNP	LOCATION	Milan	dep	223	SENT_22	[p2l849t1596r1038b1657],
129	,	,	O	,	_	0	SENT_22	[p2l849t1596r1038b1657],
130	Italy	NNP	LOCATION	Italy	dep	223	SENT_22	[p2l1068t1596r1202b1658],
131	(	NN	O	(	dep	223	SENT_22	[p2l1227t1596r1286b1657],
132	B	NN	PERSON	b	dep	223	SENT_22	[p2l1227t1596r1286b1657],
133	Pasini	NNP	PERSON	Pasini	dep	223	SENT_22	[p2l1314t1596r1492b1646],
134	MD	NNP	O	MD	dep	223	SENT_22	[p2l1522t1596r1633b1657],
135	)	NN	O	)	dep	223	SENT_22	[p2l1522t1596r1633b1657],
136	;	:	O	;	_	0	SENT_22	[p2l1522t1596r1633b1657],
137	Departments	NNP	O	Departments	dep	223	SENT_22	[p2l1663t1596r2067b1657],
138	of	IN	O	of	dep	223	SENT_22	[p2l2092t1596r2152b1646],
139	Medicine	NNP	MISC	Medicine	dep	223	SENT_22	[p2l11t1684r296b1734],
140	and	CC	O	and	dep	223	SENT_22	[p2l321t1684r431b1734],
141	Genetics	NNP	O	Genetics	dep	223	SENT_22	[p2l457t1684r753b1745],
142	,	,	O	,	_	0	SENT_22	[p2l457t1684r753b1745],
143	University	NNP	ORGANIZATION	University	dep	223	SENT_22	[p2l782t1684r1093b1746],
144	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l1117t1684r1176b1734],
145	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	dep	223	SENT_22	[p2l1200t1684r1627b1746],
146	,	,	O	,	_	0	SENT_22	[p2l1200t1684r1627b1746],
147	Philadelphia	NNP	LOCATION	Philadelphia	dep	223	SENT_22	[p2l1656t1684r2055b1746],
148	,	,	O	,	_	0	SENT_22	[p2l1656t1684r2055b1746],
149	PA	NN	ORGANIZATION	pa	dep	223	SENT_22	[p2l11t1773r113b1833],
150	,	,	O	,	_	0	SENT_22	[p2l11t1773r113b1833],
151	USA	NNP	LOCATION	USA	dep	223	SENT_22	[p2l142t1772r273b1823],
152	(	CD	NUMBER	(	dep	223	SENT_22	[p2l298t1773r357b1834],
153	B	NN	PERSON	b	dep	223	SENT_22	[p2l298t1773r357b1834],
154	Weber	NNP	PERSON	Weber	dep	223	SENT_22	[p2l382t1773r578b1823],
155	MD	NNP	O	MD	dep	223	SENT_22	[p2l602t1773r713b1834],
156	)	NN	O	)	dep	223	SENT_22	[p2l602t1773r713b1834],
157	;	:	O	;	_	0	SENT_22	[p2l602t1773r713b1834],
158	and	CC	O	and	dep	223	SENT_22	[p2l741t1773r850b1822],
159	Department	NNP	ORGANIZATION	Department	dep	223	SENT_22	[p2l879t1773r1248b1834],
160	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l1272t1772r1332b1822],
161	Preventive	NNP	ORGANIZATION	Preventive	dep	223	SENT_22	[p2l1356t1772r1685b1823],
162	Medicine	NNP	ORGANIZATION	Medicine	dep	223	SENT_22	[p2l1712t1772r1997b1823],
163	and	CC	ORGANIZATION	and	dep	223	SENT_22	[p2l2022t1773r2132b1823],
164	Public	NNP	ORGANIZATION	Public	dep	223	SENT_22	[p2l11t1860r200b1911],
165	Health	NNP	ORGANIZATION	Health	dep	223	SENT_22	[p2l228t1861r448b1921],
166	,	,	O	,	_	0	SENT_22	[p2l228t1861r448b1921],
167	Creighton	NNP	ORGANIZATION	Creighton	dep	223	SENT_22	[p2l476t1860r780b1922],
168	University	NNP	ORGANIZATION	University	dep	223	SENT_22	[p2l807t1860r1118b1922],
169	School	NNP	ORGANIZATION	School	dep	223	SENT_22	[p2l1141t1860r1351b1911],
170	of	IN	ORGANIZATION	of	dep	223	SENT_22	[p2l1378t1860r1437b1911],
171	Medicine	NNP	ORGANIZATION	Medicine	dep	223	SENT_22	[p2l1461t1860r1764b1921],
172	,	,	O	,	_	0	SENT_22	[p2l1461t1860r1764b1921],
173	Omaha	NNP	LOCATION	Omaha	dep	223	SENT_22	[p2l1792t1860r2026b1921],
174	,	,	O	,	_	0	SENT_22	[p2l1792t1860r2026b1921],
175	NE	NN	O	ne	dep	223	SENT_22	[p2l11t1949r112b2010],
176	,	,	O	,	_	0	SENT_22	[p2l11t1949r112b2010],
177	USA	NNP	LOCATION	USA	dep	223	SENT_22	[p2l141t1949r271b2000],
178	(	CD	NUMBER	(	dep	223	SENT_22	[p2l296t1949r491b2012],
179	Henry	NNP	PERSON	Henry	dep	223	SENT_22	[p2l296t1949r491b2012],
180	Lynch	NNP	PERSON	Lynch	dep	223	SENT_22	[p2l517t1949r683b2012],
181	MD	NN	O	md	dep	223	SENT_22	[p2l713t1949r804b2011],
182	)	CD	NUMBER	)	dep	223	SENT_22	[p2l713t1949r804b2011],
183	Correspondence	NN	O	correspondence	dep	223	SENT_22	[p2l9t2045r519b2106],
184	to	TO	O	to	dep	223	SENT_22	[p2l542t2046r624b2095],
185	:	:	O	:	_	0	SENT_22	[p2l542t2046r624b2095],
186	Dr	NNP	O	Dr	dep	223	SENT_22	[p2l655t2045r719b2094],
187	Steven	NNP	PERSON	Steven	dep	223	SENT_22	[p2l743t2045r948b2095],
188	Narod	NNP	PERSON	Narod	dep	223	SENT_22	[p2l979t2045r1174b2103],
189	,	,	O	,	_	0	SENT_22	[p2l979t2045r1174b2103],
190	Centre	NNP	ORGANIZATION	Centre	dep	223	SENT_22	[p2l1204t2045r1402b2095],
191	for	IN	ORGANIZATION	for	dep	223	SENT_22	[p2l1427t2044r1510b2095],
192	Research	NNP	ORGANIZATION	Research	dep	223	SENT_22	[p2l1536t2045r1816b2095],
193	on	IN	ORGANIZATION	on	dep	223	SENT_22	[p2l1845t2057r1914b2095],
194	Women	NNP	ORGANIZATION	Women	dep	223	SENT_22	[p2l7t2132r293b2183],
195	’s	POS	ORGANIZATION	’s	dep	223	SENT_22	[p2l7t2132r293b2183],
196	Health	NNP	ORGANIZATION	Health	dep	223	SENT_22	[p2l323t2132r534b2191],
197	,	,	O	,	_	0	SENT_22	[p2l323t2132r534b2191],
198	Women	NNP	O	Women	dep	223	SENT_22	[p2l562t2132r848b2182],
199	’s	POS	O	’s	dep	223	SENT_22	[p2l562t2132r848b2182],
200	College	NNP	O	College	dep	223	SENT_22	[p2l875t2132r1098b2196],
201	Hospital	NNP	O	Hospital	dep	223	SENT_22	[p2l1127t2132r1393b2194],
202	,	,	O	,	_	0	SENT_22	[p2l1127t2132r1393b2194],
203	790	CD	NUMBER	790	dep	223	SENT_22	[p2l1424t2132r1545b2183],
204	Bay	NNP	LOCATION	Bay	dep	223	SENT_22	[p2l1574t2132r1681b2195],
205	Street	NNP	LOCATION	Street	dep	223	SENT_22	[p2l1705t2132r1906b2191],
206	,	,	O	,	_	0	SENT_22	[p2l1705t2132r1906b2191],
207	Room	NNP	O	Room	dep	223	SENT_22	[p2l12t2222r181b2271],
208	750a	NNP	O	750a	dep	223	SENT_22	[p2l212t2221r388b2280],
209	,	,	O	,	_	0	SENT_22	[p2l212t2221r388b2280],
210	Toronto	NNP	LOCATION	Toronto	dep	223	SENT_22	[p2l416t2222r665b2280],
211	,	,	O	,	_	0	SENT_22	[p2l416t2222r665b2280],
212	Ontario	NNP	LOCATION	Ontario	dep	223	SENT_22	[p2l695t2221r932b2280],
213	,	,	O	,	_	0	SENT_22	[p2l695t2221r932b2280],
214	Canada	NNP	LOCATION	Canada	dep	223	SENT_22	[p2l961t2221r1190b2271],
215	M5G	NN	O	m5g	dep	223	SENT_22	[p2l1221t2221r1359b2271],
216	1N8	NN	O	1n8	dep	223	SENT_22	[p2l1389t2221r1514b2271],
217	(	CD	NUMBER	(	dep	223	SENT_22	[p2l10t2311r228b2372],
218	e	SYM	O	e	dep	223	SENT_22	[p2l10t2311r228b2372],
219	—	CD	NUMBER	—	dep	223	SENT_22	[p2l10t2311r228b2372],
220	mail	NN	O	mail	dep	223	SENT_22	[p2l10t2311r228b2372],
221	:	:	O	:	_	0	SENT_22	[p2l10t2311r228b2372],
222	steven.narod@swchsc.on.ca	NN	O	steven.narod@swchsc.on.ca	dep	223	SENT_22	[p2l258t2310r1151b2372],
223	)	NN	O	)	_	0	SENT_22	[p2l258t2310r1151b2372],

1	Introduction	NN	O	introduction	nsubjpass	12	SENT_23	[p2l10t2541r556b2609],
2	Many	JJ	O	many	amod	5	SENT_23	[p2l7t2643r220b2717],
3	familial	JJ	O	familial	amod	5	SENT_23	[p2l249t2641r516b2702],
4	breast	NN	O	breast	nn	5	SENT_23	[p2l546t2642r764b2702],
5	cancers	NNS	O	cancer	dep	1	SENT_23	[p2l797t2661r1061b2702],
6	are	VBP	O	be	cop	7	SENT_23	[p2l1096t2661r1201b2702],
7	hereditary	JJ	O	hereditary	_	0	SENT_23	[p2l1232t2642r1619b2718],
8	,	,	O	,	_	0	SENT_23	[p2l1232t2642r1619b2718],
9	and	CC	O	and	_	0	SENT_23	[p2l1655t2642r1787b2702],
10	might	MD	O	might	aux	12	SENT_23	[p2l1818t2642r2029b2718],
11	be	VB	O	be	auxpass	12	SENT_23	[p2l2058t2642r2142b2702],
12	associated	VBN	O	associate	conj_and	7	SENT_23	[p2l9t2735r374b2795],
13	with	IN	O	with	_	0	SENT_23	[p2l429t2735r588b2795],
14	germline	NN	O	germline	nn	15	SENT_23	[p2l644t2735r959b2811],
15	mutations	NNS	O	mutation	prep_with	12	SENT_23	[p2l1017t2735r1379b2795],
16	in	IN	O	in	_	0	SENT_23	[p2l1438t2735r1506b2794],
17	the	DT	O	the	det	21	SENT_23	[p2l1563t2735r1673b2795],
18	BRCA1	NN	O	brca1	nn	21	SENT_23	[p2l1730t2735r2006b2795],
19	or	CC	O	or	_	0	SENT_23	[p2l2070t2754r2145b2795],
20	BRCA2	NN	O	brca2	conj_or	18	SENT_23	[p2l6t2827r288b2888],
21	gene	NN	O	gene	prep_in	15	SENT_23	[p2l314t2828r562b2903],
22	.	.	O	.	_	0	SENT_23	[p2l314t2828r562b2903],

1	”	NN	O	”	nn	2	SENT_24	[p2l314t2828r562b2903],
2	Breast	NN	O	breast	nsubj	13	SENT_24	[p2l590t2828r817b2888],
3	and	CC	O	and	_	0	SENT_24	[p2l844t2827r976b2888],
4	ovarian	JJ	O	ovarian	amod	5	SENT_24	[p2l1004t2827r1268b2888],
5	cancers	NNS	O	cancer	nsubj	13	SENT_24	[p2l1296t2847r1561b2888],
6	in	IN	O	in	_	0	SENT_24	[p2l1589t2827r1658b2887],
7	families	NNS	O	family	prep_in	5	SENT_24	[p2l1684t2827r1958b2888],
8	with	IN	O	with	_	0	SENT_24	[p2l1985t2827r2143b2888],
9	several	JJ	O	several	amod	11	SENT_24	[p2l9t2920r250b2981],
10	affected	JJ	O	affected	amod	11	SENT_24	[p2l290t2920r572b2981],
11	members	NNS	O	member	prep_with	7	SENT_24	[p2l609t2920r941b2981],
12	are	VBP	O	be	cop	13	SENT_24	[p2l982t2940r1088b2981],
13	likely	JJ	O	likely	_	0	SENT_24	[p2l1126t2920r1315b2996],
14	to	TO	O	to	aux	16	SENT_24	[p2l1351t2935r1420b2981],
15	be	VB	O	be	cop	16	SENT_24	[p2l1458t2920r1542b2981],
16	hereditary	JJ	O	hereditary	xcomp	13	SENT_24	[p2l1580t2920r2028b2996],
17	.	.	O	.	_	0	SENT_24	[p2l1580t2920r2028b2996],

1	”	NN	O	”	npadvmod	21	SENT_25	[p2l1580t2920r2028b2996],
2	In	IN	O	in	_	0	SENT_25	[p2l2066t2922r2143b2980],
3	such	JJ	O	such	amod	4	SENT_25	[p2l9t3014r173b3074],
4	families	NNS	O	family	prep_in	21	SENT_25	[p2l207t3014r483b3074],
5	in	IN	O	in	_	0	SENT_25	[p2l520t3014r588b3073],
6	women	NNS	O	woman	prep_in	4	SENT_25	[p2l621t3033r888b3074],
7	who	WP	O	who	nsubj	8	SENT_25	[p2l921t3014r1072b3074],
8	carry	VBP	O	carry	rcmod	6	SENT_25	[p2l1111t3033r1291b3090],
9	deleterious	JJ	O	deleterious	amod	10	SENT_25	[p2l1325t3014r1716b3074],
10	BRCA1	NN	O	brca1	dobj	8	SENT_25	[p2l1752t3014r2028b3074],
11	or	CC	O	or	_	0	SENT_25	[p2l2070t3033r2145b3074],
12	BRCA2	NN	O	brca2	nn	13	SENT_25	[p2l6t3106r288b3167],
13	mutations	NNS	O	mutation	conj_or	10	SENT_25	[p2l338t3106r700b3167],
14	the	DT	O	the	det	16	SENT_25	[p2l753t3106r864b3167],
15	lifetime	NN	O	lifetime	nn	16	SENT_25	[p2l916t3106r1185b3167],
16	risk	NN	O	risk	nsubjpass	21	SENT_25	[p2l1237t3106r1367b3167],
17	of	IN	O	of	_	0	SENT_25	[p2l1418t3106r1495b3167],
18	breast	NN	O	breast	nn	19	SENT_25	[p2l1535t3106r1753b3167],
19	cancer	NN	O	cancer	prep_of	16	SENT_25	[p2l1805t3126r2041b3167],
20	is	VBZ	O	be	auxpass	21	SENT_25	[p2l2090t3106r2141b3167],
21	estimated	VBN	O	estimate	_	0	SENT_25	[p2l9t3199r356b3260],
22	to	TO	O	to	aux	25	SENT_25	[p2l393t3214r462b3260],
23	be	VB	O	be	cop	25	SENT_25	[p2l499t3199r583b3260],
24	as	RB	O	as	advmod	25	SENT_25	[p2l624t3219r691b3260],
25	high	JJ	O	high	xcomp	21	SENT_25	[p2l728t3199r886b3275],
26	as	IN	O	as	mark	40	SENT_25	[p2l925t3219r992b3260],
27	80	CD	PERCENT	80	num	28	SENT_25	[p2l1033t3200r1243b3272],
28	%	NN	PERCENT	%	nsubj	40	SENT_25	[p2l1033t3200r1243b3272],
29	,2	CD	NUMBER	,2	dep	28	SENT_25	[p2l1033t3200r1243b3272],
30	but	CC	O	but	_	0	SENT_25	[p2l1280t3200r1403b3260],
31	estimates	VBZ	O	estimate	conj_but	29	SENT_25	[p2l1441t3200r1771b3260],
32	based	VBN	O	base	_	0	SENT_25	[p2l1808t3200r2015b3260],
33	on	IN	O	on	prepc_based_on	31	SENT_25	[p2l2053t3219r2143b3260],
34	unselected	JJ	O	unselected	amod	35	SENT_25	[p2l7t3294r390b3354],
35	cases	NNS	O	case	pobj	31	SENT_25	[p2l420t3313r599b3354],
36	of	IN	O	of	_	0	SENT_25	[p2l632t3294r708b3354],
37	breast	NN	O	breast	nn	38	SENT_25	[p2l726t3294r944b3354],
38	cancer	NN	O	cancer	prep_of	35	SENT_25	[p2l974t3313r1209b3354],
39	are	VBP	O	be	cop	40	SENT_25	[p2l1237t3313r1343b3354],
40	lower	JJR	O	lower	advcl	25	SENT_25	[p2l1373t3294r1572b3354],
41	than	IN	O	than	_	0	SENT_25	[p2l1598t3294r1759b3354],
42	80	CD	PERCENT	80	num	43	SENT_25	[p2l1791t3294r2037b3356],
43	%	NN	PERCENT	%	prep_than	40	SENT_25	[p2l1791t3294r2037b3356],
44	.	.	O	.	_	0	SENT_25	[p2l1791t3294r2037b3356],

1	“	NN	O	“	nsubj	25	SENT_26	[p2l1791t3294r2037b3356],
2	In	IN	O	in	_	0	SENT_26	[p2l2066t3295r2143b3353],
3	the	DT	DURATION	the	det	5	SENT_26	[p2l7t3385r118b3446],
4	10	CD	DURATION	10	num	5	SENT_26	[p2l153t3388r232b3446],
5	years	NNS	NUMBER	year	prep_in	25	SENT_26	[p2l258t3405r440b3461],
6	after	IN	O	after	_	0	SENT_26	[p2l468t3385r630b3446],
7	diagnosis	NN	O	diagnosis	prep_after	25	SENT_26	[p2l655t3385r984b3461],
8	of	IN	O	of	_	0	SENT_26	[p2l1013t3385r1090b3446],
9	breast	NN	O	breast	nn	10	SENT_26	[p2l1104t3385r1323b3446],
10	cancer	NN	O	cancer	prep_of	7	SENT_26	[p2l1349t3405r1584b3446],
11	in	IN	O	in	_	0	SENT_26	[p2l1607t3385r1676b3445],
12	a	DT	O	a	det	13	SENT_26	[p2l1703t3405r1738b3446],
13	BRCA1	NN	O	brca1	prep_in	10	SENT_26	[p2l1762t3385r2038b3446],
14	or	CC	O	or	_	0	SENT_26	[p2l2070t3405r2145b3446],
15	BRCA2	NN	O	brca2	nn	17	SENT_26	[p2l6t3478r288b3538],
16	mutation	NN	O	mutation	nn	17	SENT_26	[p2l328t3478r659b3538],
17	carrier	NN	O	carrier	conj_or	13	SENT_26	[p2l702t3478r954b3549],
18	,	,	O	,	_	0	SENT_26	[p2l702t3478r954b3549],
19	the	DT	O	the	det	20	SENT_26	[p2l999t3477r1110b3538],
20	risk	NN	O	risk	nsubj	25	SENT_26	[p2l1152t3477r1282b3538],
21	of	IN	O	of	_	0	SENT_26	[p2l1323t3477r1400b3538],
22	contralateral	JJ	O	contralateral	amod	24	SENT_26	[p2l1433t3477r1885b3538],
23	breast	NN	O	breast	nn	24	SENT_26	[p2l1925t3477r2144b3538],
24	cancer	NN	O	cancer	prep_of	20	SENT_26	[p3l9t37r244b78],
25	is	VBZ	O	be	_	0	SENT_26	[p3l278t18r329b78],
26	about	IN	O	about	_	0	SENT_26	[p3l368t18r573b78],
27	35	CD	PERCENT	35	num	28	SENT_26	[p3l609t18r856b80],
28	%	NN	PERCENT	%	prep_about	25	SENT_26	[p3l609t18r856b80],
29	.	.	O	.	_	0	SENT_26	[p3l609t18r856b80],

1	“	NN	O	“	nn	2	SENT_27	[p3l609t18r856b80],
2	Strategies	NNS	O	strategy	nsubj	13	SENT_27	[p3l895t18r1241b94],
3	for	IN	O	for	_	0	SENT_27	[p3l1278t18r1380b78],
4	reducing	VBG	O	reduce	prepc_for	2	SENT_27	[p3l1413t18r1731b94],
5	the	DT	O	the	det	6	SENT_27	[p3l1764t18r1875b78],
6	risk	NN	O	risk	dobj	4	SENT_27	[p3l1912t18r2041b78],
7	of	IN	O	of	_	0	SENT_27	[p3l2076t18r2153b78],
8	primary	JJ	O	primary	amod	12	SENT_27	[p3l6t110r292b186],
9	and	CC	O	and	_	0	SENT_27	[p3l402t110r534b171],
10	contralateral	JJ	O	contralateral	amod	12	SENT_27	[p3l645t110r1096b171],
11	breast	NN	O	breast	nn	12	SENT_27	[p3l1205t110r1423b171],
12	cancer	NN	O	cancer	prep_of	6	SENT_27	[p3l1535t130r1770b171],
13	include	VBP	O	include	_	0	SENT_27	[p3l1878t110r2142b171],
14	prophylactic	NN	O	prophylactic	nn	15	SENT_27	[p3l6t203r454b279],
15	mastectomy	NN	O	mastectomy	dobj	13	SENT_27	[p3l589t218r1028b279],
16	and	CC	O	and	_	0	SENT_27	[p3l1162t203r1294b264],
17	chemoprevention	NN	O	chemoprevention	conj_and	15	SENT_27	[p3l1431t203r2142b279],
18	.	.	O	.	_	0	SENT_27	[p3l1431t203r2142b279],

1	”	NN	O	”	nn	2	SENT_28	[p3l1431t203r2142b279],
2	Tamoxifen	NN	O	tamoxifen	nsubj	3	SENT_28	[p3l6t297r406b357],
3	reduces	VBZ	O	reduce	_	0	SENT_28	[p3l470t297r744b357],
4	the	DT	O	the	det	5	SENT_28	[p3l811t297r922b357],
5	risk	NN	O	risk	dobj	3	SENT_28	[p3l987t297r1117b357],
6	of	IN	O	of	_	0	SENT_28	[p3l1181t297r1258b357],
7	primary	JJ	O	primary	amod	23	SENT_28	[p3l1312t297r1598b373],
8	invasive	JJ	O	invasive	amod	12	SENT_28	[p3l1661t297r1943b357],
9	and	CC	O	and	_	0	SENT_28	[p3l2011t297r2143b357],
10	premalignant	JJ	O	premalignant	amod	12	SENT_28	[p3l6t389r487b465],
11	breast	NN	O	breast	nn	12	SENT_28	[p3l519t389r737b450],
12	cancer	NN	O	cancer	nn	23	SENT_28	[p3l771t409r1006b450],
13	in	IN	O	in	_	0	SENT_28	[p3l1038t389r1105b449],
14	women	NNS	O	woman	prep_in	12	SENT_28	[p3l1137t409r1404b450],
15	at	IN	O	at	_	0	SENT_28	[p3l1438t403r1502b450],
16	high	JJ	O	high	amod	18	SENT_28	[p3l1533t389r1873b465],
17	—	NN	O	—	nn	18	SENT_28	[p3l1533t389r1873b465],
18	risk9	NN	O	risk9	prep_at	14	SENT_28	[p3l1533t389r1873b465],
19	and	CC	O	and	_	0	SENT_28	[p3l1909t389r2041b450],
20	of	IN	O	of	nn	23	SENT_28	[p3l2076t389r2153b450],
21	contralateral	JJ	O	contralateral	amod	22	SENT_28	[p3l9t482r460b543],
22	breast	NN	O	breast	pobj	20	SENT_28	[p3l548t482r767b543],
23	cancer	NN	O	cancer	prep_of	5	SENT_28	[p3l857t502r1092b543],
24	in	IN	O	in	_	0	SENT_28	[p3l1179t483r1248b542],
25	unselected	JJ	O	unselected	amod	26	SENT_28	[p3l1336t482r1719b543],
26	women	NNS	O	woman	prep_in	23	SENT_28	[p3l1806t484r2143b543],
27	.	.	O	.	_	0	SENT_28	[p3l1806t484r2143b543],

1	”	NN	O	”	ccomp	12	SENT_29	[p3l1806t484r2143b543],
2	However	RB	O	however	advmod	1	SENT_29	[p3l8t577r355b649],
3	,	,	O	,	_	0	SENT_29	[p3l8t577r355b649],
4	the	DT	O	the	det	5	SENT_29	[p3l383t576r493b636],
5	use	NN	O	use	nsubjpass	12	SENT_29	[p3l519t596r636b636],
6	of	IN	O	of	_	0	SENT_29	[p3l663t576r741b636],
7	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_29	[p3l755t576r1118b636],
8	has	VBZ	O	have	aux	12	SENT_29	[p3l1141t576r1258b636],
9	not	RB	O	not	neg	12	SENT_29	[p3l1284t590r1404b636],
10	yet	RB	O	yet	advmod	12	SENT_29	[p3l1426t590r1533b652],
11	been	VBN	O	be	auxpass	12	SENT_29	[p3l1556t576r1729b636],
12	assessed	VBN	O	assess	_	0	SENT_29	[p3l1755t576r2050b636],
13	in	IN	O	in	_	0	SENT_29	[p3l2075t576r2143b635],
14	known	JJ	O	known	amod	15	SENT_29	[p3l8t668r251b729],
15	carriers	NNS	O	carrier	prep_in	12	SENT_29	[p3l314t668r576b729],
16	of	IN	O	of	_	0	SENT_29	[p3l641t668r718b729],
17	BRCA1	NN	O	brca1	nn	20	SENT_29	[p3l767t668r1044b729],
18	or	CC	O	or	_	0	SENT_29	[p3l1112t688r1187b729],
19	BRCA2	NN	O	brca2	nn	20	SENT_29	[p3l1244t668r1526b729],
20	mutations	NNS	O	mutation	prep_of	15	SENT_29	[p3l1587t668r1969b729],
21	.	.	O	.	_	0	SENT_29	[p3l1587t668r1969b729],

1	To	TO	O	to	aux	2	SENT_30	[p3l2035t669r2141b729],
2	investigate	VB	O	investigate	_	0	SENT_30	[p3l7t762r386b837],
3	the	DT	O	the	det	5	SENT_30	[p3l454t761r565b822],
4	potential	JJ	O	potential	amod	5	SENT_30	[p3l632t761r950b837],
5	benefit	NN	O	benefit	dobj	2	SENT_30	[p3l1017t761r1266b822],
6	of	IN	O	of	_	0	SENT_30	[p3l1334t761r1411b822],
7	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_30	[p3l1467t761r1830b822],
8	in	IN	O	in	_	0	SENT_30	[p3l1897t762r1965b821],
9	the	DT	O	the	det	10	SENT_30	[p3l2031t761r2142b822],
10	reduction	NN	O	reduction	prep_in	2	SENT_30	[p3l7t855r355b915],
11	of	IN	O	of	_	0	SENT_30	[p3l410t855r487b915],
12	risk	NN	O	risk	prep_of	10	SENT_30	[p3l530t855r659b915],
13	of	IN	O	of	_	0	SENT_30	[p3l712t855r789b915],
14	contralateral	JJ	O	contralateral	amod	16	SENT_30	[p3l834t855r1285b915],
15	breast	NN	O	breast	nn	16	SENT_30	[p3l1338t855r1556b915],
16	cancer	NN	O	cancer	prep_of	12	SENT_30	[p3l1610t874r1845b915],
17	among	IN	O	among	_	0	SENT_30	[p3l1898t874r2144b931],
18	BRCAI	NNP	O	BRCAI	prep_among	2	SENT_30	[p3l6t946r282b1006],
19	or	CC	O	or	_	0	SENT_30	[p3l325t966r399b1006],
20	BRCA2	NN	O	brca2	nn	22	SENT_30	[p3l432t946r715b1006],
21	mutation	NN	O	mutation	nn	22	SENT_30	[p3l749t946r1080b1007],
22	carriers	NNS	O	carrier	prep_among	2	SENT_30	[p3l1118t946r1404b1018],
23	;	:	O	;	_	0	SENT_30	[p3l1118t946r1404b1018],
24	we	PRP	O	we	nsubj	25	SENT_30	[p3l1442t966r1540b1007],
25	studied	VBD	O	study	parataxis	2	SENT_30	[p3l1579t946r1842b1007],
26	women	NNS	O	woman	dobj	25	SENT_30	[p3l1877t966r2143b1007],
27	with	IN	O	with	_	0	SENT_30	[p3l6t1039r164b1100],
28	bilateral	JJ	O	bilateral	amod	31	SENT_30	[p3l208t1039r500b1100],
29	hereditary	JJ	O	hereditary	amod	31	SENT_30	[p3l545t1039r912b1115],
30	breast	NN	O	breast	nn	31	SENT_30	[p3l955t1039r1173b1100],
31	cancer	NN	O	cancer	prep_with	25	SENT_30	[p3l1220t1059r1455b1100],
32	and	CC	O	and	_	0	SENT_30	[p3l1501t1039r1633b1100],
33	age-matched	JJ	O	age-matched	amod	34	SENT_30	[p3l1681t1039r2143b1115],
34	controls	NNS	O	control	prep_with	25	SENT_30	[p3l9t1133r296b1193],
35	with	IN	O	with	_	0	SENT_30	[p3l322t1133r480b1193],
36	unilateral	JJ	O	unilateral	amod	39	SENT_30	[p3l505t1133r845b1193],
37	hereditary	JJ	O	hereditary	amod	39	SENT_30	[p3l870t1133r1238b1209],
38	breast	NN	O	breast	nn	39	SENT_30	[p3l1261t1133r1479b1193],
39	cancer	NN	O	cancer	prep_with	25	SENT_30	[p3l1506t1152r1758b1193],
40	.	.	O	.	_	0	SENT_30	[p3l1506t1152r1758b1193],

1	Methods	NNS	O	method	_	0	SENT_31	[p3l10t1316r398b1382],

1	Patients	NNS	O	patient	nsubjpass	12	SENT_32	[p3l9t1417r293b1475],
2	and	CC	O	and	_	0	SENT_32	[p3l321t1417r456b1475],
3	controls	NNS	O	control	nn	4	SENT_32	[p3l482t1417r761b1476],
4	Information	NN	O	information	nsubjpass	12	SENT_32	[p3l7t1507r440b1568],
5	about	IN	O	about	_	0	SENT_32	[p3l484t1507r687b1568],
6	patients	NNS	O	patient	prep_about	4	SENT_32	[p3l728t1507r1008b1583],
7	with	IN	O	with	_	0	SENT_32	[p3l1051t1507r1207b1568],
8	hereditary	JJ	O	hereditary	amod	10	SENT_32	[p3l1249t1507r1612b1583],
9	breast	NN	O	breast	nn	10	SENT_32	[p3l1652t1507r1868b1568],
10	cancer	NN	O	cancer	prep_with	6	SENT_32	[p3l1912t1527r2145b1568],
11	was	VBD	O	be	auxpass	12	SENT_32	[p3l6t1620r136b1661],
12	submitted	VBN	O	submit	_	0	SENT_32	[p3l172t1600r531b1661],
13	to	TO	O	to	_	0	SENT_32	[p3l564t1615r632b1661],
14	the	DT	O	the	det	16	SENT_32	[p3l666t1600r776b1661],
15	study	NN	O	study	nn	16	SENT_32	[p3l812t1600r1004b1676],
16	centre	NN	O	centre	prep_to	12	SENT_32	[p3l1037t1614r1255b1661],
17	by	IN	O	by	_	0	SENT_32	[p3l1287t1600r1374b1676],
18	investigators	NNS	O	investigator	agent	12	SENT_32	[p3l1405t1601r1850b1676],
19	at	IN	O	at	_	0	SENT_32	[p3l1886t1615r1949b1661],
20	each	DT	O	each	prep_at	18	SENT_32	[p3l1983t1600r2143b1661],
21	of	IN	O	of	_	0	SENT_32	[p3l9t1694r85b1754],
22	34	CD	NUMBER	34	num	24	SENT_32	[p3l104t1696r190b1754],
23	contributing	VBG	O	contribute	amod	24	SENT_32	[p3l220t1694r663b1770],
24	centres	NNS	O	centre	prep_of	20	SENT_32	[p3l690t1708r940b1754],
25	in	IN	O	in	_	0	SENT_32	[p3l969t1694r1036b1753],
26	eight	CD	NUMBER	eight	num	27	SENT_32	[p3l1064t1694r1238b1770],
27	countries	NNS	O	country	prep_in	24	SENT_32	[p3l1266t1694r1612b1754],
28	.	.	O	.	_	0	SENT_32	[p3l1266t1694r1612b1754],

1	These	DT	O	these	det	2	SENT_33	[p3l1644t1694r1862b1754],
2	centres	NNS	O	centre	nsubjpass	4	SENT_33	[p3l1891t1708r2141b1754],
3	were	VBD	O	be	auxpass	4	SENT_33	[p3l6t1806r173b1847],
4	requested	VBN	O	request	_	0	SENT_33	[p3l213t1786r561b1862],
5	to	TO	O	to	_	0	SENT_33	[p3l599t1800r667b1847],
6	complete	JJ	O	complete	amod	7	SENT_33	[p3l710t1786r1035b1862],
7	forms	NNS	O	form	prep_to	4	SENT_33	[p3l1074t1786r1277b1847],
8	for	IN	O	for	_	0	SENT_33	[p3l1317t1786r1419b1847],
9	all	DT	O	all	det	11	SENT_33	[p3l1457t1786r1536b1847],
10	known	JJ	O	known	amod	11	SENT_33	[p3l1576t1786r1817b1847],
11	cases	NNS	O	case	prep_for	7	SENT_33	[p3l1857t1806r2034b1847],
12	of	IN	O	of	_	0	SENT_33	[p3l2076t1786r2153b1847],
13	female	JJ	O	female	amod	15	SENT_33	[p3l7t1879r242b1940],
14	breast	NN	O	breast	nn	15	SENT_33	[p3l271t1879r487b1940],
15	cancer	NN	O	cancer	prep_of	11	SENT_33	[p3l517t1899r750b1940],
16	carrying	VBG	O	carry	xcomp	4	SENT_33	[p3l779t1880r1069b1955],
17	a	DT	O	a	det	19	SENT_33	[p3l1098t1899r1133b1940],
18	veriﬁed	JJ	O	veriﬁed	amod	19	SENT_33	[p3l1161t1879r1427b1940],
19	BRCA1	NN	O	brca1	dobj	16	SENT_33	[p3l1455t1880r1729b1940],
20	or	CC	O	or	_	0	SENT_33	[p3l1765t1899r1838b1940],
21	BRCA2	NN	O	brca2	nn	22	SENT_33	[p3l1864t1880r2144b1940],
22	mutation	NN	O	mutation	conj_or	19	SENT_33	[p3l7t1973r353b2033],
23	.	.	O	.	_	0	SENT_33	[p3l7t1973r353b2033],

1	Most	JJS	O	most	nsubjpass	6	SENT_34	[p3l398t1974r586b2033],
2	of	IN	O	of	_	0	SENT_34	[p3l626t1973r703b2033],
3	these	DT	O	these	det	4	SENT_34	[p3l732t1973r914b2033],
4	patients	NNS	O	patient	prep_of	1	SENT_34	[p3l953t1973r1233b2049],
5	were	VBD	O	be	auxpass	6	SENT_34	[p3l1273t1992r1441b2033],
6	identiﬁed	VBN	O	identiﬁed	_	0	SENT_34	[p3l1482t1973r1819b2033],
7	through	IN	O	through	_	0	SENT_34	[p3l1859t1973r2143b2049],
8	genetic	JJ	O	genetic	amod	9	SENT_34	[p3l7t2065r260b2141],
9	counselling	NN	O	counselling	prep_through	6	SENT_34	[p3l348t2065r752b2141],
10	and	CC	O	and	_	0	SENT_34	[p3l839t2065r969b2126],
11	risk-assessment	NN	O	risk-assessment	nn	12	SENT_34	[p3l1055t2065r1609b2126],
12	programmes	NNS	O	programme	nsubj	13	SENT_34	[p3l1693t2085r2141b2141],
13	offered	VBD	O	offer	conj_and	6	SENT_34	[p3l9t2158r257b2219],
14	to	TO	O	to	_	0	SENT_34	[p3l289t2173r357b2219],
15	women	NNS	O	woman	prep_to	13	SENT_34	[p3l389t2178r653b2219],
16	from	IN	O	from	_	0	SENT_34	[p3l684t2158r855b2219],
17	high-risk	JJ	O	high-risk	amod	18	SENT_34	[p3l886t2158r1202b2234],
18	families	NNS	O	family	prep_from	13	SENT_34	[p3l1232t2158r1524b2219],
19	.	.	O	.	_	0	SENT_34	[p3l1232t2158r1524b2219],

1	The	DT	O	the	det	3	SENT_35	[p3l1560t2158r1706b2219],
2	data	NNS	O	datum	nn	3	SENT_35	[p3l1740t2158r1891b2219],
3	centre	NN	O	centre	nsubj	4	SENT_35	[p3l1924t2173r2142b2219],
4	received	VBD	O	receive	_	0	SENT_35	[p3l7t2252r301b2312],
5	information	NN	O	information	dobj	4	SENT_35	[p3l358t2252r781b2312],
6	for	IN	O	for	_	0	SENT_35	[p3l838t2252r939b2312],
7	1243	CD	DATE	1243	num	8	SENT_35	[p3l1002t2254r1170b2312],
8	cases	NNS	O	case	prep_for	4	SENT_35	[p3l1232t2272r1409b2312],
9	of	IN	O	of	_	0	SENT_35	[p3l1469t2252r1545b2312],
10	invasive	JJ	O	invasive	amod	12	SENT_35	[p3l1592t2252r1871b2312],
11	breast	NN	O	breast	nn	12	SENT_35	[p3l1928t2252r2144b2312],
12	cancer	NN	O	cancer	prep_of	8	SENT_35	[p3l9t2364r242b2405],
13	in	IN	O	in	_	0	SENT_35	[p3l309t2344r377b2404],
14	carriers	NNS	O	carrier	prep_in	4	SENT_35	[p3l447t2344r707b2405],
15	of	IN	O	of	_	0	SENT_35	[p3l780t2344r856b2405],
16	pathogenic	JJ	O	pathogenic	amod	17	SENT_35	[p3l914t2344r1307b2420],
17	BRCAI	NN	O	brcaus	prep_of	14	SENT_35	[p3l1375t2344r1649b2405],
18	or	CC	O	or	_	0	SENT_35	[p3l1725t2364r1799b2405],
19	BRCA2	NN	O	brca2	nn	20	SENT_35	[p3l1864t2344r2144b2405],
20	mutations	NNS	O	mutation	prep_of	14	SENT_35	[p3l7t2421r386b2481],
21	.	.	O	.	_	0	SENT_35	[p3l7t2421r386b2481],

1	Of	IN	O	of	_	0	SENT_36	[p3l94t2514r194b2574],
2	the	DT	O	the	det	4	SENT_36	[p3l240t2514r351b2574],
3	1243	CD	DATE	1243	num	4	SENT_36	[p3l418t2516r587b2574],
4	cases	NNS	O	case	prep_of	11	SENT_36	[p3l649t2534r851b2587],
5	,	,	O	,	_	0	SENT_36	[p3l649t2534r851b2587],
6	296	CD	PERCENT	296	number	7	SENT_36	[p3l912t2516r1044b2574],
7	(	CD	PERCENT	(	nsubj	11	SENT_36	[p3l1109t2514r1328b2589],
8	24	CD	PERCENT	24	num	9	SENT_36	[p3l1109t2514r1328b2589],
9	%	NN	PERCENT	%	dep	7	SENT_36	[p3l1109t2514r1328b2589],
10	)	CD	NUMBER	)	dep	7	SENT_36	[p3l1109t2514r1328b2589],
11	had	VBD	O	have	_	0	SENT_36	[p3l1389t2514r1523b2574],
12	bilateral	JJ	O	bilateral	amod	14	SENT_36	[p3l1578t2514r1869b2574],
13	breast	NN	O	breast	nn	14	SENT_36	[p3l1925t2514r2143b2574],
14	cancer	NN	O	cancer	dobj	11	SENT_36	[p3l9t2626r261b2667],
15	.	.	O	.	_	0	SENT_36	[p3l9t2626r261b2667],

1	83	CD	PERCENT	83	nsubjpass	11	SENT_37	[p3l342t2609r425b2667],
2	(	CD	PERCENT	(	num	4	SENT_37	[p3l507t2606r725b2681],
3	28	CD	PERCENT	28	num	4	SENT_37	[p3l507t2606r725b2681],
4	%	NN	PERCENT	%	dep	1	SENT_37	[p3l507t2606r725b2681],
5	)	CD	NUMBER	)	num	6	SENT_37	[p3l507t2606r725b2681],
6	cases	NNS	O	case	dep	1	SENT_37	[p3l805t2626r984b2667],
7	with	IN	O	with	_	0	SENT_37	[p3l1056t2606r1215b2667],
8	bilateral	JJ	O	bilateral	amod	9	SENT_37	[p3l1285t2606r1577b2667],
9	disease	NN	O	disease	prep_with	6	SENT_37	[p3l1650t2606r1901b2667],
10	were	VBD	O	be	auxpass	11	SENT_37	[p3l1973t2626r2142b2667],
11	excluded	VBN	O	exclude	_	0	SENT_37	[p3l9t2699r332b2760],
12	from	IN	O	from	_	0	SENT_37	[p3l375t2699r547b2760],
13	our	PRP$	O	we	poss	14	SENT_37	[p3l592t2719r715b2760],
14	study	NN	O	study	prep_from	11	SENT_37	[p3l758t2699r970b2775],
15	:	:	O	:	_	0	SENT_37	[p3l758t2699r970b2775],
16	28	CD	PERCENT	28	num	20	SENT_37	[p3l1021t2702r1105b2760],
17	(	CD	PERCENT	(	number	18	SENT_37	[p3l1158t2700r1377b2775],
18	10	CD	PERCENT	10	dep	19	SENT_37	[p3l1158t2700r1377b2775],
19	%	NN	PERCENT	%	dep	20	SENT_37	[p3l1158t2700r1377b2775],
20	)	NN	O	)	nsubj	26	SENT_37	[p3l1158t2700r1377b2775],
21	who	WP	O	who	nsubj	22	SENT_37	[p3l1424t2699r1576b2760],
22	had	VBD	O	have	rcmod	20	SENT_37	[p3l1619t2699r1753b2760],
23	their	PRP$	O	they	poss	25	SENT_37	[p3l1796t2699r1964b2760],
24	first	JJ	ORDINAL	first	amod	25	SENT_37	[p3l2005t2699r2144b2760],
25	cancer	NN	O	cancer	dobj	22	SENT_37	[p3l9t2812r244b2853],
26	diagnosed	VBD	O	diagnose	parataxis	11	SENT_37	[p3l274t2793r637b2869],
27	before	IN	O	before	_	0	SENT_37	[p3l666t2793r892b2853],
28	Jan	NNP	DATE	Jan	prep_before	26	SENT_37	[p3l918t2794r1038b2867],
29	1	CD	DATE	1	num	28	SENT_37	[p3l1078t2795r1133b2866],
30	,	,	DATE	,	_	0	SENT_37	[p3l1078t2795r1133b2866],
31	1970	CD	DATE	1970	num	28	SENT_37	[p3l1176t2795r1347b2853],
32	(	CD	NUMBER	(	tmod	26	SENT_37	[p3l1385t2793r1492b2868],
33	ie	FW	O	ie	dobj	26	SENT_37	[p3l1385t2793r1492b2868],
34	,	,	O	,	_	0	SENT_37	[p3l1385t2793r1492b2868],
35	before	IN	O	before	mark	37	SENT_37	[p3l1524t2793r1750b2853],
36	tamoxifen	NN	O	tamoxifen	nsubj	37	SENT_37	[p3l1781t2793r2143b2853],
37	was	VBD	O	be	dep	33	SENT_37	[p3l6t2905r138b2946],
38	in	IN	O	in	_	0	SENT_37	[p3l166t2885r235b2945],
39	use	NN	O	use	nn	40	SENT_37	[p3l260t2885r432b2960],
40	)	NN	O	)	prep_in	37	SENT_37	[p3l260t2885r432b2960],
41	;	:	O	;	_	0	SENT_37	[p3l260t2885r432b2960],
42	39	CD	PERCENT	39	num	46	SENT_37	[p3l464t2888r548b2946],
43	(	CD	PERCENT	(	number	44	SENT_37	[p3l585t2885r804b2960],
44	13	CD	PERCENT	13	dep	45	SENT_37	[p3l585t2885r804b2960],
45	%	NN	PERCENT	%	dep	46	SENT_37	[p3l585t2885r804b2960],
46	)	NN	O	)	conj_and	33	SENT_37	[p3l585t2885r804b2960],
47	who	WP	O	who	nsubj	48	SENT_37	[p3l835t2885r986b2946],
48	had	VBD	O	have	rcmod	46	SENT_37	[p3l1013t2885r1147b2946],
49	contralateral	JJ	O	contralateral	amod	50	SENT_37	[p3l1176t2885r1627b2946],
50	cancer	NN	O	cancer	dobj	48	SENT_37	[p3l1656t2905r1892b2946],
51	within	IN	O	within	_	0	SENT_37	[p3l1915t2885r2143b2946],
52	1	CD	DURATION	1	num	53	SENT_37	[p3l16t2981r41b3038],
53	year	NN	NUMBER	year	prep_within	50	SENT_37	[p3l87t2998r239b3054],
54	of	IN	O	of	_	0	SENT_37	[p3l277t2978r354b3039],
55	the	DT	O	the	det	57	SENT_37	[p3l381t2978r492b3039],
56	initial	JJ	O	initial	amod	57	SENT_37	[p3l531t2978r734b3039],
57	diagnosis	NN	O	diagnosis	prep_of	53	SENT_37	[p3l774t2978r1126b3054],
58	;	:	O	;	_	0	SENT_37	[p3l774t2978r1126b3054],
59	14	CD	PERCENT	14	num	63	SENT_37	[p3l1176t2981r1256b3038],
60	(	CD	PERCENT	(	number	61	SENT_37	[p3l1301t2979r1474b3054],
61	5	CD	PERCENT	5	dep	62	SENT_37	[p3l1301t2979r1474b3054],
62	%	NN	PERCENT	%	dep	63	SENT_37	[p3l1301t2979r1474b3054],
63	)	NN	O	)	conj_and	33	SENT_37	[p3l1301t2979r1474b3054],
64	who	WP	O	who	nsubj	65	SENT_37	[p3l1517t2978r1667b3039],
65	had	VBD	O	have	rcmod	63	SENT_37	[p3l1706t2978r1840b3039],
66	ovarian	JJ	O	ovarian	amod	67	SENT_37	[p3l1879t2979r2143b3039],
67	cancer	NN	O	cancer	dobj	65	SENT_37	[p3l9t3091r244b3132],
68	diagnosed	VBD	O	diagnose	rcmod	67	SENT_37	[p3l285t3072r648b3148],
69	before	IN	O	before	_	0	SENT_37	[p3l687t3072r914b3132],
70	contralateral	JJ	O	contralateral	amod	72	SENT_37	[p3l958t3072r1410b3132],
71	breast	NN	O	breast	nn	72	SENT_37	[p3l1450t3072r1668b3132],
72	cancer	NN	O	cancer	prep_before	68	SENT_37	[p3l1710t3091r1964b3145],
73	;	:	O	;	_	0	SENT_37	[p3l1710t3091r1964b3145],
74	and	CC	O	and	_	0	SENT_37	[p3l2011t3072r2143b3132],
75	two	CD	PERCENT	two	num	79	SENT_37	[p3l7t3178r137b3225],
76	(	CD	PERCENT	(	number	77	SENT_37	[p3l170t3164r413b3239],
77	O-6	CD	PERCENT	o-6	dep	78	SENT_37	[p3l170t3164r413b3239],
78	%	NN	PERCENT	%	dep	79	SENT_37	[p3l170t3164r413b3239],
79	)	NN	O	)	conj_and	33	SENT_37	[p3l170t3164r413b3239],
80	who	WP	O	who	nsubj	81	SENT_37	[p3l443t3164r594b3225],
81	had	VBD	O	have	rcmod	79	SENT_37	[p3l619t3164r753b3225],
82	a	DT	O	a	det	84	SENT_37	[p3l780t3184r815b3225],
83	contralateral	JJ	O	contralateral	amod	84	SENT_37	[p3l842t3164r1294b3225],
84	mastectomy	NN	O	mastectomy	dobj	81	SENT_37	[p3l1319t3178r1757b3240],
85	before	IN	O	before	_	0	SENT_37	[p3l1779t3164r2006b3225],
86	the	DT	O	the	det	87	SENT_37	[p3l2031t3164r2142b3225],
87	development	NN	O	development	prep_before	84	SENT_37	[p3l8t3257r476b3333],
88	of	IN	O	of	_	0	SENT_37	[p3l516t3257r593b3318],
89	contralateral	JJ	O	contralateral	amod	91	SENT_37	[p3l624t3257r1075b3318],
90	breast	NN	O	breast	nn	91	SENT_37	[p3l1114t3257r1332b3318],
91	cancer	NN	O	cancer	prep_of	87	SENT_37	[p3l1372t3277r1624b3318],
92	.	.	O	.	_	0	SENT_37	[p3l1372t3277r1624b3318],

1	Synchronous	JJ	O	synchronous	amod	3	SENT_38	[p3l1672t3257r2141b3333],
2	bilateral	JJ	O	bilateral	amod	3	SENT_38	[p3l6t3351r297b3411],
3	cases	NNS	O	case	nsubjpass	5	SENT_38	[p3l343t3371r522b3411],
4	were	VBD	O	be	auxpass	5	SENT_38	[p3l565t3370r734b3411],
5	excluded	VBN	O	exclude	_	0	SENT_38	[p3l780t3351r1102b3411],
6	because	IN	O	because	mark	12	SENT_38	[p3l1144t3351r1428b3411],
7	the	DT	O	the	det	8	SENT_38	[p3l1472t3351r1583b3411],
8	patient	NN	O	patient	nsubj	12	SENT_38	[p3l1625t3351r1878b3427],
9	would	MD	O	would	aux	12	SENT_38	[p3l1918t3351r2143b3411],
10	not	RB	O	not	neg	12	SENT_38	[p3l7t3457r127b3504],
11	be	VB	O	be	cop	12	SENT_38	[p3l174t3443r259b3504],
12	able	JJ	O	able	advcl	5	SENT_38	[p3l311t3443r455b3504],
13	to	TO	O	to	aux	14	SENT_38	[p3l505t3457r574b3504],
14	take	VB	O	take	xcomp	12	SENT_38	[p3l626t3443r772b3504],
15	tamoxifen	NN	O	tamoxifen	dobj	14	SENT_38	[p3l823t3443r1185b3504],
16	before	IN	O	before	_	0	SENT_38	[p3l1234t3443r1460b3504],
17	the	DT	O	the	det	18	SENT_38	[p3l1510t3443r1621b3504],
18	onset	NN	O	onset	prep_before	14	SENT_38	[p3l1673t3457r1864b3504],
19	of	IN	O	of	_	0	SENT_38	[p3l1915t3443r1991b3504],
20	the	DT	O	the	det	22	SENT_38	[p3l2031t3443r2142b3504],
21	contralateral	JJ	O	contralateral	amod	22	SENT_38	[p3l9t3536r460b3597],
22	cancer	NN	O	cancer	prep_of	18	SENT_38	[p3l496t3556r748b3597],
23	.	.	O	.	_	0	SENT_38	[p3l496t3556r748b3597],

1	A	DT	O	a	det	2	SENT_39	[p3l785t3537r846b3596],
2	control	NN	O	control	nsubjpass	5	SENT_39	[p3l880t3536r1135b3597],
3	was	VBD	O	be	auxpass	5	SENT_39	[p3l1167t3556r1299b3597],
4	not	RB	O	not	neg	5	SENT_39	[p3l1333t3550r1454b3597],
5	identiﬁed	VBN	O	identiﬁed	_	0	SENT_39	[p3l1486t3536r1828b3597],
6	for	IN	O	for	_	0	SENT_39	[p3l1861t3536r1963b3597],
7	four	CD	NUMBER	four	num	8	SENT_39	[p3l1994t3536r2145b3597],
8	cases	NNS	O	case	prep_for	5	SENT_39	[p3l9t3650r188b3690],
9	with	IN	O	with	_	0	SENT_39	[p3l229t3630r387b3690],
10	bilateral	JJ	O	bilateral	amod	11	SENT_39	[p3l426t3630r717b3690],
11	disease	NN	O	disease	prep_with	5	SENT_39	[p3l760t3630r1011b3690],
12	who	WP	O	who	nsubjpass	15	SENT_39	[p3l1051t3630r1202b3690],
13	were	VBD	O	be	auxpass	15	SENT_39	[p3l1243t3649r1412b3690],
14	therefore	RB	O	therefore	advmod	15	SENT_39	[p3l1453t3630r1777b3690],
15	excluded	VBN	O	exclude	rcmod	11	SENT_39	[p3l1820t3630r2143b3690],
16	from	IN	O	from	_	0	SENT_39	[p4l7t23r180b84],
17	the	DT	O	the	det	18	SENT_39	[p4l212t23r323b84],
18	analyses	NNS	O	analysis	prep_from	15	SENT_39	[p4l358t23r669b99],
19	.	.	O	.	_	0	SENT_39	[p4l358t23r669b99],

1	Thus	RB	O	thus	advmod	15	SENT_40	[p4l706t23r917b96],
2	,	,	O	,	_	0	SENT_40	[p4l706t23r917b96],
3	209	CD	PERCENT	209	nsubjpass	15	SENT_40	[p4l955t26r1086b84],
4	(	CD	PERCENT	(	num	6	SENT_40	[p4l1127t23r1346b98],
5	71	CD	PERCENT	71	num	6	SENT_40	[p4l1127t23r1346b98],
6	%	NN	PERCENT	%	dep	3	SENT_40	[p4l1127t23r1346b98],
7	)	CD	NUMBER	)	num	9	SENT_40	[p4l1127t23r1346b98],
8	eligible	JJ	O	eligible	amod	9	SENT_40	[p4l1386t23r1638b99],
9	patients	NNS	O	patient	dep	3	SENT_40	[p4l1670t23r1953b99],
10	with	IN	O	with	_	0	SENT_40	[p4l1985t23r2144b84],
11	bilateral	JJ	O	bilateral	amod	13	SENT_40	[p4l6t116r297b177],
12	breast	NN	O	breast	nn	13	SENT_40	[p4l323t116r541b177],
13	cancer	NN	O	cancer	prep_with	9	SENT_40	[p4l568t136r803b177],
14	were	VBD	O	be	auxpass	15	SENT_40	[p4l825t136r994b177],
15	included	VBN	O	include	_	0	SENT_40	[p4l1021t116r1354b177],
16	.	.	O	.	_	0	SENT_40	[p4l1021t116r1354b177],

1	Controls	NNP	O	Controls	nsubjpass	3	SENT_41	[p4l95t210r408b270],
2	were	VBD	O	be	auxpass	3	SENT_41	[p4l465t229r634b270],
3	selected	VBN	O	select	_	0	SENT_41	[p4l694t210r979b270],
4	from	IN	O	from	_	0	SENT_41	[p4l1036t210r1210b270],
5	women	NNS	O	woman	prep_from	3	SENT_41	[p4l1266t229r1532b270],
6	with	IN	O	with	_	0	SENT_41	[p4l1588t210r1746b270],
7	unilateral	JJ	O	unilateral	amod	9	SENT_41	[p4l1802t210r2142b270],
8	breast	NN	O	breast	nn	9	SENT_41	[p4l6t302r224b363],
9	cancer	NN	O	cancer	prep_with	5	SENT_41	[p4l272t322r508b363],
10	in	IN	O	in	_	0	SENT_41	[p4l553t302r621b362],
11	the	DT	O	the	det	13	SENT_41	[p4l667t302r778b363],
12	registry	NN	O	registry	nn	13	SENT_41	[p4l826t302r1093b378],
13	database	NN	O	database	prep_in	9	SENT_41	[p4l1139t302r1470b363],
14	.	.	O	.	_	0	SENT_41	[p4l1139t302r1470b363],

1	They	PRP	O	they	nsubj	17	SENT_42	[p4l1522t302r1713b378],
2	were	VBD	O	be	cop	3	SENT_42	[p4l1756t322r1926b363],
3	bom	NN	O	bom	_	0	SENT_42	[p4l1972t302r2143b363],
4	within	IN	O	within	_	0	SENT_42	[p4l6t395r234b456],
5	5	CD	DURATION	5	num	6	SENT_42	[p4l262t398r298b456],
6	years	NNS	NUMBER	year	prep_within	3	SENT_42	[p4l325t415r507b471],
7	of	IN	O	of	_	0	SENT_42	[p4l535t395r612b456],
8	the	DT	O	the	det	10	SENT_42	[p4l626t395r737b456],
9	birth	NN	O	birth	nn	10	SENT_42	[p4l761t395r936b456],
10	date	NN	O	date	prep_of	6	SENT_42	[p4l962t395r1113b456],
11	of	IN	O	of	_	0	SENT_42	[p4l1140t395r1217b456],
12	the	DT	O	the	det	14	SENT_42	[p4l1231t395r1342b456],
13	bilateral-disease	NN	O	bilateral-disease	nn	14	SENT_42	[p4l1366t395r1944b456],
14	case	NN	O	case	prep_of	10	SENT_42	[p4l1971t415r2140b468],
15	,	,	O	,	_	0	SENT_42	[p4l1971t415r2140b468],
16	and	CC	O	and	_	0	SENT_42	[p4l9t489r141b549],
17	diagnosed	VBD	O	diagnose	conj_and	3	SENT_42	[p4l173t489r536b565],
18	with	IN	O	with	_	0	SENT_42	[p4l566t489r724b549],
19	breast	NN	O	breast	nn	20	SENT_42	[p4l753t489r971b549],
20	cancer	NN	O	cancer	prep_with	17	SENT_42	[p4l1003t509r1238b549],
21	at	IN	O	at	_	0	SENT_42	[p4l1269t503r1333b549],
22	an	DT	O	a	det	23	SENT_42	[p4l1365t508r1449b549],
23	age	NN	O	age	prep_at	17	SENT_42	[p4l1482t509r1597b565],
24	within	IN	O	within	_	0	SENT_42	[p4l1628t489r1857b549],
25	5	CD	DURATION	5	num	26	SENT_42	[p4l1890t491r1926b549],
26	years	NNS	NUMBER	year	prep_within	23	SENT_42	[p4l1959t508r2141b565],
27	of	IN	O	of	_	0	SENT_42	[p4l9t581r86b642],
28	age	NN	O	age	prep_of	26	SENT_42	[p4l108t601r223b657],
29	of	IN	O	of	_	0	SENT_42	[p4l256t581r333b642],
30	ﬁrst	NN	O	ﬁrst	nn	31	SENT_42	[p4l352t581r491b642],
31	diagnosis	NN	O	diagnosis	prep_of	28	SENT_42	[p4l521t581r851b657],
32	of	IN	O	of	_	0	SENT_42	[p4l884t581r961b642],
33	breast	NN	O	breast	nn	34	SENT_42	[p4l979t581r1198b642],
34	cancer	NN	O	cancer	prep_of	31	SENT_42	[p4l1228t601r1464b642],
35	of	IN	O	of	_	0	SENT_42	[p4l1493t581r1570b642],
36	the	DT	O	the	det	37	SENT_42	[p4l1589t581r1700b642],
37	case	NN	O	case	prep_of	34	SENT_42	[p4l1733t601r1899b642],
38	.	.	O	.	_	0	SENT_42	[p4l1733t601r1899b642],

1	Cases	NNS	O	case	nsubjpass	19	SENT_43	[p4l1937t581r2141b642],
2	and	CC	O	and	_	0	SENT_43	[p4l9t674r141b735],
3	controls	NNS	O	control	conj_and	1	SENT_43	[p4l178t674r465b735],
4	were	VBD	O	be	cop	5	SENT_43	[p4l500t694r670b735],
5	carriers	NNS	O	carrier	_	0	SENT_43	[p4l707t675r970b735],
6	of	IN	O	of	_	0	SENT_43	[p4l1008t674r1085b735],
7	mutations	NNS	O	mutation	prep_of	5	SENT_43	[p4l1110t674r1472b735],
8	in	IN	O	in	_	0	SENT_43	[p4l1509t675r1577b734],
9	the	DT	O	the	det	13	SENT_43	[p4l1612t674r1723b735],
10	same	JJ	O	same	amod	13	SENT_43	[p4l1760t694r1941b735],
11	gene	NN	O	gene	nn	13	SENT_43	[p4l1977t694r2142b750],
12	(	NN	O	(	nn	13	SENT_43	[p4l13t768r314b843],
13	BRCA1	NN	O	brca1	prep_in	5	SENT_43	[p4l13t768r314b843],
14	or	CC	O	or	_	0	SENT_43	[p4l354t787r429b828],
15	BRCA2	NN	O	brca2	nn	16	SENT_43	[p4l459t768r767b843],
16	)	NN	O	)	prep_in	5	SENT_43	[p4l459t768r767b843],
17	and	CC	O	and	_	0	SENT_43	[p4l808t768r940b828],
18	were	VBD	O	be	auxpass	19	SENT_43	[p4l972t787r1141b828],
19	matched	VBN	O	match	conj_and	5	SENT_43	[p4l1176t768r1488b828],
20	for	IN	O	for	_	0	SENT_43	[p4l1521t768r1624b828],
21	residence	NN	O	residence	nn	22	SENT_43	[p4l1655t768r1992b828],
22	(	NN	O	(	prep_for	19	SENT_43	[p4l2033t768r2140b843],
23	ie	FW	O	ie	dobj	5	SENT_43	[p4l2033t768r2140b843],
24	,	,	O	,	_	0	SENT_43	[p4l2033t768r2140b843],

1	1876	CD	DATE	1876	_	0	SENT_44	[p4l96t939r172b965],
2	THE	DT	O	the	det	3	SENT_44	[p4l1468t944r1534b964],
3	LANCET	NN	O	lancet	dep	1	SENT_44	[p4l1544t944r1673b965],
4	-	:	O	-	_	0	SENT_44	[p4l1683t951r1690b958],
5	Vol	NN	O	vol	dep	3	SENT_44	[p4l1700t944r1744b965],
6	356	CD	NUMBER	356	number	7	SENT_44	[p4l1754t945r1799b965],
7	°	CD	NUMBER	°	dep	5	SENT_44	[p4l1810t951r1818b958],
8	December	NNP	DATE	December	tmod	5	SENT_44	[p4l1828t944r1959b965],
9	2	CD	DATE	2	num	8	SENT_44	[p4l1968t945r1990b968],
10	,	,	DATE	,	_	0	SENT_44	[p4l1968t945r1990b968],
11	2000	CD	DATE	2000	num	8	SENT_44	[p4l2001t945r2063b965],
12	ARTICLES	NNS	O	article	dep	1	SENT_44	[p4l1913t987r2067b1008],

1	Cases	NNS	O	case	_	0	SENT_45	[p4l1127t1154r1275b1198],
2	with	IN	O	with	_	0	SENT_45	[p4l1292t1154r1395b1198],
3	bilateral	JJ	O	bilateral	amod	7	SENT_45	[p4l1417t1154r1612b1198],
4	Controls	NNP	O	Controls	nn	7	SENT_45	[p4l1784t1154r1988b1198],
5	disease	NN	O	disease	nn	7	SENT_45	[p4l1127t1230r1312b1274],
6	(	NN	O	(	nn	7	SENT_45	[p4l1332t1230r1529b1284],
7	n	NN	O	n	prep_with	1	SENT_45	[p4l1332t1230r1529b1284],
8	=	JJ	O	=	dep	1	SENT_45	[p4l1332t1230r1529b1284],
9	209	CD	NUMBER	209	number	10	SENT_45	[p4l1332t1230r1529b1284],
10	)	CD	NUMBER	)	num	15	SENT_45	[p4l1332t1230r1529b1284],
11	(	NN	O	(	nn	15	SENT_45	[p4l1784t1230r1982b1284],
12	n	NN	O	n	nn	15	SENT_45	[p4l1784t1230r1982b1284],
13	=	JJ	O	=	amod	15	SENT_45	[p4l1784t1230r1982b1284],
14	384	CD	NUMBER	384	num	15	SENT_45	[p4l1784t1230r1982b1284],
15	)	NN	O	)	dep	8	SENT_45	[p4l1784t1230r1982b1284],

1	Year	NN	DURATION	year	dep	8	SENT_46	[p4l18t1343r129b1386],
2	of	IN	O	of	_	0	SENT_46	[p4l147t1342r193b1386],
3	birth	NN	O	birth	prep_of	1	SENT_46	[p4l211t1342r348b1386],
4	*	CD	NUMBER	*	num	3	SENT_46	[p4l211t1342r348b1386],
5	1945-2	CD	NUMBER	1945-2	num	6	SENT_46	[p4l1124t1342r1298b1386],
6	(	NN	O	(	dep	8	SENT_46	[p4l1320t1342r1464b1395],
7	10-5	CD	NUMBER	10-5	num	8	SENT_46	[p4l1320t1342r1464b1395],
8	)	CD	NUMBER	)	dep	12	SENT_46	[p4l1320t1342r1464b1395],
9	1946-2	CD	NUMBER	1946-2	num	10	SENT_46	[p4l1788t1342r1962b1386],
10	(	NN	O	(	dep	8	SENT_46	[p4l1984t1342r2127b1396],
11	10-4	CD	NUMBER	10-4	num	12	SENT_46	[p4l1984t1342r2127b1396],
12	)	NN	O	)	_	0	SENT_46	[p4l1984t1342r2127b1396],

1	Year	NN	DURATION	year	dep	8	SENT_47	[p4l18t1492r129b1535],
2	of	IN	O	of	_	0	SENT_47	[p4l147t1491r193b1535],
3	diagnosis	NN	O	diagnosis	prep_of	1	SENT_47	[p4l209t1491r468b1545],
4	*	CD	NUMBER	*	num	3	SENT_47	[p4l209t1491r468b1545],
5	1984-5	CD	NUMBER	1984-5	num	6	SENT_47	[p4l1124t1491r1299b1535],
6	(	NN	O	(	dep	8	SENT_47	[p4l1320t1491r1431b1545],
7	6-4	CD	NUMBER	6-4	num	8	SENT_47	[p4l1320t1491r1431b1545],
8	)	CD	NUMBER	)	dep	12	SENT_47	[p4l1320t1491r1431b1545],
9	1986-8	CD	NUMBER	1986-8	num	10	SENT_47	[p4l1788t1491r1964b1535],
10	(	NN	O	(	dep	8	SENT_47	[p4l1984t1491r2095b1545],
11	6-3	CD	NUMBER	6-3	num	12	SENT_47	[p4l1984t1491r2095b1545],
12	)	NN	O	)	_	0	SENT_47	[p4l1984t1491r2095b1545],

1	Year	NN	DURATION	year	dep	8	SENT_48	[p4l18t1638r129b1681],
2	of	IN	O	of	_	0	SENT_48	[p4l147t1637r193b1681],
3	interview	NN	O	interview	prep_of	1	SENT_48	[p4l211t1637r459b1681],
4	*	CD	NUMBER	*	num	3	SENT_48	[p4l211t1637r459b1681],
5	1997-9	CD	NUMBER	1997-9	num	6	SENT_48	[p4l1124t1637r1299b1681],
6	(	NN	O	(	dep	8	SENT_48	[p4l1320t1637r1431b1691],
7	1-3	CD	NUMBER	1-3	num	8	SENT_48	[p4l1320t1637r1431b1691],
8	)	CD	NUMBER	)	dep	13	SENT_48	[p4l1320t1637r1431b1691],
9	1997-8	CD	NUMBER	1997-8	num	10	SENT_48	[p4l1788t1637r1964b1681],
10	(	NN	O	(	dep	8	SENT_48	[p4l1984t1637r2095b1691],
11	1-8	CD	NUMBER	1-8	num	13	SENT_48	[p4l1984t1637r2095b1691],
12	)	CD	NUMBER	)	num	13	SENT_48	[p4l1984t1637r2095b1691],
13	Age	NN	O	age	dep	19	SENT_48	[p4l18t1749r112b1802],
14	at	IN	O	at	_	0	SENT_48	[p4l131t1750r179b1792],
15	1st	JJ	ORDINAL	1st	amod	17	SENT_48	[p4l198t1749r277b1792],
16	breast	NN	O	breast	nn	17	SENT_48	[p4l297t1749r449b1792],
17	cancer	NN	O	cancer	prep_at	13	SENT_48	[p4l468t1759r634b1792],
18	(	CD	NUMBER	(	num	19	SENT_48	[p4l652t1749r851b1802],
19	years	NNS	NUMBER	year	dep	25	SENT_48	[p4l652t1749r851b1802],
20	)	CD	NUMBER	)	number	21	SENT_48	[p4l652t1749r851b1802],
21	*	CD	NUMBER	*	dep	19	SENT_48	[p4l652t1749r851b1802],
22	39-4	CD	NUMBER	39-4	num	23	SENT_48	[p4l1188t1748r1300b1792],
23	(	NN	O	(	dep	21	SENT_48	[p4l1320t1748r1431b1802],
24	8-9	CD	NUMBER	8-9	num	25	SENT_48	[p4l1320t1748r1431b1802],
25	)	CD	NUMBER	)	dep	29	SENT_48	[p4l1320t1748r1431b1802],
26	40-6	CD	NUMBER	40-6	num	27	SENT_48	[p4l1851t1748r1963b1792],
27	(	NN	O	(	dep	25	SENT_48	[p4l1984t1748r2095b1802],
28	8-8	CD	NUMBER	8-8	num	29	SENT_48	[p4l1984t1748r2095b1802],
29	)	NN	O	)	_	0	SENT_48	[p4l1984t1748r2095b1802],

1	Age	NNP	O	Age	_	0	SENT_49	[p4l18t1894r112b1947],
2	at	IN	O	at	advmod	4	SENT_49	[p4l131t1895r179b1937],
3	1st	CD	ORDINAL	1st	pobj	2	SENT_49	[p4l198t1894r277b1937],
4	breast	NN	O	breast	dobj	5	SENT_49	[p4l297t1894r450b1937],
5	cancer	NN	O	cancer	dep	1	SENT_49	[p4l468t1904r634b1937],
6	(	CD	NUMBER	(	num	7	SENT_49	[p4l652t1894r854b1947],
7	years	NNS	NUMBER	year	tmod	5	SENT_49	[p4l652t1894r854b1947],
8	)	VBP	O	)	ccomp	5	SENT_49	[p4l652t1894r854b1947],
9	1	CD	NUMBER	1	dobj	8	SENT_49	[p4l652t1894r854b1947],
10	'	''	O	'	_	0	SENT_49	[p4l652t1894r854b1947],
11	<	JJR	O	<	dep	35	SENT_49	[p4l20t1968r115b2012],
12	30	CD	NUMBER	30	num	14	SENT_49	[p4l20t1968r115b2012],
13	31	CD	NUMBER	31	num	14	SENT_49	[p4l1188t1968r1250b2012],
14	(	NN	O	(	dep	23	SENT_49	[p4l1271t1968r1404b2021],
15	15	CD	PERCENT	15	num	16	SENT_49	[p4l1271t1968r1404b2021],
16	%	NN	PERCENT	%	dep	14	SENT_49	[p4l1271t1968r1404b2021],
17	)	CD	NUMBER	)	number	18	SENT_49	[p4l1271t1968r1404b2021],
18	40	CD	NUMBER	40	num	19	SENT_49	[p4l1851t1968r1914b2012],
19	(	NN	O	(	dep	16	SENT_49	[p4l1934t1968r2067b2021],
20	10	CD	PERCENT	10	num	21	SENT_49	[p4l1934t1968r2067b2021],
21	%	NN	PERCENT	%	dep	23	SENT_49	[p4l1934t1968r2067b2021],
22	)	CD	PERCENT	)	num	23	SENT_49	[p4l1934t1968r2067b2021],
23	30-39	CD	PERCENT	30-39	dep	32	SENT_49	[p4l19t2042r175b2085],
24	88	CD	PERCENT	88	num	25	SENT_49	[p4l1188t2042r1251b2085],
25	(	NN	PERCENT	(	dep	23	SENT_49	[p4l1271t2042r1404b2095],
26	42	CD	PERCENT	42	num	27	SENT_49	[p4l1271t2042r1404b2095],
27	%	NN	PERCENT	%	dep	25	SENT_49	[p4l1271t2042r1404b2095],
28	)	CD	PERCENT	)	number	29	SENT_49	[p4l1271t2042r1404b2095],
29	152	CD	PERCENT	152	num	27	SENT_49	[p4l1821t2042r1913b2085],
30	(	CD	PERCENT	(	num	32	SENT_49	[p4l1935t2042r2067b2095],
31	40	CD	PERCENT	40	num	32	SENT_49	[p4l1935t2042r2067b2095],
32	%	NN	PERCENT	%	dep	11	SENT_49	[p4l1935t2042r2067b2095],
33	)	CD	NUMBER	)	num	34	SENT_49	[p4l1935t2042r2067b2095],
34	40-49	CD	NUMBER	40-49	dep	32	SENT_49	[p4l19t2115r175b2159],
35	66	CD	NUMBER	66	prep	8	SENT_49	[p4l1189t2115r1250b2159],
36	(	NN	O	(	dep	35	SENT_49	[p4l1271t2115r1404b2169],
37	32	CD	PERCENT	32	num	38	SENT_49	[p4l1271t2115r1404b2169],
38	%	NN	PERCENT	%	dep	35	SENT_49	[p4l1271t2115r1404b2169],
39	)	CD	NUMBER	)	dep	35	SENT_49	[p4l1271t2115r1404b2169],
40	142	CD	NUMBER	142	advmod	35	SENT_49	[p4l1821t2115r1913b2158],
41	(	NN	O	(	dep	40	SENT_49	[p4l1935t2115r2067b2168],
42	37	CD	PERCENT	37	num	43	SENT_49	[p4l1935t2115r2067b2168],
43	%	NN	PERCENT	%	dep	40	SENT_49	[p4l1935t2115r2067b2168],
44	)	CD	NUMBER	)	npadvmod	45	SENT_49	[p4l1935t2115r2067b2168],
45	>	JJR	O	>	dep	35	SENT_49	[p4l22t2190r128b2234],
46	50	CD	NUMBER	50	num	47	SENT_49	[p4l22t2190r128b2234],
47	24	CD	NUMBER	24	dep	35	SENT_49	[p4l1189t2190r1251b2233],
48	(	NN	O	(	dep	55	SENT_49	[p4l1271t2190r1404b2243],
49	12	CD	PERCENT	12	num	50	SENT_49	[p4l1271t2190r1404b2243],
50	%	NN	PERCENT	%	dep	48	SENT_49	[p4l1271t2190r1404b2243],
51	)	CD	PERCENT	)	number	52	SENT_49	[p4l1271t2190r1404b2243],
52	50	CD	PERCENT	50	dep	50	SENT_49	[p4l1852t2190r1914b2234],
53	(	CD	PERCENT	(	dep	55	SENT_49	[p4l1934t2190r2067b2243],
54	13	CD	PERCENT	13	num	55	SENT_49	[p4l1934t2190r2067b2243],
55	%	NN	PERCENT	%	dep	1	SENT_49	[p4l1934t2190r2067b2243],
56	)	CD	NUMBER	)	dep	55	SENT_49	[p4l1934t2190r2067b2243],

1	Age	NN	O	age	dep	9	SENT_50	[p4l18t2337r112b2391],
2	at	IN	O	at	_	0	SENT_50	[p4l131t2339r179b2380],
3	2nd	JJ	ORDINAL	2nd	amod	5	SENT_50	[p4l199t2337r287b2380],
4	breast	NN	O	breast	nn	5	SENT_50	[p4l309t2337r460b2380],
5	cancer	NN	O	cancer	prep_at	1	SENT_50	[p4l479t2348r645b2380],
6	(	CD	NUMBER	(	num	7	SENT_50	[p4l663t2337r862b2391],
7	years	NNS	NUMBER	year	dep	9	SENT_50	[p4l663t2337r862b2391],
8	)	CD	NUMBER	)	num	9	SENT_50	[p4l663t2337r862b2391],
9	*	CD	NUMBER	*	dep	13	SENT_50	[p4l663t2337r862b2391],
10	45-5	CD	NUMBER	45-5	num	11	SENT_50	[p4l1188t2337r1299b2380],
11	(	NN	O	(	dep	9	SENT_50	[p4l1320t2337r1431b2390],
12	9-8	CD	NUMBER	9-8	num	13	SENT_50	[p4l1320t2337r1431b2390],
13	)	NN	O	)	_	0	SENT_50	[p4l1320t2337r1431b2390],

1	Mutationt	JJ	O	mutationt	amod	2	SENT_51	[p4l21t2483r270b2536],
2	BRCA1	NN	O	brca1	dep	9	SENT_51	[p4l20t2557r179b2600],
3	168	CD	NUMBER	168	num	4	SENT_51	[p4l1157t2557r1251b2600],
4	(	NN	O	(	dep	2	SENT_51	[p4l1271t2557r1404b2610],
5	80	CD	PERCENT	80	num	6	SENT_51	[p4l1271t2557r1404b2610],
6	%	NN	PERCENT	%	dep	9	SENT_51	[p4l1271t2557r1404b2610],
7	)	CD	NUMBER	)	number	8	SENT_51	[p4l1271t2557r1404b2610],
8	308	CD	NUMBER	308	num	9	SENT_51	[p4l1818t2557r1914b2600],
9	(	NN	O	(	dep	12	SENT_51	[p4l1934t2557r2067b2610],
10	80	CD	PERCENT	80	num	11	SENT_51	[p4l1934t2557r2067b2610],
11	%	NN	PERCENT	%	dep	9	SENT_51	[p4l1934t2557r2067b2610],
12	)	CD	NUMBER	)	dep	13	SENT_51	[p4l1934t2557r2067b2610],
13	BRCA2	NN	O	brca2	dep	17	SENT_51	[p4l20t2631r180b2674],
14	41	CD	PERCENT	41	num	13	SENT_51	[p4l1188t2631r1250b2673],
15	(	CD	PERCENT	(	num	17	SENT_51	[p4l1271t2630r1404b2684],
16	20	CD	PERCENT	20	num	17	SENT_51	[p4l1271t2630r1404b2684],
17	%	NN	PERCENT	%	dep	23	SENT_51	[p4l1271t2630r1404b2684],
18	)	CD	NUMBER	)	number	19	SENT_51	[p4l1271t2630r1404b2684],
19	76	CD	NUMBER	76	num	20	SENT_51	[p4l1853t2630r1913b2674],
20	(	NN	O	(	dep	17	SENT_51	[p4l1934t2630r2067b2684],
21	20	CD	PERCENT	20	number	22	SENT_51	[p4l1934t2630r2067b2684],
22	%	NN	PERCENT	%	amod	20	SENT_51	[p4l1934t2630r2067b2684],
23	)	CD	NUMBER	)	_	0	SENT_51	[p4l1934t2630r2067b2684],

1	Parity	NN	O	parity	nn	2	SENT_52	[p4l21t2777r161b2831],
2	o	NN	O	o	dep	11	SENT_52	[p4l19t2852r49b2896],
3	36	CD	PERCENT	36	num	4	SENT_52	[p4l1188t2852r1250b2896],
4	(	NN	PERCENT	(	dep	2	SENT_52	[p4l1271t2852r1404b2905],
5	17	CD	PERCENT	17	num	6	SENT_52	[p4l1271t2852r1404b2905],
6	%	NN	PERCENT	%	dep	4	SENT_52	[p4l1271t2852r1404b2905],
7	)	CD	NUMBER	)	number	8	SENT_52	[p4l1271t2852r1404b2905],
8	60	CD	NUMBER	60	num	6	SENT_52	[p4l1852t2852r1914b2896],
9	(	NN	O	(	dep	11	SENT_52	[p4l1934t2852r2067b2905],
10	16	CD	PERCENT	16	num	11	SENT_52	[p4l1934t2852r2067b2905],
11	%	NN	PERCENT	%	dep	17	SENT_52	[p4l1934t2852r2067b2905],
12	)	CD	PERCENT	)	number	13	SENT_52	[p4l1934t2852r2067b2905],
13	1	CD	PERCENT	1	dep	11	SENT_52	[p4l22t2926r49b2969],
14	29	CD	PERCENT	29	num	15	SENT_52	[p4l1189t2926r1250b2969],
15	(	NN	PERCENT	(	dep	13	SENT_52	[p4l1271t2926r1404b2979],
16	14	CD	PERCENT	14	num	17	SENT_52	[p4l1271t2926r1404b2979],
17	%	NN	PERCENT	%	dep	26	SENT_52	[p4l1271t2926r1404b2979],
18	)	CD	NUMBER	)	num	20	SENT_52	[p4l1271t2926r1404b2979],
19	65	CD	NUMBER	65	num	20	SENT_52	[p4l1852t2926r1913b2969],
20	(	NN	O	(	dep	17	SENT_52	[p4l1934t2926r2067b2979],
21	17	CD	PERCENT	17	num	22	SENT_52	[p4l1934t2926r2067b2979],
22	%	NN	PERCENT	%	dep	20	SENT_52	[p4l1934t2926r2067b2979],
23	)	CD	NUMBER	)	number	24	SENT_52	[p4l1934t2926r2067b2979],
24	22	CD	NUMBER	22	num	22	SENT_52	[p4l22t2999r93b3042],
25	144	CD	NUMBER	144	num	26	SENT_52	[p4l1157t3000r1251b3042],
26	(	NN	O	(	dep	28	SENT_52	[p4l1271t2999r1404b3053],
27	70	CD	PERCENT	70	num	28	SENT_52	[p4l1271t2999r1404b3053],
28	%	NN	PERCENT	%	dep	34	SENT_52	[p4l1271t2999r1404b3053],
29	)	CD	NUMBER	)	number	30	SENT_52	[p4l1271t2999r1404b3053],
30	259	CD	NUMBER	259	num	31	SENT_52	[p4l1819t2999r1913b3043],
31	(	NN	O	(	dep	28	SENT_52	[p4l1934t2999r2067b3052],
32	66	CD	PERCENT	66	number	33	SENT_52	[p4l1934t2999r2067b3052],
33	%	NN	PERCENT	%	amod	31	SENT_52	[p4l1934t2999r2067b3052],
34	)	CD	NUMBER	)	_	0	SENT_52	[p4l1934t2999r2067b3052],

1	Place	NN	O	place	dep	8	SENT_53	[p4l21t3150r154b3193],
2	of	IN	O	of	_	0	SENT_53	[p4l173t3149r219b3193],
3	residencet	NN	O	residencet	nn	4	SENT_53	[p4l237t3149r502b3203],
4	Canada	NNP	LOCATION	Canada	prep_of	1	SENT_53	[p4l20t3224r197b3268],
5	47	CD	PERCENT	47	num	4	SENT_53	[p4l1188t3224r1249b3267],
6	(	CD	PERCENT	(	dep	8	SENT_53	[p4l1271t3224r1404b3277],
7	23	CD	PERCENT	23	num	8	SENT_53	[p4l1271t3224r1404b3277],
8	%	NN	PERCENT	%	dep	15	SENT_53	[p4l1271t3224r1404b3277],
9	)	CD	NUMBER	)	number	10	SENT_53	[p4l1271t3224r1404b3277],
10	81	CD	NUMBER	81	num	11	SENT_53	[p4l1852t3224r1914b3268],
11	(	NN	O	(	dep	8	SENT_53	[p4l1935t3224r2067b3277],
12	21	CD	PERCENT	21	number	13	SENT_53	[p4l1935t3224r2067b3277],
13	%	NN	PERCENT	%	amod	11	SENT_53	[p4l1935t3224r2067b3277],
14	)	CD	NUMBER	)	num	15	SENT_53	[p4l1935t3224r2067b3277],
15	USA	NNP	ORGANIZATION	USA	dep	24	SENT_53	[p4l22t3298r118b3341],
16	98	CD	PERCENT	98	num	15	SENT_53	[p4l1189t3298r1251b3341],
17	(	CD	PERCENT	(	number	18	SENT_53	[p4l1271t3298r1404b3351],
18	47	CD	PERCENT	47	num	19	SENT_53	[p4l1271t3298r1404b3351],
19	%	NN	PERCENT	%	dep	15	SENT_53	[p4l1271t3298r1404b3351],
20	)	CD	NUMBER	)	num	22	SENT_53	[p4l1271t3298r1404b3351],
21	194	CD	NUMBER	194	num	22	SENT_53	[p4l1821t3298r1914b3341],
22	(	NN	O	(	dep	19	SENT_53	[p4l1934t3298r2067b3351],
23	51	CD	PERCENT	51	num	24	SENT_53	[p4l1934t3298r2067b3351],
24	%	NN	PERCENT	%	dep	30	SENT_53	[p4l1934t3298r2067b3351],
25	)	CD	NUMBER	)	num	26	SENT_53	[p4l1934t3298r2067b3351],
26	Europe	NNP	ORGANIZATION	Europe	dep	24	SENT_53	[p4l22t3372r183b3424],
27	64	CD	PERCENT	64	num	26	SENT_53	[p4l1189t3371r1251b3415],
28	(	CD	PERCENT	(	num	30	SENT_53	[p4l1271t3371r1404b3425],
29	31	CD	PERCENT	31	num	30	SENT_53	[p4l1271t3371r1404b3425],
30	%	NN	PERCENT	%	dep	36	SENT_53	[p4l1271t3371r1404b3425],
31	)	CD	NUMBER	)	number	32	SENT_53	[p4l1271t3371r1404b3425],
32	109	CD	NUMBER	109	num	33	SENT_53	[p4l1821t3371r1913b3415],
33	(	NN	O	(	dep	30	SENT_53	[p4l1935t3371r2067b3424],
34	25	CD	PERCENT	25	number	35	SENT_53	[p4l1935t3371r2067b3424],
35	%	NN	PERCENT	%	amod	33	SENT_53	[p4l1935t3371r2067b3424],
36	)	CD	NUMBER	)	_	0	SENT_53	[p4l1935t3371r2067b3424],

1	Race	NN	O	race	dep	10	SENT_54	[p4l21t3524r142b3567],
2	or	CC	O	or	_	0	SENT_54	[p4l160t3534r208b3567],
3	ethnic	JJ	O	ethnic	amod	6	SENT_54	[p4l225t3523r376b3567],
4	groupt	JJ	O	groupt	amod	6	SENT_54	[p4l395t3524r562b3577],
5	Ashkenazi	NNP	MISC	Ashkenazi	nn	6	SENT_54	[p4l18t3598r255b3642],
6	Jewish	NNP	MISC	Jewish	conj_or	1	SENT_54	[p4l276t3598r432b3642],
7	61	CD	PERCENT	61	num	6	SENT_54	[p4l1189t3598r1250b3641],
8	(	CD	PERCENT	(	dep	10	SENT_54	[p4l1271t3598r1404b3651],
9	29	CD	PERCENT	29	num	10	SENT_54	[p4l1271t3598r1404b3651],
10	%	NN	PERCENT	%	dep	21	SENT_54	[p4l1271t3598r1404b3651],
11	)	CD	NUMBER	)	number	12	SENT_54	[p4l1271t3598r1404b3651],
12	128	CD	NUMBER	128	num	13	SENT_54	[p4l1821t3598r1914b3642],
13	(	NN	O	(	dep	10	SENT_54	[p4l1935t3598r2067b3651],
14	33	CD	PERCENT	33	number	15	SENT_54	[p4l1935t3598r2067b3651],
15	%	NN	PERCENT	%	amod	13	SENT_54	[p4l1935t3598r2067b3651],
16	)	CD	NUMBER	)	num	19	SENT_54	[p4l1935t3598r2067b3651],
17	French-Canadian	JJ	MISC	french-canadian	amod	19	SENT_54	[p4l22t3672r411b3715],
18	15	CD	NUMBER	15	tmod	17	SENT_54	[p4l1190t3672r1250b3715],
19	(	NN	O	(	dep	13	SENT_54	[p4l1271t3672r1370b3725],
20	7	CD	PERCENT	7	num	21	SENT_54	[p4l1271t3672r1370b3725],
21	%	NN	PERCENT	%	dep	36	SENT_54	[p4l1271t3672r1370b3725],
22	)	CD	NUMBER	)	number	23	SENT_54	[p4l1271t3672r1370b3725],
23	28	CD	NUMBER	28	num	24	SENT_54	[p4l1852t3672r1914b3715],
24	(	NN	O	(	dep	21	SENT_54	[p4l1935t3672r2034b3725],
25	7	CD	PERCENT	7	number	26	SENT_54	[p4l1935t3672r2034b3725],
26	%	NN	PERCENT	%	amod	24	SENT_54	[p4l1935t3672r2034b3725],
27	)	CD	NUMBER	)	num	36	SENT_54	[p4l1935t3672r2034b3725],
28	Other	JJ	O	other	amod	36	SENT_54	[p4l20t3745r149b3789],
29	white	JJ	O	white	amod	36	SENT_54	[p4l166t3746r289b3789],
30	123	CD	PERCENT	123	number	31	SENT_54	[p4l1157t3745r1250b3789],
31	(	CD	PERCENT	(	amod	36	SENT_54	[p4l1271t3745r1404b3799],
32	59	CD	PERCENT	59	num	33	SENT_54	[p4l1271t3745r1404b3799],
33	%	NN	PERCENT	%	dep	31	SENT_54	[p4l1271t3745r1404b3799],
34	)	CD	NUMBER	)	number	35	SENT_54	[p4l1271t3745r1404b3799],
35	221	CD	NUMBER	221	num	36	SENT_54	[p4l1819t3745r1914b3788],
36	(	NN	O	(	dep	39	SENT_54	[p4l1935t3745r2067b3799],
37	57	CD	PERCENT	57	num	38	SENT_54	[p4l1935t3745r2067b3799],
38	%	NN	PERCENT	%	dep	36	SENT_54	[p4l1935t3745r2067b3799],
39	)	CD	NUMBER	)	_	0	SENT_54	[p4l1935t3745r2067b3799],

1	Non	JJ	O	non	amod	2	SENT_55	[p5l22t17r249b61],
2	—	NN	O	—	_	0	SENT_55	[p5l22t17r249b61],
3	white	JJ	O	white	amod	10	SENT_55	[p5l22t17r249b61],
4	10	CD	PERCENT	10	number	5	SENT_55	[p5l1190t17r1251b61],
5	(	CD	PERCENT	(	prep	3	SENT_55	[p5l1271t17r1370b70],
6	5	CD	PERCENT	5	num	7	SENT_55	[p5l1271t17r1370b70],
7	%	NN	PERCENT	%	dep	5	SENT_55	[p5l1271t17r1370b70],
8	)	CD	NUMBER	)	number	9	SENT_55	[p5l1271t17r1370b70],
9	7	CD	NUMBER	7	num	10	SENT_55	[p5l1886t17r1912b60],
10	(	NN	O	(	dep	2	SENT_55	[p5l1935t17r2034b70],
11	2	CD	PERCENT	2	number	12	SENT_55	[p5l1935t17r2034b70],
12	%	NN	PERCENT	%	amod	10	SENT_55	[p5l1935t17r2034b70],
13	)	CD	NUMBER	)	dep	2	SENT_55	[p5l1935t17r2034b70],

1	Smoking	NN	O	smoking	nn	2	SENT_56	[p5l18t159r231b213],
2	historyti	NNS	O	historytus	dep	12	SENT_56	[p5l250t159r473b213],
3	Never	RB	O	never	advmod	7	SENT_56	[p5l22t233r156b276],
4	106	CD	PERCENT	106	number	5	SENT_56	[p5l1157t233r1250b276],
5	(	CD	PERCENT	(	pobj	3	SENT_56	[p5l1271t233r1404b286],
6	56	CD	PERCENT	56	num	7	SENT_56	[p5l1271t233r1404b286],
7	%	NN	PERCENT	%	dep	2	SENT_56	[p5l1271t233r1404b286],
8	)	CD	NUMBER	)	dep	7	SENT_56	[p5l1271t233r1404b286],
9	198	CD	NUMBER	198	num	10	SENT_56	[p5l1821t233r1914b276],
10	(	NN	O	(	dep	12	SENT_56	[p5l1935t233r2067b286],
11	58	CD	PERCENT	58	num	12	SENT_56	[p5l1935t233r2067b286],
12	%	NN	PERCENT	%	dep	14	SENT_56	[p5l1935t233r2067b286],
13	)	CD	NUMBER	)	dep	12	SENT_56	[p5l1935t233r2067b286],
14	Before	IN	O	before	dep	17	SENT_56	[p5l22t306r173b350],
15	1st	JJ	ORDINAL	1st	amod	16	SENT_56	[p5l195t307r271b350],
16	breast	NN	O	breast	pobj	14	SENT_56	[p5l290t307r440b350],
17	cancer	NN	O	cancer	dep	21	SENT_56	[p5l458t317r616b350],
18	39	CD	PERCENT	39	num	17	SENT_56	[p5l1188t306r1250b350],
19	(	CD	PERCENT	(	num	21	SENT_56	[p5l1271t306r1404b360],
20	21	CD	PERCENT	21	num	21	SENT_56	[p5l1271t306r1404b360],
21	%	NN	PERCENT	%	dep	27	SENT_56	[p5l1271t306r1404b360],
22	)	CD	NUMBER	)	number	23	SENT_56	[p5l1271t306r1404b360],
23	76	CD	NUMBER	76	num	24	SENT_56	[p5l1854t306r1914b350],
24	(	NN	O	(	dep	21	SENT_56	[p5l1935t306r2068b360],
25	22	CD	PERCENT	22	number	26	SENT_56	[p5l1935t306r2068b360],
26	%	NN	PERCENT	%	amod	24	SENT_56	[p5l1935t306r2068b360],
27	)	CD	NUMBER	)	dep	28	SENT_56	[p5l1935t306r2068b360],
28	After	IN	O	after	dep	31	SENT_56	[p5l18t381r130b425],
29	1st	JJ	ORDINAL	1st	amod	30	SENT_56	[p5l150t381r225b425],
30	breast	NN	O	breast	pobj	28	SENT_56	[p5l245t381r395b425],
31	cancer	NN	O	cancer	dep	35	SENT_56	[p5l413t391r571b425],
32	44	CD	PERCENT	44	num	31	SENT_56	[p5l1188t381r1251b424],
33	(	CD	PERCENT	(	num	35	SENT_56	[p5l1271t381r1404b434],
34	23	CD	PERCENT	23	num	35	SENT_56	[p5l1271t381r1404b434],
35	%	NN	PERCENT	%	dep	40	SENT_56	[p5l1271t381r1404b434],
36	)	CD	PERCENT	)	number	37	SENT_56	[p5l1271t381r1404b434],
37	65	CD	PERCENT	65	dep	35	SENT_56	[p5l1852t381r1914b425],
38	19	CD	PERCENT	19	num	39	SENT_56	[p5l1953t381r2068b434],
39	%	NN	PERCENT	%	dep	37	SENT_56	[p5l1953t381r2068b434],
40	)	CD	NUMBER	)	_	0	SENT_56	[p5l1953t381r2068b434],

1	*	NN	O	*	nn	2	SENT_57	[p5l23t489r210b532],
2	values	NNS	O	value	nsubj	6	SENT_57	[p5l23t489r210b532],
3	are	VBP	O	be	cop	6	SENT_57	[p5l230t499r304b532],
4	mean	JJ	O	mean	amod	6	SENT_57	[p5l326t499r452b532],
5	(	JJ	O	(	amod	6	SENT_57	[p5l475t489r573b542],
6	SD	NN	O	sd	_	0	SENT_57	[p5l475t489r573b542],
7	)	CD	NUMBER	)	dep	6	SENT_57	[p5l475t489r573b542],
8	or	CC	O	or	_	0	SENT_57	[p5l594t499r640b532],
9	Tnumber	NNP	PERCENT	Tnumber	conj_or	6	SENT_57	[p5l659t489r870b542],
10	(	CD	PERCENT	(	num	11	SENT_57	[p5l889t489r969b542],
11	%	NN	PERCENT	%	dep	9	SENT_57	[p5l889t489r969b542],
12	)	CD	NUMBER	)	dep	9	SENT_57	[p5l889t489r969b542],
13	.	.	O	.	_	0	SENT_57	[p5l889t489r969b542],

1	3	CD	NUMBER	3	_	0	SENT_58	[p5l992t489r1225b543],
2	:	:	O	:	_	0	SENT_58	[p5l992t489r1225b543],
3	Smoking	VBG	O	smoke	amod	4	SENT_58	[p5l992t489r1225b543],
4	information	NN	O	information	nsubj	6	SENT_58	[p5l1245t489r1509b532],
5	was	VBD	O	be	aux	6	SENT_58	[p5l1529t499r1621b532],
6	missing	VBG	O	miss	dep	1	SENT_58	[p5l1643t489r1825b543],
7	for	IN	O	for	_	0	SENT_58	[p5l1842t489r1906b532],
8	20	CD	NUMBER	20	num	10	SENT_58	[p5l1924t489r1986b532],
9	bilateral-disease	NN	O	bilateral-disease	nn	10	SENT_58	[p5l21t559r410b602],
10	cases	NNS	O	case	prep_for	6	SENT_58	[p5l430t569r569b602],
11	and	CC	O	and	_	0	SENT_58	[p5l590t559r673b602],
12	45	CD	NUMBER	45	num	13	SENT_58	[p5l695t559r757b602],
13	controls	NNS	O	control	prep_for	6	SENT_58	[p5l777t559r980b602],
14	.	.	O	.	_	0	SENT_58	[p5l777t559r980b602],

1	Table	NNP	O	Table	_	0	SENT_59	[p5l18t653r192b705],
2	1	CD	NUMBER	1	num	1	SENT_59	[p5l223t653r279b705],
3	:	:	O	:	_	0	SENT_59	[p5l223t653r279b705],
4	Characteristics	NNS	O	characteristic	dep	1	SENT_59	[p5l310t652r821b705],
5	of	IN	O	of	_	0	SENT_59	[p5l847t652r910b705],
6	cases	NNS	O	case	conj_and	6	SENT_59	[p5l933t665r1126b705],
7	with	IN	O	with	_	0	SENT_59	[p5l1150t652r1291b705],
8	bilateral	JJ	O	bilateral	amod	9	SENT_59	[p5l1321t652r1588b705],
9	disease	NN	O	disease	prep_with	6	SENT_59	[p5l1616t652r1869b705],
10	and	CC	O	and	_	0	SENT_59	[p5l1896t653r2012b705],
11	of	IN	O	of	_	0	SENT_59	[p5l2039t652r2103b705],
12	controls	NNS	O	control	prep_of	6	SENT_59	[p5l19t737r289b790],

1	Europe	NNP	LOCATION	Europe	nn	5	SENT_60	[p5l17t940r281b1014],
2	or	CC	O	or	_	0	SENT_60	[p5l335t958r408b999],
3	North	NNP	LOCATION	North	conj_or	1	SENT_60	[p5l455t939r677b999],
4	America	NNP	LOCATION	America	nn	5	SENT_60	[p5l726t939r1055b1013],
5	)	NN	O	)	_	0	SENT_60	[p5l726t939r1055b1013],
6	at	IN	O	at	_	0	SENT_60	[p5l1114t952r1178b999],
7	time	NN	O	time	prep_at	5	SENT_60	[p5l1227t939r1386b999],
8	of	IN	O	of	_	0	SENT_60	[p5l1439t939r1516b999],
9	diagnosis	NN	O	diagnosis	prep_of	5	SENT_60	[p5l1558t939r1907b1014],
10	.	.	O	.	_	0	SENT_60	[p5l1558t939r1907b1014],

1	Each	DT	O	each	det	2	SENT_61	[p5l1963t939r2144b999],
2	control	NN	O	control	nsubjpass	4	SENT_61	[p5l19t1030r273b1090],
3	was	VBD	O	be	auxpass	4	SENT_61	[p5l302t1050r433b1090],
4	followed	VBN	O	follow	_	0	SENT_61	[p5l464t1030r772b1090],
5	up	RP	O	up	prt	4	SENT_61	[p5l801t1050r892b1105],
6	for	IN	O	for	_	0	SENT_61	[p5l923t1030r1025b1090],
7	a	DT	O	a	det	9	SENT_61	[p5l1055t1050r1090b1090],
8	similar	JJ	O	similar	amod	9	SENT_61	[p5l1122t1030r1364b1090],
9	length	NN	O	length	prep_for	4	SENT_61	[p5l1391t1030r1615b1105],
10	of	IN	O	of	_	0	SENT_61	[p5l1646t1030r1723b1090],
11	time	NN	O	time	prep_of	9	SENT_61	[p5l1743t1030r1901b1090],
12	as	IN	O	as	_	0	SENT_61	[p5l1934t1050r2000b1090],
13	the	DT	O	the	det	15	SENT_61	[p5l2031t1030r2142b1090],
14	matched	VBN	O	match	amod	15	SENT_61	[p5l17t1122r328b1183],
15	case	NN	O	case	prep_as	4	SENT_61	[p5l362t1142r527b1182],
16	.	.	O	.	_	0	SENT_61	[p5l362t1142r527b1182],

1	Women	NNS	O	woman	nsubj	3	SENT_62	[p5l562t1123r851b1183],
2	were	VBD	O	be	cop	3	SENT_62	[p5l881t1142r1049b1183],
3	ineligible	JJ	O	ineligible	_	0	SENT_62	[p5l1082t1122r1405b1197],
4	to	TO	O	to	aux	5	SENT_62	[p5l1438t1136r1507b1182],
5	serve	VB	O	serve	xcomp	3	SENT_62	[p5l1541t1142r1719b1183],
6	as	IN	O	as	_	0	SENT_62	[p5l1753t1142r1820b1182],
7	controls	NNS	O	control	prep_as	5	SENT_62	[p5l1855t1122r2141b1182],
8	if	IN	O	if	mark	11	SENT_62	[p5l17t1215r73b1274],
9	they	PRP	O	they	nsubjpass	11	SENT_62	[p5l130t1215r282b1290],
10	were	VBD	O	be	auxpass	11	SENT_62	[p5l346t1234r514b1275],
11	diagnosed	VBN	O	diagnose	dep	5	SENT_62	[p5l584t1215r945b1290],
12	before	IN	O	before	_	0	SENT_62	[p5l1011t1215r1236b1275],
13	1970	CD	DATE	1970	prep_before	11	SENT_62	[p5l1313t1217r1507b1287],
14	,	,	O	,	_	0	SENT_62	[p5l1313t1217r1507b1287],
15	if	IN	O	if	mark	17	SENT_62	[p5l1577t1215r1632b1274],
16	they	PRP	O	they	nsubj	17	SENT_62	[p5l1689t1215r1841b1290],
17	had	VBD	O	have	dep	11	SENT_62	[p5l1906t1215r2039b1275],
18	a	DT	O	a	det	20	SENT_62	[p5l2108t1234r2143b1275],
19	contralateral	JJ	O	contralateral	amod	20	SENT_62	[p5l19t1306r468b1366],
20	mastectomy	NN	O	mastectomy	dobj	17	SENT_62	[p5l515t1320r971b1381],
21	,	,	O	,	_	0	SENT_62	[p5l515t1320r971b1381],
22	or	CC	O	or	_	0	SENT_62	[p5l1023t1326r1097b1366],
23	if	IN	O	if	mark	25	SENT_62	[p5l1142t1306r1198b1365],
24	they	PRP	O	they	nsubj	25	SENT_62	[p5l1235t1306r1387b1381],
25	had	VBD	O	have	conj_or	11	SENT_62	[p5l1432t1306r1565b1366],
26	a	DT	O	a	det	27	SENT_62	[p5l1614t1326r1649b1366],
27	diagnosis	NN	O	diagnosis	dobj	25	SENT_62	[p5l1698t1306r2026b1381],
28	of	IN	O	of	_	0	SENT_62	[p5l2076t1306r2153b1366],
29	ovarian	JJ	O	ovarian	amod	30	SENT_62	[p5l19t1399r282b1459],
30	cancer	NN	O	cancer	prep_of	27	SENT_62	[p5l323t1418r557b1458],
31	before	IN	O	before	_	0	SENT_62	[p5l594t1398r819b1458],
32	or	CC	O	or	_	0	SENT_62	[p5l862t1418r937b1458],
33	during	IN	O	during	_	0	SENT_62	[p5l976t1398r1213b1473],
34	the	DT	O	the	det	35	SENT_62	[p5l1251t1398r1361b1458],
35	follow-up	NN	O	follow-up	prep_before	25	SENT_62	[p5l1402t1398r1766b1473],
36	.	.	O	.	_	0	SENT_62	[p5l1402t1398r1766b1473],

1	For	IN	O	for	_	0	SENT_63	[p5l1812t1399r1942b1458],
2	each	DT	O	each	det	3	SENT_63	[p5l1982t1398r2143b1458],
3	case	NN	O	case	prep_for	9	SENT_63	[p5l19t1510r165b1551],
4	with	IN	O	with	_	0	SENT_63	[p5l207t1491r364b1551],
5	bilateral	JJ	O	bilateral	amod	6	SENT_63	[p5l405t1491r695b1551],
6	cancer	NN	O	cancer	prep_with	3	SENT_63	[p5l739t1510r993b1563],
7	,	,	O	,	_	0	SENT_63	[p5l739t1510r993b1563],
8	we	PRP	O	we	nsubj	20	SENT_63	[p5l1037t1510r1135b1551],
9	attempted	VBD	O	attempt	_	0	SENT_63	[p5l1180t1491r1544b1566],
10	to	TO	O	to	aux	11	SENT_63	[p5l1586t1504r1654b1551],
11	identify	VB	O	identify	xcomp	9	SENT_63	[p5l1699t1491r1971b1566],
12	two	CD	NUMBER	two	num	13	SENT_63	[p5l2011t1504r2141b1551],
13	controls	NNS	O	control	dobj	11	SENT_63	[p5l19t1581r305b1642],
14	with	IN	O	with	_	0	SENT_63	[p5l334t1581r491b1642],
15	unilateral	JJ	O	unilateral	amod	16	SENT_63	[p5l518t1581r857b1642],
16	disease	NN	O	disease	prep_with	11	SENT_63	[p5l887t1581r1158b1653],
17	,	,	O	,	_	0	SENT_63	[p5l887t1581r1158b1653],
18	and	CC	O	and	_	0	SENT_63	[p5l1192t1581r1323b1642],
19	were	VBD	O	be	cop	20	SENT_63	[p5l1350t1601r1518b1642],
20	able	JJ	O	able	conj_and	9	SENT_63	[p5l1549t1581r1692b1642],
21	to	TO	O	to	aux	22	SENT_63	[p5l1721t1595r1790b1642],
22	do	VB	O	do	xcomp	20	SENT_63	[p5l1822t1581r1909b1642],
23	so	RB	O	so	advmod	22	SENT_63	[p5l1941t1601r2013b1642],
24	for	IN	O	for	_	0	SENT_63	[p5l2043t1581r2145b1642],
25	175	CD	NUMBER	175	prep_for	22	SENT_63	[p5l27t1677r148b1735],
26	of	IN	O	of	_	0	SENT_63	[p5l183t1674r259b1735],
27	the	DT	O	the	det	29	SENT_63	[p5l276t1674r387b1735],
28	213	CD	NUMBER	213	num	29	SENT_63	[p5l417t1677r547b1735],
29	cases	NNS	O	case	prep_of	25	SENT_63	[p5l580t1694r759b1735],
30	of	IN	O	of	_	0	SENT_63	[p5l790t1674r866b1735],
31	bilateral	JJ	O	bilateral	amod	33	SENT_63	[p5l882t1674r1173b1735],
32	breast	NN	O	breast	nn	33	SENT_63	[p5l1200t1674r1417b1735],
33	cancer	NN	O	cancer	prep_of	29	SENT_63	[p5l1445t1694r1696b1735],
34	:	:	O	:	_	0	SENT_63	[p5l1445t1694r1696b1735],
35	one	CD	NUMBER	one	num	36	SENT_63	[p5l1731t1694r1858b1735],
36	control	NN	O	control	nsubjpass	38	SENT_63	[p5l1888t1674r2142b1735],
37	was	VBD	O	be	auxpass	38	SENT_63	[p5l16t1788r147b1828],
38	found	VBN	O	find	parataxis	9	SENT_63	[p5l174t1768r387b1828],
39	for	IN	O	for	_	0	SENT_63	[p5l412t1768r514b1828],
40	an	DT	O	a	det	44	SENT_63	[p5l540t1787r623b1828],
41	additional	JJ	O	additional	amod	44	SENT_63	[p5l650t1768r1010b1828],
42	34	CD	NUMBER	34	num	44	SENT_63	[p5l1038t1770r1124b1828],
43	bilateral-disease	NN	O	bilateral-disease	nn	44	SENT_63	[p5l1149t1768r1724b1828],
44	cases	NNS	O	case	prep_for	38	SENT_63	[p5l1753t1788r1952b1828],
45	.	.	O	.	_	0	SENT_63	[p5l1753t1788r1952b1828],

1	Cases	NNS	O	case	nsubj	9	SENT_64	[p5l105t1860r308b1921],
2	with	IN	O	with	_	0	SENT_64	[p5l375t1860r532b1921],
3	bilateral	JJ	O	bilateral	amod	4	SENT_64	[p5l596t1860r887b1921],
4	disease	NN	O	disease	prep_with	1	SENT_64	[p5l954t1860r1205b1921],
5	and	CC	O	and	_	0	SENT_64	[p5l1273t1860r1405b1921],
6	controls	NNS	O	control	conj_and	4	SENT_64	[p5l1473t1860r1759b1921],
7	had	VBD	O	have	aux	9	SENT_64	[p5l1825t1860r1958b1921],
8	not	RB	O	not	neg	9	SENT_64	[p5l2024t1874r2144b1921],
9	received	VBN	O	receive	_	0	SENT_64	[p5l17t1953r313b2014],
10	tamoxifen	NN	O	tamoxifen	dobj	9	SENT_64	[p5l337t1953r698b2013],
11	before	IN	O	before	_	0	SENT_64	[p5l720t1953r945b2013],
12	diagnosis	NN	O	diagnosis	prep_before	9	SENT_64	[p5l972t1953r1300b2028],
13	of	IN	O	of	_	0	SENT_64	[p5l1327t1953r1404b2013],
14	initial	JJ	O	initial	amod	16	SENT_64	[p5l1418t1953r1620b2013],
15	breast	NN	O	breast	nn	16	SENT_64	[p5l1644t1953r1861b2013],
16	cancer	NN	O	cancer	prep_of	12	SENT_64	[p5l1887t1973r2137b2013],
17	.	.	O	.	_	0	SENT_64	[p5l1887t1973r2137b2013],

1	All	PDT	O	all	predet	3	SENT_65	[p5l16t2046r119b2105],
2	the	DT	O	the	det	3	SENT_65	[p5l158t2046r269b2106],
3	exposures	NNS	O	exposure	nsubjpass	11	SENT_65	[p5l310t2065r661b2121],
4	to	TO	O	to	_	0	SENT_65	[p5l701t2059r770b2106],
5	tamoxifen	NN	O	tamoxifen	prep_to	3	SENT_65	[p5l810t2046r1171b2106],
6	in	IN	O	in	_	0	SENT_65	[p5l1209t2046r1277b2105],
7	cases	NNS	O	case	prep_in	5	SENT_65	[p5l1317t2065r1495b2106],
8	and	CC	O	and	_	0	SENT_65	[p5l1537t2046r1669b2106],
9	controls	NNS	O	control	prep_in	5	SENT_65	[p5l1709t2046r1995b2106],
10	are	VBP	O	be	auxpass	11	SENT_65	[p5l2037t2065r2142b2106],
11	deﬁned	VBN	O	deﬁned	_	0	SENT_65	[p5l19t2137r285b2197],
12	for	IN	O	for	_	0	SENT_65	[p5l323t2137r424b2197],
13	the	DT	O	the	det	14	SENT_65	[p5l460t2137r570b2197],
14	period	NN	O	period	prep_for	11	SENT_65	[p5l608t2137r840b2212],
15	equivalent	JJ	O	equivalent	amod	14	SENT_65	[p5l879t2137r1249b2212],
16	to	TO	O	to	_	0	SENT_65	[p5l1286t2151r1355b2197],
17	that	DT	O	that	prep_to	15	SENT_65	[p5l1394t2137r1535b2197],
18	before	IN	O	before	_	0	SENT_65	[p5l1570t2137r1796b2197],
19	development	NN	O	development	prep_before	17	SENT_65	[p5l1836t2137r2142b2212, p5l17t2243r203b2290],
20	of	IN	O	of	_	0	SENT_65	[p5l229t2229r306b2290],
21	the	DT	O	the	det	23	SENT_65	[p5l321t2229r432b2290],
22	contralateral	JJ	O	contralateral	amod	23	SENT_65	[p5l461t2229r910b2290],
23	cancer	NN	O	cancer	prep_of	19	SENT_65	[p5l937t2249r1172b2290],
24	of	IN	O	of	_	0	SENT_65	[p5l1197t2229r1274b2290],
25	the	DT	O	the	det	27	SENT_65	[p5l1289t2229r1400b2290],
26	matched	VBN	O	match	amod	27	SENT_65	[p5l1426t2229r1737b2290],
27	case	NN	O	case	prep_of	23	SENT_65	[p5l1764t2249r1930b2290],
28	.	.	O	.	_	0	SENT_65	[p5l1764t2249r1930b2290],

1	Because	IN	O	because	_	0	SENT_66	[p5l103t2324r394b2383],
2	of	IN	O	of	prepc_because_of	10	SENT_66	[p5l456t2323r532b2383],
3	the	DT	O	the	det	4	SENT_66	[p5l581t2323r691b2383],
4	requirement	NN	O	requirement	pobj	10	SENT_66	[p5l751t2323r1195b2398],
5	for	IN	O	for	_	0	SENT_66	[p5l1253t2323r1355b2383],
6	genetic	JJ	O	genetic	amod	7	SENT_66	[p5l1412t2323r1665b2398],
7	testing	NN	O	testing	prep_for	4	SENT_66	[p5l1725t2323r1964b2398],
8	our	PRP$	O	we	poss	9	SENT_66	[p5l2023t2342r2145b2383],
9	patients	NNS	O	patient	nsubj	10	SENT_66	[p5l16t2414r298b2489],
10	represent	VBP	O	represent	_	0	SENT_66	[p5l353t2428r687b2489],
11	prevalent	JJ	O	prevalent	amod	12	SENT_66	[p5l739t2414r1073b2489],
12	cases	NNS	O	case	dobj	10	SENT_66	[p5l1128t2434r1329b2486],
13	;	:	O	;	_	0	SENT_66	[p5l1128t2434r1329b2486],
14	the	DT	DATE	the	det	16	SENT_66	[p5l1386t2414r1496b2474],
15	median	JJ	DATE	median	amod	16	SENT_66	[p5l1551t2414r1819b2474],
16	year	NN	DATE	year	nsubj	26	SENT_66	[p5l1871t2434r2022b2489],
17	of	IN	O	of	_	0	SENT_66	[p5l2076t2414r2153b2474],
18	diagnosis	NN	O	diagnosis	prep_of	16	SENT_66	[p5l19t2506r347b2581],
19	of	IN	O	of	_	0	SENT_66	[p5l389t2506r466b2566],
20	the	DT	O	the	det	23	SENT_66	[p5l494t2506r604b2566],
21	ﬁrst	JJ	O	ﬁrst	amod	23	SENT_66	[p5l644t2506r783b2567],
22	breast	NN	O	breast	nn	23	SENT_66	[p5l819t2506r1037b2567],
23	cancer	NN	O	cancer	prep_of	18	SENT_66	[p5l1077t2526r1311b2566],
24	was	VBD	O	be	cop	26	SENT_66	[p5l1346t2526r1477b2567],
25	1986	CD	DATE	1986	num	26	SENT_66	[p5l1527t2509r1697b2567],
26	(	CD	NUMBER	(	parataxis	10	SENT_66	[p5l1745t2507r2137b2581],
27	1970-98	CD	NUMBER	1970-98	num	28	SENT_66	[p5l1745t2507r2137b2581],
28	)	NN	O	)	dep	26	SENT_66	[p5l1745t2507r2137b2581],
29	.	.	O	.	_	0	SENT_66	[p5l1745t2507r2137b2581],

1	Our	PRP$	O	we	poss	2	SENT_67	[p5l20t2599r164b2659],
2	study	NN	O	study	nsubj	4	SENT_67	[p5l233t2599r428b2674],
3	was	VBD	O	be	cop	4	SENT_67	[p5l495t2618r626b2659],
4	restricted	JJ	O	restricted	_	0	SENT_67	[p5l697t2599r1033b2659],
5	to	TO	O	to	_	0	SENT_67	[p5l1103t2612r1172b2659],
6	living	VBG	O	live	amod	7	SENT_67	[p5l1244t2599r1440b2674],
7	patients	NNS	O	patient	prep_to	4	SENT_67	[p5l1507t2599r1788b2674],
8	because	IN	O	because	mark	13	SENT_67	[p5l1859t2599r2142b2659],
9	mutation	NN	O	mutation	nn	10	SENT_67	[p5l17t2690r346b2750],
10	analysis	NN	O	analysis	nsubjpass	13	SENT_67	[p5l381t2690r654b2765],
11	can	MD	O	can	aux	13	SENT_67	[p5l691t2710r814b2750],
12	be	VB	O	be	auxpass	13	SENT_67	[p5l845t2690r929b2750],
13	done	VBN	O	do	dep	4	SENT_67	[p5l964t2690r1140b2750],
14	only	RB	O	only	advmod	13	SENT_67	[p5l1176t2690r1329b2765],
15	in	IN	O	in	_	0	SENT_67	[p5l1361t2690r1429b2749],
16	living	VBG	O	live	amod	17	SENT_67	[p5l1461t2690r1657b2765],
17	women	NNS	O	woman	prep_in	13	SENT_67	[p5l1688t2710r1973b2762],
18	,	,	O	,	_	0	SENT_67	[p5l1688t2710r1973b2762],
19	and	CC	O	and	_	0	SENT_67	[p5l2012t2690r2143b2750],
20	because	IN	O	because	mark	25	SENT_67	[p5l16t2782r299b2842],
21	risk	NN	O	risk	nn	23	SENT_67	[p5l392t2782r521b2843],
22	factor	NN	O	factor	nn	23	SENT_67	[p5l611t2782r819b2842],
23	information	NN	O	information	nsubjpass	25	SENT_67	[p5l910t2782r1336b2843],
24	was	VBD	O	be	auxpass	25	SENT_67	[p5l1427t2802r1558b2843],
25	obtained	VBN	O	obtain	conj_and	13	SENT_67	[p5l1654t2782r1966b2842],
26	by	IN	O	by	_	0	SENT_67	[p5l2057t2782r2144b2857],
27	questionnaire	NN	O	questionnaire	agent	25	SENT_67	[p5l19t2875r524b2950],
28	.	.	O	.	_	0	SENT_67	[p5l19t2875r524b2950],

1	The	DT	O	the	det	2	SENT_68	[p5l629t2875r776b2935],
2	questionnaires	NNS	O	questionnaire	nsubjpass	4	SENT_68	[p5l878t2875r1396b2950],
3	were	VBD	O	be	auxpass	4	SENT_68	[p5l1496t2894r1664b2935],
4	completed	VBN	O	complete	_	0	SENT_68	[p5l1767t2875r2143b2950],
5	between	IN	O	between	_	0	SENT_68	[p5l16t2966r316b3026],
6	1980	CD	DATE	1980	prep_between	4	SENT_68	[p5l351t2969r522b3026],
7	and	CC	DATE	and	_	0	SENT_68	[p5l552t2966r683b3026],
8	2000	CD	DATE	2000	num	9	SENT_68	[p5l711t2969r888b3026],
9	(	NN	O	(	prep_between	4	SENT_68	[p5l923t2966r1040b3040],
10	on	IN	O	on	_	0	SENT_68	[p5l923t2966r1040b3040],
11	average	JJ	O	average	amod	13	SENT_68	[p5l1067t2986r1333b3041],
12	ll-8	JJ	O	ll-8	amod	13	SENT_68	[p5l1370t2969r1518b3026],
13	years	NNS	DURATION	year	prep_on	4	SENT_68	[p5l1544t2986r1725b3041],
14	after	IN	O	after	_	0	SENT_68	[p5l1755t2966r1916b3026],
15	initial	JJ	O	initial	amod	17	SENT_68	[p5l1940t2966r2143b3026],
16	diagnosis	NN	O	diagnosis	nn	17	SENT_68	[p5l19t3058r399b3133],
17	)	NN	O	)	prep_after	4	SENT_68	[p5l19t3058r399b3133],
18	.	.	O	.	_	0	SENT_68	[p5l19t3058r399b3133],

1	Mutation	NN	O	mutation	nn	3	SENT_69	[p5l19t3247r329b3306],
2	analysis	NN	O	analysis	nn	3	SENT_69	[p5l358t3247r639b3319],
3	Mutations	NNS	O	mutation	nsubjpass	5	SENT_69	[p5l17t3337r390b3397],
4	were	VBD	O	be	auxpass	5	SENT_69	[p5l433t3357r601b3398],
5	assayed	VBN	O	assay	_	0	SENT_69	[p5l647t3337r915b3412],
6	by	IN	O	by	_	0	SENT_69	[p5l957t3337r1044b3412],
7	several	JJ	O	several	amod	10	SENT_69	[p5l1087t3337r1327b3398],
8	established	JJ	O	established	amod	10	SENT_69	[p5l1372t3337r1767b3398],
9	detection	NN	O	detection	nn	10	SENT_69	[p5l1811t3337r2143b3398],
10	techniques	NNS	O	technique	agent	5	SENT_69	[p5l17t3430r426b3505],
11	,	,	O	,	_	0	SENT_69	[p5l17t3430r426b3505],
12	and	CC	O	and	_	0	SENT_69	[p5l476t3430r607b3490],
13	all	DT	O	all	det	14	SENT_69	[p5l653t3430r733b3490],
14	mutations	NNS	O	mutation	nsubjpass	16	SENT_69	[p5l777t3430r1138b3490],
15	were	VBD	O	be	auxpass	16	SENT_69	[p5l1183t3449r1351b3490],
16	conﬁrmed	VBN	O	conﬁrmed	conj_and	5	SENT_69	[p5l1398t3430r1765b3490],
17	by	IN	O	by	_	0	SENT_69	[p5l1808t3430r1895b3505],
18	direct	JJ	O	direct	amod	19	SENT_69	[p5l1939t3430r2144b3490],
19	sequencing	NN	O	sequencing	agent	16	SENT_69	[p5l19t3521r422b3596],
20	of	IN	O	of	_	0	SENT_69	[p5l477t3521r553b3581],
21	DNA	NN	O	dna	nn	22	SENT_69	[p5l598t3522r799b3581],
22	samples	NNS	O	sample	prep_of	19	SENT_69	[p5l853t3521r1155b3596],
23	.	.	O	.	_	0	SENT_69	[p5l853t3521r1155b3596],

1	For	IN	O	for	_	0	SENT_70	[p5l1215t3522r1346b3581],
2	women	NNS	O	woman	prep_for	9	SENT_70	[p5l1397t3541r1662b3581],
3	in	IN	O	in	_	0	SENT_70	[p5l1717t3521r1784b3580],
4	Ontario	NNP	LOCATION	Ontario	prep_in	2	SENT_70	[p5l1841t3521r2140b3593],
5	,	,	O	,	_	0	SENT_70	[p5l1841t3521r2140b3593],
6	DNA	NNP	O	DNA	nn	7	SENT_70	[p5l18t3614r218b3673],
7	samples	NNS	O	sample	nsubjpass	9	SENT_70	[p5l245t3613r526b3688],
8	were	VBD	O	be	auxpass	9	SENT_70	[p5l552t3633r721b3674],
9	screened	VBN	O	screen	_	0	SENT_70	[p5l749t3613r1062b3674],
10	by	IN	O	by	_	0	SENT_70	[p5l1086t3613r1173b3688],
11	the	DT	O	the	det	14	SENT_70	[p5l1197t3613r1307b3673],
12	protein	NN	O	protein	nn	14	SENT_70	[p5l1333t3614r1592b3688],
13	truncation	NN	O	truncation	nn	14	SENT_70	[p5l1618t3614r1993b3673],
14	test	NN	O	test	agent	9	SENT_70	[p5l2018t3627r2144b3673],
15	for	IN	O	for	_	0	SENT_70	[p5l17t3706r119b3766],
16	mutations	NNS	O	mutation	prep_for	14	SENT_70	[p5l148t3706r508b3766],
17	in	IN	O	in	_	0	SENT_70	[p5l541t3706r609b3765],
18	exon	NN	O	exon	prep_in	16	SENT_70	[p5l640t3726r811b3766],
19	11	CD	NUMBER	11	num	18	SENT_70	[p5l850t3708r921b3765],
20	of	IN	O	of	_	0	SENT_70	[p5l963t3706r1040b3766],
21	BRCAI	NNP	O	BRCAI	prep_of	18	SENT_70	[p5l1059t3706r1334b3766],
22	and	CC	O	and	_	0	SENT_70	[p5l1371t3706r1503b3766],
23	exons	NNS	O	exon	prep_of	18	SENT_70	[p5l1536t3725r1736b3766],
24	10	CD	NUMBER	10	num	23	SENT_70	[p5l1778t3708r1856b3766],
25	and	CC	O	and	_	0	SENT_70	[p5l1891t3706r2023b3766],
26	11	CD	NUMBER	11	conj_and	21	SENT_70	[p5l2063t3708r2134b3765],

1	of	IN	O	of	_	0	SENT_71	[p6l19t23r96b83],
2	BRCA2	NN	O	brca2	pobj	1	SENT_71	[p6l116t23r462b83],
3	.	.	O	.	_	0	SENT_71	[p6l116t23r462b83],

1	“	NN	O	“	nsubjpass	7	SENT_72	[p6l116t23r462b83],
2	The	DT	O	the	det	5	SENT_72	[p6l497t23r644b83],
3	Ashkenazi	NNP	MISC	Ashkenazi	nn	5	SENT_72	[p6l674t23r1042b83],
4	Jewish	JJ	MISC	jewish	amod	5	SENT_72	[p6l1069t23r1304b97],
5	women	NNS	O	woman	dep	1	SENT_72	[p6l1333t43r1598b83],
6	were	VBD	O	be	auxpass	7	SENT_72	[p6l1628t43r1796b83],
7	screened	VBN	O	screen	_	0	SENT_72	[p6l1831t23r2143b83],
8	for	IN	O	for	_	0	SENT_72	[p6l17t115r119b175],
9	three	CD	NUMBER	three	num	11	SENT_72	[p6l158t115r339b175],
10	founder	NN	O	founder	nn	11	SENT_72	[p6l381t115r666b176],
11	mutations	NNS	O	mutation	prep_for	7	SENT_72	[p6l705t116r1089b187],
12	,	,	O	,	_	0	SENT_72	[p6l705t116r1089b187],
13	two	CD	NUMBER	two	prep_for	7	SENT_72	[p6l1133t129r1263b176],
14	in	IN	O	in	_	0	SENT_72	[p6l1307t116r1374b175],
15	BRCAI	NNP	O	BRCAI	nn	17	SENT_72	[p6l1414t116r1689b175],
16	(	CD	NUMBER	(	num	17	SENT_72	[p6l1742t115r2144b190],
17	185delAG	NN	O	185delag	prep_in	13	SENT_72	[p6l1742t115r2144b190],
18	and	CC	O	and	_	0	SENT_72	[p6l19t208r150b268],
19	5382insC	NN	O	5382insc	nn	20	SENT_72	[p6l190t208r564b282],
20	)	NN	O	)	prep_for	7	SENT_72	[p6l190t208r564b282],
21	and	CC	O	and	_	0	SENT_72	[p6l608t208r739b268],
22	one	CD	NUMBER	one	conj_and	11	SENT_72	[p6l777t227r904b268],
23	in	IN	O	in	_	0	SENT_72	[p6l942t208r1010b267],
24	BRCA2	NN	O	brca2	nn	27	SENT_72	[p6l1044t208r1325b268],
25	(	CD	NUMBER	(	num	27	SENT_72	[p6l1366t208r1849b282],
26	6174de1T	NN	O	6174de1t	nn	27	SENT_72	[p6l1366t208r1849b282],
27	)	NN	O	)	prep_in	7	SENT_72	[p6l1366t208r1849b282],
28	.	.	O	.	_	0	SENT_72	[p6l1366t208r1849b282],

1	”	NN	O	”	_	0	SENT_73	[p6l1366t208r1849b282],
2	French	JJ	MISC	french	dep	1	SENT_73	[p6l1887t208r2143b268],

1	Cases	NNS	O	case	_	0	SENT_74	[p6l897t366r1045b410],
2	with	IN	O	with	_	0	SENT_74	[p6l1064t366r1167b410],
3	bilateral	JJ	O	bilateral	amod	8	SENT_74	[p6l1188t366r1384b410],
4	Controls	NNP	O	Controls	nn	8	SENT_74	[p6l1480t366r1684b410],
5	p	NN	O	p	nn	8	SENT_74	[p6l1957t377r1983b419],
6	disease	NN	O	disease	nn	8	SENT_74	[p6l897t441r1083b484],
7	(	NN	O	(	nn	8	SENT_74	[p6l1103t441r1300b494],
8	n	NN	O	n	prep_with	1	SENT_74	[p6l1103t441r1300b494],
9	=	JJ	O	=	dep	1	SENT_74	[p6l1103t441r1300b494],
10	209	CD	NUMBER	209	number	11	SENT_74	[p6l1103t441r1300b494],
11	)	CD	NUMBER	)	num	16	SENT_74	[p6l1103t441r1300b494],
12	(	NN	O	(	nn	16	SENT_74	[p6l1481t441r1678b494],
13	n	NN	O	n	nn	16	SENT_74	[p6l1481t441r1678b494],
14	=	JJ	O	=	amod	16	SENT_74	[p6l1481t441r1678b494],
15	384	CD	NUMBER	384	num	16	SENT_74	[p6l1481t441r1678b494],
16	)	NN	O	)	dep	9	SENT_74	[p6l1481t441r1678b494],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_75	[p6l17t553r268b596],
2	use	NN	O	use	dep	10	SENT_75	[p6l290t553r402b596],
3	*	CD	NUMBER	*	number	4	SENT_75	[p6l290t553r402b596],
4	22	CD	NUMBER	22	num	5	SENT_75	[p6l932t553r992b596],
5	(	NN	O	(	dep	2	SENT_75	[p6l1014t553r1147b606],
6	11	CD	PERCENT	11	number	7	SENT_75	[p6l1014t553r1147b606],
7	%	NN	PERCENT	%	amod	5	SENT_75	[p6l1014t553r1147b606],
8	)	CD	NUMBER	)	dep	10	SENT_75	[p6l1014t553r1147b606],
9	81	CD	NUMBER	81	num	10	SENT_75	[p6l1513t553r1576b596],
10	(	NN	O	(	dep	14	SENT_75	[p6l1597t553r1729b606],
11	21	CD	PERCENT	21	num	12	SENT_75	[p6l1597t553r1729b606],
12	%	NN	PERCENT	%	dep	10	SENT_75	[p6l1597t553r1729b606],
13	)	CD	NUMBER	)	num	14	SENT_75	[p6l1597t553r1729b606],
14	0-003	CD	NUMBER	0-003	_	0	SENT_75	[p6l1955t553r2100b596],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_76	[p6l17t703r268b746],
2	duration	NN	O	duration	_	0	SENT_76	[p6l289t703r487b746],
3	(	CD	NUMBER	(	num	4	SENT_76	[p6l508t703r707b756],
4	years	NNS	NUMBER	year	dep	2	SENT_76	[p6l508t703r707b756],
5	)	CD	NUMBER	)	number	6	SENT_76	[p6l508t703r707b756],
6	*	CD	NUMBER	*	num	7	SENT_76	[p6l508t703r707b756],
7	o	NN	O	o	dep	4	SENT_76	[p6l19t776r48b820],
8	187	CD	NUMBER	187	num	9	SENT_76	[p6l900t776r992b820],
9	(	NN	O	(	dep	2	SENT_76	[p6l1014t776r1147b830],
10	90	CD	PERCENT	90	number	11	SENT_76	[p6l1014t776r1147b830],
11	%	NN	PERCENT	%	amod	9	SENT_76	[p6l1014t776r1147b830],
12	)	CD	NUMBER	)	number	13	SENT_76	[p6l1014t776r1147b830],
13	303	CD	NUMBER	303	num	14	SENT_76	[p6l1480t776r1576b820],
14	(	NN	O	(	dep	2	SENT_76	[p6l1597t776r1729b830],
15	79	CD	PERCENT	79	number	16	SENT_76	[p6l1597t776r1729b830],
16	%	NN	PERCENT	%	amod	14	SENT_76	[p6l1597t776r1729b830],
17	)	CD	NUMBER	)	dep	14	SENT_76	[p6l1597t776r1729b830],
18	.	.	O	.	_	0	SENT_76	[p6l1959t812r1966b819],

1	.	.	O	.	_	0	SENT_77	[p6l1992t812r1999b819],

1	<	JJR	O	<	dep	11	SENT_78	[p6l21t850r93b893],
2	2	CD	NUMBER	2	num	4	SENT_78	[p6l21t850r93b893],
3	13	CD	NUMBER	13	num	4	SENT_78	[p6l933t850r993b894],
4	(	NN	O	(	dep	1	SENT_78	[p6l1014t850r1114b904],
5	6	CD	PERCENT	6	num	6	SENT_78	[p6l1014t850r1114b904],
6	%	NN	PERCENT	%	dep	4	SENT_78	[p6l1014t850r1114b904],
7	)	CD	PERCENT	)	number	8	SENT_78	[p6l1014t850r1114b904],
8	50	CD	PERCENT	50	num	6	SENT_78	[p6l1514t850r1576b894],
9	(	CD	PERCENT	(	dep	11	SENT_78	[p6l1597t850r1729b904],
10	13	CD	PERCENT	13	num	11	SENT_78	[p6l1597t850r1729b904],
11	%	NN	PERCENT	%	dep	16	SENT_78	[p6l1597t850r1729b904],
12	)	CD	NUMBER	)	num	13	SENT_78	[p6l1597t850r1729b904],
13	0-010	CD	NUMBER	0-010	dep	11	SENT_78	[p6l1955t850r2100b894],
14	2-4	CD	NUMBER	2-4	num	16	SENT_78	[p6l19t925r109b968],
15	3	CD	NUMBER	3	num	16	SENT_78	[p6l964t925r993b968],
16	(	NN	O	(	dep	31	SENT_78	[p6l1014t925r1114b978],
17	1	CD	PERCENT	1	num	18	SENT_78	[p6l1014t925r1114b978],
18	%	NN	PERCENT	%	dep	16	SENT_78	[p6l1014t925r1114b978],
19	)	CD	NUMBER	)	number	20	SENT_78	[p6l1014t925r1114b978],
20	19	CD	NUMBER	19	num	21	SENT_78	[p6l1515t925r1575b968],
21	(	NN	O	(	npadvmod	26	SENT_78	[p6l1597t925r1696b978],
22	5	CD	PERCENT	5	number	23	SENT_78	[p6l1597t925r1696b978],
23	%	NN	PERCENT	%	amod	21	SENT_78	[p6l1597t925r1696b978],
24	)	CD	NUMBER	)	number	25	SENT_78	[p6l1597t925r1696b978],
25	0-047	CD	NUMBER	0-047	num	21	SENT_78	[p6l1955t925r2099b968],
26	>	JJR	O	>	amod	29	SENT_78	[p6l19t1010r47b1037],
27	4	CD	NUMBER	4	number	28	SENT_78	[p6l68t999r98b1041],
28	6	CD	NUMBER	6	amod	29	SENT_78	[p6l965t998r993b1042],
29	(	NN	O	(	dep	18	SENT_78	[p6l1014t998r1114b1052],
30	3	CD	PERCENT	3	num	31	SENT_78	[p6l1014t998r1114b1052],
31	%	NN	PERCENT	%	dep	38	SENT_78	[p6l1014t998r1114b1052],
32	)	CD	NUMBER	)	number	33	SENT_78	[p6l1014t998r1114b1052],
33	12	CD	NUMBER	12	num	34	SENT_78	[p6l1515t998r1574b1041],
34	(	NN	O	(	dep	31	SENT_78	[p6l1597t998r1696b1052],
35	3	CD	PERCENT	3	number	36	SENT_78	[p6l1597t998r1696b1052],
36	%	NN	PERCENT	%	amod	34	SENT_78	[p6l1597t998r1696b1052],
37	)	CD	NUMBER	)	num	38	SENT_78	[p6l1597t998r1696b1052],
38	0-850	CD	NUMBER	0-850	_	0	SENT_78	[p6l1955t998r2100b1042],

1	Oophorectomy	NNP	O	Oophorectomy	nn	2	SENT_79	[p6l18t1144r400b1198],
2	*	NNP	O	*	dep	33	SENT_79	[p6l18t1144r400b1198],
3	Ever	RB	O	ever	prep	2	SENT_79	[p6l21t1219r119b1262],
4	13	CD	PERCENT	13	number	5	SENT_79	[p6l933t1218r993b1262],
5	(	CD	PERCENT	(	amod	10	SENT_79	[p6l1014t1218r1114b1272],
6	6	CD	PERCENT	6	num	7	SENT_79	[p6l1014t1218r1114b1272],
7	%	NN	PERCENT	%	dep	5	SENT_79	[p6l1014t1218r1114b1272],
8	)	CD	NUMBER	)	number	9	SENT_79	[p6l1014t1218r1114b1272],
9	57	CD	NUMBER	57	num	10	SENT_79	[p6l1514t1219r1574b1262],
10	(	NN	O	(	pobj	3	SENT_79	[p6l1597t1218r1729b1272],
11	15	CD	PERCENT	15	num	12	SENT_79	[p6l1597t1218r1729b1272],
12	%	NN	PERCENT	%	dep	23	SENT_79	[p6l1597t1218r1729b1272],
13	)	CD	NUMBER	)	number	14	SENT_79	[p6l1597t1218r1729b1272],
14	0-004	CD	NUMBER	0-004	num	12	SENT_79	[p6l1955t1218r2100b1262],
15	Before	IN	O	before	_	0	SENT_79	[p6l21t1293r172b1336],
16	cancer	NN	O	cancer	nn	18	SENT_79	[p6l192t1303r350b1336],
17	5	CD	NUMBER	5	num	18	SENT_79	[p6l965t1293r993b1336],
18	(	NN	O	(	prep_before	12	SENT_79	[p6l1014t1293r1114b1346],
19	2	CD	PERCENT	2	number	20	SENT_79	[p6l1014t1293r1114b1346],
20	%	NN	PERCENT	%	amod	18	SENT_79	[p6l1014t1293r1114b1346],
21	)	CD	PERCENT	)	number	22	SENT_79	[p6l1014t1293r1114b1346],
22	19	CD	PERCENT	19	num	23	SENT_79	[p6l1515t1293r1576b1336],
23	(	NN	PERCENT	(	rcmod	10	SENT_79	[p6l1597t1293r1696b1346],
24	5	CD	PERCENT	5	number	25	SENT_79	[p6l1597t1293r1696b1346],
25	%	NN	PERCENT	%	amod	23	SENT_79	[p6l1597t1293r1696b1346],
26	)	CD	NUMBER	)	num	27	SENT_79	[p6l1597t1293r1696b1346],
27	0-100	CD	NUMBER	0-100	npadvmod	28	SENT_79	[p6l1955t1293r2100b1336],
28	After	IN	O	after	dep	23	SENT_79	[p6l17t1366r129b1410],
29	cancer	NN	O	cancer	pobj	28	SENT_79	[p6l147t1377r305b1410],
30	8	CD	PERCENT	8	num	31	SENT_79	[p6l964t1366r993b1410],
31	(	NN	PERCENT	(	dep	33	SENT_79	[p6l1014t1366r1114b1420],
32	4	CD	PERCENT	4	num	33	SENT_79	[p6l1014t1366r1114b1420],
33	%	NN	PERCENT	%	dep	40	SENT_79	[p6l1014t1366r1114b1420],
34	)	CD	NUMBER	)	number	35	SENT_79	[p6l1014t1366r1114b1420],
35	38	CD	NUMBER	38	num	36	SENT_79	[p6l1513t1366r1576b1410],
36	(	NN	O	(	dep	33	SENT_79	[p6l1597t1366r1729b1420],
37	10	CD	PERCENT	10	number	38	SENT_79	[p6l1597t1366r1729b1420],
38	%	NN	PERCENT	%	amod	36	SENT_79	[p6l1597t1366r1729b1420],
39	)	CD	NUMBER	)	num	40	SENT_79	[p6l1597t1366r1729b1420],
40	0-010	CD	NUMBER	0-010	_	0	SENT_79	[p6l1955t1366r2100b1410],

1	Surgery	NN	O	surgery	nn	3	SENT_80	[p6l17t1512r231b1566],
2	*	CD	NUMBER	*	num	3	SENT_80	[p6l17t1512r231b1566],
3	Lumpectomy	NNP	O	Lumpectomy	_	0	SENT_80	[p6l21t1587r321b1640],
4	73	CD	PERCENT	73	number	5	SENT_80	[p6l933t1586r993b1630],
5	(	CD	PERCENT	(	dep	3	SENT_80	[p6l1014t1586r1147b1639],
6	36	CD	PERCENT	36	num	7	SENT_80	[p6l1014t1586r1147b1639],
7	%	NN	PERCENT	%	dep	5	SENT_80	[p6l1014t1586r1147b1639],
8	)	CD	NUMBER	)	number	9	SENT_80	[p6l1014t1586r1147b1639],
9	169	CD	NUMBER	169	dep	3	SENT_80	[p6l1483t1586r1576b1630],
10	(	NN	O	(	dep	9	SENT_80	[p6l1597t1586r1730b1640],
11	45	CD	PERCENT	45	num	12	SENT_80	[p6l1597t1586r1730b1640],
12	%	NN	PERCENT	%	dep	3	SENT_80	[p6l1597t1586r1730b1640],
13	)	CD	NUMBER	)	dep	12	SENT_80	[p6l1597t1586r1730b1640],
14	.	.	O	.	_	0	SENT_80	[p6l1959t1622r1966b1629],

1	.	.	O	.	_	0	SENT_81	[p6l1992t1622r1999b1629],

1	Mastectomy	NN	O	mastectomy	dep	8	SENT_82	[p6l21t1660r310b1714],
2	131	CD	NUMBER	131	num	3	SENT_82	[p6l900t1660r993b1703],
3	(	NN	O	(	dep	1	SENT_82	[p6l1014t1660r1147b1713],
4	64	CD	PERCENT	64	num	5	SENT_82	[p6l1014t1660r1147b1713],
5	%	NN	PERCENT	%	dep	8	SENT_82	[p6l1014t1660r1147b1713],
6	)	CD	NUMBER	)	number	7	SENT_82	[p6l1014t1660r1147b1713],
7	209	CD	NUMBER	209	num	8	SENT_82	[p6l1481t1660r1576b1703],
8	(	NN	O	(	dep	12	SENT_82	[p6l1597t1660r1729b1713],
9	55	CD	PERCENT	55	num	10	SENT_82	[p6l1597t1660r1729b1713],
10	%	NN	PERCENT	%	dep	8	SENT_82	[p6l1597t1660r1729b1713],
11	)	CD	NUMBER	)	num	12	SENT_82	[p6l1597t1660r1729b1713],
12	0-070	CD	NUMBER	0-070	_	0	SENT_82	[p6l1955t1660r2100b1703],

1	Radiotherapy	NN	O	radiotherapy	nn	2	SENT_83	[p6l20t1811r368b1864],
2	*	NN	O	*	dep	9	SENT_83	[p6l20t1811r368b1864],
3	101	CD	PERCENT	101	num	4	SENT_83	[p6l900t1811r993b1854],
4	(	CD	PERCENT	(	dep	2	SENT_83	[p6l1014t1811r1147b1864],
5	48	CD	PERCENT	48	num	6	SENT_83	[p6l1014t1811r1147b1864],
6	%	NN	PERCENT	%	dep	9	SENT_83	[p6l1014t1811r1147b1864],
7	)	CD	NUMBER	)	number	8	SENT_83	[p6l1014t1811r1147b1864],
8	212	CD	NUMBER	212	num	9	SENT_83	[p6l1481t1811r1574b1854],
9	(	NN	O	(	dep	13	SENT_83	[p6l1597t1811r1729b1864],
10	55	CD	PERCENT	55	num	11	SENT_83	[p6l1597t1811r1729b1864],
11	%	NN	PERCENT	%	dep	9	SENT_83	[p6l1597t1811r1729b1864],
12	)	CD	NUMBER	)	num	13	SENT_83	[p6l1597t1811r1729b1864],
13	0-110	CD	NUMBER	0-110	_	0	SENT_83	[p6l1955t1811r2100b1854],

1	chemotherapy	NN	O	chemotherapy	dep	9	SENT_84	[p6l18t1963r400b2016],
2	*	CD	NUMBER	*	num	1	SENT_84	[p6l18t1963r400b2016],
3	88	CD	NUMBER	88	num	4	SENT_84	[p6l931t1963r993b2006],
4	(	NN	O	(	dep	1	SENT_84	[p6l1014t1963r1147b2016],
5	42	CD	PERCENT	42	num	6	SENT_84	[p6l1014t1963r1147b2016],
6	%	NN	PERCENT	%	dep	9	SENT_84	[p6l1014t1963r1147b2016],
7	)	CD	NUMBER	)	number	8	SENT_84	[p6l1014t1963r1147b2016],
8	234	CD	NUMBER	234	num	9	SENT_84	[p6l1481t1963r1576b2006],
9	(	NN	O	(	dep	20	SENT_84	[p6l1597t1963r1729b2016],
10	61	CD	PERCENT	61	num	11	SENT_84	[p6l1597t1963r1729b2016],
11	%	NN	PERCENT	%	dep	9	SENT_84	[p6l1597t1963r1729b2016],
12	)	CD	NUMBER	)	number	13	SENT_84	[p6l1597t1963r1729b2016],
13	0-0001	CD	NUMBER	0-0001	num	14	SENT_84	[p6l1955t1963r2133b2006],
14	Information	NN	O	information	nsubj	20	SENT_84	[p6l21t2070r286b2114],
15	on	IN	O	on	_	0	SENT_84	[p6l308t2081r362b2114],
16	type	NN	O	type	prep_on	14	SENT_84	[p6l382t2073r480b2124],
17	of	IN	O	of	_	0	SENT_84	[p6l500t2070r547b2114],
18	surgery	NN	O	surgery	prep_of	16	SENT_84	[p6l563t2077r735b2125],
19	was	VBD	O	be	aux	20	SENT_84	[p6l752t2081r844b2114],
20	missing	VBG	O	miss	_	0	SENT_84	[p6l866t2071r1049b2125],
21	for	IN	O	for	_	0	SENT_84	[p6l1065t2070r1129b2114],
22	five	CD	NUMBER	five	num	23	SENT_84	[p6l1145t2070r1227b2114],
23	cases	NNS	O	case	prep_for	20	SENT_84	[p6l1247t2081r1386b2114],
24	with	IN	O	with	_	0	SENT_84	[p6l1405t2071r1498b2114],
25	bilateral	JJ	O	bilateral	amod	26	SENT_84	[p6l1521t2071r1708b2114],
26	disease	NN	O	disease	prep_with	23	SENT_84	[p6l1730t2071r1915b2114],
27	and	CC	O	and	_	0	SENT_84	[p6l1936t2071r2020b2114],
28	six	CD	NUMBER	six	num	29	SENT_84	[p6l2042t2071r2105b2114],
29	controls	NNS	O	control	conj_and	26	SENT_84	[p6l18t2141r221b2184],
30	.	.	O	.	_	0	SENT_84	[p6l18t2141r221b2184],

1	All	DT	O	all	det	3	SENT_85	[p6l243t2141r295b2183],
2	p	NN	O	p	nn	3	SENT_85	[p6l320t2151r344b2193],
3	values	NNS	O	value	nsubjpass	5	SENT_85	[p6l362t2141r515b2184],
4	were	VBD	O	be	auxpass	5	SENT_85	[p6l534t2151r645b2184],
5	calculated	VBN	O	calculate	_	0	SENT_85	[p6l665t2141r905b2184],
6	with	IN	O	with	_	0	SENT_85	[p6l926t2141r1019b2184],
7	a	DT	O	a	det	11	SENT_85	[p6l1040t2151r1065b2184],
8	univariate	JJ	O	univariate	amod	11	SENT_85	[p6l1088t2141r1317b2184],
9	conditional	JJ	O	conditional	amod	11	SENT_85	[p6l1337t2141r1594b2184],
10	logistic	JJ	O	logistic	amod	11	SENT_85	[p6l1618t2141r1782b2195],
11	regression	NN	O	regression	prep_with	5	SENT_85	[p6l1803t2141r2064b2195],
12	.	.	O	.	_	0	SENT_85	[p6l1803t2141r2064b2195],

1	*	NN	O	*	nn	2	SENT_86	[p6l23t2210r209b2253],
2	values	NNS	O	value	nsubj	4	SENT_86	[p6l23t2210r209b2253],
3	are	VBP	O	be	cop	4	SENT_86	[p6l230t2220r303b2253],
4	number	NN	O	number	_	0	SENT_86	[p6l325t2210r503b2253],
5	(	CD	PERCENT	(	num	6	SENT_86	[p6l522t2210r603b2263],
6	%	NN	PERCENT	%	dep	4	SENT_86	[p6l522t2210r603b2263],
7	)	CD	NUMBER	)	dep	6	SENT_86	[p6l522t2210r603b2263],
8	.	.	O	.	_	0	SENT_86	[p6l522t2210r603b2263],

1	Table	NNP	O	Table	_	0	SENT_87	[p6l17t2286r191b2339],
2	2	CD	NUMBER	2	num	1	SENT_87	[p6l220t2285r278b2338],
3	:	:	O	:	_	0	SENT_87	[p6l220t2285r278b2338],
4	Factors	NNS	O	factor	dep	1	SENT_87	[p6l311t2286r559b2339],
5	associated	VBN	O	associate	partmod	4	SENT_87	[p6l586t2285r947b2339],
6	with	IN	O	with	_	0	SENT_87	[p6l974t2285r1114b2339],
7	treatment	NN	O	treatment	prep_with	5	SENT_87	[p6l1141t2287r1474b2339],
8	of	IN	O	of	_	0	SENT_87	[p6l1500t2285r1563b2339],
9	first	JJ	ORDINAL	first	amod	11	SENT_87	[p6l1584t2285r1716b2339],
10	breast	NN	O	breast	nn	11	SENT_87	[p6l1744t2286r1952b2339],
11	cancer	NN	O	cancer	prep_of	7	SENT_87	[p6l18t2383r245b2422],

1	Canadian	JJ	MISC	canadian	amod	2	SENT_88	[p6l11t2592r358b2652],
2	women	NNS	O	woman	nsubjpass	4	SENT_88	[p6l449t2611r715b2652],
3	were	VBD	O	be	auxpass	4	SENT_88	[p6l805t2611r974b2652],
4	screened	VBN	O	screen	_	0	SENT_88	[p6l1069t2592r1382b2652],
5	for	IN	O	for	_	0	SENT_88	[p6l1474t2591r1576b2652],
6	six	CD	NUMBER	six	num	8	SENT_88	[p6l1668t2592r1763b2652],
7	founder	NN	O	founder	nn	8	SENT_88	[p6l1854t2591r2139b2652],
8	mutations	NNS	O	mutation	prep_for	4	SENT_88	[p6l8t2685r439b2745],
9	.	.	O	.	_	0	SENT_88	[p6l8t2685r439b2745],

1	”	NN	O	”	nn	3	SENT_89	[p6l8t2685r439b2745],
2	Other	JJ	O	other	amod	3	SENT_89	[p6l476t2685r687b2745],
3	women	NNS	O	woman	nsubjpass	8	SENT_89	[p6l717t2704r982b2745],
4	in	IN	O	in	_	0	SENT_89	[p6l1015t2685r1084b2744],
5	the	DT	O	the	det	6	SENT_89	[p6l1116t2685r1227b2745],
6	study	NN	O	study	prep_in	3	SENT_89	[p6l1262t2685r1457b2761],
7	were	VBD	O	be	auxpass	8	SENT_89	[p6l1486t2705r1655b2745],
8	screened	VBN	O	screen	_	0	SENT_89	[p6l1691t2685r2004b2745],
9	for	IN	O	for	_	0	SENT_89	[p6l2037t2685r2139b2745],
10	mutations	NNS	O	mutation	prep_for	8	SENT_89	[p6l8t2777r369b2838],
11	by	IN	O	by	_	0	SENT_89	[p6l472t2777r559b2853],
12	techniques	NNS	O	technique	agent	8	SENT_89	[p6l659t2777r1046b2853],
13	done	VBN	O	do	partmod	12	SENT_89	[p6l1152t2777r1327b2838],
14	routinely	RB	O	routinely	advmod	13	SENT_89	[p6l1431t2777r1755b2853],
15	in	IN	O	in	_	0	SENT_89	[p6l1856t2777r1923b2837],
16	the	DT	O	the	det	18	SENT_89	[p6l2025t2777r2136b2838],
17	participating	VBG	O	participate	amod	18	SENT_89	[p6l7t2871r464b2946],
18	laboratories	NNS	O	laboratory	prep_in	13	SENT_89	[p6l540t2870r981b2931],
19	.	.	O	.	_	0	SENT_89	[p6l540t2870r981b2931],

1	These	DT	O	these	det	2	SENT_90	[p6l1062t2870r1282b2931],
2	techniques	NNS	O	technique	nsubj	3	SENT_90	[p6l1359t2870r1746b2946],
3	included	VBD	O	include	_	0	SENT_90	[p6l1824t2870r2137b2931],
4	direct	JJ	O	direct	amod	5	SENT_90	[p6l9t2964r214b3024],
5	sequencing	NN	O	sequencing	dobj	3	SENT_90	[p6l289t2964r692b3040],
6	of	IN	O	of	_	0	SENT_90	[p6l766t2964r843b3024],
7	DNA	NN	MISC	dna	prep_of	5	SENT_90	[p6l908t2965r1128b3037],
8	,	,	O	,	_	0	SENT_90	[p6l908t2965r1128b3037],
9	protein	NN	O	protein	nn	11	SENT_90	[p6l1205t2964r1465b3040],
10	truncation	NN	O	truncation	nn	11	SENT_90	[p6l1538t2964r1914b3024],
11	test	NN	O	test	prep_of	5	SENT_90	[p6l1987t2978r2134b3037],
12	,	,	O	,	_	0	SENT_90	[p6l1987t2978r2134b3037],
13	heteroduplex	JJ	O	heteroduplex	amod	14	SENT_90	[p6l7t3056r483b3132],
14	analysis	NN	O	analysis	prep_of	5	SENT_90	[p6l509t3056r805b3132],
15	,	,	O	,	_	0	SENT_90	[p6l509t3056r805b3132],
16	single	JJ	O	single	amod	20	SENT_90	[p6l835t3056r1296b3132],
17	—	NN	O	—	nn	20	SENT_90	[p6l835t3056r1296b3132],
18	strand	NN	O	strand	nn	20	SENT_90	[p6l835t3056r1296b3132],
19	conformation	NN	O	conformation	nn	20	SENT_90	[p6l1324t3056r1811b3117],
20	analysis	NN	O	analysis	conj_and	7	SENT_90	[p6l1838t3056r2134b3132],
21	,	,	O	,	_	0	SENT_90	[p6l1838t3056r2134b3132],
22	and	CC	O	and	_	0	SENT_90	[p6l10t3149r142b3210],
23	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	25	SENT_90	[p6l183t3149r663b3225],
24	oligonucleotide	NN	O	oligonucleotide	nn	25	SENT_90	[p6l704t3149r1256b3225],
25	hybridisation	NN	O	hybridisation	conj_and	7	SENT_90	[p6l1296t3149r1788b3225],
26	.	.	O	.	_	0	SENT_90	[p6l1296t3149r1788b3225],

1	In	IN	O	in	_	0	SENT_91	[p6l1834t3150r1911b3209],
2	every	DT	O	every	det	3	SENT_91	[p6l1951t3169r2139b3225],
3	woman	NN	O	woman	prep_in	14	SENT_91	[p6l7t3262r294b3316],
4	,	,	O	,	_	0	SENT_91	[p6l7t3262r294b3316],
5	the	DT	O	the	det	7	SENT_91	[p6l326t3243r437b3303],
6	actual	JJ	O	actual	amod	7	SENT_91	[p6l469t3243r682b3303],
7	sequence	NN	O	sequence	nsubjpass	14	SENT_91	[p6l713t3262r1041b3319],
8	Variant	JJ	O	variant	amod	7	SENT_91	[p6l1070t3243r1319b3303],
9	in	IN	O	in	_	0	SENT_91	[p6l1348t3243r1417b3302],
10	BRCA1	NN	O	brca1	prep_in	8	SENT_91	[p6l1444t3243r1720b3303],
11	or	CC	O	or	_	0	SENT_91	[p6l1756t3262r1831b3303],
12	BRCA2	NN	O	brca2	prep_in	8	SENT_91	[p6l1856t3243r2138b3303],
13	was	VBD	O	be	auxpass	14	SENT_91	[p6l7t3355r138b3396],
14	established	VBN	O	establish	_	0	SENT_91	[p6l167t3335r562b3396],
15	by	IN	O	by	_	0	SENT_91	[p6l586t3335r674b3411],
16	direct	JJ	O	direct	amod	17	SENT_91	[p6l699t3335r904b3396],
17	sequencing	NN	O	sequencing	agent	14	SENT_91	[p6l930t3335r1333b3411],
18	of	IN	O	of	_	0	SENT_91	[p6l1360t3335r1436b3396],
19	DNA	NN	O	dna	prep_of	17	SENT_91	[p6l1452t3336r1670b3396],
20	.	.	O	.	_	0	SENT_91	[p6l1452t3336r1670b3396],

1	Study	NNP	O	Study	nn	4	SENT_92	[p7l7t63r209b135],
2	protocol	NN	O	protocol	nn	4	SENT_92	[p7l230t64r517b135],
3	Bilateral-disease	NN	MISC	bilateral-disease	nn	4	SENT_92	[p7l9t153r593b214],
4	cases	NNS	O	case	nsubj	7	SENT_92	[p7l701t173r879b214],
5	and	CC	O	and	_	0	SENT_92	[p7l987t153r1118b214],
6	controls	NNS	O	control	conj_and	4	SENT_92	[p7l1224t153r1511b214],
7	completed	VBD	O	complete	_	0	SENT_92	[p7l1619t153r1995b229],
8	a	DT	O	a	det	9	SENT_92	[p7l2101t173r2136b214],
9	questionnaire	NN	O	questionnaire	dobj	7	SENT_92	[p7l10t247r496b322],
10	that	WDT	O	that	nsubj	11	SENT_92	[p7l564t246r705b307],
11	asked	VBD	O	ask	rcmod	9	SENT_92	[p7l773t246r972b307],
12	about	IN	O	about	_	0	SENT_92	[p7l1041t246r1245b307],
13	medical	JJ	O	medical	amod	16	SENT_92	[p7l1312t246r1593b307],
14	and	CC	O	and	_	0	SENT_92	[p7l1662t246r1794b307],
15	surgical	JJ	O	surgical	conj_and	13	SENT_92	[p7l1863t246r2136b322],
16	treatment	NN	O	treatment	prep_about	11	SENT_92	[p7l8t354r360b400],
17	of	IN	O	of	_	0	SENT_92	[p7l387t340r464b400],
18	their	PRP$	O	they	poss	21	SENT_92	[p7l480t340r647b400],
19	initial	JJ	O	initial	amod	21	SENT_92	[p7l672t340r874b400],
20	breast	NN	O	breast	nn	21	SENT_92	[p7l899t340r1117b400],
21	cancer	NN	O	cancer	prep_of	16	SENT_92	[p7l1144t359r1396b400],
22	.	.	O	.	_	0	SENT_92	[p7l1144t359r1396b400],

1	In	IN	O	in	_	0	SENT_93	[p7l1428t341r1504b399],
2	some	DT	O	some	det	3	SENT_93	[p7l1532t359r1717b400],
3	centres	NNS	O	centre	prep_in	7	SENT_93	[p7l1746t354r1998b400],
4	the	DT	O	the	det	5	SENT_93	[p7l2025t340r2136b400],
5	questionnaire	NN	O	questionnaire	nsubjpass	7	SENT_93	[p7l10t432r496b508],
6	was	VBD	O	be	auxpass	7	SENT_93	[p7l545t452r677b493],
7	administered	VBN	O	administer	_	0	SENT_93	[p7l730t432r1198b493],
8	by	IN	O	by	_	0	SENT_93	[p7l1246t432r1334b508],
9	telephone	NN	O	telephone	nn	10	SENT_93	[p7l1381t432r1733b508],
10	interview	NN	O	interview	agent	7	SENT_93	[p7l1784t432r2132b493],
11	.	.	O	.	_	0	SENT_93	[p7l1784t432r2132b493],

1	The	DT	DURATION	the	det	2	SENT_94	[p7l7t525r155b586],
2	years	NNS	DURATION	year	nsubjpass	13	SENT_94	[p7l177t545r359b601],
3	of	IN	O	of	_	0	SENT_94	[p7l386t525r463b586],
4	diagnosis	NN	O	diagnosis	prep_of	2	SENT_94	[p7l479t525r807b601],
5	of	IN	O	of	_	0	SENT_94	[p7l834t525r911b586],
6	the	DT	O	the	dep	7	SENT_94	[p7l925t525r1036b586],
7	initial	JJ	O	initial	prep_of	4	SENT_94	[p7l1061t525r1263b586],
8	and	CC	O	and	_	0	SENT_94	[p7l1290t525r1421b586],
9	contralateral	JJ	O	contralateral	amod	11	SENT_94	[p7l1447t525r1897b586],
10	breast	NN	O	breast	nn	11	SENT_94	[p7l1920t525r2138b586],
11	cancer	NN	O	cancer	prep_of	4	SENT_94	[p7l10t638r244b679],
12	were	VBD	O	be	auxpass	13	SENT_94	[p7l291t639r460b679],
13	recorded	VBN	O	record	_	0	SENT_94	[p7l510t619r848b679],
14	.	.	O	.	_	0	SENT_94	[p7l510t619r848b679],

1	Women	NNS	O	woman	nsubjpass	3	SENT_95	[p7l901t620r1191b679],
2	were	VBD	O	be	auxpass	3	SENT_95	[p7l1238t638r1407b679],
3	asked	VBN	O	ask	_	0	SENT_95	[p7l1460t619r1658b679],
4	if	IN	O	if	mark	7	SENT_95	[p7l1708t619r1764b678],
5	they	PRP	O	they	nsubj	7	SENT_95	[p7l1803t619r1957b695],
6	had	VBD	O	have	aux	7	SENT_95	[p7l2004t619r2137b679],
7	received	VBN	O	receive	dep	3	SENT_95	[p7l8t710r304b771],
8	tamoxifen	NN	O	tamoxifen	dobj	7	SENT_95	[p7l345t710r706b771],
9	for	IN	O	for	_	0	SENT_95	[p7l747t710r849b770],
10	first	JJ	ORDINAL	first	amod	12	SENT_95	[p7l888t710r1026b771],
11	breast	NN	O	breast	nn	12	SENT_95	[p7l1065t710r1283b771],
12	cancer	NN	O	cancer	prep_for	8	SENT_95	[p7l1325t730r1579b782],
13	,	,	O	,	_	0	SENT_95	[p7l1325t730r1579b782],
14	and	CC	O	and	_	0	SENT_95	[p7l1625t710r1757b771],
15	if	IN	O	if	mark	31	SENT_95	[p7l1798t710r1853b770],
16	so	RB	O	so	advmod	31	SENT_95	[p7l1886t730r1982b782],
17	,	,	O	,	_	0	SENT_95	[p7l1886t730r1982b782],
18	the	DT	O	the	det	19	SENT_95	[p7l2025t710r2136b771],
19	dose	NN	O	dose	nsubjpass	31	SENT_95	[p7l9t802r192b874],
20	,	,	O	,	_	0	SENT_95	[p7l9t802r192b874],
21	dates	NNS	O	date	conj_and	19	SENT_95	[p7l226t802r431b874],
22	,	,	O	,	_	0	SENT_95	[p7l226t802r431b874],
23	and	CC	O	and	_	0	SENT_95	[p7l466t802r597b863],
24	duration	NN	O	duration	nsubjpass	31	SENT_95	[p7l629t802r936b863],
25	of	IN	O	of	_	0	SENT_95	[p7l967t802r1044b863],
26	treatment	NN	O	treatment	prep_of	24	SENT_95	[p7l1063t816r1433b863],
27	:	:	O	:	_	0	SENT_95	[p7l1063t816r1433b863],
28	tamoxifen	NN	O	tamoxifen	nn	29	SENT_95	[p7l1468t802r1829b863],
29	use	NN	O	use	nsubjpass	31	SENT_95	[p7l1858t822r1975b863],
30	was	VBD	O	be	auxpass	31	SENT_95	[p7l2004t822r2135b863],
31	deﬁned	VBN	O	deﬁned	dep	3	SENT_95	[p7l9t896r276b956],
32	as	IN	O	as	_	0	SENT_95	[p7l324t916r391b956],
33	that	DT	O	that	prep_as	31	SENT_95	[p7l438t896r578b956],
34	given	VBN	O	give	partmod	33	SENT_95	[p7l623t896r813b972],
35	as	IN	O	as	prep	34	SENT_95	[p7l860t916r927b956],
36	treatment	NN	O	treatment	pobj	35	SENT_95	[p7l974t910r1325b956],
37	for	IN	O	for	_	0	SENT_95	[p7l1370t896r1472b956],
38	the	DT	O	the	det	41	SENT_95	[p7l1515t896r1626b956],
39	initial	JJ	O	initial	amod	41	SENT_95	[p7l1673t896r1875b956],
40	breast	NN	O	breast	nn	41	SENT_95	[p7l1920t896r2138b956],
41	cancer	NN	O	cancer	prep_for	36	SENT_95	[p7l10t1007r263b1059],
42	,	,	O	,	_	0	SENT_95	[p7l10t1007r263b1059],
43	and	CC	O	and	_	0	SENT_95	[p7l293t987r425b1048],
44	not	RB	O	not	prep	34	SENT_95	[p7l449t1001r569b1048],
45	for	IN	O	for	dep	35	SENT_95	[p7l593t987r694b1048],
46	the	DT	O	the	det	48	SENT_95	[p7l717t987r828b1047],
47	recurrent	JJ	O	recurrent	amod	48	SENT_95	[p7l853t1001r1186b1048],
48	cancer	NN	O	cancer	pobj	45	SENT_95	[p7l1213t1007r1464b1048],
49	.	.	O	.	_	0	SENT_95	[p7l1213t1007r1464b1048],

1	Women	NNS	O	woman	nsubjpass	4	SENT_96	[p7l1492t988r1781b1048],
2	were	VBD	O	be	auxpass	4	SENT_96	[p7l1804t1007r1973b1048],
3	also	RB	O	also	advmod	4	SENT_96	[p7l2001t987r2135b1048],
4	asked	VBN	O	ask	dep	14	SENT_96	[p7l10t1080r208b1141],
5	to	TO	O	to	aux	6	SENT_96	[p7l257t1095r326b1141],
6	report	VB	O	report	xcomp	4	SENT_96	[p7l376t1095r596b1156],
7	on	IN	O	on	_	0	SENT_96	[p7l646t1100r735b1141],
8	the	DT	O	the	det	9	SENT_96	[p7l783t1080r894b1141],
9	type	NN	O	type	prep_on	6	SENT_96	[p7l944t1095r1094b1156],
10	of	IN	O	of	_	0	SENT_96	[p7l1146t1080r1223b1141],
11	surgical	JJ	O	surgical	amod	12	SENT_96	[p7l1263t1080r1537b1156],
12	treatment	NN	O	treatment	prep_of	9	SENT_96	[p7l1585t1095r1938b1141],
13	they	PRP	O	they	nsubj	14	SENT_96	[p7l1985t1080r2139b1156],
14	received	VBD	O	receive	_	0	SENT_96	[p7l8t1174r304b1234],
15	(	CD	NUMBER	(	num	16	SENT_96	[p7l342t1174r841b1250],
16	lumpectomy	NN	O	lumpectomy	dobj	14	SENT_96	[p7l342t1174r841b1250],
17	,	,	O	,	_	0	SENT_96	[p7l342t1174r841b1250],
18	unilateral	JJ	O	unilateral	amod	19	SENT_96	[p7l877t1174r1216b1234],
19	mastectomy	NN	O	mastectomy	dobj	14	SENT_96	[p7l1248t1188r1705b1250],
20	,	,	O	,	_	0	SENT_96	[p7l1248t1188r1705b1250],
21	or	CC	O	or	_	0	SENT_96	[p7l1742t1193r1817b1234],
22	bilateral	JJ	O	bilateral	amod	24	SENT_96	[p7l1846t1174r2136b1234],
23	mastectomy	NN	O	mastectomy	nn	24	SENT_96	[p7l8t1267r494b1342],
24	)	NN	O	)	conj_or	16	SENT_96	[p7l8t1267r494b1342],
25	.	.	O	.	_	0	SENT_96	[p7l8t1267r494b1342],

1	They	PRP	O	they	nsubjpass	3	SENT_97	[p7l551t1266r741b1342],
2	were	VBD	O	be	auxpass	3	SENT_97	[p7l790t1286r959b1327],
3	asked	VBN	O	ask	_	0	SENT_97	[p7l1014t1266r1212b1327],
4	if	IN	O	if	mark	7	SENT_97	[p7l1265t1266r1320b1326],
5	they	PRP	O	they	nsubj	7	SENT_97	[p7l1362t1266r1516b1342],
6	had	VBD	O	have	aux	7	SENT_97	[p7l1565t1266r1698b1327],
7	undergone	VBN	O	undergo	dep	3	SENT_97	[p7l1750t1266r2136b1342],
8	bilateral	JJ	O	bilateral	amod	9	SENT_97	[p7l7t1359r297b1420],
9	oophorectomy	NN	O	oophorectomy	xcomp	7	SENT_97	[p7l385t1359r928b1435],
10	,	,	O	,	_	0	SENT_97	[p7l385t1359r928b1435],
11	before	IN	O	before	dep	7	SENT_97	[p7l1014t1359r1240b1420],
12	cancer	NN	O	cancer	nn	13	SENT_97	[p7l1328t1379r1563b1420],
13	diagnosis	NN	O	diagnosis	pobj	11	SENT_97	[p7l1647t1359r1976b1435],
14	or	CC	O	or	_	0	SENT_97	[p7l2065t1379r2139b1420],
15	thereafter	RB	O	thereafter	conj_or	11	SENT_97	[p7l8t1453r375b1526],
16	,	,	O	,	_	0	SENT_97	[p7l8t1453r375b1526],
17	and	CC	O	and	_	0	SENT_97	[p7l463t1453r594b1513],
18	if	IN	O	if	mark	21	SENT_97	[p7l676t1453r732b1512],
19	they	PRP	O	they	nsubj	21	SENT_97	[p7l804t1453r957b1529],
20	had	VBD	O	have	aux	21	SENT_97	[p7l1037t1453r1170b1513],
21	had	VBN	O	have	dep	3	SENT_97	[p7l1251t1453r1385b1513],
22	chemotherapy	NN	O	chemotherapy	dobj	21	SENT_97	[p7l1469t1453r1983b1529],
23	or	CC	O	or	_	0	SENT_97	[p7l2065t1473r2139b1513],
24	radiotherapy	NN	O	radiotherapy	dobj	21	SENT_97	[p7l8t1545r467b1621],
25	for	IN	O	for	_	0	SENT_97	[p7l492t1545r594b1606],
26	the	DT	O	the	det	29	SENT_97	[p7l618t1545r729b1606],
27	initial	JJ	O	initial	amod	29	SENT_97	[p7l757t1545r959b1606],
28	breast	NN	O	breast	nn	29	SENT_97	[p7l985t1545r1203b1606],
29	cancer	NN	O	cancer	prep_for	22	SENT_97	[p7l1231t1565r1482b1606],
30	.	.	O	.	_	0	SENT_97	[p7l1231t1565r1482b1606],

1	Whether	IN	O	whether	complm	3	SENT_98	[p7l1513t1545r1829b1606],
2	patients	NNS	O	patient	nsubj	3	SENT_98	[p7l1854t1545r2135b1621],
3	smoked	VBD	O	smoke	ccomp	14	SENT_98	[p7l9t1638r307b1711],
4	,	,	O	,	_	0	SENT_98	[p7l9t1638r307b1711],
5	their	PRP$	O	they	poss	7	SENT_98	[p7l340t1638r507b1699],
6	reproductive	JJ	O	reproductive	amod	7	SENT_98	[p7l534t1638r989b1714],
7	history	NN	O	history	nsubjpass	14	SENT_98	[p7l1019t1638r1285b1714],
8	,	,	O	,	_	0	SENT_98	[p7l1019t1638r1285b1714],
9	and	CC	O	and	_	0	SENT_98	[p7l1319t1638r1451b1699],
10	ethnic	JJ	O	ethnic	amod	11	SENT_98	[p7l1482t1638r1701b1699],
11	origin	NN	O	origin	nsubjpass	14	SENT_98	[p7l1732t1638r1940b1714],
12	were	VBD	O	be	auxpass	14	SENT_98	[p7l1968t1658r2136b1699],
13	also	RB	O	also	advmod	14	SENT_98	[p7l10t1732r145b1792],
14	recorded	VBN	O	record	_	0	SENT_98	[p7l172t1732r509b1792],
15	.	.	O	.	_	0	SENT_98	[p7l172t1732r509b1792],

1	Statistical	JJ	O	statistical	amod	2	SENT_99	[p7l7t1920r355b1980],
2	analysis	NN	O	analysis	_	0	SENT_99	[p7l380t1922r662b1993],
3	A	DT	O	a	det	6	SENT_99	[p7l6t2013r67b2071],
4	matched	VBN	O	match	amod	6	SENT_99	[p7l95t2012r407b2072],
5	case-control	JJ	O	case-control	amod	6	SENT_99	[p7l438t2012r875b2072],
6	analysis	NN	O	analysis	nsubjpass	8	SENT_99	[p7l907t2012r1180b2088],
7	was	VBD	O	be	auxpass	8	SENT_99	[p7l1210t2032r1341b2072],
8	done	VBN	O	do	rcmod	2	SENT_99	[p7l1374t2012r1570b2072],
9	.	.	O	.	_	0	SENT_99	[p7l1374t2012r1570b2072],

1	The	DT	O	the	det	2	SENT_100	[p7l1604t2012r1751b2072],
2	frequency	NN	O	frequency	nsubjpass	10	SENT_100	[p7l1782t2012r2139b2088],
3	and	CC	O	and	_	0	SENT_100	[p7l10t2104r142b2165],
4	mean	VB	O	mean	dep	6	SENT_100	[p7l201t2124r399b2165],
5	duration	NN	O	duration	dobj	4	SENT_100	[p7l459t2104r766b2165],
6	of	IN	O	of	conj_and	2	SENT_100	[p7l826t2104r903b2165],
7	tamoxifen	NN	O	tamoxifen	nn	8	SENT_100	[p7l952t2104r1314b2165],
8	use	NN	O	use	pobj	6	SENT_100	[p7l1372t2124r1489b2165],
9	were	VBD	O	be	auxpass	10	SENT_100	[p7l1548t2124r1717b2165],
10	compared	VBN	O	compare	_	0	SENT_100	[p7l1778t2104r2137b2180],
11	between	IN	O	between	_	0	SENT_100	[p7l7t2197r307b2258],
12	bilateral-disease	NN	O	bilateral-disease	nn	13	SENT_100	[p7l334t2197r910b2258],
13	cases	NNS	O	case	prep_between	10	SENT_100	[p7l941t2217r1119b2258],
14	and	CC	O	and	_	0	SENT_100	[p7l1151t2197r1282b2258],
15	controls	NNS	O	control	conj_and	13	SENT_100	[p7l1312t2197r1619b2258],
16	.	.	O	.	_	0	SENT_100	[p7l1312t2197r1619b2258],

1	The	DT	O	the	det	2	SENT_101	[p7l1652t2197r1800b2258],
2	duration	NN	O	duration	nsubjpass	7	SENT_101	[p7l1830t2197r2137b2258],
3	of	IN	O	of	_	0	SENT_101	[p7l10t2291r86b2351],
4	tamoxifen	NN	O	tamoxifen	nn	5	SENT_101	[p7l103t2291r464b2351],
5	use	NN	O	use	prep_of	2	SENT_101	[p7l490t2311r607b2351],
6	was	VBD	O	be	auxpass	7	SENT_101	[p7l633t2311r764b2351],
7	compared	VBN	O	compare	_	0	SENT_101	[p7l794t2291r1153b2367],
8	by	IN	O	by	_	0	SENT_101	[p7l1178t2291r1265b2367],
9	Wilcoxon	NNP	PERSON	Wilcoxon	poss	12	SENT_101	[p7l1289t2291r1692b2351],
10	’s	POS	O	’s	_	0	SENT_101	[p7l1289t2291r1692b2351],
11	two-sample	JJ	O	two-sample	amod	12	SENT_101	[p7l1720t2291r2136b2367],
12	test	NN	O	test	agent	7	SENT_101	[p7l8t2397r152b2444],
13	.	.	O	.	_	0	SENT_101	[p7l8t2397r152b2444],

1	The	DT	O	the	det	4	SENT_102	[p7l233t2383r380b2444],
2	univariate	JJ	O	univariate	amod	4	SENT_102	[p7l456t2383r813b2444],
3	odds	NNS	O	odds	nn	4	SENT_102	[p7l891t2383r1060b2444],
4	ratios	NNS	O	ratio	nsubjpass	17	SENT_102	[p7l1137t2383r1333b2444],
5	and	CC	O	and	_	0	SENT_102	[p7l1413t2383r1544b2444],
6	p	NN	O	p	nn	7	SENT_102	[p7l1619t2403r1663b2459],
7	values	NNS	O	value	nsubjpass	17	SENT_102	[p7l1739t2383r1959b2444],
8	for	IN	O	for	_	0	SENT_102	[p7l2037t2383r2139b2444],
9	contralateral	JJ	O	contralateral	amod	11	SENT_102	[p7l10t2476r460b2537],
10	breast	NN	O	breast	nn	11	SENT_102	[p7l497t2476r715b2537],
11	cancer	NN	O	cancer	prep_for	7	SENT_102	[p7l754t2496r988b2537],
12	associated	VBN	O	associate	partmod	11	SENT_102	[p7l1026t2476r1389b2537],
13	with	IN	O	with	_	0	SENT_102	[p7l1426t2476r1583b2537],
14	tamoxifen	NN	O	tamoxifen	nn	15	SENT_102	[p7l1621t2476r1982b2537],
15	use	NN	O	use	prep_with	12	SENT_102	[p7l2019t2496r2136b2537],
16	were	VBD	O	be	auxpass	17	SENT_102	[p7l7t2589r175b2630],
17	calculated	VBN	O	calculate	_	0	SENT_102	[p7l209t2570r571b2630],
18	with	IN	O	with	_	0	SENT_102	[p7l601t2570r759b2630],
19	conditional	JJ	O	conditional	amod	21	SENT_102	[p7l791t2570r1196b2630],
20	logistic	JJ	O	logistic	amod	21	SENT_102	[p7l1228t2570r1479b2646],
21	regression	NN	O	regression	prep_with	17	SENT_102	[p7l1511t2570r1891b2646],
22	.	.	O	.	_	0	SENT_102	[p7l1511t2570r1891b2646],

1	Cases	NNS	O	case	nsubjpass	9	SENT_103	[p7l1932t2570r2135b2630],
2	with	IN	O	with	_	0	SENT_103	[p7l7t2662r164b2723],
3	bilateral	JJ	O	bilateral	amod	4	SENT_103	[p7l192t2662r483b2723],
4	disease	NN	O	disease	prep_with	1	SENT_103	[p7l516t2662r765b2723],
5	and	CC	O	and	_	0	SENT_103	[p7l798t2662r930b2723],
6	controls	NNS	O	control	prep_with	1	SENT_103	[p7l962t2662r1248b2723],
7	were	VBD	O	be	auxpass	9	SENT_103	[p7l1279t2682r1447b2723],
8	also	RB	O	also	advmod	9	SENT_103	[p7l1480t2662r1615b2723],
9	compared	VBN	O	compare	_	0	SENT_103	[p7l1649t2662r2007b2738],
10	for	IN	O	for	_	0	SENT_103	[p7l2037t2662r2139b2723],
11	parity	NN	O	parity	prep_for	9	SENT_103	[p7l7t2756r235b2831],
12	,	,	O	,	_	0	SENT_103	[p7l7t2756r235b2831],
13	smoking	NN	O	smoking	nn	14	SENT_103	[p7l269t2755r573b2831],
14	history	NN	O	history	prep_for	9	SENT_103	[p7l599t2755r866b2831],
15	,	,	O	,	_	0	SENT_103	[p7l599t2755r866b2831],
16	oophorectomy	NN	O	oophorectomy	prep_for	9	SENT_103	[p7l900t2755r1442b2831],
17	,	,	O	,	_	0	SENT_103	[p7l900t2755r1442b2831],
18	and	CC	O	and	_	0	SENT_103	[p7l1477t2755r1608b2816],
19	other	JJ	O	other	amod	21	SENT_103	[p7l1640t2755r1828b2816],
20	medical	JJ	O	medical	amod	21	SENT_103	[p7l1855t2755r2136b2816],
21	treatments	NNS	O	treatment	conj_and	11	SENT_103	[p7l8t2863r390b2909],
22	with	IN	O	with	_	0	SENT_103	[p7l414t2849r572b2909],
23	Wilcoxon	NNP	PERSON	Wilcoxon	poss	26	SENT_103	[p7l593t2849r997b2909],
24	’s	POS	O	’s	_	0	SENT_103	[p7l593t2849r997b2909],
25	two-sample	JJ	O	two-sample	amod	26	SENT_103	[p7l1022t2849r1438b2925],
26	test	NN	O	test	prep_with	9	SENT_103	[p7l1462t2863r1588b2909],
27	for	IN	O	for	_	0	SENT_103	[p7l1611t2849r1713b2909],
28	continuous	JJ	O	continuous	amod	29	SENT_103	[p7l1736t2849r2135b2909],
29	variables	NNS	O	variable	prep_for	26	SENT_103	[p7l6t2941r319b3002],
30	and	CC	O	and	_	0	SENT_103	[p7l357t2941r489b3002],
31	univariate	JJ	O	univariate	amod	34	SENT_103	[p7l523t2941r878b3002],
32	conditional	JJ	O	conditional	amod	34	SENT_103	[p7l915t2941r1320b3002],
33	logistic	JJ	O	logistic	amod	34	SENT_103	[p7l1355t2941r1606b3017],
34	regression	NN	O	regression	prep_with	9	SENT_103	[p7l1641t2941r2003b3017],
35	for	IN	O	for	_	0	SENT_103	[p7l2037t2941r2139b3001],
36	categorical	JJ	O	categorical	amod	37	SENT_103	[p7l10t3034r393b3110],
37	variables	NNS	O	variable	prep_for	34	SENT_103	[p7l418t3034r752b3095],
38	.	.	O	.	_	0	SENT_103	[p7l418t3034r752b3095],

1	To	TO	O	to	aux	2	SENT_104	[p7l92t3129r198b3188],
2	estimate	VB	O	estimate	purpcl	28	SENT_104	[p7l225t3128r522b3188],
3	the	DT	O	the	det	5	SENT_104	[p7l546t3128r656b3188],
4	odds	NNS	O	odds	nn	5	SENT_104	[p7l683t3128r851b3188],
5	ratio	NN	O	ratio	dobj	2	SENT_104	[p7l876t3128r1039b3188],
6	for	IN	O	for	_	0	SENT_104	[p7l1064t3128r1166b3188],
7	contralateral	JJ	O	contralateral	amod	9	SENT_104	[p7l1189t3128r1640b3188],
8	breast	NN	O	breast	nn	9	SENT_104	[p7l1662t3128r1880b3188],
9	cancer	NN	O	cancer	prep_for	2	SENT_104	[p7l1905t3147r2139b3188],
10	associated	VBN	O	associate	partmod	9	SENT_104	[p7l10t3220r374b3281],
11	with	IN	O	with	_	0	SENT_104	[p7l419t3220r577b3281],
12	tamoxifen	NN	O	tamoxifen	nn	13	SENT_104	[p7l623t3220r984b3280],
13	use	NN	O	use	prep_with	10	SENT_104	[p7l1030t3240r1169b3293],
14	,	,	O	,	_	0	SENT_104	[p7l1030t3240r1169b3293],
15	after	IN	O	after	mark	25	SENT_104	[p7l1222t3220r1384b3280],
16	adjustment	NN	O	adjustment	nsubj	25	SENT_104	[p7l1431t3220r1833b3296],
17	for	IN	O	for	_	0	SENT_104	[p7l1879t3220r1981b3280],
18	the	DT	O	the	det	20	SENT_104	[p7l2025t3220r2136b3280],
19	other	JJ	O	other	amod	20	SENT_104	[p7l10t3313r198b3374],
20	covariates	NNS	O	covariate	prep_for	16	SENT_104	[p7l237t3314r612b3386],
21	,	,	O	,	_	0	SENT_104	[p7l237t3314r612b3386],
22	including	VBG	O	include	_	0	SENT_104	[p7l654t3313r993b3389],
23	other	JJ	O	other	amod	24	SENT_104	[p7l1032t3313r1220b3374],
24	treatments	NNS	O	treatment	prep_including	20	SENT_104	[p7l1257t3328r1640b3374],
25	received	VBD	O	receive	advcl	10	SENT_104	[p7l1680t3313r1997b3386],
26	,	,	O	,	_	0	SENT_104	[p7l1680t3313r1997b3386],
27	we	PRP	O	we	nsubj	28	SENT_104	[p7l2038t3333r2136b3374],
28	used	VBD	O	use	_	0	SENT_104	[p7l8t3407r174b3467],
29	a	DT	O	a	det	34	SENT_104	[p7l213t3427r248b3467],
30	multivariate	JJ	O	multivariate	amod	31	SENT_104	[p7l286t3407r716b3467],
31	conditional	JJ	O	conditional	amod	34	SENT_104	[p7l756t3407r1161b3467],
32	logistic	JJ	O	logistic	amod	34	SENT_104	[p7l1199t3407r1450b3483],
33	regression	NN	O	regression	nn	34	SENT_104	[p7l1488t3407r1851b3483],
34	model	NN	O	model	dobj	28	SENT_104	[p7l1887t3407r2131b3467],
35	.	.	O	.	_	0	SENT_104	[p7l1887t3407r2131b3467],

1	THE	DT	O	the	det	4	SENT_105	[p7l92t3584r158b3604],
2	LANCET	NN	O	lancet	nn	4	SENT_105	[p7l167t3584r297b3605],
3	°	CD	NUMBER	°	num	4	SENT_105	[p7l306t3591r314b3598],
4	Vol	NN	O	vol	_	0	SENT_105	[p7l323t3584r367b3605],
5	356	CD	NUMBER	356	dep	4	SENT_105	[p7l377t3585r423b3605],
6	-	:	O	-	_	0	SENT_105	[p7l433t3591r441b3598],
7	December	NNP	DATE	December	dep	5	SENT_105	[p7l451t3584r583b3605],
8	2	CD	DATE	2	num	7	SENT_105	[p7l592t3585r614b3608],
9	,	,	DATE	,	_	0	SENT_105	[p7l592t3585r614b3608],
10	2000	CD	DATE	2000	num	7	SENT_105	[p7l624t3585r686b3605],
11	1877	CD	DATE	1877	num	12	SENT_105	[p7l1986t3579r2062b3605],
12	ARTICLES	NNS	O	article	dep	7	SENT_105	[p7l91t3627r244b3648],

1	To	TO	O	to	aux	2	SENT_106	[p8l7t80r113b140],
2	control	VB	O	control	csubjpass	16	SENT_106	[p8l190t79r445b140],
3	for	IN	O	for	_	0	SENT_106	[p8l520t79r622b140],
4	possible	JJ	O	possible	amod	5	SENT_106	[p8l692t79r980b155],
5	confounding	NN	O	confounding	prep_for	2	SENT_106	[p8l1056t79r1535b155],
6	,	,	O	,	_	0	SENT_106	[p8l1056t79r1535b155],
7	ethnic	JJ	O	ethnic	amod	8	SENT_106	[p8l1613t79r1833b140],
8	group	NN	O	group	prep_for	2	SENT_106	[p8l1907t99r2140b155],
9	,	,	O	,	_	0	SENT_106	[p8l1907t99r2140b155],
10	smoking	NN	O	smoking	prep_for	2	SENT_106	[p8l9t172r333b248],
11	,	,	O	,	_	0	SENT_106	[p8l9t172r333b248],
12	and	CC	O	and	_	0	SENT_106	[p8l367t172r499b233],
13	parity	NN	O	parity	conj_and	5	SENT_106	[p8l527t173r736b248],
14	were	VBD	O	be	auxpass	16	SENT_106	[p8l763t192r932b233],
15	also	RB	O	also	advmod	16	SENT_106	[p8l963t172r1099b233],
16	included	VBN	O	include	_	0	SENT_106	[p8l1130t172r1443b233],
17	in	IN	O	in	_	0	SENT_106	[p8l1473t173r1541b232],
18	the	DT	O	the	det	20	SENT_106	[p8l1569t172r1680b233],
19	multivariate	JJ	O	multivariate	amod	20	SENT_106	[p8l1710t172r2142b233],
20	analysis	NN	O	analysis	prep_in	16	SENT_106	[p8l9t266r304b342],
21	.	.	O	.	_	0	SENT_106	[p8l9t266r304b342],

1	To	TO	O	to	aux	2	SENT_107	[p8l356t267r462b326],
2	estimate	VB	O	estimate	purpcl	19	SENT_107	[p8l513t266r811b326],
3	the	DT	O	the	det	5	SENT_107	[p8l858t266r969b326],
4	protective	JJ	O	protective	amod	5	SENT_107	[p8l1017t266r1375b342],
5	effect	NN	O	effect	dobj	2	SENT_107	[p8l1424t266r1619b326],
6	of	IN	O	of	_	0	SENT_107	[p8l1667t266r1744b326],
7	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_107	[p8l1781t266r2144b326],
8	separately	RB	O	separately	advmod	2	SENT_107	[p8l9t358r367b434],
9	for	IN	O	for	_	0	SENT_107	[p8l417t358r519b419],
10	BRCA1	NN	O	brca1	nn	13	SENT_107	[p8l566t358r842b419],
11	and	CC	O	and	_	0	SENT_107	[p8l900t358r1033b419],
12	BRCA2	NN	O	brca2	conj_and	10	SENT_107	[p8l1081t358r1364b419],
13	carriers	NNS	O	carrier	prep_for	2	SENT_107	[p8l1416t358r1701b431],
14	,	,	O	,	_	0	SENT_107	[p8l1416t358r1701b431],
15	odds	NNS	O	odds	nn	17	SENT_107	[p8l1757t358r1926b419],
16	ratio	NN	O	ratio	nn	17	SENT_107	[p8l1978t358r2141b419],
17	estimates	NNS	O	estimate	nsubjpass	19	SENT_107	[p8l9t452r339b512],
18	were	VBD	O	be	auxpass	19	SENT_107	[p8l391t471r560b512],
19	generated	VBN	O	generate	_	0	SENT_107	[p8l611t451r964b527],
20	for	IN	O	for	_	0	SENT_107	[p8l1015t451r1117b512],
21	these	DT	O	these	det	22	SENT_107	[p8l1166t451r1349b512],
22	subgroups	NNS	O	subgroup	prep_for	19	SENT_107	[p8l1402t451r1772b527],
23	with	IN	O	with	_	0	SENT_107	[p8l1823t451r1981b512],
24	the	DT	O	the	det	26	SENT_107	[p8l2031t451r2142b512],
25	matched-pair	JJ	O	matched-pair	amod	26	SENT_107	[p8l7t545r494b621],
26	subsets	NNS	O	subset	prep_with	22	SENT_107	[p8l525t545r801b605],
27	.	.	O	.	_	0	SENT_107	[p8l525t545r801b605],

1	All	DT	O	all	det	2	SENT_108	[p8l837t545r941b604],
2	calculations	NNS	O	calculation	nsubjpass	4	SENT_108	[p8l976t545r1398b605],
3	were	VBD	O	be	auxpass	4	SENT_108	[p8l1431t564r1600b605],
4	done	VBN	O	do	_	0	SENT_108	[p8l1634t545r1810b605],
5	with	IN	O	with	_	0	SENT_108	[p8l1842t545r2000b605],
6	the	DT	O	the	det	9	SENT_108	[p8l2031t545r2142b605],
7	SAS	NNP	O	SAS	nn	9	SENT_108	[p8l10t637r162b698],
8	(	CD	NUMBER	(	num	9	SENT_108	[p8l197t637r481b712],
9	version	NN	O	version	prep_with	4	SENT_108	[p8l197t637r481b712],
10	8.0	CD	NUMBER	8.0	number	11	SENT_108	[p8l509t638r647b712],
11	)	CD	NUMBER	)	dep	9	SENT_108	[p8l509t638r647b712],
12	statistical	JJ	O	statistical	amod	13	SENT_108	[p8l680t637r1013b698],
13	package	NN	O	package	dep	11	SENT_108	[p8l1038t637r1346b713],
14	.	.	O	.	_	0	SENT_108	[p8l1038t637r1346b713],

1	Results	NNS	O	result	_	0	SENT_109	[p8l10t820r351b886],

1	The	DT	O	the	det	2	SENT_110	[p8l7t918r154b979],
2	characteristics	NNS	O	characteristic	nsubj	15	SENT_110	[p8l192t918r700b979],
3	of	IN	O	of	_	0	SENT_110	[p8l738t918r815b979],
4	the	DT	O	the	det	6	SENT_110	[p8l839t918r950b979],
5	209	CD	NUMBER	209	num	6	SENT_110	[p8l988t921r1119b979],
6	cases	NNS	O	case	prep_of	2	SENT_110	[p8l1159t938r1337b979],
7	with	IN	O	with	_	0	SENT_110	[p8l1373t918r1531b979],
8	bilateral	JJ	O	bilateral	amod	9	SENT_110	[p8l1563t918r1855b979],
9	disease	NN	O	disease	prep_with	6	SENT_110	[p8l1891t918r2142b979],
10	and	CC	O	and	_	0	SENT_110	[p8l9t1011r141b1072],
11	384	CD	NUMBER	384	num	14	SENT_110	[p8l182t1014r315b1072],
12	unilateral	JJ	O	unilateral	amod	14	SENT_110	[p8l356t1011r696b1072],
13	disease	NN	O	disease	nn	14	SENT_110	[p8l737t1011r988b1072],
14	controls	NNS	O	control	prep_with	6	SENT_110	[p8l1029t1011r1317b1072],
15	were	VBD	O	be	_	0	SENT_110	[p8l1356t1031r1525b1072],
16	much	RB	O	much	advmod	15	SENT_110	[p8l1565t1011r1771b1072],
17	the	DT	O	the	det	18	SENT_110	[p8l1809t1011r1920b1072],
18	same	JJ	O	same	pobj	16	SENT_110	[p8l1962t1031r2142b1072],

1	(	RB	O	(	advmod	2	SENT_111	[p8l14t1105r213b1180],
2	table	NN	O	table	_	0	SENT_111	[p8l14t1105r213b1180],
3	1	CD	NUMBER	1	dep	2	SENT_111	[p8l257t1105r342b1180],
4	)	NN	O	)	dep	3	SENT_111	[p8l257t1105r342b1180],
5	.	.	O	.	_	0	SENT_111	[p8l257t1105r342b1180],

1	The	DT	O	the	det	3	SENT_112	[p8l381t1105r528b1165],
2	average	JJ	O	average	amod	3	SENT_112	[p8l565t1125r831b1181],
3	time	NN	O	time	nsubj	14	SENT_112	[p8l866t1105r1025b1165],
4	from	IN	O	from	_	0	SENT_112	[p8l1059t1105r1233b1165],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_112	[p8l1266t1105r1405b1165],
6	cancer	NN	O	cancer	prep_from	3	SENT_112	[p8l1440t1124r1675b1165],
7	to	TO	O	to	_	0	SENT_112	[p8l1706t1119r1775b1165],
8	diagnosis	NN	O	diagnosis	prep_to	6	SENT_112	[p8l1812t1105r2142b1181],
9	of	IN	O	of	_	0	SENT_112	[p8l9t1197r86b1258],
10	contralateral	JJ	O	contralateral	amod	11	SENT_112	[p8l122t1197r574b1258],
11	cancer	NN	O	cancer	prep_of	8	SENT_112	[p8l620t1217r856b1258],
12	was	VBD	O	be	cop	14	SENT_112	[p8l897t1217r1028b1258],
13	6-1	CD	NUMBER	6-1	num	14	SENT_112	[p8l1078t1200r1180b1258],
14	years	NNS	NUMBER	year	_	0	SENT_112	[p8l1232t1217r1413b1273],
15	for	IN	O	for	_	0	SENT_112	[p8l1459t1197r1562b1258],
16	the	DT	O	the	det	17	SENT_112	[p8l1604t1197r1715b1258],
17	cases	NNS	O	case	prep_for	14	SENT_112	[p8l1762t1217r1941b1258],
18	with	IN	O	with	_	0	SENT_112	[p8l1986t1197r2144b1258],
19	bilateral	JJ	O	bilateral	amod	20	SENT_112	[p8l6t1290r298b1351],
20	disease	NN	O	disease	prep_with	17	SENT_112	[p8l332t1290r603b1351],
21	.	.	O	.	_	0	SENT_112	[p8l332t1290r603b1351],

1	The	DT	O	the	det	3	SENT_113	[p8l639t1290r787b1351],
2	average	JJ	O	average	amod	3	SENT_113	[p8l822t1310r1089b1366],
3	period	NN	O	period	nsubj	8	SENT_113	[p8l1121t1290r1353b1366],
4	of	IN	O	of	_	0	SENT_113	[p8l1387t1290r1464b1351],
5	follow-up	NN	O	follow-up	prep_of	3	SENT_113	[p8l1486t1290r1831b1366],
6	was	VBD	O	be	cop	8	SENT_113	[p8l1863t1310r1995b1351],
7	9-7	CD	NUMBER	9-7	num	8	SENT_113	[p8l2031t1293r2139b1351],
8	years	NNS	NUMBER	year	_	0	SENT_113	[p8l6t1403r187b1460],
9	for	IN	O	for	_	0	SENT_113	[p8l214t1384r317b1444],
10	controls	NNS	O	control	prep_for	8	SENT_113	[p8l342t1384r652b1457],
11	,	,	O	,	_	0	SENT_113	[p8l342t1384r652b1457],
12	and	CC	O	and	_	0	SENT_113	[p8l683t1384r814b1444],
13	every	DT	O	every	det	14	SENT_113	[p8l842t1403r1030b1460],
14	control	NN	O	control	nsubjpass	16	SENT_113	[p8l1055t1384r1310b1444],
15	was	VBD	O	be	auxpass	16	SENT_113	[p8l1336t1404r1467b1444],
16	followed	VBN	O	follow	conj_and	8	SENT_113	[p8l1494t1384r1802b1444],
17	up	RP	O	up	prt	16	SENT_113	[p8l1828t1403r1919b1460],
18	for	IN	O	for	_	0	SENT_113	[p8l1947t1384r2049b1444],
19	as	RB	O	as	advmod	20	SENT_113	[p8l2075t1404r2141b1444],
20	long	JJ	O	long	prep_for	16	SENT_113	[p8l8t1476r165b1552],
21	as	IN	O	as	_	0	SENT_113	[p8l190t1496r258b1537],
22	the	DT	O	the	det	24	SENT_113	[p8l285t1476r396b1537],
23	matched	VBN	O	match	amod	24	SENT_113	[p8l422t1476r735b1537],
24	case	NN	O	case	prep_as	20	SENT_113	[p8l763t1496r929b1537],
25	.	.	O	.	_	0	SENT_113	[p8l763t1496r929b1537],

1	Table	NNP	O	Table	nsubj	5	SENT_114	[p8l92t1569r302b1630],
2	2	CD	NUMBER	2	num	5	SENT_114	[p8l359t1572r398b1629],
3	shows	NNS	O	show	nn	5	SENT_114	[p8l456t1569r671b1630],
4	tamoxifen	NN	O	tamoxifen	nn	5	SENT_114	[p8l727t1569r1089b1630],
5	use	NN	O	use	_	0	SENT_114	[p8l1142t1589r1282b1642],
6	,	,	O	,	_	0	SENT_114	[p8l1142t1589r1282b1642],
7	which	WDT	O	which	nsubj	9	SENT_114	[p8l1338t1569r1554b1630],
8	was	VBD	O	be	cop	9	SENT_114	[p8l1606t1589r1739b1630],
9	higher	JJR	O	higher	rcmod	5	SENT_114	[p8l1793t1569r2023b1645],
10	in	IN	O	in	_	0	SENT_114	[p8l2075t1570r2144b1629],
11	controls	NNS	O	control	prep_in	9	SENT_114	[p8l9t1663r297b1723],
12	than	IN	O	than	dep	15	SENT_114	[p8l322t1663r483b1723],
13	in	IN	O	in	_	0	SENT_114	[p8l507t1663r575b1722],
14	cases	NNS	O	case	prep_in	12	SENT_114	[p8l601t1682r780b1723],
15	with	IN	O	with	dep	5	SENT_114	[p8l804t1663r962b1723],
16	bilateral	JJ	O	bilateral	amod	17	SENT_114	[p8l985t1663r1276b1723],
17	disease	NN	O	disease	pobj	15	SENT_114	[p8l1302t1663r1573b1723],
18	.	.	O	.	_	0	SENT_114	[p8l1302t1663r1573b1723],

1	In	IN	O	in	_	0	SENT_115	[p8l1603t1664r1679b1722],
2	women	NNS	O	woman	prep_in	17	SENT_115	[p8l1702t1682r1968b1723],
3	who	WP	O	who	nsubj	5	SENT_115	[p8l1990t1663r2141b1723],
4	had	VBD	O	have	aux	5	SENT_115	[p8l6t1755r140b1816],
5	taken	VBN	O	take	rcmod	2	SENT_115	[p8l167t1755r363b1816],
6	tamoxifen	NN	O	tamoxifen	dobj	5	SENT_115	[p8l389t1755r751b1816],
7	the	DT	O	the	det	8	SENT_115	[p8l778t1755r889b1816],
8	likelihood	NN	O	likelihood	nsubjpass	17	SENT_115	[p8l917t1755r1272b1816],
9	of	IN	O	of	_	0	SENT_115	[p8l1301t1755r1378b1816],
10	developing	VBG	O	develop	amod	11	SENT_115	[p8l1396t1755r1788b1831],
11	cancer	NN	O	cancer	prep_of	8	SENT_115	[p8l1815t1775r2050b1816],
12	in	IN	O	in	_	0	SENT_115	[p8l2076t1755r2143b1815],
13	the	DT	O	the	det	15	SENT_115	[p8l7t1848r118b1909],
14	contralateral	JJ	O	contralateral	amod	15	SENT_115	[p8l152t1848r603b1909],
15	breast	NN	O	breast	prep_in	11	SENT_115	[p8l632t1848r851b1909],
16	was	VBD	O	be	auxpass	17	SENT_115	[p8l879t1868r1011b1909],
17	reduced	VBN	O	reduce	_	0	SENT_115	[p8l1043t1848r1334b1909],
18	(	RB	O	(	advmod	17	SENT_115	[p8l1371t1848r1570b1924],
19	table	NN	O	table	nn	21	SENT_115	[p8l1371t1848r1570b1924],
20	3	CD	NUMBER	3	num	21	SENT_115	[p8l1604t1849r1696b1924],
21	)	NN	O	)	dobj	17	SENT_115	[p8l1604t1849r1696b1924],
22	.	.	O	.	_	0	SENT_115	[p8l1604t1849r1696b1924],

1	The	DT	O	the	det	2	SENT_116	[p8l1732t1848r1879b1909],
2	results	NNS	O	result	nsubj	23	SENT_116	[p8l1910t1848r2142b1909],
3	of	IN	O	of	_	0	SENT_116	[p8l9t1942r86b2002],
4	the	DT	O	the	det	6	SENT_116	[p8l166t1942r277b2002],
5	multivariate	JJ	O	multivariate	amod	6	SENT_116	[p8l367t1942r800b2002],
6	analysis	NN	O	analysis	prep_of	2	SENT_116	[p8l892t1942r1189b2018],
7	,	,	O	,	_	0	SENT_116	[p8l892t1942r1189b2018],
8	controlling	VBG	O	control	partmod	23	SENT_116	[p8l1284t1942r1676b2018],
9	for	IN	O	for	_	0	SENT_116	[p8l1765t1942r1867b2002],
10	other	JJ	O	other	amod	11	SENT_116	[p8l1956t1942r2145b2002],
11	treatments	NNS	O	treatment	prep_for	8	SENT_116	[p8l7t2048r414b2107],
12	,	,	O	,	_	0	SENT_116	[p8l7t2048r414b2107],
13	ethnic	JJ	O	ethnic	amod	14	SENT_116	[p8l443t2034r662b2095],
14	group	NN	O	group	prep_for	8	SENT_116	[p8l686t2054r919b2110],
15	,	,	O	,	_	0	SENT_116	[p8l686t2054r919b2110],
16	parity	NN	O	parity	prep_for	8	SENT_116	[p8l945t2034r1174b2110],
17	,	,	O	,	_	0	SENT_116	[p8l945t2034r1174b2110],
18	and	CC	O	and	_	0	SENT_116	[p8l1202t2034r1335b2095],
19	smoking	NN	O	smoking	prep_for	8	SENT_116	[p8l1360t2034r1684b2110],
20	,	,	O	,	_	0	SENT_116	[p8l1360t2034r1684b2110],
21	were	VBD	O	be	cop	23	SENT_116	[p8l1709t2054r1879b2095],
22	mostly	RB	O	mostly	advmod	23	SENT_116	[p8l1904t2034r2145b2110],
23	similar	JJ	O	similar	_	0	SENT_116	[p8l9t2127r252b2188],
24	to	TO	O	to	_	0	SENT_116	[p8l294t2142r363b2188],
25	those	DT	O	those	prep_to	23	SENT_116	[p8l409t2127r599b2188],
26	of	IN	O	of	_	0	SENT_116	[p8l646t2127r723b2188],
27	univariate	JJ	O	univariate	amod	32	SENT_116	[p8l757t2128r1114b2188],
28	analysis	NN	O	analysis	nn	32	SENT_116	[p8l1161t2127r1435b2203],
29	(	NN	O	(	nn	32	SENT_116	[p8l1487t2127r1687b2203],
30	table	NN	O	table	nn	32	SENT_116	[p8l1487t2127r1687b2203],
31	3	CD	NUMBER	3	num	32	SENT_116	[p8l1734t2128r1827b2203],
32	)	NN	O	)	prep_of	25	SENT_116	[p8l1734t2128r1827b2203],
33	.	.	O	.	_	0	SENT_116	[p8l1734t2128r1827b2203],

1	Among	IN	O	among	_	0	SENT_117	[p8l1875t2128r2145b2203],
2	tamoxifen	NN	O	tamoxifen	nn	3	SENT_117	[p8l7t2221r369b2281],
3	users	NNS	O	user	prep_among	16	SENT_117	[p8l402t2240r606b2294],
4	,	,	O	,	_	0	SENT_117	[p8l402t2240r606b2294],
5	the	DT	O	the	det	7	SENT_117	[p8l643t2221r754b2281],
6	average	JJ	O	average	amod	7	SENT_117	[p8l790t2241r1057b2297],
7	duration	NN	O	duration	nsubj	16	SENT_117	[p8l1093t2221r1401b2281],
8	of	IN	O	of	_	0	SENT_117	[p8l1436t2221r1513b2281],
9	use	NN	O	use	prep_of	7	SENT_117	[p8l1536t2241r1654b2281],
10	for	IN	O	for	_	0	SENT_117	[p8l1688t2221r1790b2281],
11	bilateraldisease	NN	O	bilateraldisease	nn	12	SENT_117	[p8l1820t2221r2143b2281, p8l9t2313r260b2374],
12	cases	NNS	O	case	prep_for	16	SENT_117	[p8l310t2333r489b2374],
13	was	VBD	O	be	cop	16	SENT_117	[p8l538t2333r669b2374],
14	3-27	CD	NUMBER	3-27	num	16	SENT_117	[p8l721t2316r876b2374],
15	(	CD	NUMBER	(	num	16	SENT_117	[p8l934t2313r1076b2388],
16	SD	NN	O	sd	dep	30	SENT_117	[p8l934t2313r1076b2388],
17	3-01	CD	NUMBER	3-01	number	18	SENT_117	[p8l1128t2314r1313b2388],
18	)	CD	NUMBER	)	num	19	SENT_117	[p8l1128t2314r1313b2388],
19	years	NNS	NUMBER	year	tmod	16	SENT_117	[p8l1365t2333r1569b2389],
20	,	,	O	,	_	0	SENT_117	[p8l1365t2333r1569b2389],
21	and	CC	O	and	_	0	SENT_117	[p8l1622t2313r1755b2374],
22	was	VBD	O	be	cop	24	SENT_117	[p8l1801t2333r1933b2374],
23	2-67	CD	NUMBER	2-67	num	24	SENT_117	[p8l1984t2316r2139b2374],
24	(	CD	NUMBER	(	conj_and	16	SENT_117	[p8l14t2407r227b2482],
25	2-14	CD	NUMBER	2-14	number	26	SENT_117	[p8l14t2407r227b2482],
26	)	CD	NUMBER	)	num	27	SENT_117	[p8l14t2407r227b2482],
27	years	NNS	NUMBER	year	npadvmod	24	SENT_117	[p8l258t2426r440b2482],
28	for	IN	O	for	_	0	SENT_117	[p8l469t2406r571b2467],
29	controls	NNS	O	control	prep_for	24	SENT_117	[p8l598t2406r885b2467],
30	(	VBP	O	(	_	0	SENT_117	[p8l920t2407r1261b2482],
31	p	NN	O	p	nsubj	32	SENT_117	[p8l920t2407r1261b2482],
32	=	JJ	O	=	xcomp	30	SENT_117	[p8l920t2407r1261b2482],
33	0-40	CD	NUMBER	0-40	num	34	SENT_117	[p8l920t2407r1261b2482],
34	)	NN	O	)	nsubj	30	SENT_117	[p8l920t2407r1261b2482],
35	.	.	O	.	_	0	SENT_117	[p8l920t2407r1261b2482],

1	The	DT	O	the	det	3	SENT_118	[p8l1294t2406r1441b2467],
2	average	JJ	O	average	amod	3	SENT_118	[p8l1471t2426r1738b2482],
3	age	NN	O	age	nsubj	11	SENT_118	[p8l1768t2426r1884b2482],
4	at	IN	O	at	_	0	SENT_118	[p8l1914t2421r1979b2467],
5	ﬁrst	NN	O	ﬁrst	nn	6	SENT_118	[p8l2005t2406r2144b2467],
6	use	NN	O	use	prep_at	3	SENT_118	[p8l7t2520r124b2560],
7	of	IN	O	of	_	0	SENT_118	[p8l161t2500r238b2560],
8	tamoxifen	NN	O	tamoxifen	prep_of	6	SENT_118	[p8l261t2500r624b2560],
9	was	VBD	O	be	cop	11	SENT_118	[p8l656t2520r787b2560],
10	43-7	CD	NUMBER	43-7	num	11	SENT_118	[p8l824t2502r980b2560],
11	(	NN	O	(	_	0	SENT_118	[p8l1023t2500r1236b2575],
12	120	CD	NUMBER	120	number	13	SENT_118	[p8l1023t2500r1236b2575],
13	)	CD	NUMBER	)	num	14	SENT_118	[p8l1023t2500r1236b2575],
14	years	NNS	NUMBER	year	npadvmod	11	SENT_118	[p8l1275t2519r1456b2576],
15	for	IN	O	for	_	0	SENT_118	[p8l1492t2500r1594b2560],
16	the	DT	O	the	det	17	SENT_118	[p8l1625t2500r1736b2560],
17	cases	NNS	O	case	prep_for	11	SENT_118	[p8l1773t2520r1952b2560],
18	with	IN	O	with	_	0	SENT_118	[p8l1986t2500r2144b2560],
19	bilateral	JJ	O	bilateral	amod	20	SENT_118	[p8l6t2592r298b2653],
20	disease	NN	O	disease	prep_with	11	SENT_118	[p8l325t2592r577b2653],
21	and	CC	O	and	_	0	SENT_118	[p8l605t2592r737b2653],
22	45-7	CD	NUMBER	45-7	num	23	SENT_118	[p8l764t2595r920b2653],
23	(	CD	NUMBER	(	conj_and	20	SENT_118	[p8l955t2592r1122b2667],
24	9-0	CD	NUMBER	9-0	number	25	SENT_118	[p8l955t2592r1122b2667],
25	)	CD	NUMBER	)	num	26	SENT_118	[p8l955t2592r1122b2667],
26	years	NNS	NUMBER	year	npadvmod	11	SENT_118	[p8l1152t2612r1334b2668],
27	for	IN	O	for	_	0	SENT_118	[p8l1361t2592r1464b2653],
28	the	DT	O	the	det	29	SENT_118	[p8l1487t2592r1598b2653],
29	controls	NNS	O	control	prep_for	11	SENT_118	[p8l1626t2592r1934b2653],
30	.	.	O	.	_	0	SENT_118	[p8l1626t2592r1934b2653],

1	There	EX	O	there	expl	2	SENT_119	[p8l92t2685r310b2746],
2	were	VBD	O	be	_	0	SENT_119	[p8l349t2705r518b2746],
3	476	CD	NUMBER	476	num	4	SENT_119	[p8l559t2688r692b2746],
4	patients	NNS	O	patient	nsubj	2	SENT_119	[p8l733t2686r1016b2761],
5	with	IN	O	with	_	0	SENT_119	[p8l1056t2685r1214b2746],
6	BRCA1	NN	O	brca1	nn	7	SENT_119	[p8l1251t2686r1527b2746],
7	mutations	NNS	O	mutation	nsubj	8	SENT_119	[p8l1571t2686r1934b2746],
8	(	VBP	O	(	prepc_with	2	SENT_119	[p8l1981t2686r2140b2761],
9	168	CD	NUMBER	168	num	10	SENT_119	[p8l1981t2686r2140b2761],
10	cases	NNS	O	case	dobj	8	SENT_119	[p8l9t2799r188b2839],
11	with	IN	O	with	_	0	SENT_119	[p8l214t2779r373b2839],
12	bilateral	JJ	O	bilateral	amod	13	SENT_119	[p8l396t2779r689b2839],
13	disease	NN	O	disease	prep_with	8	SENT_119	[p8l716t2779r967b2839],
14	and	CC	O	and	_	0	SENT_119	[p8l996t2779r1128b2839],
15	308	CD	NUMBER	308	num	16	SENT_119	[p8l1156t2781r1287b2839],
16	controls	NNS	O	control	conj_and	13	SENT_119	[p8l1318t2779r1633b2854],
17	)	RB	O	)	advmod	8	SENT_119	[p8l1318t2779r1633b2854],
18	and	CC	O	and	_	0	SENT_119	[p8l1667t2779r1799b2839],
19	117	CD	NUMBER	117	nsubj	23	SENT_119	[p8l1834t2781r1957b2838],
20	with	IN	O	with	_	0	SENT_119	[p8l1985t2779r2143b2839],
21	BRCA2	NN	O	brca2	nn	22	SENT_119	[p8l6t2871r288b2932],
22	mutations	NNS	O	mutation	prep_with	19	SENT_119	[p8l351t2871r714b2932],
23	(	VBP	O	(	conj_and	8	SENT_119	[p8l786t2871r892b2946],
24	41	CD	NUMBER	41	num	26	SENT_119	[p8l786t2871r892b2946],
25	bilateral-disease	JJ	O	bilateral-disease	amod	26	SENT_119	[p8l965t2871r1542b2932],
26	cases	NNS	O	case	dobj	23	SENT_119	[p8l1610t2891r1789b2932],
27	and	CC	O	and	_	0	SENT_119	[p8l1857t2871r1989b2932],
28	76	CD	NUMBER	76	num	29	SENT_119	[p8l2055t2874r2141b2932],
29	controls	NNS	O	control	dobj	23	SENT_119	[p8l9t2964r349b3040],
30	)	RB	O	)	advmod	23	SENT_119	[p8l9t2964r349b3040],
31	.	.	O	.	_	0	SENT_119	[p8l9t2964r349b3040],

1	BRCA1	NN	O	brca1	nn	3	SENT_120	[p8l390t2965r667b3025],
2	mutation	NN	O	mutation	nn	3	SENT_120	[p8l709t2965r1040b3025],
3	carriers	NNS	O	carrier	nsubjpass	5	SENT_120	[p8l1078t2965r1341b3025],
4	were	VBD	O	be	auxpass	5	SENT_120	[p8l1378t2984r1548b3025],
5	diagnosed	VBN	O	diagnose	_	0	SENT_120	[p8l1587t2964r1950b3040],
6	with	IN	O	with	_	0	SENT_120	[p8l1985t2964r2144b3025],
7	their	PRP$	O	they	poss	9	SENT_120	[p8l7t3058r175b3118],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_120	[p8l199t3058r339b3118],
9	cancer	NN	O	cancer	prep_with	5	SENT_120	[p8l366t3077r601b3118],
10	at	IN	O	at	_	0	SENT_120	[p8l628t3072r692b3118],
11	a	DT	O	a	det	12	SENT_120	[p8l720t3078r755b3118],
12	mean	NN	O	mean	prep_at	9	SENT_120	[p8l782t3077r981b3118],
13	of	IN	O	of	_	0	SENT_120	[p8l1008t3058r1086b3118],
14	38-9	CD	NUMBER	38-9	num	15	SENT_120	[p8l1104t3060r1259b3118],
15	(	CD	NUMBER	(	prep_of	12	SENT_120	[p8l1296t3058r1462b3133],
16	8-3	CD	NUMBER	8-3	number	17	SENT_120	[p8l1296t3058r1462b3133],
17	)	CD	NUMBER	)	num	18	SENT_120	[p8l1296t3058r1462b3133],
18	years	NNS	NUMBER	year	tmod	15	SENT_120	[p8l1493t3077r1675b3134],
19	and	CC	O	and	_	0	SENT_120	[p8l1705t3058r1837b3118],
20	BRCA2	NN	O	brca2	nn	22	SENT_120	[p8l1862t3058r2144b3118],
21	mutation	NN	O	mutation	nn	22	SENT_120	[p8l7t3150r338b3211],
22	carriers	NNS	O	carrier	prep_of	12	SENT_120	[p8l375t3150r637b3211],
23	at	IN	O	at	_	0	SENT_120	[p8l676t3164r740b3211],
24	45-2	CD	NUMBER	45-2	num	25	SENT_120	[p8l775t3153r933b3211],
25	(	CD	NUMBER	(	prep_at	22	SENT_120	[p8l977t3151r1143b3225],
26	9-3	CD	NUMBER	9-3	number	27	SENT_120	[p8l977t3151r1143b3225],
27	)	CD	NUMBER	)	num	28	SENT_120	[p8l977t3151r1143b3225],
28	years	NNS	NUMBER	year	tmod	5	SENT_120	[p8l1183t3170r1385b3226],
29	.	.	O	.	_	0	SENT_120	[p8l1183t3170r1385b3226],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_121	[p8l1424t3150r1824b3211],
2	use	NN	O	use	nsubjpass	4	SENT_121	[p8l1858t3170r1975b3211],
3	was	VBD	O	be	auxpass	4	SENT_121	[p8l2010t3170r2142b3211],
4	reported	VBN	O	report	_	0	SENT_121	[p8l7t3243r315b3319],
5	for	IN	O	for	_	0	SENT_121	[p8l352t3243r454b3304],
6	64	CD	PERCENT	64	number	7	SENT_121	[p8l493t3246r577b3304],
7	(	CD	PERCENT	(	prep_for	4	SENT_121	[p8l623t3244r841b3319],
8	13	CD	PERCENT	13	num	9	SENT_121	[p8l623t3244r841b3319],
9	%	NN	PERCENT	%	dep	7	SENT_121	[p8l623t3244r841b3319],
10	)	CD	NUMBER	)	num	13	SENT_121	[p8l623t3244r841b3319],
11	BRCA1	NN	O	brca1	nn	13	SENT_121	[p8l883t3244r1159b3304],
12	mutation	NN	O	mutation	nn	13	SENT_121	[p8l1201t3244r1532b3304],
13	carriers	NNS	O	carrier	dep	9	SENT_121	[p8l1571t3244r1833b3304],
14	and	CC	O	and	_	0	SENT_121	[p8l1874t3243r2006b3304],
15	for	IN	O	for	_	0	SENT_121	[p8l2043t3243r2145b3304],
16	39	CD	PERCENT	39	number	17	SENT_121	[p8l9t3339r94b3397],
17	(	CD	PERCENT	(	conj_and	7	SENT_121	[p8l134t3337r353b3412],
18	33	CD	PERCENT	33	number	19	SENT_121	[p8l134t3337r353b3412],
19	%	NN	PERCENT	%	amod	17	SENT_121	[p8l134t3337r353b3412],
20	)	CD	NUMBER	)	num	23	SENT_121	[p8l134t3337r353b3412],
21	BRCA2	NN	O	brca2	nn	23	SENT_121	[p8l387t3337r670b3397],
22	mutation	NN	O	mutation	nn	23	SENT_121	[p8l700t3337r1031b3397],
23	carriers	NNS	O	carrier	dep	4	SENT_121	[p8l1063t3337r1345b3397],
24	.	.	O	.	_	0	SENT_121	[p8l1063t3337r1345b3397],

1	The	DT	O	the	det	3	SENT_122	[p8l1381t3337r1528b3397],
2	protective	JJ	O	protective	amod	3	SENT_122	[p8l1559t3337r1917b3413],
3	effect	NN	O	effect	nsubj	7	SENT_122	[p8l1950t3337r2144b3397],
4	of	IN	O	of	_	0	SENT_122	[p8l9t3429r86b3490],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_122	[p8l146t3429r509b3490],
6	was	VBD	O	be	cop	7	SENT_122	[p8l577t3449r709b3490],
7	apparent	JJ	O	apparent	dep	48	SENT_122	[p8l783t3443r1101b3505],
8	in	IN	O	in	_	0	SENT_122	[p8l1171t3429r1239b3489],
9	BRCA1	NN	O	brca1	nn	13	SENT_122	[p8l1307t3429r1584b3490],
10	and	CC	O	and	_	0	SENT_122	[p8l1661t3429r1793b3490],
11	BRCA2	NN	O	brca2	conj_and	9	SENT_122	[p8l1862t3429r2144b3490],
12	mutation	NN	O	mutation	nn	13	SENT_122	[p8l7t3522r338b3582],
13	carriers	NNS	O	carrier	prep_in	7	SENT_122	[p8l364t3522r649b3593],
14	;	:	O	;	_	0	SENT_122	[p8l364t3522r649b3593],
15	of	IN	O	of	_	0	SENT_122	[p8l679t3521r756b3582],
16	the	DT	O	the	det	20	SENT_122	[p8l770t3521r881b3582],
17	BRCA1	NN	O	brca1	nn	20	SENT_122	[p8l905t3522r1181b3582],
18	mutation	NN	O	mutation	nn	20	SENT_122	[p8l1211t3522r1542b3582],
19	bilateral-disease	NN	O	bilateral-disease	nn	20	SENT_122	[p8l1564t3521r2142b3582],
20	cases	NNS	O	case	prep_of	34	SENT_122	[p9l9t37r188b78],
21	and	CC	O	and	_	0	SENT_122	[p9l223t18r356b78],
22	matched	VBN	O	match	amod	23	SENT_122	[p9l387t18r700b78],
23	controls	NNS	O	control	conj_and	20	SENT_122	[p9l733t18r1043b90],
24	,	,	O	,	_	0	SENT_122	[p9l733t18r1043b90],
25	the	DT	O	the	det	28	SENT_122	[p9l1078t18r1189b78],
26	univariate	JJ	O	univariate	amod	28	SENT_122	[p9l1221t18r1578b78],
27	odds	NNS	O	odds	nn	28	SENT_122	[p9l1612t18r1781b78],
28	ratio	NN	O	ratio	nsubj	34	SENT_122	[p9l1814t18r1978b78],
29	was	VBD	O	be	cop	34	SENT_122	[p9l2010t37r2142b78],
30	0-38	CD	PERCENT	0-38	num	34	SENT_122	[p9l9t112r165b170],
31	(	CD	PERCENT	(	number	32	SENT_122	[p9l219t109r407b184],
32	95	CD	PERCENT	95	dep	33	SENT_122	[p9l219t109r407b184],
33	%	NN	PERCENT	%	dep	34	SENT_122	[p9l219t109r407b184],
34	CI	NN	O	ci	parataxis	7	SENT_122	[p9l460t109r551b170],
35	0-19-0-74	CD	NUMBER	0-19-0-74	num	36	SENT_122	[p9l598t109r988b184],
36	)	NN	O	)	nn	42	SENT_122	[p9l598t109r988b184],
37	and	CC	O	and	_	0	SENT_122	[p9l1041t109r1173b170],
38	of	IN	O	of	nn	42	SENT_122	[p9l1220t109r1297b170],
39	the	DT	O	the	det	41	SENT_122	[p9l1331t109r1442b170],
40	BRCA2	NN	MISC	brca2	nn	41	SENT_122	[p9l1486t109r1769b170],
41	mutation	NN	O	mutation	pobj	38	SENT_122	[p9l1812t109r2143b170],
42	carriers	NNS	O	carrier	dep	34	SENT_122	[p9l9t203r272b263],
43	the	DT	O	the	det	45	SENT_122	[p9l299t202r410b263],
44	odds	NNS	O	odds	nn	45	SENT_122	[p9l438t202r607b263],
45	ratio	NN	O	ratio	dep	42	SENT_122	[p9l634t203r797b263],
46	was	VBD	O	be	cop	48	SENT_122	[p9l824t222r956b263],
47	0-63	CD	NUMBER	0-63	num	48	SENT_122	[p9l985t205r1140b263],
48	(	CD	NUMBER	(	_	0	SENT_122	[p9l1176t203r1619b278],
49	0-20-1-50	CD	NUMBER	0-20-1-50	num	50	SENT_122	[p9l1176t203r1619b278],
50	)	NN	O	)	nsubj	48	SENT_122	[p9l1176t203r1619b278],
51	.	.	O	.	_	0	SENT_122	[p9l1176t203r1619b278],

1	The	DT	DATE	the	det	3	SENT_123	[p9l92t296r238b356],
2	median	JJ	DATE	median	amod	3	SENT_123	[p9l262t296r528b356],
3	year	NN	DATE	year	nsubj	17	SENT_123	[p9l549t316r700b372],
4	of	IN	O	of	_	0	SENT_123	[p9l723t296r800b356],
5	diagnosis	NN	O	diagnosis	prep_of	3	SENT_123	[p9l814t296r1140b372],
6	of	IN	O	of	_	0	SENT_123	[p9l1167t296r1243b356],
7	first	JJ	ORDINAL	first	amod	9	SENT_123	[p9l1257t296r1394b356],
8	breast	NN	O	breast	nn	9	SENT_123	[p9l1416t296r1632b356],
9	cancer	NN	O	cancer	prep_of	5	SENT_123	[p9l1656t315r1889b356],
10	for	IN	O	for	_	0	SENT_123	[p9l1910t296r2012b356],
11	the	DT	O	the	det	13	SENT_123	[p9l2033t296r2142b356],
12	593	CD	NUMBER	593	num	13	SENT_123	[p9l10t391r139b449],
13	patients	NNS	O	patient	prep_for	9	SENT_123	[p9l184t388r464b464],
14	was	VBD	O	be	cop	17	SENT_123	[p9l507t408r638b449],
15	1986	CD	DATE	1986	num	17	SENT_123	[p9l692t391r861b449],
16	(	CD	NUMBER	(	num	17	SENT_123	[p9l912t388r1133b464],
17	range	NN	O	range	_	0	SENT_123	[p9l912t388r1133b464],
18	1970-88	CD	NUMBER	1970-88	num	19	SENT_123	[p9l1186t389r1542b463],
19	)	NN	O	)	dep	17	SENT_123	[p9l1186t389r1542b463],
20	.	.	O	.	_	0	SENT_123	[p9l1186t389r1542b463],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_124	[p9l1589t388r1984b449],
2	use	NN	O	use	nsubjpass	4	SENT_124	[p9l2026t408r2143b449],
3	was	VBD	O	be	auxpass	4	SENT_124	[p9l6t501r136b542],
4	reported	VBN	O	report	dep	12	SENT_124	[p9l161t481r466b557],
5	by	IN	O	by	_	0	SENT_124	[p9l488t481r574b557],
6	23	CD	PERCENT	23	number	7	SENT_124	[p9l598t484r682b542],
7	(	CD	PERCENT	(	agent	4	SENT_124	[p9l715t482r885b557],
8	4	CD	PERCENT	4	number	9	SENT_124	[p9l715t482r885b557],
9	%	NN	PERCENT	%	amod	7	SENT_124	[p9l715t482r885b557],
10	)	CD	NUMBER	)	num	11	SENT_124	[p9l715t482r885b557],
11	women	NNS	O	woman	nsubj	12	SENT_124	[p9l913t501r1177b542],
12	diagnosed	VBD	O	diagnose	_	0	SENT_124	[p9l1201t481r1561b557],
13	before	IN	O	before	_	0	SENT_124	[p9l1583t481r1807b542],
14	1980	CD	DATE	1980	prep_before	12	SENT_124	[p9l1840t484r2033b554],
15	,	,	O	,	_	0	SENT_124	[p9l1840t484r2033b554],
16	by	IN	O	by	_	0	SENT_124	[p9l2058t481r2145b557],
17	91	CD	PERCENT	91	num	18	SENT_124	[p9l10t577r87b635],
18	(	CD	PERCENT	(	prep_by	12	SENT_124	[p9l130t575r347b650],
19	15	CD	PERCENT	15	number	20	SENT_124	[p9l130t575r347b650],
20	%	NN	PERCENT	%	amod	18	SENT_124	[p9l130t575r347b650],
21	)	CD	NUMBER	)	nsubj	34	SENT_124	[p9l130t575r347b650],
22	diagnosed	VBN	O	diagnose	partmod	21	SENT_124	[p9l382t575r741b651],
23	from	IN	O	from	_	0	SENT_124	[p9l768t575r940b635],
24	1980	CD	DATE	1980	prep_from	22	SENT_124	[p9l976t577r1146b635],
25	to	TO	DATE	to	_	0	SENT_124	[p9l1175t589r1243b635],
26	1989	CD	DATE	1989	prep_to	22	SENT_124	[p9l1282t577r1450b635],
27	and	CC	O	and	_	0	SENT_124	[p9l1483t575r1613b635],
28	by	IN	O	by	_	0	SENT_124	[p9l1639t575r1726b651],
29	158	CD	PERCENT	158	num	30	SENT_124	[p9l1761t577r1884b635],
30	(	CD	PERCENT	(	agent	22	SENT_124	[p9l1921t575r2137b650],
31	26	CD	PERCENT	26	number	32	SENT_124	[p9l1921t575r2137b650],
32	%	NN	PERCENT	%	amod	30	SENT_124	[p9l1921t575r2137b650],
33	)	CD	NUMBER	)	dep	22	SENT_124	[p9l1921t575r2137b650],
34	diagnosed	VBD	O	diagnose	rcmod	18	SENT_124	[p9l9t667r368b743],
35	since	IN	O	since	_	0	SENT_124	[p9l405t667r581b728],
36	1990	CD	DATE	1990	prep_since	34	SENT_124	[p9l626t670r817b728],
37	.	.	O	.	_	0	SENT_124	[p9l626t670r817b728],

1	The	DT	O	the	det	3	SENT_125	[p9l857t667r1003b728],
2	odds	NNS	O	odds	nn	3	SENT_125	[p9l1041t667r1209b728],
3	ratio	NN	O	ratio	nsubj	16	SENT_125	[p9l1245t667r1407b728],
4	for	IN	O	for	_	0	SENT_125	[p9l1444t667r1545b728],
5	second	JJ	ORDINAL	second	amod	7	SENT_125	[p9l1580t667r1827b728],
6	primary	JJ	O	primary	amod	7	SENT_125	[p9l1862t667r2145b743],
7	cancer	NN	O	cancer	prep_for	3	SENT_125	[p9l9t780r242b821],
8	associated	VBN	O	associate	partmod	7	SENT_125	[p9l270t760r631b821],
9	with	IN	O	with	_	0	SENT_125	[p9l657t760r814b821],
10	tamoxifen	NN	O	tamoxifen	nn	11	SENT_125	[p9l841t760r1199b821],
11	use	NN	O	use	prep_with	8	SENT_125	[p9l1227t780r1343b821],
12	was	VBD	O	be	cop	16	SENT_125	[p9l1370t780r1501b821],
13	0-30	CD	NUMBER	0-30	number	14	SENT_125	[p9l1532t763r1687b821],
14	(	CD	NUMBER	(	num	16	SENT_125	[p9l1723t761r2137b836],
15	0-04-2-48	CD	DATE	0-04-2-48	num	16	SENT_125	[p9l1723t761r2137b836],
16	)	NN	O	)	_	0	SENT_125	[p9l1723t761r2137b836],
17	for	IN	O	for	_	0	SENT_125	[p9l7t854r109b914],
18	women	NNS	O	woman	prep_for	16	SENT_125	[p9l133t874r397b914],
19	treated	VBN	O	treat	partmod	18	SENT_125	[p9l425t854r674b914],
20	before	IN	O	before	_	0	SENT_125	[p9l700t854r924b914],
21	1980	CD	DATE	1980	prep_before	19	SENT_125	[p9l962t856r1155b927],
22	,	,	O	,	_	0	SENT_125	[p9l962t856r1155b927],
23	0-29	CD	NUMBER	0-29	num	25	SENT_125	[p9l1189t856r1342b915],
24	(	NN	O	(	nn	25	SENT_125	[p9l1380t854r1467b929],
25	o	NN	O	o	conj_and	16	SENT_125	[p9l1380t854r1467b929],
26	-	:	O	-	_	0	SENT_125	[p9l1380t854r1467b929],
27	12-0-71	CD	NUMBER	12-0-71	num	28	SENT_125	[p9l1485t854r1793b929],
28	)	NN	O	)	dep	25	SENT_125	[p9l1485t854r1793b929],
29	for	IN	O	for	_	0	SENT_125	[p9l1828t854r1929b914],
30	those	DT	O	those	prep_for	28	SENT_125	[p9l1955t854r2143b914],
31	treated	VBN	O	treat	partmod	30	SENT_125	[p9l7t946r256b1007],
32	from	IN	O	from	_	0	SENT_125	[p9l284t946r456b1007],
33	1980	CD	DATE	1980	num	35	SENT_125	[p9l494t949r663b1007],
34	to	TO	DATE	to	dep	35	SENT_125	[p9l693t960r761b1007],
35	1989	CD	DATE	1989	prep_from	31	SENT_125	[p9l801t949r993b1019],
36	,	,	O	,	_	0	SENT_125	[p9l801t949r993b1019],
37	and	CC	O	and	_	0	SENT_125	[p9l1027t946r1157b1007],
38	0-68	CD	NUMBER	0-68	number	39	SENT_125	[p9l1187t949r1342b1007],
39	(	CD	NUMBER	(	conj_and	16	SENT_125	[p9l1379t947r1793b1021],
40	0-33-1-40	CD	NUMBER	0-33-1-40	num	41	SENT_125	[p9l1379t947r1793b1021],
41	)	NN	O	)	dep	39	SENT_125	[p9l1379t947r1793b1021],
42	for	IN	O	for	_	0	SENT_125	[p9l1827t946r1928b1007],
43	those	DT	O	those	prep_for	39	SENT_125	[p9l1955t946r2142b1007],
44	treated	VBN	O	treat	partmod	43	SENT_125	[p9l7t1040r254b1100],
45	since	IN	O	since	_	0	SENT_125	[p9l280t1040r453b1100],
46	1990	CD	DATE	1990	prep_since	44	SENT_125	[p9l488t1042r676b1100],
47	.	.	O	.	_	0	SENT_125	[p9l488t1042r676b1100],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_126	[p9l705t1039r1096b1100],
2	use	NN	O	use	nsubjpass	4	SENT_126	[p9l1119t1059r1234b1100],
3	was	VBD	O	be	auxpass	4	SENT_126	[p9l1259t1059r1388b1100],
4	associated	VBN	O	associate	_	0	SENT_126	[p9l1415t1040r1773b1100],
5	with	IN	O	with	_	0	SENT_126	[p9l1795t1040r1951b1100],
6	odds	NNS	O	odds	nn	7	SENT_126	[p9l1976t1040r2142b1100],
7	ratios	NNS	O	ratio	prep_with	4	SENT_126	[p9l7t1133r202b1193],
8	of	IN	O	of	_	0	SENT_126	[p9l231t1133r307b1193],
9	0-36	CD	NUMBER	0-36	num	10	SENT_126	[p9l325t1135r479b1193],
10	(	CD	NUMBER	(	prep_of	7	SENT_126	[p9l514t1133r928b1208],
11	0-17-0-75	CD	NUMBER	0-17-0-75	num	12	SENT_126	[p9l514t1133r928b1208],
12	)	NN	O	)	dep	7	SENT_126	[p9l514t1133r928b1208],
13	and	CC	O	and	_	0	SENT_126	[p9l962t1133r1093b1193],
14	0-71	CD	NUMBER	0-71	number	15	SENT_126	[p9l1121t1135r1268b1193],
15	(	CD	NUMBER	(	prep_with	4	SENT_126	[p9l1310t1133r1724b1208],
16	0-30-1-69	CD	NUMBER	0-30-1-69	num	17	SENT_126	[p9l1310t1133r1724b1208],
17	)	NN	O	)	dep	15	SENT_126	[p9l1310t1133r1724b1208],
18	for	IN	O	for	_	0	SENT_126	[p9l1756t1133r1857b1193],
19	women	NNS	O	woman	prep_for	4	SENT_126	[p9l1879t1152r2143b1193],
20	diagnosed	VBN	O	diagnose	partmod	19	SENT_126	[p9l9t1225r368b1301],
21	in	IN	O	in	_	0	SENT_126	[p9l423t1225r491b1285],
22	North	NNP	LOCATION	North	nn	23	SENT_126	[p9l544t1225r764b1286],
23	America	NNP	LOCATION	America	prep_in	20	SENT_126	[p9l817t1225r1119b1286],
24	and	CC	O	and	_	0	SENT_126	[p9l1176t1225r1307b1286],
25	Europe	NNP	LOCATION	Europe	conj_and	23	SENT_126	[p9l1362t1226r1646b1301],
26	,	,	O	,	_	0	SENT_126	[p9l1362t1226r1646b1301],
27	respectively	RB	O	respectively	advmod	20	SENT_126	[p9l1703t1225r2137b1301],
28	.	.	O	.	_	0	SENT_126	[p9l1703t1225r2137b1301],

1	However	RB	O	however	advmod	9	SENT_127	[p9l8t1319r351b1391],
2	,	,	O	,	_	0	SENT_127	[p9l8t1319r351b1391],
3	the	DT	O	the	det	6	SENT_127	[p9l396t1318r506b1379],
4	two	CD	NUMBER	two	num	6	SENT_127	[p9l548t1333r677b1379],
5	odds	NNS	O	odds	nn	6	SENT_127	[p9l722t1318r889b1379],
6	ratios	NNS	O	ratio	nsubj	9	SENT_127	[p9l932t1319r1127b1379],
7	did	VBD	O	do	aux	9	SENT_127	[p9l1171t1318r1285b1379],
8	not	RB	O	not	neg	9	SENT_127	[p9l1326t1332r1445b1379],
9	differ	VB	O	differ	_	0	SENT_127	[p9l1486t1318r1676b1379],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_127	[p9l1717t1318r2145b1394],
11	(	CD	NUMBER	(	num	13	SENT_127	[p9l14t1412r81b1488],
12	p	NN	O	p	nn	13	SENT_127	[p9l14t1412r81b1488],
13	value	NN	O	value	nn	18	SENT_127	[p9l132t1412r319b1472],
14	for	IN	O	for	_	0	SENT_127	[p9l370t1412r471b1472],
15	interaction	NN	O	interaction	prep_for	13	SENT_127	[p9l520t1412r1174b1487],
16	=	JJ	O	=	amod	18	SENT_127	[p9l520t1412r1174b1487],
17	0-21	CD	NUMBER	0-21	tmod	16	SENT_127	[p9l520t1412r1174b1487],
18	)	NN	O	)	dobj	9	SENT_127	[p9l520t1412r1174b1487],
19	.	.	O	.	_	0	SENT_127	[p9l520t1412r1174b1487],

1	The	DT	O	the	det	3	SENT_128	[p9l1229t1412r1376b1472],
2	protective	JJ	O	protective	amod	3	SENT_128	[p9l1426t1412r1780b1488],
3	effect	NN	O	effect	nsubj	7	SENT_128	[p9l1833t1412r2025b1472],
4	of	IN	O	of	_	0	SENT_128	[p9l2077t1412r2153b1472],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_128	[p9l7t1504r366b1565],
6	was	VBD	O	be	cop	7	SENT_128	[p9l405t1524r535b1565],
7	greater	JJR	O	greater	_	0	SENT_128	[p9l578t1518r826b1580],
8	in	IN	O	in	_	0	SENT_128	[p9l865t1504r932b1564],
9	North	NNP	LOCATION	North	nn	10	SENT_128	[p9l971t1504r1191b1565],
10	America	NNP	LOCATION	America	prep_in	7	SENT_128	[p9l1229t1504r1531b1565],
11	than	IN	O	than	advmod	17	SENT_128	[p9l1572t1504r1732b1565],
12	in	IN	O	in	_	0	SENT_128	[p9l1772t1504r1840b1564],
13	Europe	NNP	LOCATION	Europe	prep_in	11	SENT_128	[p9l1880t1505r2142b1580],
14	(	CD	NUMBER	(	num	15	SENT_128	[p9l14t1597r191b1673],
15	data	NNS	O	datum	npadvmod	16	SENT_128	[p9l14t1597r191b1673],
16	not	RB	O	not	advmod	11	SENT_128	[p9l237t1612r356b1658],
17	shown	VBN	O	show	partmod	10	SENT_128	[p9l403t1597r683b1673],
18	)	NN	O	)	dobj	17	SENT_128	[p9l403t1597r683b1673],
19	.	.	O	.	_	0	SENT_128	[p9l403t1597r683b1673],

1	The	DT	O	the	det	3	SENT_129	[p9l733t1597r880b1658],
2	European	JJ	MISC	european	amod	3	SENT_129	[p9l927t1598r1277b1673],
3	patients	NNS	O	patient	nsubj	4	SENT_129	[p9l1322t1598r1603b1673],
4	differed	VBD	O	differ	_	0	SENT_129	[p9l1652t1597r1926b1658],
5	from	IN	O	from	_	0	SENT_129	[p9l1972t1597r2143b1658],
6	American	JJ	LOCATION	american	amod	7	SENT_129	[p9l6t1691r356b1751],
7	patients	NNS	O	patient	prep_from	4	SENT_129	[p9l388t1691r668b1767],
8	in	IN	O	in	_	0	SENT_129	[p9l704t1691r771b1750],
9	that	IN	O	that	complm	11	SENT_129	[p9l805t1691r944b1751],
10	they	PRP	O	they	nsubj	11	SENT_129	[p9l977t1691r1129b1767],
11	had	VBD	O	have	prepc_in	4	SENT_129	[p9l1160t1691r1293b1751],
12	a	DT	O	a	det	14	SENT_129	[p9l1329t1710r1363b1751],
13	higher	JJR	O	higher	amod	14	SENT_129	[p9l1397t1691r1624b1767],
14	proportion	NN	O	proportion	dobj	11	SENT_129	[p9l1655t1691r2042b1767],
15	of	IN	O	of	_	0	SENT_129	[p9l2077t1691r2153b1751],
16	BRCA1	NN	O	brca1	nn	17	SENT_129	[p9l6t1783r279b1844],
17	mutations	NNS	O	mutation	prep_of	14	SENT_129	[p9l314t1783r673b1844],
18	(	VBP	O	(	rcmod	14	SENT_129	[p9l710t1784r822b1858],
19	56	CD	PERCENT	56	number	20	SENT_129	[p9l710t1784r822b1858],
20	[	CD	PERCENT	[	dobj	18	SENT_129	[p9l864t1783r1071b1859],
21	88	CD	PERCENT	88	num	22	SENT_129	[p9l864t1783r1071b1859],
22	%	NN	PERCENT	%	dep	20	SENT_129	[p9l864t1783r1071b1859],
23	]	SYM	O	]	dep	20	SENT_129	[p9l864t1783r1071b1859],
24	-	:	O	-	_	0	SENT_129	[p9l1113t1804r1180b1844],
25	vs	CC	O	vs	cc	27	SENT_129	[p9l1113t1804r1180b1844],
26	75	CD	NUMBER	75	num	27	SENT_129	[p9l1211t1786r1293b1844],
27	[	NN	O	[	nsubj	51	SENT_129	[p9l1337t1783r1398b1859],
28	7	CD	PERCENT	7	number	30	SENT_129	[p9l1337t1783r1398b1859],
29	7	CD	PERCENT	7	number	30	SENT_129	[p9l1407t1783r1607b1859],
30	%	NN	PERCENT	%	amod	27	SENT_129	[p9l1407t1783r1607b1859],
31	]	CD	NUMBER	]	num	32	SENT_129	[p9l1407t1783r1607b1859],
32	)	NN	O	)	dep	27	SENT_129	[p9l1407t1783r1607b1859],
33	,	,	O	,	_	0	SENT_129	[p9l1407t1783r1607b1859],
34	a	DT	O	a	det	36	SENT_129	[p9l1642t1803r1677b1844],
35	younger	JJR	O	younger	amod	36	SENT_129	[p9l1705t1803r1998b1859],
36	age	NN	O	age	dep	43	SENT_129	[p9l2027t1803r2142b1859],
37	at	IN	O	at	_	0	SENT_129	[p9l9t1891r73b1937],
38	first	JJ	ORDINAL	first	amod	39	SENT_129	[p9l102t1876r240b1937],
39	cancer	NN	O	cancer	prep_at	36	SENT_129	[p9l271t1896r504b1937],
40	diagnosis	NN	O	diagnosis	dep	43	SENT_129	[p9l533t1876r860b1952],
41	(	CD	NUMBER	(	num	40	SENT_129	[p9l898t1877r1078b1952],
42	38-5	CD	NUMBER	38-5	num	43	SENT_129	[p9l898t1877r1078b1952],
43	years	NNS	NUMBER	year	dep	51	SENT_129	[p9l1111t1896r1291b1952],
44	[	JJ	O	[	amod	45	SENT_129	[p9l1332t1876r1469b1952],
45	SD	NN	O	sd	dep	43	SENT_129	[p9l1332t1876r1469b1952],
46	7-4	CD	NUMBER	7-4	num	47	SENT_129	[p9l1503t1876r1636b1952],
47	]	CD	NUMBER	]	dep	45	SENT_129	[p9l1503t1876r1636b1952],
48	-223	CD	NUMBER	-223	num	50	SENT_129	[p9l1677t1898r1745b1937],
49	40-8	CD	NUMBER	40-8	num	50	SENT_129	[p9l1775t1879r1930b1937],
50	years	NNS	NUMBER	year	nsubj	51	SENT_129	[p9l1962t1896r2142b1952],
51	[	VBP	O	[	parataxis	4	SENT_129	[p9l17t1970r228b2045],
52	9-3	CD	NUMBER	9-3	number	53	SENT_129	[p9l17t1970r228b2045],
53	]	CD	NUMBER	]	num	54	SENT_129	[p9l17t1970r228b2045],
54	)	NN	O	)	dobj	51	SENT_129	[p9l17t1970r228b2045],
55	,	,	O	,	_	0	SENT_129	[p9l17t1970r228b2045],
56	and	CC	O	and	_	0	SENT_129	[p9l268t1970r398b2030],
57	a	DT	O	a	det	60	SENT_129	[p9l435t1990r469b2030],
58	more	RBR	O	more	advmod	59	SENT_129	[p9l504t1989r688b2030],
59	recent	JJ	O	recent	amod	60	SENT_129	[p9l723t1984r944b2030],
60	diagnosis	NN	O	diagnosis	dobj	51	SENT_129	[p9l979t1970r1305b2046],
61	of	IN	O	of	_	0	SENT_129	[p9l1343t1970r1419b2030],
62	ﬁrst	NN	O	ﬁrst	nn	65	SENT_129	[p9l1443t1970r1581b2030],
63	primary	JJ	O	primary	amod	65	SENT_129	[p9l1613t1970r1896b2046],
64	breast	NN	O	breast	nn	65	SENT_129	[p9l1928t1970r2144b2030],
65	cancer	NN	O	cancer	prep_of	60	SENT_129	[p9l9t2082r242b2123],
66	(	CD	NUMBER	(	num	67	SENT_129	[p9l272t2062r762b2138],
67	March/April	NN	O	march/april	dep	60	SENT_129	[p9l272t2062r762b2138],
68	,	,	O	,	_	0	SENT_129	[p9l272t2062r762b2138],
69	1987	CD	DATE	1987	appos	67	SENT_129	[p9l800t2065r968b2123],
70	-	:	O	-	_	0	SENT_129	[p9l998t2083r1066b2123],
71	vs	CC	O	vs	_	0	SENT_129	[p9l998t2083r1066b2123],
72	May/June	NNP	O	May/June	dobj	51	SENT_129	[p9l1090t2062r1459b2138],
73	,	,	O	,	_	0	SENT_129	[p9l1090t2062r1459b2138],
74	1985	CD	DATE	1985	num	75	SENT_129	[p9l1498t2063r1720b2137],
75	)	NN	O	)	appos	72	SENT_129	[p9l1498t2063r1720b2137],
76	.	.	O	.	_	0	SENT_129	[p9l1498t2063r1720b2137],

1	The	DT	O	the	det	3	SENT_130	[p9l92t2156r239b2216],
2	protective	JJ	O	protective	amod	3	SENT_130	[p9l280t2156r638b2232],
3	effect	NN	O	effect	nsubj	8	SENT_130	[p9l681t2155r874b2216],
4	of	IN	O	of	_	0	SENT_130	[p9l916t2155r993b2216],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_130	[p9l1023t2155r1386b2216],
6	was	VBD	O	be	cop	8	SENT_130	[p9l1425t2175r1557b2216],
7	slightly	RB	O	slightly	advmod	8	SENT_130	[p9l1601t2156r1856b2232],
8	greater	JJR	O	greater	dep	25	SENT_130	[p9l1895t2170r2145b2232],
9	for	IN	O	for	_	0	SENT_130	[p9l7t2249r110b2309],
10	women	NNS	O	woman	prep_for	8	SENT_130	[p9l150t2268r417b2309],
11	who	WP	O	who	nsubjpass	13	SENT_130	[p9l459t2249r609b2309],
12	were	VBD	O	be	auxpass	13	SENT_130	[p9l654t2268r823b2309],
13	diagnosed	VBN	O	diagnose	rcmod	10	SENT_130	[p9l869t2249r1233b2325],
14	with	IN	O	with	_	0	SENT_130	[p9l1275t2249r1433b2309],
15	the	DT	O	the	det	18	SENT_130	[p9l1476t2249r1587b2309],
16	second	JJ	ORDINAL	second	amod	18	SENT_130	[p9l1633t2249r1883b2309],
17	breast	NN	O	breast	nn	18	SENT_130	[p9l1925t2249r2144b2309],
18	cancer	NN	O	cancer	prep_with	13	SENT_130	[p9l9t2361r245b2402],
19	at	IN	O	at	_	0	SENT_130	[p9l277t2355r342b2402],
20	or	CC	O	or	_	0	SENT_130	[p9l376t2361r451b2402],
21	after	IN	O	after	_	0	SENT_130	[p9l484t2341r646b2402],
22	age	NN	O	age	prep_at	13	SENT_130	[p9l679t2361r795b2417],
23	50	CD	DURATION	50	num	24	SENT_130	[p9l832t2344r916b2402],
24	years	NNS	NUMBER	year	tmod	13	SENT_130	[p9l951t2361r1132b2417],
25	(	VBP	O	(	_	0	SENT_130	[p9l1173t2342r1381b2416],
26	0-39	CD	NUMBER	0-39	dobj	25	SENT_130	[p9l1173t2342r1381b2416],
27	,	,	O	,	_	0	SENT_130	[p9l1173t2342r1381b2416],
28	0-14-1-08	CD	NUMBER	0-14-1-08	num	29	SENT_130	[p9l1420t2342r1810b2416],
29	)	NN	O	)	npadvmod	30	SENT_130	[p9l1420t2342r1810b2416],
30	than	IN	O	than	advmod	25	SENT_130	[p9l1849t2341r2010b2402],
31	for	IN	O	for	_	0	SENT_130	[p9l2043t2341r2145b2402],
32	those	DT	O	those	prep_for	25	SENT_130	[p9l7t2434r197b2495],
33	who	WP	O	who	nsubjpass	35	SENT_130	[p9l225t2434r376b2495],
34	were	VBD	O	be	auxpass	35	SENT_130	[p9l405t2454r574b2495],
35	diagnosed	VBN	O	diagnose	rcmod	32	SENT_130	[p9l605t2434r968b2510],
36	with	IN	O	with	_	0	SENT_130	[p9l995t2434r1153b2495],
37	contralateral	JJ	O	contralateral	amod	39	SENT_130	[p9l1183t2434r1635b2495],
38	breast	NN	O	breast	nn	39	SENT_130	[p9l1662t2434r1880b2495],
39	cancer	NN	O	cancer	prep_with	35	SENT_130	[p9l1910t2454r2145b2495],
40	before	IN	O	before	_	0	SENT_130	[p9l6t2528r233b2588],
41	age	NN	O	age	prep_before	35	SENT_130	[p9l272t2548r388b2604],
42	50	CD	NUMBER	50	num	41	SENT_130	[p9l428t2530r513b2588],
43	(	CD	NUMBER	(	num	44	SENT_130	[p9l558t2528r766b2603],
44	0-47	CD	NUMBER	0-47	nsubj	25	SENT_130	[p9l558t2528r766b2603],
45	,	,	O	,	_	0	SENT_130	[p9l558t2528r766b2603],
46	0-25-0-88	CD	NUMBER	0-25-0-88	num	47	SENT_130	[p9l808t2528r1223b2603],
47	)	NN	O	)	appos	44	SENT_130	[p9l808t2528r1223b2603],
48	.	.	O	.	_	0	SENT_130	[p9l808t2528r1223b2603],

1	The	DT	O	the	det	3	SENT_131	[p9l1264t2528r1412b2588],
2	protective	JJ	O	protective	amod	3	SENT_131	[p9l1448t2528r1806b2604],
3	effect	NN	O	effect	nsubj	6	SENT_131	[p9l1845t2528r2039b2588],
4	of	IN	O	of	_	0	SENT_131	[p9l2076t2528r2153b2588],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_131	[p9l7t2620r369b2681],
6	increased	VBN	O	increase	_	0	SENT_131	[p9l393t2620r732b2681],
7	with	IN	O	with	_	0	SENT_131	[p9l754t2620r913b2681],
8	duration	NN	O	duration	prep_with	6	SENT_131	[p9l937t2620r1245b2681],
9	of	IN	O	of	_	0	SENT_131	[p9l1270t2620r1347b2681],
10	tamoxifen	NN	O	tamoxifen	nn	11	SENT_131	[p9l1361t2620r1723b2681],
11	use	NN	O	use	prep_of	8	SENT_131	[p9l1746t2640r1864b2681],
12	up	IN	DURATION	up	advmod	6	SENT_131	[p9l1888t2640r1979b2696],
13	to	TO	DURATION	to	_	0	SENT_131	[p9l2005t2634r2074b2681],
14	4	CD	DURATION	4	num	15	SENT_131	[p9l2101t2623r2141b2680],
15	years	NNS	NUMBER	year	tmod	16	SENT_131	[p9l6t2733r187b2789],
16	(	RB	O	(	amod	19	SENT_131	[p9l238t2713r437b2788],
17	table	NN	O	table	nn	19	SENT_131	[p9l238t2713r437b2788],
18	3	CD	NUMBER	3	num	19	SENT_131	[p9l483t2714r575b2789],
19	)	NN	O	)	prep_to	12	SENT_131	[p9l483t2714r575b2789],
20	.	.	O	.	_	0	SENT_131	[p9l483t2714r575b2789],

1	We	PRP	O	we	nsubj	2	SENT_132	[p9l621t2714r744b2774],
2	recorded	VBD	O	record	_	0	SENT_132	[p9l787t2713r1107b2774],
3	a	DT	O	a	det	5	SENT_132	[p9l1151t2733r1187b2774],
4	small	JJ	O	small	amod	5	SENT_132	[p9l1231t2713r1418b2774],
5	increase	NN	O	increase	dobj	2	SENT_132	[p9l1461t2714r1750b2774],
6	in	IN	O	in	_	0	SENT_132	[p9l1794t2714r1862b2773],
7	risk	NN	O	risk	prep_in	2	SENT_132	[p9l1905t2713r2034b2774],
8	of	IN	O	of	_	0	SENT_132	[p9l2076t2713r2153b2774],
9	contralateral	JJ	O	contralateral	amod	11	SENT_132	[p9l9t2807r460b2867],
10	breast	NN	O	breast	nn	11	SENT_132	[p9l494t2807r712b2867],
11	cancer	NN	O	cancer	prep_of	7	SENT_132	[p9l748t2826r983b2867],
12	in	IN	O	in	_	0	SENT_132	[p9l1016t2807r1084b2866],
13	the	DT	O	the	det	15	SENT_132	[p9l1117t2807r1229b2867],
14	multivariate	JJ	O	multivariate	amod	15	SENT_132	[p9l1264t2807r1696b2867],
15	analysis	NN	O	analysis	prep_in	11	SENT_132	[p9l1733t2807r2007b2882],
16	for	IN	O	for	prep	2	SENT_132	[p9l2043t2807r2145b2867],

1	Univariate	JJ	O	univariate	amod	2	SENT_133	[p9l973t2966r1219b3010],
2	analysis	NN	O	analysis	dep	12	SENT_133	[p9l1238t2966r1435b3020],
3	Multivariate	JJ	O	multivariate	amod	5	SENT_133	[p9l1618t2966r1910b3010],
4	analysis	NN	O	analysis	nn	5	SENT_133	[p9l1929t2966r2126b3020],
5	odds	NNS	O	odds	dep	2	SENT_133	[p9l972t3041r1086b3085],
6	ratio	NN	O	ratio	dep	12	SENT_133	[p9l1107t3041r1216b3085],
7	(	CD	PERCENT	(	num	6	SENT_133	[p9l1236t3041r1358b3094],
8	95	CD	PERCENT	95	num	12	SENT_133	[p9l1236t3041r1358b3094],
9	%	NN	PERCENT	%	nn	12	SENT_133	[p9l1236t3041r1358b3094],
10	Cl	NN	O	cl	nn	12	SENT_133	[p9l1377t3041r1445b3094],
11	)	CD	NUMBER	)	num	12	SENT_133	[p9l1377t3041r1445b3094],
12	odds	NNS	O	odds	dep	17	SENT_133	[p9l1616t3041r1730b3085],
13	ratio	NN	O	ratio	dep	12	SENT_133	[p9l1751t3041r1860b3085],
14	(	CD	PERCENT	(	number	15	SENT_133	[p9l1879t3041r2002b3094],
15	95	CD	PERCENT	95	num	16	SENT_133	[p9l1879t3041r2002b3094],
16	%	NN	PERCENT	%	dep	13	SENT_133	[p9l1879t3041r2002b3094],
17	Cl	NN	O	cl	_	0	SENT_133	[p9l2021t3041r2089b3094],
18	)	CD	NUMBER	)	num	17	SENT_133	[p9l2021t3041r2089b3094],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_134	[p9l12t3152r263b3196],
2	use	NN	O	use	_	0	SENT_134	[p9l285t3163r367b3196],
3	Never	RB	O	never	advmod	2	SENT_134	[p9l15t3227r149b3270],
4	1-00	CD	NUMBER	1-00	num	5	SENT_134	[p9l975t3227r1085b3270],
5	1-00	CD	NUMBER	1-00	pobj	3	SENT_134	[p9l1618t3227r1728b3270],
6	Ever	RB	O	ever	prep	2	SENT_134	[p9l16t3301r114b3344],
7	O-45	NN	O	o-45	nn	9	SENT_134	[p9l973t3300r1084b3344],
8	(	CD	NUMBER	(	num	9	SENT_134	[p9l1105t3300r1392b3354],
9	O-26-0-76	NN	O	o-26-0-76	pobj	6	SENT_134	[p9l1105t3300r1392b3354],
10	)	CD	NUMBER	)	num	9	SENT_134	[p9l1105t3300r1392b3354],
11	O-50	NN	O	o-50	nn	14	SENT_134	[p9l1616t3300r1728b3344],
12	(	CD	NUMBER	(	num	14	SENT_134	[p9l1749t3300r2035b3354],
13	O-28-0-89	NN	O	o-28-0-89	nn	14	SENT_134	[p9l1749t3300r2035b3354],
14	)	NN	O	)	dep	2	SENT_134	[p9l1749t3300r2035b3354],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_135	[p9l12t3450r263b3494],
2	duration	NN	O	duration	dep	9	SENT_135	[p9l283t3450r482b3494],
3	(	CD	NUMBER	(	num	4	SENT_135	[p9l502t3451r671b3504],
4	years	NNS	NUMBER	year	dep	2	SENT_135	[p9l502t3451r671b3504],
5	)	CD	NUMBER	)	dep	4	SENT_135	[p9l502t3451r671b3504],
6	o	NN	O	o	dep	9	SENT_135	[p9l13t3525r42b3569],
7	1-00	CD	NUMBER	1-00	num	6	SENT_135	[p9l975t3525r1085b3569],
8	1-00	CD	NUMBER	1-00	num	9	SENT_135	[p9l1618t3525r1728b3569],
9	<	JJR	O	<	dep	12	SENT_135	[p9l14t3600r74b3643],
10	2	CD	NUMBER	2	num	11	SENT_135	[p9l14t3600r74b3643],
11	0-41	CD	NUMBER	0-41	dep	9	SENT_135	[p9l973t3600r1084b3643],
12	(	NN	O	(	dep	15	SENT_135	[p9l1105t3600r1392b3653],
13	0-21-0-82	CD	NUMBER	0-21-0-82	num	12	SENT_135	[p9l1105t3600r1392b3653],
14	)	CD	NUMBER	)	num	15	SENT_135	[p9l1105t3600r1392b3653],
15	o-47	NN	O	o-47	dep	18	SENT_135	[p9l1616t3600r1727b3643],
16	(	CD	NUMBER	(	num	17	SENT_135	[p9l1749t3600r2035b3653],
17	0-23-0-99	CD	NUMBER	0-23-0-99	dep	15	SENT_135	[p9l1749t3600r2035b3653],
18	)	NN	O	)	dep	21	SENT_135	[p9l1749t3600r2035b3653],
19	2-4	CD	NUMBER	2-4	num	18	SENT_135	[p9l14t3673r103b3716],
20	0-29	CD	NUMBER	0-29	num	21	SENT_135	[p9l973t3673r1084b3717],
21	(	NN	O	(	dep	23	SENT_135	[p9l1105t3673r1392b3727],
22	0-08-0-98	CD	NUMBER	0-08-0-98	num	23	SENT_135	[p9l1105t3673r1392b3727],
23	)	CD	NUMBER	)	dep	29	SENT_135	[p9l1105t3673r1392b3727],
24	0-25	CD	NUMBER	0-25	num	25	SENT_135	[p9l1616t3673r1728b3717],
25	(	NN	O	(	dep	23	SENT_135	[p9l1749t3673r2036b3727],
26	0-07-0-91	CD	NUMBER	0-07-0-91	number	27	SENT_135	[p9l1749t3673r2036b3727],
27	)	CD	NUMBER	)	npadvmod	28	SENT_135	[p9l1749t3673r2036b3727],
28	>	JJR	O	>	amod	25	SENT_135	[p9l14t3748r76b3791],
29	4	CD	NUMBER	4	dep	30	SENT_135	[p9l14t3748r76b3791],
30	o-90	NN	O	o-90	dep	32	SENT_135	[p9l973t3748r1085b3792],
31	(	CD	NUMBER	(	num	30	SENT_135	[p9l1105t3748r1392b3801],
32	O-31-2-65	NN	O	o-31-2-65	dep	35	SENT_135	[p9l1105t3748r1392b3801],
33	)	CD	NUMBER	)	num	32	SENT_135	[p9l1105t3748r1392b3801],
34	1-53	CD	NUMBER	1-53	num	35	SENT_135	[p9l1618t3748r1728b3792],
35	(	NN	O	(	dep	37	SENT_135	[p9l1749t3748r2035b3801],
36	0-44-5-27	CD	NUMBER	0-44-5-27	num	37	SENT_135	[p9l1749t3748r2035b3801],
37	)	NN	O	)	_	0	SENT_135	[p9l1749t3748r2035b3801],

1	Bilateral	JJ	O	bilateral	amod	2	SENT_136	[p10l15t84r216b128],
2	oophorectomy	NN	O	oophorectomy	_	0	SENT_136	[p10l237t84r584b138],
3	No	DT	O	no	det	5	SENT_136	[p10l15t159r75b202],
4	1-00	CD	NUMBER	1-00	num	5	SENT_136	[p10l975t159r1085b202],
5	1-00	CD	NUMBER	1-00	dep	2	SENT_136	[p10l1618t159r1728b202],
6	Yes	UH	O	yes	dep	9	SENT_136	[p10l12t233r99b276],
7	O-39	CD	NUMBER	o-39	num	9	SENT_136	[p10l973t232r1084b276],
8	(	CD	NUMBER	(	num	9	SENT_136	[p10l1105t232r1392b286],
9	O-20-0-74	NN	O	o-20-0-74	rcmod	5	SENT_136	[p10l1105t232r1392b286],
10	)	CD	NUMBER	)	num	11	SENT_136	[p10l1105t232r1392b286],
11	O-42	NN	O	o-42	dep	5	SENT_136	[p10l1616t232r1727b276],
12	(	CD	NUMBER	(	num	14	SENT_136	[p10l1749t232r2035b286],
13	O-22-0-83	NN	O	o-22-0-83	nn	14	SENT_136	[p10l1749t232r2035b286],
14	)	NN	O	)	dep	2	SENT_136	[p10l1749t232r2035b286],

1	Timing	NN	O	timing	dep	14	SENT_137	[p10l12t379r176b433],
2	of	IN	O	of	_	0	SENT_137	[p10l193t379r240b423],
3	bilateral	JJ	O	bilateral	amod	4	SENT_137	[p10l257t379r453b423],
4	oophorectomy	NN	O	oophorectomy	prep_of	1	SENT_137	[p10l474t380r821b433],
5	No	DT	O	no	det	7	SENT_137	[p10l15t455r75b498],
6	1-00	CD	NUMBER	1-00	num	7	SENT_137	[p10l975t454r1085b498],
7	1-00	CD	NUMBER	1-00	dep	4	SENT_137	[p10l1618t454r1728b498],
8	Before	IN	O	before	dep	10	SENT_137	[p10l16t529r166b572],
9	cancer	NN	O	cancer	pobj	8	SENT_137	[p10l187t539r345b572],
10	O-42	NN	O	o-42	rcmod	7	SENT_137	[p10l973t529r1083b572],
11	(	CD	NUMBER	(	num	10	SENT_137	[p10l1105t529r1392b582],
12	0-14-1-20	CD	NUMBER	0-14-1-20	num	13	SENT_137	[p10l1105t529r1392b582],
13	)	NN	O	)	dep	14	SENT_137	[p10l1105t529r1392b582],
14	O-43	NN	O	o-43	dep	18	SENT_137	[p10l1616t529r1727b572],
15	(	CD	NUMBER	(	num	14	SENT_137	[p10l1749t529r2035b582],
16	0-15-1-25	CD	NUMBER	0-15-1-25	num	17	SENT_137	[p10l1749t529r2035b582],
17	)	CD	NUMBER	)	dep	14	SENT_137	[p10l1749t529r2035b582],
18	After	IN	O	after	dep	20	SENT_137	[p10l12t602r124b646],
19	cancer	NN	O	cancer	pobj	18	SENT_137	[p10l141t613r300b646],
20	O-37	NN	O	o-37	dep	22	SENT_137	[p10l973t602r1083b646],
21	(	CD	NUMBER	(	num	20	SENT_137	[p10l1105t602r1392b656],
22	O-17-0-82	NN	O	o-17-0-82	dep	24	SENT_137	[p10l1105t602r1392b656],
23	)	CD	NUMBER	)	num	22	SENT_137	[p10l1105t602r1392b656],
24	O-42	NN	O	o-42	dep	27	SENT_137	[p10l1616t602r1727b646],
25	(	CD	NUMBER	(	num	24	SENT_137	[p10l1749t602r2035b656],
26	O-18-0-96	NN	O	o-18-0-96	nn	27	SENT_137	[p10l1749t602r2035b656],
27	)	NN	O	)	_	0	SENT_137	[p10l1749t602r2035b656],

1	Chemotherapy	NNP	O	Chemotherapy	nn	2	SENT_138	[p10l13t750r366b804],
2	No	NNP	O	No	_	0	SENT_138	[p10l15t826r75b869],
3	1-00	CD	NUMBER	1-00	num	4	SENT_138	[p10l975t825r1085b869],
4	1-00	CD	NUMBER	1-00	dep	2	SENT_138	[p10l1618t825r1728b869],
5	Yes	UH	O	yes	dep	8	SENT_138	[p10l12t900r99b943],
6	O-42	CD	NUMBER	o-42	num	8	SENT_138	[p10l973t900r1083b943],
7	(	CD	NUMBER	(	num	8	SENT_138	[p10l1105t900r1392b953],
8	O-29-0-63	NN	O	o-29-0-63	rcmod	4	SENT_138	[p10l1105t900r1392b953],
9	)	CD	NUMBER	)	num	10	SENT_138	[p10l1105t900r1392b953],
10	O-40	NN	O	o-40	dep	4	SENT_138	[p10l1616t900r1728b943],
11	(	CD	NUMBER	(	num	13	SENT_138	[p10l1749t900r2035b953],
12	O-26-0-60	NN	O	o-26-0-60	nn	13	SENT_138	[p10l1749t900r2035b953],
13	)	NN	O	)	dep	2	SENT_138	[p10l1749t900r2035b953],

1	Radiotherapy	NN	O	radiotherapy	_	0	SENT_139	[p10l15t1031r336b1085],
2	No	DT	O	no	det	4	SENT_139	[p10l15t1108r75b1151],
3	1-00	CD	NUMBER	1-00	num	4	SENT_139	[p10l975t1107r1085b1151],
4	1-00	CD	NUMBER	1-00	dep	1	SENT_139	[p10l1618t1107r1728b1151],
5	Yes	UH	O	yes	dep	8	SENT_139	[p10l12t1182r99b1225],
6	O-76	CD	NUMBER	o-76	num	8	SENT_139	[p10l973t1181r1084b1225],
7	(	CD	NUMBER	(	num	8	SENT_139	[p10l1105t1181r1392b1235],
8	O-54-1-O6	NN	O	o-54-1-o6	rcmod	4	SENT_139	[p10l1105t1181r1392b1235],
9	)	CD	NUMBER	)	num	10	SENT_139	[p10l1105t1181r1392b1235],
10	O-93	NN	O	o-93	dep	4	SENT_139	[p10l1616t1181r1728b1225],
11	(	CD	NUMBER	(	num	13	SENT_139	[p10l1749t1181r2035b1235],
12	O-58-1-48	NN	O	o-58-1-48	nn	13	SENT_139	[p10l1749t1181r2035b1235],
13	)	NN	O	)	dep	1	SENT_139	[p10l1749t1181r2035b1235],

1	We	PRP	O	we	nsubj	2	SENT_140	[p10l12t1321r84b1364],
2	adjusted	VBD	O	adjust	_	0	SENT_140	[p10l105t1321r306b1375],
3	for	IN	O	for	_	0	SENT_140	[p10l326t1321r390b1364],
4	other	JJ	O	other	amod	5	SENT_140	[p10l408t1321r531b1364],
5	treatments	NNS	O	treatment	prep_for	2	SENT_140	[p10l547t1324r822b1372],
6	,	,	O	,	_	0	SENT_140	[p10l547t1324r822b1372],
7	ethnic	JJ	O	ethnic	amod	8	SENT_140	[p10l845t1321r988b1365],
8	group	NN	O	group	conj_and	5	SENT_140	[p10l1006t1328r1152b1375],
9	,	,	O	,	_	0	SENT_140	[p10l1006t1328r1152b1375],
10	parity	NN	O	parity	conj_and	5	SENT_140	[p10l1177t1321r1316b1375],
11	,	,	O	,	_	0	SENT_140	[p10l1177t1321r1316b1375],
12	and	CC	O	and	_	0	SENT_140	[p10l1338t1321r1423b1364],
13	smoking	NN	O	smoking	nn	14	SENT_140	[p10l1445t1321r1644b1375],
14	habits	NNS	O	habit	conj_and	5	SENT_140	[p10l1664t1321r1821b1372],
15	,	,	O	,	_	0	SENT_140	[p10l1664t1321r1821b1372],
16	in	IN	O	in	_	0	SENT_140	[p10l1846t1321r1881b1364],
17	multivariate	JJ	O	multivariate	amod	18	SENT_140	[p10l15t1391r289b1434],
18	analysis	NN	O	analysis	prep_in	2	SENT_140	[p10l310t1391r516b1444],
19	.	.	O	.	_	0	SENT_140	[p10l310t1391r516b1444],

1	Overall	JJ	O	overall	amod	4	SENT_141	[p10l539t1390r697b1434],
2	multivariate	JJ	O	multivariate	amod	4	SENT_141	[p10l721t1391r996b1434],
3	p	NN	O	p	nn	4	SENT_141	[p10l1019t1401r1043b1443],
4	value	NN	O	value	nsubj	9	SENT_141	[p10l1061t1391r1185b1434],
5	for	IN	O	for	_	0	SENT_141	[p10l1204t1390r1268b1434],
6	tamoxifen	NN	O	tamoxifen	nn	7	SENT_141	[p10l1284t1390r1516b1434],
7	duration	NN	O	duration	prep_for	4	SENT_141	[p10l1538t1391r1730b1434],
8	was	VBD	O	be	cop	9	SENT_141	[p10l1750t1401r1842b1434],
9	0-03	CD	NUMBER	0-03	_	0	SENT_141	[p10l1863t1390r1987b1434],
10	.	.	O	.	_	0	SENT_141	[p10l1863t1390r1987b1434],

1	Table	NNP	O	Table	_	0	SENT_142	[p10l12t1484r186b1537],
2	3	CD	NUMBER	3	num	1	SENT_142	[p10l214t1483r273b1537],
3	:	:	O	:	_	0	SENT_142	[p10l214t1483r273b1537],
4	Association	NNP	O	Association	dep	1	SENT_142	[p10l302t1483r692b1537],
5	between	IN	O	between	_	0	SENT_142	[p10l722t1484r1002b1537],
6	tamoxifen	NN	O	tamoxifen	prep_between	4	SENT_142	[p10l1028t1483r1381b1549],
7	,	,	O	,	_	0	SENT_142	[p10l1028t1483r1381b1549],
8	oophorectomy	NN	O	oophorectomy	prep_between	4	SENT_142	[p10l1410t1484r1903b1550],
9	,	,	O	,	_	0	SENT_142	[p10l1410t1484r1903b1550],
10	chemotherapy	NN	O	chemotherapy	prep_between	4	SENT_142	[p10l13t1570r506b1635],
11	,	,	O	,	_	0	SENT_142	[p10l13t1570r506b1635],
12	and	CC	O	and	_	0	SENT_142	[p10l535t1570r652b1623],
13	radiotherapy	NN	O	radiotherapy	prep_between	4	SENT_142	[p10l682t1570r1097b1635],
14	and	CC	O	and	_	0	SENT_142	[p10l1122t1570r1238b1623],
15	risk	NN	O	risk	conj_and	6	SENT_142	[p10l1269t1570r1389b1623],
16	of	IN	O	of	_	0	SENT_142	[p10l1414t1570r1477b1623],
17	contralateral	JJ	O	contralateral	amod	19	SENT_142	[p10l1500t1570r1925b1623],
18	breast	NN	O	breast	nn	19	SENT_142	[p10l15t1655r223b1707],
19	cancer	NN	O	cancer	prep_of	15	SENT_142	[p10l250t1667r476b1707],
20	those	DT	O	those	dep	15	SENT_142	[p10l14t1826r203b1887],
21	who	WP	O	who	nsubj	23	SENT_142	[p10l234t1826r384b1887],
22	had	VBD	O	have	aux	23	SENT_142	[p10l416t1826r550b1887],
23	used	VBN	O	use	rcmod	4	SENT_142	[p10l581t1826r747b1887],
24	tamoxifen	NN	O	tamoxifen	dobj	23	SENT_142	[p10l779t1826r1140b1887],
25	for	IN	O	for	_	0	SENT_142	[p10l1170t1826r1273b1887],
26	more	JJR	DURATION	more	mwe	27	SENT_142	[p10l1302t1846r1487b1887],
27	than	IN	DURATION	than	quantmod	28	SENT_142	[p10l1519t1826r1680b1887],
28	4	CD	DURATION	4	num	29	SENT_142	[p10l1712t1829r1753b1886],
29	years	NNS	NUMBER	year	prep_for	24	SENT_142	[p10l1784t1846r1988b1902],
30	,	,	O	,	_	0	SENT_142	[p10l1784t1846r1988b1902],
31	but	CC	O	but	cc	33	SENT_142	[p10l2022t1826r2144b1887],
32	there	EX	O	there	expl	33	SENT_142	[p10l14t1919r195b1980],
33	were	VBD	O	be	dep	23	SENT_142	[p10l242t1939r411b1980],
34	only	RB	O	only	advmod	33	SENT_142	[p10l461t1919r614b1995],
35	six	CD	NUMBER	six	num	36	SENT_142	[p10l661t1920r755b1980],
36	cases	NNS	O	case	pobj	34	SENT_142	[p10l804t1939r982b1980],
37	with	IN	O	with	_	0	SENT_142	[p10l1030t1919r1188b1980],
38	bilateral	JJ	O	bilateral	amod	39	SENT_142	[p10l1233t1919r1524b1980],
39	disease	NN	O	disease	prep_with	34	SENT_142	[p10l1574t1919r1824b1980],
40	and	CC	O	and	_	0	SENT_142	[p10l1874t1919r2005b1980],
41	12	CD	NUMBER	12	num	42	SENT_142	[p10l2063t1922r2141b1979],
42	controls	NNS	O	control	conj_and	39	SENT_142	[p10l16t2013r302b2073],
43	in	IN	O	in	_	0	SENT_142	[p10l330t2013r398b2072],
44	this	DT	O	this	det	45	SENT_142	[p10l423t2013r549b2073],
45	subgroup	NN	O	subgroup	prep_in	33	SENT_142	[p10l578t2013r934b2089],
46	.	.	O	.	_	0	SENT_142	[p10l578t2013r934b2089],

1	Oestrogen-receptor	JJ	O	oestrogen-receptor	amod	2	SENT_143	[p10l101t2105r803b2181],
2	status	NN	O	status	nsubj	4	SENT_143	[p10l842t2119r1045b2166],
3	was	VBD	O	be	cop	4	SENT_143	[p10l1086t2125r1217b2166],
4	available	JJ	O	available	_	0	SENT_143	[p10l1260t2105r1569b2166],
5	for	IN	O	for	_	0	SENT_143	[p10l1609t2105r1711b2166],
6	only	RB	O	only	quantmod	8	SENT_143	[p10l1751t2105r1904b2181],
7	a	DT	O	a	quantmod	8	SENT_143	[p10l1944t2125r1979b2166],
8	few	JJ	O	few	num	9	SENT_143	[p10l2019t2105r2144b2166],
9	patients	NNS	O	patient	prep_for	4	SENT_143	[p10l13t2199r315b2274],
10	.	.	O	.	_	0	SENT_143	[p10l13t2199r315b2274],

1	In	IN	O	in	_	0	SENT_144	[p10l360t2199r437b2258],
2	such	JJ	O	such	amod	3	SENT_144	[p10l477t2198r641b2259],
3	patients	NNS	O	patient	prep_in	34	SENT_144	[p10l678t2199r960b2274],
4	with	IN	O	with	_	0	SENT_144	[p10l1000t2198r1157b2259],
5	bilateral	JJ	O	bilateral	amod	6	SENT_144	[p10l1195t2198r1485b2259],
6	disease	NN	O	disease	prep_with	3	SENT_144	[p10l1527t2198r1776b2259],
7	16	CD	NUMBER	16	num	6	SENT_144	[p10l1826t2201r1904b2259],
8	of	IN	O	of	_	0	SENT_144	[p10l1947t2198r2024b2259],
9	56	CD	PERCENT	56	number	10	SENT_144	[p10l2056t2201r2140b2259],
10	(	CD	PERCENT	(	amod	13	SENT_144	[p10l20t2292r238b2367],
11	29	CD	PERCENT	29	num	12	SENT_144	[p10l20t2292r238b2367],
12	%	NN	PERCENT	%	dep	10	SENT_144	[p10l20t2292r238b2367],
13	)	NN	O	)	prep_of	6	SENT_144	[p10l20t2292r238b2367],
14	who	WP	O	who	nsubj	16	SENT_144	[p10l274t2292r425b2352],
15	had	VBD	O	have	aux	16	SENT_144	[p10l457t2292r591b2352],
16	ﬁrst	VBN	O	ﬁrst	ccomp	13	SENT_144	[p10l622t2292r761b2352],
17	primary	JJ	O	primary	amod	18	SENT_144	[p10l791t2292r1076b2368],
18	cancers	NNS	O	cancer	dobj	16	SENT_144	[p10l1107t2311r1371b2352],
19	and	CC	O	and	_	0	SENT_144	[p10l1406t2292r1538b2352],
20	22	CD	NUMBER	22	prep_of	6	SENT_144	[p10l1572t2294r1657b2351],
21	of	IN	O	of	_	0	SENT_144	[p10l1693t2292r1770b2352],
22	74	CD	PERCENT	74	num	23	SENT_144	[p10l1794t2294r1879b2351],
23	(	CD	PERCENT	(	prep_of	20	SENT_144	[p10l1919t2292r2137b2367],
24	30	CD	PERCENT	30	number	25	SENT_144	[p10l1919t2292r2137b2367],
25	%	NN	PERCENT	%	amod	26	SENT_144	[p10l1919t2292r2137b2367],
26	)	NN	O	)	nsubj	34	SENT_144	[p10l1919t2292r2137b2367],
27	who	WP	O	who	nsubj	28	SENT_144	[p10l13t2384r163b2445],
28	had	VBD	O	have	rcmod	26	SENT_144	[p10l224t2384r358b2445],
29	contralateral	JJ	O	contralateral	amod	31	SENT_144	[p10l420t2384r870b2445],
30	breast	NN	O	breast	nn	31	SENT_144	[p10l930t2384r1148b2445],
31	cancers	NNS	O	cancer	dobj	28	SENT_144	[p10l1209t2404r1473b2445],
32	were	VBD	O	be	cop	34	SENT_144	[p10l1534t2404r1703b2445],
33	oestrogenreceptor	NN	O	oestrogenreceptor	npadvmod	34	SENT_144	[p10l1766t2398r2142b2460, p10l14t2492r313b2553],
34	positive	JJ	O	positive	_	0	SENT_144	[p10l365t2477r659b2553],
35	.	.	O	.	_	0	SENT_144	[p10l365t2477r659b2553],

1	Of	IN	O	of	_	0	SENT_145	[p10l721t2477r820b2538],
2	the	DT	O	the	det	3	SENT_145	[p10l864t2477r974b2538],
3	women	NNS	O	woman	prep_of	21	SENT_145	[p10l1028t2497r1294b2538],
4	who	WP	O	who	nsubj	7	SENT_145	[p10l1346t2477r1497b2538],
5	did	VBD	O	do	aux	7	SENT_145	[p10l1554t2477r1668b2538],
6	not	RB	O	not	neg	7	SENT_145	[p10l1722t2492r1842b2538],
7	receive	VB	O	receive	rcmod	3	SENT_145	[p10l1895t2478r2142b2538],
8	tamoxifen	NN	O	tamoxifen	dobj	7	SENT_145	[p10l14t2571r395b2643],
9	,	,	O	,	_	0	SENT_145	[p10l14t2571r395b2643],
10	17	CD	NUMBER	17	nsubj	21	SENT_145	[p10l457t2573r534b2630],
11	of	IN	O	of	_	0	SENT_145	[p10l588t2571r665b2631],
12	64	CD	PERCENT	64	number	13	SENT_145	[p10l707t2573r791b2631],
13	(	CD	PERCENT	(	prep_of	10	SENT_145	[p10l849t2571r1066b2645],
14	27	CD	PERCENT	27	num	15	SENT_145	[p10l849t2571r1066b2645],
15	%	NN	PERCENT	%	dep	13	SENT_145	[p10l849t2571r1066b2645],
16	)	CD	NUMBER	)	num	18	SENT_145	[p10l849t2571r1066b2645],
17	contralateral	JJ	O	contralateral	amod	18	SENT_145	[p10l1123t2571r1573b2631],
18	tumours	NNS	O	tumour	dep	15	SENT_145	[p10l1622t2584r1924b2631],
19	were	VBD	O	be	cop	21	SENT_145	[p10l1973t2590r2142b2631],
20	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	21	SENT_145	[p10l16t2676r695b2738],
21	positive	JJ	O	positive	_	0	SENT_145	[p10l744t2662r1041b2738],
22	,	,	O	,	_	0	SENT_145	[p10l744t2662r1041b2738],
23	and	CC	O	and	_	0	SENT_145	[p10l1098t2662r1229b2723],
24	of	IN	O	of	conj_and	21	SENT_145	[p10l1283t2662r1360b2723],
25	those	DT	O	those	pobj	24	SENT_145	[p10l1402t2662r1591b2723],
26	who	WP	O	who	nsubj	27	SENT_145	[p10l1643t2662r1793b2723],
27	received	VBD	O	receive	rcmod	25	SENT_145	[p10l1847t2662r2143b2723],
28	tamoxifen	NN	O	tamoxifen	dobj	27	SENT_145	[p10l14t2755r395b2828],
29	,	,	O	,	_	0	SENT_145	[p10l14t2755r395b2828],
30	ﬁve	NN	O	ﬁve	appos	28	SENT_145	[p10l439t2755r564b2816],
31	of	IN	O	of	_	0	SENT_145	[p10l606t2755r683b2816],
32	ten	CD	PERCENT	ten	num	33	SENT_145	[p10l714t2770r826b2816],
33	(	CD	PERCENT	(	prep_of	30	SENT_145	[p10l873t2756r1091b2831],
34	50	CD	PERCENT	50	num	35	SENT_145	[p10l873t2756r1091b2831],
35	%	NN	PERCENT	%	tmod	27	SENT_145	[p10l873t2756r1091b2831],
36	)	CD	NUMBER	)	num	38	SENT_145	[p10l873t2756r1091b2831],
37	contralateral	JJ	O	contralateral	amod	38	SENT_145	[p10l1140t2755r1589b2816],
38	tumours	NNS	O	tumour	nsubj	49	SENT_145	[p10l1630t2770r1932b2816],
39	were	VBD	O	be	cop	49	SENT_145	[p10l1973t2775r2142b2816],
40	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	43	SENT_145	[p10l16t2863r695b2925],
41	positive	JJ	O	positive	amod	43	SENT_145	[p10l751t2849r1026b2925],
42	(	NN	O	(	nn	43	SENT_145	[p10l1092t2849r1288b2924],
43	odds	NNS	O	odds	nn	49	SENT_145	[p10l1092t2849r1288b2924],
44	ratio	NN	O	ratio	nn	46	SENT_145	[p10l1349t2849r1511b2909],
45	277	CD	NUMBER	277	num	46	SENT_145	[p10l1575t2851r1729b2908],
46	[	NN	O	[	dep	43	SENT_145	[p10l1802t2849r1985b2924],
47	95	CD	PERCENT	95	number	48	SENT_145	[p10l1802t2849r1985b2924],
48	%	NN	PERCENT	%	amod	49	SENT_145	[p10l1802t2849r1985b2924],
49	CI	NN	O	ci	rcmod	35	SENT_145	[p10l2052t2849r2142b2909],
50	0-71-10-8	CD	NUMBER	0-71-10-8	num	51	SENT_145	[p10l16t2941r431b3017],
51	]	NN	O	]	dep	35	SENT_145	[p10l16t2941r431b3017],
52	;	:	O	;	_	0	SENT_145	[p10l16t2941r431b3017],
53	p	NN	O	p	dep	25	SENT_145	[p10l459t2942r774b3017],
54	=	JJ	O	=	amod	56	SENT_145	[p10l459t2942r774b3017],
55	0-15	CD	NUMBER	0-15	tmod	54	SENT_145	[p10l459t2942r774b3017],
56	)	NN	O	)	dep	53	SENT_145	[p10l459t2942r774b3017],
57	.	.	O	.	_	0	SENT_145	[p10l459t2942r774b3017],

1	We	PRP	O	we	nsubj	17	SENT_146	[p10l97t3035r218b3095],
2	also	RB	O	also	advmod	3	SENT_146	[p10l294t3034r429b3095],
3	noted	VBD	O	note	_	0	SENT_146	[p10l503t3034r709b3095],
4	a	DT	O	a	det	5	SENT_146	[p10l784t3054r819b3095],
5	difference	NN	O	difference	dobj	3	SENT_146	[p10l894t3034r1247b3095],
6	in	IN	O	in	_	0	SENT_146	[p10l1321t3035r1389b3094],
7	the	DT	O	the	det	8	SENT_146	[p10l1461t3034r1572b3095],
8	frequency	NN	O	frequency	prep_in	3	SENT_146	[p10l1646t3034r2003b3110],
9	of	IN	O	of	_	0	SENT_146	[p10l2076t3034r2153b3095],
10	oophorectomy	NN	O	oophorectomy	prep_of	8	SENT_146	[p10l16t3128r539b3204],
11	between	IN	O	between	_	0	SENT_146	[p10l585t3128r885b3188],
12	cases	NNS	O	case	prep_between	10	SENT_146	[p10l935t3148r1114b3188],
13	with	IN	O	with	_	0	SENT_146	[p10l1163t3128r1321b3188],
14	bilateral	JJ	O	bilateral	amod	15	SENT_146	[p10l1368t3128r1659b3188],
15	disease	NN	O	disease	prep_with	3	SENT_146	[p10l1710t3128r1960b3188],
16	and	CC	O	and	_	0	SENT_146	[p10l2012t3128r2143b3188],
17	controls	VBZ	O	control	conj_and	3	SENT_146	[p10l16t3220r302b3281],
18	(	RB	O	(	advmod	17	SENT_146	[p10l416t3220r614b3295],
19	table	NN	O	table	nn	21	SENT_146	[p10l416t3220r614b3295],
20	2	CD	NUMBER	2	num	21	SENT_146	[p10l723t3221r816b3295],
21	)	NN	O	)	dobj	3	SENT_146	[p10l723t3221r816b3295],
22	.	.	O	.	_	0	SENT_146	[p10l723t3221r816b3295],

1	Oophorectomies	NNS	O	oophorectomy	nsubj	6	SENT_147	[p10l930t3220r1526b3296],
2	done	VBN	O	do	partmod	1	SENT_147	[p10l1635t3220r1811b3281],
3	before	IN	O	before	_	0	SENT_147	[p10l1916t3220r2142b3281],
4	menopause	NN	O	menopause	prep_before	2	SENT_147	[p10l14t3333r423b3389],
5	might	MD	O	might	aux	6	SENT_147	[p10l451t3313r662b3389],
6	affect	VB	O	affect	_	0	SENT_147	[p10l691t3313r885b3374],
7	the	DT	O	the	det	11	SENT_147	[p10l912t3313r1022b3374],
8	subsequent	JJ	O	subsequent	amod	11	SENT_147	[p10l1053t3313r1459b3389],
9	breast	NN	O	breast	nn	11	SENT_147	[p10l1485t3313r1703b3374],
10	cancer	NN	O	cancer	nn	11	SENT_147	[p10l1731t3333r1966b3374],
11	risk	NN	O	risk	dobj	6	SENT_147	[p10l1992t3313r2137b3374],
12	.	.	O	.	_	0	SENT_147	[p10l1992t3313r2137b3374],

1	Among	IN	O	among	_	0	SENT_148	[p10l12t3408r281b3483],
2	185	CD	NUMBER	185	num	3	SENT_148	[p10l340t3409r462b3467],
3	women	NNS	O	woman	prep_among	26	SENT_148	[p10l516t3427r782b3467],
4	diagnosed	VBN	O	diagnose	partmod	3	SENT_148	[p10l834t3407r1196b3483],
5	with	IN	O	with	_	0	SENT_148	[p10l1246t3407r1403b3467],
6	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_148	[p10l1453t3407r1592b3467],
7	breast	NN	O	breast	nn	8	SENT_148	[p10l1641t3407r1859b3467],
8	cancer	NN	O	cancer	prep_with	4	SENT_148	[p10l1910t3426r2145b3467],
9	before	IN	O	before	_	0	SENT_148	[p10l13t3499r238b3560],
10	age	NN	O	age	prep_before	8	SENT_148	[p10l275t3519r391b3575],
11	50	CD	DURATION	50	num	12	SENT_148	[p10l429t3502r514b3560],
12	years	NNS	NUMBER	year	tmod	4	SENT_148	[p10l548t3519r729b3575],
13	and	CC	O	and	_	0	SENT_148	[p10l767t3499r899b3560],
14	their	PRP$	O	they	poss	16	SENT_148	[p10l932t3499r1100b3560],
15	matched	VBN	O	match	amod	16	SENT_148	[p10l1132t3499r1443b3560],
16	controls	NNS	O	control	tmod	4	SENT_148	[p10l1479t3499r1788b3572],
17	,	,	O	,	_	0	SENT_148	[p10l1479t3499r1788b3572],
18	the	DT	O	the	det	20	SENT_148	[p10l1826t3499r1936b3560],
19	odds	NNS	O	odds	nn	20	SENT_148	[p10l1973t3499r2141b3560],
20	ratio	NN	O	ratio	nsubj	26	SENT_148	[p10l14t3593r176b3653],
21	associated	VBN	O	associate	partmod	20	SENT_148	[p10l209t3592r573b3653],
22	with	IN	O	with	_	0	SENT_148	[p10l601t3592r758b3653],
23	oophorectomy	NN	O	oophorectomy	prep_with	21	SENT_148	[p10l789t3592r1312b3668],
24	was	VBD	O	be	cop	26	SENT_148	[p10l1338t3612r1469b3653],
25	031	CD	NUMBER	031	number	26	SENT_148	[p10l1502t3595r1651b3653],
26	(	CD	NUMBER	(	_	0	SENT_148	[p10l1696t3593r2137b3668],
27	015-067	CD	NUMBER	015-067	num	28	SENT_148	[p10l1696t3593r2137b3668],
28	)	NN	O	)	dep	26	SENT_148	[p10l1696t3593r2137b3668],
29	.	.	O	.	_	0	SENT_148	[p10l1696t3593r2137b3668],

1	The	DT	O	the	det	3	SENT_149	[p10l13t3686r161b3746],
2	protective	JJ	O	protective	amod	3	SENT_149	[p10l195t3686r552b3762],
3	effect	NN	O	effect	nsubj	8	SENT_149	[p10l589t3686r782b3746],
4	of	IN	O	of	_	0	SENT_149	[p10l818t3686r895b3746],
5	oophorectomy	NN	O	oophorectomy	prep_of	3	SENT_149	[p10l922t3686r1445b3762],
6	was	VBD	O	be	cop	8	SENT_149	[p10l1476t3706r1608b3746],
7	much	RB	O	much	advmod	8	SENT_149	[p10l1644t3686r1849b3746],
8	less	RBR	O	less	dep	23	SENT_149	[p10l1883t3686r2007b3746],
9	for	IN	O	for	_	0	SENT_149	[p10l2043t3686r2145b3746],
10	those	DT	O	those	prep_for	8	SENT_149	[p11l14t15r203b76],
11	who	WP	O	who	nsubj	12	SENT_149	[p11l251t15r401b76],
12	had	VBD	O	have	conj_or	12	SENT_149	[p11l450t15r584b76],
13	their	PRP$	O	they	poss	16	SENT_149	[p11l632t15r799b76],
14	ﬁrst	JJ	O	ﬁrst	amod	16	SENT_149	[p11l845t15r984b76],
15	breast	NN	O	breast	nn	16	SENT_149	[p11l1030t15r1248b76],
16	cancer	NN	O	cancer	dobj	12	SENT_149	[p11l1298t35r1532b76],
17	at	IN	O	at	_	0	SENT_149	[p11l1581t29r1644b76],
18	or	CC	O	or	_	0	SENT_149	[p11l1694t35r1768b76],
19	after	IN	O	after	_	0	SENT_149	[p11l1817t15r1978b76],
20	age	NN	O	age	nn	22	SENT_149	[p11l2026t35r2142b91],
21	50	CD	DURATION	50	num	22	SENT_149	[p11l17t111r101b169],
22	years	NNS	NUMBER	year	prep_at	12	SENT_149	[p11l164t128r345b184],
23	(	VBP	O	(	_	0	SENT_149	[p11l414t109r622b184],
24	085	CD	NUMBER	085	nsubj	23	SENT_149	[p11l414t109r622b184],
25	,	,	O	,	_	0	SENT_149	[p11l414t109r622b184],
26	022-336	CD	NUMBER	022-336	num	27	SENT_149	[p11l689t109r1103b184],
27	)	NN	O	)	appos	24	SENT_149	[p11l689t109r1103b184],
28	.	.	O	.	_	0	SENT_149	[p11l689t109r1103b184],

1	However	RB	O	however	advmod	20	SENT_150	[p11l1170t109r1517b181],
2	,	,	O	,	_	0	SENT_150	[p11l1170t109r1517b181],
3	the	DT	O	the	det	4	SENT_150	[p11l1581t108r1692b169],
4	interaction	NN	O	interaction	nsubj	20	SENT_150	[p11l1755t109r2143b169],
5	between	IN	O	between	_	0	SENT_150	[p11l13t202r313b262],
6	oophorectomy	NN	O	oophorectomy	prep_between	4	SENT_150	[p11l344t202r867b278],
7	and	CC	O	and	_	0	SENT_150	[p11l896t202r1028b262],
8	age	NN	O	age	prep_between	4	SENT_150	[p11l1059t222r1175b278],
9	of	IN	O	of	_	0	SENT_150	[p11l1206t202r1283b262],
10	breast	NN	O	breast	nn	12	SENT_150	[p11l1301t202r1519b262],
11	cancer	NN	O	cancer	nn	12	SENT_150	[p11l1549t221r1784b262],
12	diagnosis	NN	O	diagnosis	prep_of	6	SENT_150	[p11l1813t202r2141b278],
13	was	VBD	O	be	cop	20	SENT_150	[p11l13t314r144b355],
14	not	RB	O	not	neg	20	SENT_150	[p11l201t308r321b355],
15	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_150	[p11l378t294r745b370],
16	(	NN	O	(	nn	20	SENT_150	[p11l807t295r1147b370],
17	p	NN	O	p	nn	20	SENT_150	[p11l807t295r1147b370],
18	=	JJ	O	=	amod	20	SENT_150	[p11l807t295r1147b370],
19	0-23	CD	NUMBER	0-23	num	20	SENT_150	[p11l807t295r1147b370],
20	)	NN	O	)	_	0	SENT_150	[p11l807t295r1147b370],
21	.	.	O	.	_	0	SENT_150	[p11l807t295r1147b370],

1	The	DT	O	the	det	3	SENT_151	[p11l1207t294r1355b355],
2	protective	JJ	O	protective	amod	3	SENT_151	[p11l1410t294r1767b370],
3	effect	NN	O	effect	nsubj	7	SENT_151	[p11l1826t294r2019b355],
4	of	IN	O	of	_	0	SENT_151	[p11l2076t294r2153b355],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_151	[p11l14t387r375b448],
6	was	VBD	O	be	cop	7	SENT_151	[p11l415t407r546b448],
7	present	JJ	DATE	present	conj_and	7	SENT_151	[p11l589t402r853b463],
8	in	IN	O	in	_	0	SENT_151	[p11l895t387r963b447],
9	the	DT	O	the	det	10	SENT_151	[p11l1004t387r1114b448],
10	subgroups	NNS	O	subgroup	prep_in	7	SENT_151	[p11l1159t387r1528b463],
11	of	IN	O	of	_	0	SENT_151	[p11l1573t387r1650b448],
12	women	NNS	O	woman	prep_of	10	SENT_151	[p11l1680t407r1946b448],
13	with	IN	O	with	_	0	SENT_151	[p11l1986t387r2143b448],
14	oophorectomy	NN	O	oophorectomy	prep_with	7	SENT_151	[p11l16t481r539b557],
15	(	CD	NUMBER	(	num	14	SENT_151	[p11l689t481r825b556],
16	0-3	CD	NUMBER	0-3	num	17	SENT_151	[p11l689t481r825b556],
17	6	CD	NUMBER	6	dep	14	SENT_151	[p11l835t483r896b554],
18	,	,	O	,	_	0	SENT_151	[p11l835t483r896b554],
19	O	NN	O	o	appos	17	SENT_151	[p11l1047t483r1086b541],
20	-	:	O	-	_	0	SENT_151	[p11l1096t507r1107b518],
21	07-1	CD	NUMBER	07-1	num	23	SENT_151	[p11l1117t483r1283b541],
22	-81	CD	NUMBER	-81	num	23	SENT_151	[p11l1301t481r1436b556],
23	)	NN	O	)	dep	17	SENT_151	[p11l1301t481r1436b556],
24	and	CC	O	and	_	0	SENT_151	[p11l1589t481r1721b541],
25	without	IN	O	without	_	0	SENT_151	[p11l1865t481r2144b541],
26	oophorectomy	NN	O	oophorectomy	nn	27	SENT_151	[p11l16t573r539b649],
27	(	NN	O	(	prep_without	7	SENT_151	[p11l607t574r815b648],
28	049	CD	NUMBER	049	num	27	SENT_151	[p11l607t574r815b648],
29	,	,	O	,	_	0	SENT_151	[p11l607t574r815b648],
30	028-083	CD	NUMBER	028-083	num	31	SENT_151	[p11l884t574r1298b648],
31	)	NN	O	)	attr	7	SENT_151	[p11l884t574r1298b648],
32	.	.	O	.	_	0	SENT_151	[p11l884t574r1298b648],

1	The	DT	O	the	det	3	SENT_152	[p11l1367t573r1514b634],
2	odds	NNS	O	odds	nn	3	SENT_152	[p11l1581t573r1749b634],
3	ratio	NN	O	ratio	nsubj	19	SENT_152	[p11l1814t573r1977b634],
4	for	IN	O	for	_	0	SENT_152	[p11l2043t573r2145b634],
5	tamoxifen	NN	O	tamoxifen	nn	6	SENT_152	[p11l14t666r375b727],
6	use	NN	O	use	prep_for	3	SENT_152	[p11l420t686r537b727],
7	combined	VBN	O	combine	partmod	6	SENT_152	[p11l585t666r943b727],
8	with	IN	O	with	_	0	SENT_152	[p11l987t666r1145b727],
9	oophorectomy	NN	O	oophorectomy	prep_with	7	SENT_152	[p11l1192t666r1734b742],
10	,	,	O	,	_	0	SENT_152	[p11l1192t666r1734b742],
11	compared	VBN	O	compare	_	0	SENT_152	[p11l1785t666r2143b742],
12	with	IN	O	with	prepc_compared_with	7	SENT_152	[p11l13t760r170b820],
13	no	DT	O	no	det	14	SENT_152	[p11l195t779r284b820],
14	tamoxifen	NN	O	tamoxifen	pobj	7	SENT_152	[p11l312t760r673b820],
15	or	CC	O	or	_	0	SENT_152	[p11l700t779r774b820],
16	oophorectomy	NN	O	oophorectomy	conj_or	14	SENT_152	[p11l799t760r1322b836],
17	was	VBD	O	be	cop	19	SENT_152	[p11l1345t780r1476b820],
18	0-16	CD	NUMBER	0-16	num	19	SENT_152	[p11l1506t762r1661b820],
19	(	CD	NUMBER	(	_	0	SENT_152	[p11l1696t760r2137b835],
20	004-069	CD	NUMBER	004-069	num	21	SENT_152	[p11l1696t760r2137b835],
21	)	NN	O	)	dep	19	SENT_152	[p11l1696t760r2137b835],
22	.	.	O	.	_	0	SENT_152	[p11l1696t760r2137b835],

1	We	PRP	O	we	nsubj	2	SENT_153	[p11l97t853r218b913],
2	showed	VBD	O	show	_	0	SENT_153	[p11l272t852r542b913],
3	a	DT	O	a	det	5	SENT_153	[p11l596t872r631b913],
4	protective	JJ	O	protective	amod	5	SENT_153	[p11l682t852r1038b928],
5	effect	NN	O	effect	dobj	2	SENT_153	[p11l1092t852r1286b913],
6	in	IN	O	in	_	0	SENT_153	[p11l1337t852r1405b912],
7	women	NNS	O	woman	prep_in	2	SENT_153	[p11l1455t872r1721b913],
8	who	WP	O	who	nsubjpass	11	SENT_153	[p11l1771t852r1921b913],
9	were	VBD	O	be	auxpass	11	SENT_153	[p11l1973t872r2142b913],
10	initially	RB	O	initially	advmod	11	SENT_153	[p11l14t945r281b1021],
11	treated	VBN	O	treat	rcmod	7	SENT_153	[p11l333t945r584b1006],
12	with	IN	O	with	_	0	SENT_153	[p11l637t945r795b1006],
13	chemotherapy	NN	O	chemotherapy	prep_with	11	SENT_153	[p11l850t945r1363b1021],
14	for	IN	O	for	_	0	SENT_153	[p11l1416t945r1518b1006],
15	the	DT	O	the	det	18	SENT_153	[p11l1570t945r1680b1006],
16	ﬁrst	JJ	O	ﬁrst	amod	18	SENT_153	[p11l1735t945r1874b1006],
17	breast	NN	O	breast	nn	18	SENT_153	[p11l1926t945r2144b1006],
18	cancer	NN	O	cancer	prep_for	13	SENT_153	[p11l16t1059r267b1100],
19	.	.	O	.	_	0	SENT_153	[p11l16t1059r267b1100],

1	These	DT	O	these	det	2	SENT_154	[p11l321t1040r540b1100],
2	women	NNS	O	woman	nsubj	3	SENT_154	[p11l589t1059r855b1100],
3	had	VBD	O	have	_	0	SENT_154	[p11l902t1040r1035b1100],
4	a	DT	O	a	det	7	SENT_154	[p11l1087t1059r1122b1100],
5	60	CD	PERCENT	60	number	6	SENT_154	[p11l1175t1040r1332b1102],
6	%	NN	PERCENT	%	amod	7	SENT_154	[p11l1175t1040r1332b1102],
7	reduction	NN	O	reduction	dobj	3	SENT_154	[p11l1386t1040r1733b1100],
8	in	IN	O	in	_	0	SENT_154	[p11l1782t1040r1850b1099],
9	risk	NN	O	risk	prep_in	7	SENT_154	[p11l1898t1040r2027b1100],
10	of	IN	O	of	_	0	SENT_154	[p11l2076t1040r2153b1100],
11	contralateral	JJ	O	contralateral	amod	16	SENT_154	[p11l16t1131r465b1192],
12	cancer	NN	O	cancer	nn	16	SENT_154	[p11l521t1151r755b1192],
13	(	NN	O	(	nn	16	SENT_154	[p11l812t1131r1011b1206],
14	table	NN	O	table	nn	16	SENT_154	[p11l812t1131r1011b1206],
15	3	CD	NUMBER	3	num	16	SENT_154	[p11l1067t1131r1159b1206],
16	)	NN	O	)	prep_of	9	SENT_154	[p11l1067t1131r1159b1206],
17	.	.	O	.	_	0	SENT_154	[p11l1067t1131r1159b1206],

1	The	DT	O	the	det	3	SENT_155	[p11l1217t1131r1364b1192],
2	protective	JJ	O	protective	amod	3	SENT_155	[p11l1417t1131r1774b1207],
3	effect	NN	O	effect	nsubj	8	SENT_155	[p11l1829t1131r2022b1192],
4	of	IN	O	of	_	0	SENT_155	[p11l2076t1131r2153b1192],
5	chemotherapy	NN	O	chemotherapy	prep_of	3	SENT_155	[p11l16t1224r529b1300],
6	did	VBD	O	do	aux	8	SENT_155	[p11l577t1224r691b1285],
7	not	RB	O	not	neg	8	SENT_155	[p11l738t1239r858b1285],
8	seem	VB	O	seem	dep	26	SENT_155	[p11l906t1244r1086b1285],
9	to	TO	O	to	aux	11	SENT_155	[p11l1133t1239r1202b1285],
10	be	VB	O	be	cop	11	SENT_155	[p11l1251t1224r1335b1285],
11	due	JJ	O	due	xcomp	8	SENT_155	[p11l1385t1224r1515b1285],
12	to	TO	O	to	_	0	SENT_155	[p11l1563t1239r1632b1285],
13	its	PRP$	O	its	poss	14	SENT_155	[p11l1682t1225r1761b1285],
14	effect	NN	O	effect	prep_to	11	SENT_155	[p11l1812t1224r2005b1285],
15	on	IN	O	on	_	0	SENT_155	[p11l2054t1244r2143b1285],
16	ovarian	JJ	O	ovarian	amod	17	SENT_155	[p11l16t1318r279b1378],
17	function	NN	O	function	prep_on	14	SENT_155	[p11l308t1318r631b1391],
18	;	:	O	;	_	0	SENT_155	[p11l308t1318r631b1391],
19	it	PRP	O	it	nsubj	21	SENT_155	[p11l665t1318r713b1378],
20	was	VBD	O	be	cop	21	SENT_155	[p11l740t1338r872b1378],
21	present	JJ	DATE	present	parataxis	8	SENT_155	[p11l903t1332r1167b1394],
22	in	IN	O	in	_	0	SENT_155	[p11l1196t1318r1264b1377],
23	women	NNS	O	woman	prep_in	21	SENT_155	[p11l1292t1337r1558b1378],
24	without	IN	O	without	_	0	SENT_155	[p11l1586t1318r1865b1378],
25	ovaries	NNS	O	ovary	prep_without	21	SENT_155	[p11l1896t1318r2141b1378],
26	(	VBP	O	(	_	0	SENT_155	[p11l20t1411r227b1484],
27	0-43	CD	NUMBER	0-43	nsubj	37	SENT_155	[p11l20t1411r227b1484],
28	,	,	O	,	_	0	SENT_155	[p11l20t1411r227b1484],
29	012-154	CD	NUMBER	012-154	num	30	SENT_155	[p11l277t1411r666b1484],
30	)	NN	O	)	conj_and	27	SENT_155	[p11l277t1411r666b1484],
31	and	CC	O	and	_	0	SENT_155	[p11l718t1410r849b1470],
32	in	IN	O	in	_	0	SENT_155	[p11l894t1410r962b1469],
33	those	DT	O	those	prep_in	34	SENT_155	[p11l1005t1410r1194b1470],
34	with	IN	O	with	conj_and	27	SENT_155	[p11l1238t1410r1395b1470],
35	their	PRP$	O	they	poss	36	SENT_155	[p11l1439t1410r1606b1470],
36	ovaries	NNS	O	ovary	pobj	34	SENT_155	[p11l1649t1410r1895b1470],
37	intact	JJ	O	intact	xcomp	26	SENT_155	[p11l1941t1410r2144b1470],
38	(	CD	NUMBER	(	num	39	SENT_155	[p11l20t1503r227b1577],
39	0-45	CD	NUMBER	0-45	nsubj	26	SENT_155	[p11l20t1503r227b1577],
40	,	,	O	,	_	0	SENT_155	[p11l20t1503r227b1577],
41	031-058	CD	NUMBER	031-058	num	42	SENT_155	[p11l259t1503r672b1576],
42	)	NN	O	)	appos	39	SENT_155	[p11l259t1503r672b1576],
43	.	.	O	.	_	0	SENT_155	[p11l259t1503r672b1576],

1	For	IN	O	for	_	0	SENT_156	[p11l99t1596r224b1655],
2	tamoxifen	NN	O	tamoxifen	prep_for	24	SENT_156	[p11l253t1595r600b1655],
3	use	NN	O	use	nsubj	24	SENT_156	[p11l630t1615r763b1668],
4	,	,	O	,	_	0	SENT_156	[p11l630t1615r763b1668],
5	oophorectomy	NN	O	oophorectomy	conj_and	3	SENT_156	[p11l799t1595r1320b1671],
6	,	,	O	,	_	0	SENT_156	[p11l799t1595r1320b1671],
7	and	CC	O	and	_	0	SENT_156	[p11l1355t1595r1482b1655],
8	chemotherapy	NN	O	chemotherapy	conj_and	3	SENT_156	[p11l1514t1595r2007b1671],
9	the	DT	O	the	det	11	SENT_156	[p11l2036t1595r2142b1655],
10	protective	JJ	O	protective	amod	11	SENT_156	[p11l13t1687r355b1763],
11	effect	NN	O	effect	nsubjpass	20	SENT_156	[p11l383t1687r569b1748],
12	on	IN	O	on	_	0	SENT_156	[p11l595t1707r681b1748],
13	the	DT	O	the	det	14	SENT_156	[p11l705t1687r811b1748],
14	risk	NN	O	risk	prep_on	11	SENT_156	[p11l837t1687r961b1748],
15	of	IN	O	of	_	0	SENT_156	[p11l986t1687r1060b1748],
16	contralateral	JJ	O	contralateral	amod	18	SENT_156	[p11l1077t1687r1509b1748],
17	breast	NN	O	breast	nn	18	SENT_156	[p11l1533t1687r1742b1748],
18	cancer	NN	O	cancer	prep_of	14	SENT_156	[p11l1768t1707r1994b1748],
19	was	VBD	O	be	auxpass	20	SENT_156	[p11l2015t1707r2142b1748],
20	analysed	VBN	O	analyse	rcmod	3	SENT_156	[p11l16t1780r310b1856],
21	according	VBG	O	accord	_	0	SENT_156	[p11l359t1780r698b1856],
22	to	TO	O	to	prepc_according_to	20	SENT_156	[p11l743t1795r809b1841],
23	time	NN	O	time	pobj	20	SENT_156	[p11l859t1781r1011b1841],
24	elapsed	VBD	O	elapse	_	0	SENT_156	[p11l1061t1780r1315b1856],
25	since	IN	O	since	_	0	SENT_156	[p11l1364t1781r1534b1841],
26	initial	JJ	O	initial	amod	31	SENT_156	[p11l1582t1780r1776b1841],
27	diagnosis	NN	O	diagnosis	nn	31	SENT_156	[p11l1826t1780r2141b1856],
28	(	NN	O	(	nn	31	SENT_156	[p11l20t1874r210b1949],
29	table	NN	O	table	nn	31	SENT_156	[p11l20t1874r210b1949],
30	4	CD	NUMBER	4	num	31	SENT_156	[p11l237t1874r327b1949],
31	)	NN	O	)	prep_since	24	SENT_156	[p11l237t1874r327b1949],
32	.	.	O	.	_	0	SENT_156	[p11l237t1874r327b1949],

1	Chemotherapy	NN	O	chemotherapy	nsubj	3	SENT_157	[p11l360t1874r876b1950],
2	greatly	RB	O	greatly	advmod	3	SENT_157	[p11l899t1874r1131b1950],
3	reduced	VBD	O	reduce	_	0	SENT_157	[p11l1153t1874r1432b1934],
4	the	DT	O	the	det	5	SENT_157	[p11l1457t1874r1563b1934],
5	risk	NN	O	risk	dobj	3	SENT_157	[p11l1588t1874r1712b1934],
6	of	IN	O	of	_	0	SENT_157	[p11l1736t1874r1810b1934],
7	diagnosis	NN	O	diagnosis	prep_of	5	SENT_157	[p11l1826t1874r2142b1950],

1	1878	CD	DATE	1878	_	0	SENT_158	[p11l96t2046r172b2072],
2	THE	DT	O	the	det	3	SENT_158	[p11l1468t2051r1534b2071],
3	LANCET	NN	O	lancet	dep	1	SENT_158	[p11l1544t2051r1673b2072],
4	-	:	O	-	_	0	SENT_158	[p11l1683t2058r1690b2065],
5	Vol	NN	O	vol	dep	1	SENT_158	[p11l1700t2051r1744b2072],
6	356	CD	NUMBER	356	num	5	SENT_158	[p11l1754t2052r1799b2072],
7	-	:	O	-	_	0	SENT_158	[p11l1810t2058r1818b2065],
8	December	NNP	DATE	December	dep	5	SENT_158	[p11l1828t2051r1959b2072],
9	2	CD	DATE	2	num	8	SENT_158	[p11l1968t2052r1990b2075],
10	,	,	DATE	,	_	0	SENT_158	[p11l1968t2052r1990b2075],
11	2000	CD	DATE	2000	num	8	SENT_158	[p11l2001t2052r2063b2072],
12	ARTICLES	NNS	O	article	dep	8	SENT_158	[p11l1913t2094r2067b2115],

1	Years	NNS	DURATION	year	_	0	SENT_159	[p11l445t2317r582b2360],
2	since	IN	O	since	_	0	SENT_159	[p11l600t2316r729b2360],
3	diagnosis	NN	O	diagnosis	prep_since	1	SENT_159	[p11l749t2316r979b2370],
4	of	IN	O	of	_	0	SENT_159	[p11l998t2316r1045b2360],
5	primary	JJ	O	primary	amod	7	SENT_159	[p11l1063t2316r1242b2370],
6	breast	NN	O	breast	nn	7	SENT_159	[p11l1262t2317r1414b2360],
7	cancer	NN	O	cancer	prep_of	1	SENT_159	[p11l1433t2327r1599b2360],

1	1-2	CD	NUMBER	1-2	nsubj	24	SENT_160	[p11l449t2420r535b2463],
2	2-5	CD	NUMBER	2-5	number	3	SENT_160	[p11l927t2420r1016b2464],
3	5-10	CD	NUMBER	5-10	num	4	SENT_160	[p11l1374t2420r1496b2464],
4	>	JJR	O	>	dep	1	SENT_160	[p11l1806t2420r1901b2464],
5	10	CD	NUMBER	10	num	8	SENT_160	[p11l1806t2420r1901b2464],
6	(	NN	O	(	nn	8	SENT_160	[p11l447t2495r526b2548],
7	58	CD	NUMBER	58	num	8	SENT_160	[p11l447t2495r526b2548],
8	cases	NNS	O	case	dep	4	SENT_160	[p11l545t2505r699b2546],
9	;	:	O	;	_	0	SENT_160	[p11l545t2505r699b2546],
10	(	CD	NUMBER	(	number	11	SENT_160	[p11l927t2495r1003b2548],
11	57	CD	NUMBER	57	num	12	SENT_160	[p11l927t2495r1003b2548],
12	cases	NNS	O	case	dep	4	SENT_160	[p11l1025t2505r1178b2546],
13	;	:	O	;	_	0	SENT_160	[p11l1025t2505r1178b2546],
14	(	CD	NUMBER	(	number	15	SENT_160	[p11l1374t2495r1452b2548],
15	51	CD	NUMBER	51	num	16	SENT_160	[p11l1374t2495r1452b2548],
16	cases	NNS	O	case	dep	12	SENT_160	[p11l1472t2505r1626b2546],
17	;	:	O	;	_	0	SENT_160	[p11l1472t2505r1626b2546],
18	(	CD	NUMBER	(	num	20	SENT_160	[p11l1806t2495r1884b2548],
19	43	CD	NUMBER	43	num	20	SENT_160	[p11l1806t2495r1884b2548],
20	cases	NNS	O	case	dep	4	SENT_160	[p11l1904t2505r2058b2546],
21	;	:	O	;	_	0	SENT_160	[p11l1904t2505r2058b2546],
22	111	CD	NUMBER	111	num	23	SENT_160	[p11l449t2569r542b2612],
23	controls	NNS	O	control	dep	20	SENT_160	[p11l562t2569r767b2622],
24	)	VBP	O	)	_	0	SENT_160	[p11l562t2569r767b2622],
25	111	CD	NUMBER	111	num	26	SENT_160	[p11l929t2569r1021b2612],
26	controls	NNS	O	control	nsubj	27	SENT_160	[p11l1042t2569r1247b2622],
27	)	VBP	O	)	ccomp	24	SENT_160	[p11l1042t2569r1247b2622],
28	93	CD	NUMBER	93	num	29	SENT_160	[p11l1374t2568r1436b2612],
29	controls	NNS	O	control	nsubj	30	SENT_160	[p11l1456t2569r1661b2622],
30	)	VBP	O	)	ccomp	27	SENT_160	[p11l1456t2569r1661b2622],
31	69	CD	NUMBER	69	num	32	SENT_160	[p11l1806t2569r1868b2612],
32	controls	NNS	O	control	dobj	30	SENT_160	[p11l1888t2569r2093b2622],
33	)	IN	O	)	prep	30	SENT_160	[p11l1888t2569r2093b2622],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_161	[p11l13t2709r264b2753],
2	use	NN	O	use	_	0	SENT_161	[p11l286t2720r368b2753],
3	Never	RB	O	never	advmod	7	SENT_161	[p11l16t2784r150b2827],
4	1-00	CD	NUMBER	1-00	num	5	SENT_161	[p11l449t2783r559b2827],
5	1-00	CD	NUMBER	1-00	pobj	3	SENT_161	[p11l928t2783r1038b2827],
6	1-00	CD	NUMBER	1-00	num	7	SENT_161	[p11l1375t2783r1485b2827],
7	1-00	CD	NUMBER	1-00	dep	2	SENT_161	[p11l1807t2783r1917b2827],
8	Ever	RB	O	ever	prep	7	SENT_161	[p11l17t2858r115b2901],
9	0-40	CD	NUMBER	0-40	num	10	SENT_161	[p11l447t2858r559b2901],
10	0-41	CD	NUMBER	0-41	pobj	8	SENT_161	[p11l926t2858r1038b2901],
11	0-38	CD	NUMBER	0-38	num	12	SENT_161	[p11l1374t2858r1485b2901],
12	1-00	CD	NUMBER	1-00	dep	2	SENT_161	[p11l1808t2858r1917b2901],

1	Oophorectomy	NNP	O	Oophorectomy	nn	2	SENT_162	[p11l14t3080r367b3133],
2	Never	NNP	O	Never	dep	6	SENT_162	[p11l16t3155r150b3198],
3	1-00	CD	NUMBER	1-00	dep	2	SENT_162	[p11l449t3154r559b3198],
4	1-00	CD	NUMBER	1-00	dep	6	SENT_162	[p11l929t3154r1038b3198],
5	1-00	CD	NUMBER	1-00	num	6	SENT_162	[p11l1375t3154r1485b3198],
6	1-00	CD	NUMBER	1-00	dep	11	SENT_162	[p11l1807t3154r1917b3198],
7	Ever	RB	O	ever	prep	6	SENT_162	[p11l17t3229r115b3273],
8	0-15	CD	NUMBER	0-15	num	9	SENT_162	[p11l447t3229r558b3273],
9	0-81	CD	NUMBER	0-81	pobj	7	SENT_162	[p11l926t3229r1038b3273],
10	0-43	CD	NUMBER	0-43	num	11	SENT_162	[p11l1373t3229r1485b3273],
11	0-23	CD	NUMBER	0-23	_	0	SENT_162	[p11l1805t3229r1916b3273],

1	Chemotherapy	NNP	O	Chemotherapy	nn	2	SENT_163	[p11l14t3462r367b3515],
2	Never	NNP	O	Never	dep	6	SENT_163	[p11l16t3536r150b3579],
3	1-00	CD	NUMBER	1-00	dep	2	SENT_163	[p11l449t3535r559b3579],
4	1-00	CD	NUMBER	1-00	dep	6	SENT_163	[p11l928t3535r1038b3579],
5	1-00	CD	NUMBER	1-00	num	6	SENT_163	[p11l1375t3535r1485b3579],
6	1-00	CD	NUMBER	1-00	dep	11	SENT_163	[p11l1807t3535r1917b3579],
7	Ever	RB	O	ever	prep	6	SENT_163	[p11l17t3610r115b3654],
8	0-18	CD	NUMBER	0-18	num	9	SENT_163	[p11l447t3610r559b3654],
9	0-54	CD	NUMBER	0-54	pobj	7	SENT_163	[p11l926t3610r1038b3654],
10	0-48	CD	NUMBER	0-48	num	11	SENT_163	[p11l1373t3610r1485b3654],
11	0-67	CD	NUMBER	0-67	_	0	SENT_163	[p11l1805t3610r1915b3654],

1	Table	NNP	O	Table	_	0	SENT_164	[p12l13t19r185b73],
2	4	CD	NUMBER	4	num	1	SENT_164	[p12l213t19r271b72],
3	:	:	O	:	_	0	SENT_164	[p12l213t19r271b72],
4	Odds	NNS	O	odds	nn	5	SENT_164	[p12l302t18r464b73],
5	ratio	NN	O	ratio	dep	16	SENT_164	[p12l493t18r640b73],
6	(	CD	PERCENT	(	number	7	SENT_164	[p12l667t18r833b85],
7	95	CD	PERCENT	95	dep	8	SENT_164	[p12l667t18r833b85],
8	%	NN	PERCENT	%	dep	5	SENT_164	[p12l667t18r833b85],
9	CI	NN	O	ci	nn	10	SENT_164	[p12l859t18r951b85],
10	)	NN	O	)	dep	16	SENT_164	[p12l859t18r951b85],
11	for	IN	O	for	_	0	SENT_164	[p12l979t18r1067b73],
12	contralateral	JJ	O	contralateral	amod	14	SENT_164	[p12l1091t19r1512b73],
13	breast	NN	O	breast	nn	14	SENT_164	[p12l1542t19r1748b73],
14	cancer	NN	O	cancer	prep_for	10	SENT_164	[p12l1775t32r2017b84],
15	,	,	O	,	_	0	SENT_164	[p12l1775t32r2017b84],
16	associated	VBN	O	associate	dep	1	SENT_164	[p12l15t113r373b166],
17	with	IN	O	with	_	0	SENT_164	[p12l398t113r538b166],
18	treatment	NN	O	treatment	prep_with	16	SENT_164	[p12l563t115r913b177],
19	,	,	O	,	_	0	SENT_164	[p12l563t115r913b177],
20	by	IN	O	by	_	0	SENT_164	[p12l944t113r1016b178],
21	time	NN	O	time	prep_by	16	SENT_164	[p12l1038t113r1185b166],
22	since	IN	O	since	mark	38	SENT_164	[p12l1211t113r1385b166],
23	primary	JJ	O	primary	amod	25	SENT_164	[p12l1414t113r1656b178],
24	breast	NN	O	breast	nn	25	SENT_164	[p12l1683t113r1889b166],
25	cancer	NN	O	cancer	nsubj	38	SENT_164	[p12l1915t126r2139b166],
26	of	IN	O	of	_	0	SENT_164	[p12l11t280r85b341],
27	contralateral	JJ	O	contralateral	amod	29	SENT_164	[p12l101t280r533b341],
28	breast	NN	O	breast	nn	29	SENT_164	[p12l555t280r765b341],
29	cancers	NNS	O	cancer	prep_of	25	SENT_164	[p12l790t300r1043b341],
30	within	IN	O	within	_	0	SENT_164	[p12l1067t280r1286b341],
31	2	CD	DURATION	2	num	32	SENT_164	[p12l1311t283r1349b340],
32	years	NNS	NUMBER	year	prep_within	29	SENT_164	[p12l1373t300r1547b356],
33	of	IN	O	of	_	0	SENT_164	[p12l1574t280r1648b341],
34	treatment	NN	O	treatment	prep_of	32	SENT_164	[p12l1662t294r2000b341],
35	but	CC	O	but	prep	34	SENT_164	[p12l2022t280r2140b341],
36	the	DT	O	the	det	37	SENT_164	[p12l9t373r115b434],
37	risk	NN	O	risk	dep	35	SENT_164	[p12l142t373r266b434],
38	rose	VBD	O	rise	dep	21	SENT_164	[p12l290t393r430b434],
39	after	IN	O	after	_	0	SENT_164	[p12l458t373r614b434],
40	10	CD	DURATION	10	num	41	SENT_164	[p12l647t376r722b434],
41	years	NNS	NUMBER	year	prep_after	38	SENT_164	[p12l749t393r942b449],
42	.	.	O	.	_	0	SENT_164	[p12l749t393r942b449],

1	The	DT	O	the	det	3	SENT_165	[p12l973t373r1114b434],
2	main	JJ	O	main	amod	3	SENT_165	[p12l1141t374r1315b434],
3	effect	NN	O	effect	nsubj	7	SENT_165	[p12l1343t373r1528b434],
4	of	IN	O	of	_	0	SENT_165	[p12l1556t373r1629b434],
5	chemotherapy	NN	O	chemotherapy	prep_of	3	SENT_165	[p12l1647t373r2140b449],
6	therefore	RB	O	therefore	advmod	7	SENT_165	[p12l9t467r319b527],
7	seemed	VBD	O	seem	_	0	SENT_165	[p12l395t467r651b527],
8	to	TO	O	to	aux	11	SENT_165	[p12l724t481r790b527],
9	be	VB	O	be	cop	11	SENT_165	[p12l864t467r945b527],
10	the	DT	O	the	det	11	SENT_165	[p12l1018t467r1124b527],
11	eradication	NN	O	eradication	xcomp	7	SENT_165	[p12l1200t467r1584b527],
12	of	IN	O	of	_	0	SENT_165	[p12l1659t467r1732b527],
13	prevalent	JJ	O	prevalent	amod	15	SENT_165	[p12l1795t467r2135b543],
14	,	,	O	,	_	0	SENT_165	[p12l1795t467r2135b543],
15	subclinical	JJ	O	subclinical	amod	18	SENT_165	[p12l11t559r375b620],
16	contralateral	JJ	O	contralateral	amod	18	SENT_165	[p12l406t559r838b620],
17	breast	NN	O	breast	nn	18	SENT_165	[p12l865t559r1075b620],
18	cancers	NNS	O	cancer	prep_of	11	SENT_165	[p12l1104t579r1377b620],
19	.	.	O	.	_	0	SENT_165	[p12l1104t579r1377b620],

1	The	DT	O	the	det	3	SENT_166	[p12l1410t559r1552b620],
2	protective	JJ	O	protective	amod	3	SENT_166	[p12l1580t559r1923b635],
3	effect	NN	O	effect	nsubj	8	SENT_166	[p12l1953t559r2139b620],
4	of	IN	O	of	_	0	SENT_166	[p12l11t652r85b713],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_166	[p12l99t652r446b713],
6	did	VBD	O	do	aux	8	SENT_166	[p12l471t652r581b713],
7	not	RB	O	not	neg	8	SENT_166	[p12l605t667r719b713],
8	persist	VB	O	persist	_	0	SENT_166	[p12l742t653r965b728],
9	longer	JJR	O	longer	advmod	8	SENT_166	[p12l989t652r1207b728],
10	than	IN	O	than	_	0	SENT_166	[p12l1229t652r1384b713],
11	10	CD	DURATION	10	num	12	SENT_166	[p12l1416t655r1491b713],
12	years	NNS	NUMBER	year	tmod	13	SENT_166	[p12l1516t672r1690b728],
13	(	RB	O	(	amod	16	SENT_166	[p12l1722t652r1913b728],
14	table	NN	O	table	nn	16	SENT_166	[p12l1722t652r1913b728],
15	4	CD	NUMBER	4	num	16	SENT_166	[p12l1939t653r2030b728],
16	)	NN	O	)	prep_than	8	SENT_166	[p12l1939t653r2030b728],
17	;	:	O	;	_	0	SENT_166	[p12l1939t653r2030b728],
18	by	IN	O	by	_	0	SENT_166	[p12l2056t652r2140b728],
19	contrast	NN	O	contrast	prep_by	27	SENT_166	[p12l11t760r307b819],
20	,	,	O	,	_	0	SENT_166	[p12l11t760r307b819],
21	the	DT	O	the	det	23	SENT_166	[p12l393t746r499b806],
22	protective	JJ	O	protective	amod	23	SENT_166	[p12l582t746r925b822],
23	effect	NN	O	effect	nsubj	27	SENT_166	[p12l1010t746r1196b806],
24	of	IN	O	of	_	0	SENT_166	[p12l1280t746r1354b806],
25	oophorectomy	NN	O	oophorectomy	prep_of	23	SENT_166	[p12l1429t746r1931b822],
26	was	VBD	O	be	aux	27	SENT_166	[p12l2011t766r2137b806],
27	longlasting	VBG	O	longlast	parataxis	8	SENT_166	[p12l9t838r402b914],
28	.	.	O	.	_	0	SENT_166	[p12l9t838r402b914],

1	This	DT	O	this	det	2	SENT_167	[p12l434t838r591b899],
2	difference	NN	O	difference	nsubj	4	SENT_167	[p12l621t838r960b899],
3	is	VBZ	O	be	cop	4	SENT_167	[p12l988t838r1037b899],
4	consistent	JJ	O	consistent	_	0	SENT_167	[p12l1068t838r1414b899],
5	with	IN	O	with	_	0	SENT_167	[p12l1439t838r1590b899],
6	the	DT	O	the	det	7	SENT_167	[p12l1617t838r1723b899],
7	notion	NN	O	notion	prep_with	4	SENT_167	[p12l1751t838r1977b899],
8	that	IN	O	that	complm	11	SENT_167	[p12l2004t838r2139b899],
9	oophorectomy	NN	O	oophorectomy	nsubj	11	SENT_167	[p12l11t931r513b1007],
10	permanently	RB	O	permanently	advmod	11	SENT_167	[p12l554t931r992b1007],
11	reduces	VBZ	O	reduce	ccomp	4	SENT_167	[p12l1035t931r1298b992],
12	endogenous	JJ	O	endogenous	amod	14	SENT_167	[p12l1345t931r1758b1007],
13	oestrogen	NN	O	oestrogen	nn	14	SENT_167	[p12l1805t946r2139b1007],
14	exposure	NN	O	exposure	dobj	11	SENT_167	[p12l11t1044r339b1101],
15	,	,	O	,	_	0	SENT_167	[p12l11t1044r339b1101],
16	whereas	IN	O	whereas	mark	26	SENT_167	[p12l401t1025r678b1085],
17	the	DT	O	the	det	18	SENT_167	[p12l739t1025r846b1085],
18	effect	NN	O	effect	nsubj	26	SENT_167	[p12l909t1025r1095b1085],
19	of	IN	O	of	_	0	SENT_167	[p12l1156t1025r1230b1085],
20	tamoxifen	NN	O	tamoxifen	prep_of	18	SENT_167	[p12l1281t1025r1627b1085],
21	on	IN	O	on	_	0	SENT_167	[p12l1689t1045r1775b1085],
22	reducing	VBG	O	reduce	prepc_on	20	SENT_167	[p12l1836t1025r2140b1101],
23	hormone	NN	O	hormone	nn	24	SENT_167	[p12l8t1117r322b1178],
24	exposure	NN	O	exposure	dobj	22	SENT_167	[p12l366t1137r673b1193],
25	is	VBZ	O	be	cop	26	SENT_167	[p12l716t1117r765b1178],
26	temporary	JJ	O	temporary	advcl	11	SENT_167	[p12l809t1131r1184b1193],
27	.	.	O	.	_	0	SENT_167	[p12l809t1131r1184b1193],

1	However	RB	O	however	advmod	14	SENT_168	[p12l1232t1118r1564b1190],
2	,	,	O	,	_	0	SENT_168	[p12l1232t1118r1564b1190],
3	the	DT	O	the	det	4	SENT_168	[p12l1609t1117r1715b1178],
4	number	NN	O	number	nsubj	14	SENT_168	[p12l1758t1117r2032b1178],
5	of	IN	O	of	_	0	SENT_168	[p12l2074t1117r2148b1178],
6	patients	NNS	O	patient	prep_of	4	SENT_168	[p12l8t1210r279b1286],
7	in	IN	O	in	_	0	SENT_168	[p12l314t1210r379b1270],
8	each	DT	O	each	prep_in	6	SENT_168	[p12l413t1210r569b1271],
9	of	IN	O	of	_	0	SENT_168	[p12l603t1210r677b1271],
10	these	DT	O	these	det	11	SENT_168	[p12l700t1210r876b1271],
11	subcategories	NNS	O	subcategory	prep_of	8	SENT_168	[p12l911t1210r1374b1286],
12	was	VBD	O	be	cop	14	SENT_168	[p12l1407t1230r1533b1271],
13	fairly	RB	O	fairly	advmod	14	SENT_168	[p12l1568t1210r1742b1286],
14	small	JJ	O	small	_	0	SENT_168	[p12l1775t1210r1974b1283],
15	,	,	O	,	_	0	SENT_168	[p12l1775t1210r1974b1283],
16	and	CC	O	and	_	0	SENT_168	[p12l2012t1210r2138b1271],
17	the	DT	O	the	det	19	SENT_168	[p12l9t1304r115b1364],
18	conﬁdence	NN	O	conﬁdence	nn	19	SENT_168	[p12l168t1304r542b1364],
19	limits	NNS	O	limit	nsubj	26	SENT_168	[p12l594t1304r782b1364],
20	of	IN	O	of	_	0	SENT_168	[p12l836t1304r910b1364],
21	the	DT	O	the	det	22	SENT_168	[p12l950t1304r1056b1364],
22	estimates	NNS	O	estimate	prep_of	19	SENT_168	[p12l1109t1304r1425b1364],
23	for	IN	O	for	_	0	SENT_168	[p12l1477t1304r1575b1364],
24	the	DT	O	the	det	25	SENT_168	[p12l1624t1304r1730b1364],
25	subgroups	NNS	O	subgroup	prep_for	22	SENT_168	[p12l1783t1304r2137b1380],
26	overlap	VBP	O	overlap	conj_and	14	SENT_168	[p12l11t1396r279b1472],
27	.	.	O	.	_	0	SENT_168	[p12l11t1396r279b1472],

1	We	PRP	O	we	nsubj	2	SENT_169	[p12l411t1397r528b1457],
2	examined	VBD	O	examine	_	0	SENT_169	[p12l659t1396r992b1457],
3	whether	IN	O	whether	complm	14	SENT_169	[p12l1119t1396r1401b1457],
4	tamoxifen	NN	O	tamoxifen	nn	5	SENT_169	[p12l1528t1396r1874b1457],
5	use	NN	O	use	nsubj	14	SENT_169	[p12l2002t1416r2135b1469],
6	,	,	O	,	_	0	SENT_169	[p12l2002t1416r2135b1469],
7	oophorectomy	NN	O	oophorectomy	nsubj	14	SENT_169	[p12l11t1489r532b1565],
8	,	,	O	,	_	0	SENT_169	[p12l11t1489r532b1565],
9	and	CC	O	and	_	0	SENT_169	[p12l633t1489r760b1550],
10	chemotherapy	NN	O	chemotherapy	conj_and	5	SENT_169	[p12l858t1489r1351b1565],
11	were	VBD	O	be	cop	14	SENT_169	[p12l1445t1509r1607b1550],
12	independent	JJ	O	independent	amod	14	SENT_169	[p12l1705t1489r2139b1565],
13	protective	JJ	O	protective	amod	14	SENT_169	[p12l8t1583r350b1659],
14	factors	NNS	O	factor	ccomp	2	SENT_169	[p12l396t1583r647b1656],
15	,	,	O	,	_	0	SENT_169	[p12l396t1583r647b1656],
16	using	VBG	O	use	partmod	14	SENT_169	[p12l694t1583r879b1659],
17	a	DT	O	a	det	22	SENT_169	[p12l924t1603r958b1643],
18	conditional	JJ	O	conditional	amod	19	SENT_169	[p12l1004t1583r1393b1643],
19	multivariate	JJ	O	multivariate	amod	22	SENT_169	[p12l1437t1583r1851b1643],
20	logistic	JJ	O	logistic	amod	22	SENT_169	[p12l1897t1583r2138b1659],
21	regression	NN	O	regression	nn	22	SENT_169	[p12l9t1675r357b1751],
22	analysis	NN	O	analysis	dobj	16	SENT_169	[p12l391t1675r673b1751],
23	.	.	O	.	_	0	SENT_169	[p12l391t1675r673b1751],

1	All	DT	O	all	det	3	SENT_170	[p12l709t1675r809b1735],
2	three	CD	NUMBER	three	num	3	SENT_170	[p12l842t1675r1016b1736],
3	treatments	NNS	O	treatment	nsubj	10	SENT_170	[p12l1048t1689r1416b1736],
4	were	VBD	O	be	cop	10	SENT_170	[p12l1449t1695r1610b1736],
5	independently	RB	O	independently	advmod	10	SENT_170	[p12l1644t1675r2140b1751],
6	protective	JJ	O	protective	amod	10	SENT_170	[p12l8t1769r350b1844],
7	(	NN	O	(	nn	10	SENT_170	[p12l416t1768r607b1844],
8	table	NN	O	table	nn	10	SENT_170	[p12l416t1768r607b1844],
9	3	CD	NUMBER	3	num	10	SENT_170	[p12l669t1769r760b1844],
10	)	NN	O	)	_	0	SENT_170	[p12l669t1769r760b1844],
11	,	,	O	,	_	0	SENT_170	[p12l669t1769r760b1844],
12	and	CC	O	and	_	0	SENT_170	[p12l824t1768r950b1829],
13	the	DT	O	the	det	14	SENT_170	[p12l1009t1768r1115b1829],
14	effects	NNS	O	effect	nsubj	16	SENT_170	[p12l1177t1768r1392b1829],
15	were	VBD	O	be	cop	16	SENT_170	[p12l1451t1788r1613b1829],
16	present	JJ	DATE	present	conj_and	10	SENT_170	[p12l1671t1783r1925b1844],
17	after	IN	O	after	_	0	SENT_170	[p12l1985t1768r2141b1829],
18	adjustment	NN	O	adjustment	prep_after	16	SENT_170	[p12l11t1862r397b1937],
19	for	IN	O	for	_	0	SENT_170	[p12l421t1862r519b1922],
20	ethnic	JJ	O	ethnic	amod	21	SENT_170	[p12l543t1862r753b1922],
21	group	NN	O	group	prep_for	16	SENT_170	[p12l779t1881r1001b1938],
22	,	,	O	,	_	0	SENT_170	[p12l779t1881r1001b1938],
23	smoking	NN	O	smoking	prep_for	16	SENT_170	[p12l1030t1862r1341b1938],
24	,	,	O	,	_	0	SENT_170	[p12l1030t1862r1341b1938],
25	and	CC	O	and	_	0	SENT_170	[p12l1370t1862r1496b1922],
26	parity	NN	O	parity	prep_for	16	SENT_170	[p12l1520t1862r1737b1938],
27	.	.	O	.	_	0	SENT_170	[p12l1520t1862r1737b1938],

1	Discussion	NN	O	discussion	nsubj	4	SENT_171	[p12l12t2044r495b2111],
2	Our	PRP$	O	we	poss	3	SENT_171	[p12l12t2144r156b2204],
3	results	NNS	O	result	dep	1	SENT_171	[p12l201t2144r431b2204],
4	suggest	VBP	O	suggest	_	0	SENT_171	[p12l482t2158r743b2220],
5	that	IN	O	that	complm	13	SENT_171	[p12l789t2144r930b2204],
6	the	DT	O	the	det	7	SENT_171	[p12l976t2144r1086b2204],
7	risk	NN	O	risk	nsubjpass	13	SENT_171	[p12l1134t2144r1263b2204],
8	of	IN	O	of	_	0	SENT_171	[p12l1310t2144r1387b2204],
9	contralateral	JJ	O	contralateral	amod	11	SENT_171	[p12l1425t2144r1876b2204],
10	breast	NN	O	breast	nn	11	SENT_171	[p12l1922t2144r2139b2204],
11	cancer	NN	O	cancer	prep_of	7	SENT_171	[p12l11t2256r246b2297],
12	is	VBZ	O	be	auxpass	13	SENT_171	[p12l298t2236r349b2297],
13	reduced	VBN	O	reduce	ccomp	4	SENT_171	[p12l404t2236r695b2297],
14	by	IN	O	by	_	0	SENT_171	[p12l748t2236r835b2312],
15	50	CD	PERCENT	50	num	16	SENT_171	[p12l891t2236r1049b2299],
16	%	NN	PERCENT	%	agent	13	SENT_171	[p12l891t2236r1049b2299],
17	in	IN	O	in	_	0	SENT_171	[p12l1108t2236r1176b2296],
18	carriers	NNS	O	carrier	prep_in	16	SENT_171	[p12l1232t2236r1493b2297],
19	of	IN	O	of	_	0	SENT_171	[p12l1551t2236r1628b2297],
20	BRCAI	NN	O	brcaus	nn	23	SENT_171	[p12l1670t2236r1946b2297],
21	and	CC	O	and	_	0	SENT_171	[p12l2007t2236r2138b2297],
22	BRCA2	NN	O	brca2	nn	23	SENT_171	[p12l8t2330r289b2390],
23	mutations	NNS	O	mutation	prep_of	18	SENT_171	[p12l360t2330r721b2390],
24	when	WRB	O	when	advmod	27	SENT_171	[p12l793t2329r988b2390],
25	tamoxifen	NN	O	tamoxifen	nsubjpass	27	SENT_171	[p12l1059t2329r1421b2390],
26	is	VBZ	O	be	auxpass	27	SENT_171	[p12l1493t2329r1544b2390],
27	used	VBN	O	use	advcl	13	SENT_171	[p12l1617t2329r1783b2390],
28	for	IN	O	for	_	0	SENT_171	[p12l1855t2329r1957b2390],
29	the	DT	O	the	det	30	SENT_171	[p12l2027t2329r2137b2390],
30	treatment	NN	O	treatment	prep_for	27	SENT_171	[p12l9t2437r361b2483],
31	of	IN	O	of	_	0	SENT_171	[p12l404t2423r481b2483],
32	the	DT	O	the	det	35	SENT_171	[p12l512t2423r623b2483],
33	initial	JJ	O	initial	amod	35	SENT_171	[p12l666t2423r868b2483],
34	breast	NN	O	breast	nn	35	SENT_171	[p12l910t2423r1127b2483],
35	cancer	NN	O	cancer	prep_of	30	SENT_171	[p12l1170t2442r1422b2483],
36	.	.	O	.	_	0	SENT_171	[p12l1170t2442r1422b2483],

1	Women	NNS	O	woman	nsubj	7	SENT_172	[p12l1467t2424r1756b2483],
2	and	CC	O	and	_	0	SENT_172	[p12l1800t2423r1932b2483],
3	their	PRP$	O	they	poss	4	SENT_172	[p12l1973t2423r2141b2483],
4	physicians	NNS	O	physician	conj_and	1	SENT_172	[p12l8t2515r377b2591],
5	were	VBD	O	be	cop	7	SENT_172	[p12l402t2535r571b2576],
6	not	RB	O	not	neg	7	SENT_172	[p12l596t2529r715b2576],
7	aware	JJ	O	aware	_	0	SENT_172	[p12l741t2535r947b2576],
8	of	IN	O	of	_	0	SENT_172	[p12l974t2515r1051b2576],
9	the	DT	O	the	det	10	SENT_172	[p12l1065t2515r1176b2576],
10	BRCAI	NN	O	brcaus	prep_of	7	SENT_172	[p12l1199t2515r1475b2576],
11	or	CC	O	or	_	0	SENT_172	[p12l1506t2535r1580b2576],
12	BRCA2	NN	O	brca2	nn	14	SENT_172	[p12l1601t2515r1883b2576],
13	carrier	NN	O	carrier	nn	14	SENT_172	[p12l1908t2515r2140b2576],
14	status	NN	O	status	conj_or	10	SENT_172	[p12l11t2623r215b2669],
15	at	IN	O	at	_	0	SENT_172	[p12l253t2623r317b2669],
16	the	DT	O	the	det	17	SENT_172	[p12l351t2608r461b2669],
17	time	NN	O	time	prep_at	7	SENT_172	[p12l497t2609r655b2669],
18	of	IN	O	of	_	0	SENT_172	[p12l693t2608r770b2669],
19	initial	JJ	O	initial	amod	20	SENT_172	[p12l795t2608r997b2669],
20	diagnosis	NN	O	diagnosis	prep_of	17	SENT_172	[p12l1034t2608r1383b2684],
21	.	.	O	.	_	0	SENT_172	[p12l1034t2608r1383b2684],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_173	[p12l1422t2608r1820b2669],
2	use	NN	O	use	nsubjpass	4	SENT_173	[p12l1854t2628r1971b2669],
3	was	VBD	O	be	auxpass	4	SENT_173	[p12l2005t2628r2137b2669],
4	reported	VBN	O	report	_	0	SENT_173	[p12l9t2702r316b2778],
5	more	RBR	O	more	advmod	6	SENT_173	[p12l347t2721r532b2762],
6	often	RB	O	often	advmod	4	SENT_173	[p12l566t2702r748b2762],
7	by	IN	O	by	_	0	SENT_173	[p12l778t2702r866b2778],
8	BRCA2	NN	O	brca2	nn	10	SENT_173	[p12l893t2702r1175b2762],
9	mutation	NN	O	mutation	nn	10	SENT_173	[p12l1205t2702r1535b2762],
10	carriers	NNS	O	carrier	agent	4	SENT_173	[p12l1568t2702r1829b2762],
11	than	IN	O	than	prep	4	SENT_173	[p12l1862t2702r2023b2762],
12	by	IN	O	by	pcomp	11	SENT_173	[p12l2053t2702r2140b2778],
13	BRCAI	NN	O	brcaus	nn	15	SENT_173	[p12l8t2794r283b2855],
14	mutation	NN	O	mutation	nn	15	SENT_173	[p12l360t2794r690b2855],
15	carriers	NNS	O	carrier	pobj	12	SENT_173	[p12l764t2794r1046b2855],
16	.	.	O	.	_	0	SENT_173	[p12l764t2794r1046b2855],

1	This	DT	O	this	det	2	SENT_174	[p12l1123t2794r1285b2855],
2	difference	NN	O	difference	nsubj	3	SENT_174	[p12l1361t2794r1714b2855],
3	is	VBZ	O	be	_	0	SENT_174	[p12l1787t2794r1838b2855],
4	to	TO	O	to	aux	6	SENT_174	[p12l1912t2808r1981b2855],
5	be	VB	O	be	auxpass	6	SENT_174	[p12l2053t2794r2137b2855],
6	expected	VBN	O	expect	xcomp	3	SENT_174	[p12l11t2887r349b2963],
7	,	,	O	,	_	0	SENT_174	[p12l11t2887r349b2963],
8	in	IN	O	in	_	0	SENT_174	[p12l379t2888r447b2947],
9	view	NN	O	view	prep_in	3	SENT_174	[p12l473t2888r636b2948],
10	of	IN	O	of	_	0	SENT_174	[p12l663t2887r740b2948],
11	the	DT	O	the	det	13	SENT_174	[p12l757t2887r868b2948],
12	older	JJR	O	older	amod	13	SENT_174	[p12l898t2887r1081b2948],
13	age	NN	O	age	prep_of	9	SENT_174	[p12l1108t2907r1224b2963],
14	of	IN	O	of	_	0	SENT_174	[p12l1254t2887r1331b2948],
15	onset	NN	O	onset	prep_of	13	SENT_174	[p12l1350t2902r1539b2948],
16	of	IN	O	of	_	0	SENT_174	[p12l1567t2887r1644b2948],
17	breast	NN	O	breast	nn	18	SENT_174	[p12l1660t2887r1878b2948],
18	cancer	NN	O	cancer	prep_of	15	SENT_174	[p12l1906t2907r2140b2948],
19	in	IN	O	in	_	0	SENT_174	[p12l9t2981r77b3040],
20	the	DT	O	the	det	23	SENT_174	[p12l134t2981r245b3041],
21	BRCA2	NN	O	brca2	nn	23	SENT_174	[p12l301t2981r583b3041],
22	mutation	NN	O	mutation	nn	23	SENT_174	[p12l639t2981r969b3041],
23	carriers	NNS	O	carrier	prep_in	18	SENT_174	[p12l1028t2981r1290b3041],
24	than	IN	O	than	prep	3	SENT_174	[p12l1348t2981r1509b3041],
25	in	IN	O	in	pcomp	24	SENT_174	[p12l1566t2981r1634b3040],
26	the	DT	O	the	det	29	SENT_174	[p12l1690t2981r1801b3041],
27	BRCAI	NN	O	brcaus	nn	29	SENT_174	[p12l1857t2981r2133b3041],
28	mutation	NN	O	mutation	nn	29	SENT_174	[p12l9t3072r339b3133],
29	carriers	NNS	O	carrier	pobj	25	SENT_174	[p12l371t3072r654b3133],
30	.	.	O	.	_	0	SENT_174	[p12l371t3072r654b3133],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_175	[p12l690t3072r1176b3144],
2	,	,	O	,	_	0	SENT_175	[p12l690t3072r1176b3144],
3	most	JJS	O	most	amod	5	SENT_175	[p12l1211t3086r1387b3133],
4	breast	NN	O	breast	nn	5	SENT_175	[p12l1416t3072r1634b3133],
5	tumours	NNS	O	tumour	nsubj	13	SENT_175	[p12l1664t3086r1966b3133],
6	that	WDT	O	that	nsubj	7	SENT_175	[p12l1998t3072r2139b3133],
7	arise	VBP	O	arise	rcmod	5	SENT_175	[p13l11t18r172b78],
8	in	IN	O	in	_	0	SENT_175	[p13l212t18r280b77],
9	BRCAI	NN	O	brcaus	nn	11	SENT_175	[p13l318t18r594b78],
10	mutation	NN	O	mutation	nn	11	SENT_175	[p13l638t18r968b78],
11	carriers	NNS	O	carrier	prep_in	7	SENT_175	[p13l1009t18r1271b78],
12	are	VBP	O	be	cop	13	SENT_175	[p13l1313t37r1419b78],
13	oestrogen-receptor	JJ	O	oestrogen-receptor	_	0	SENT_175	[p13l1461t32r2140b93],
14	negative	JJ	O	negative	advmod	13	SENT_175	[p13l9t111r428b187],
15	,	,	O	,	_	0	SENT_175	[p13l9t111r428b187],
16	‘	JJ	O	‘	amod	17	SENT_175	[p13l9t111r428b187],
17	4	CD	NUMBER	4	attr	13	SENT_175	[p13l9t111r428b187],
18	"	``	O	"	punct	17	SENT_175	[p13l9t111r428b187],
19	5	CD	NUMBER	5	dep	26	SENT_175	[p13l9t111r428b187],
20	whereas	IN	O	whereas	dep	26	SENT_175	[p13l459t111r744b171],
21	BRCA2-mutation-associated	JJ	O	brca2-mutation-associated	amod	22	SENT_175	[p13l775t111r1807b171],
22	tumours	NNS	O	tumour	nsubj	26	SENT_175	[p13l1837t125r2137b171],
23	are	VBP	O	be	cop	26	SENT_175	[p13l11t223r116b264],
24	typically	RB	O	typically	advmod	26	SENT_175	[p13l165t203r466b279],
25	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	26	SENT_175	[p13l513t217r1193b279],
26	positive	JJ	O	positive	dep	17	SENT_175	[p13l1238t203r1583b279],
27	.	.	O	.	_	0	SENT_175	[p13l1238t203r1583b279],

1	”	NN	O	”	nn	3	SENT_176	[p13l1238t203r1583b279],
2	The	DT	O	the	det	3	SENT_176	[p13l1631t203r1779b264],
3	effect	NN	O	effect	nsubj	36	SENT_176	[p13l1829t203r2023b264],
4	of	IN	O	of	_	0	SENT_176	[p13l2072t203r2148b264],
5	tamoxifen	NN	O	tamoxifen	prep_of	3	SENT_176	[p13l9t296r370b357],
6	in	IN	O	in	_	0	SENT_176	[p13l412t297r480b356],
7	the	DT	O	the	det	11	SENT_176	[p13l521t296r631b357],
8	National	NNP	O	National	nn	11	SENT_176	[p13l672t296r988b357],
9	Surgical	NNP	O	Surgical	nn	11	SENT_176	[p13l1033t296r1322b372],
10	Adjuvant	JJ	O	adjuvant	amod	11	SENT_176	[p13l1362t296r1696b372],
11	Breast	NN	O	breast	nsubj	19	SENT_176	[p13l1738t297r1964b357],
12	and	CC	O	and	_	0	SENT_176	[p13l2007t296r2138b357],
13	Bowel	NN	O	bowel	nn	18	SENT_176	[p13l10t390r232b450],
14	(	CD	NUMBER	(	num	18	SENT_176	[p13l290t390r631b464],
15	NSABP	NN	ORGANIZATION	nsabp	nn	18	SENT_176	[p13l290t390r631b464],
16	)	CD	NUMBER	)	num	18	SENT_176	[p13l290t390r631b464],
17	P1	NN	O	p1	nn	18	SENT_176	[p13l688t391r775b449],
18	trial	NN	O	trial	nsubj	19	SENT_176	[p13l835t390r976b450],
19	seemed	VBD	O	seem	prepc_in	5	SENT_176	[p13l1029t390r1297b450],
20	to	TO	O	to	aux	22	SENT_176	[p13l1347t403r1415b450],
21	be	VB	O	be	auxpass	22	SENT_176	[p13l1467t390r1551b450],
22	limited	VBN	O	limit	xcomp	19	SENT_176	[p13l1603t390r1855b450],
23	to	TO	O	to	_	0	SENT_176	[p13l1906t403r1975b450],
24	the	DT	O	the	det	25	SENT_176	[p13l2027t390r2137b450],
25	prevention	NN	O	prevention	prep_to	22	SENT_176	[p13l8t481r395b557],
26	of	IN	O	of	_	0	SENT_176	[p13l444t481r521b542],
27	oestrogen-receptor	NN	O	oestrogen-receptor	nn	29	SENT_176	[p13l560t495r1239b557],
28	positive	JJ	O	positive	amod	29	SENT_176	[p13l1284t481r1558b557],
29	tumours	NNS	O	tumour	prep_of	25	SENT_176	[p13l1607t482r1957b554],
30	,9	CD	NUMBER	,9	tmod	22	SENT_176	[p13l1607t482r1957b554],
31	and	CC	O	and	_	0	SENT_176	[p13l2007t481r2138b542],
32	some	DT	O	some	det	33	SENT_176	[p13l11t594r196b635],
33	workers	NNS	O	worker	nsubj	34	SENT_176	[p13l227t574r554b635],
34	”	VBP	O	”	conj_and	19	SENT_176	[p13l227t574r554b635],
35	have	VBP	O	have	aux	36	SENT_176	[p13l585t575r749b635],
36	predicted	VBN	O	predict	_	0	SENT_176	[p13l780t575r1120b651],
37	that	IN	O	that	complm	43	SENT_176	[p13l1150t575r1291b635],
38	anti-oestrogen	JJ	O	anti-oestrogen	amod	39	SENT_176	[p13l1323t575r1838b651],
39	therapy	NN	O	therapy	nsubj	43	SENT_176	[p13l1868t575r2140b651],
40	will	MD	O	will	aux	43	SENT_176	[p13l8t668r135b728],
41	therefore	RB	O	therefore	advmod	43	SENT_176	[p13l159t668r482b728],
42	be	VB	O	be	cop	43	SENT_176	[p13l505t668r589b728],
43	ineffective	JJ	O	ineffective	ccomp	36	SENT_176	[p13l614t668r979b728],
44	as	IN	O	as	_	0	SENT_176	[p13l1005t688r1072b728],
45	chemoprevention	NN	O	chemoprevention	prep_as	43	SENT_176	[p13l1100t668r1728b744],
46	for	IN	O	for	_	0	SENT_176	[p13l1751t668r1853b728],
47	women	NNS	O	woman	prep_for	43	SENT_176	[p13l1873t687r2139b728],
48	with	IN	O	with	_	0	SENT_176	[p13l8t760r165b821],
49	BRCAI	NN	O	brcaus	nn	50	SENT_176	[p13l193t760r469b821],
50	mutations	NNS	O	mutation	prep_with	47	SENT_176	[p13l503t760r885b821],
51	.	.	O	.	_	0	SENT_176	[p13l503t760r885b821],

1	We	PRP	O	we	nsubj	3	SENT_177	[p13l918t761r1040b821],
2	have	VBP	O	have	aux	3	SENT_177	[p13l1069t760r1233b821],
3	shown	VBN	O	show	_	0	SENT_177	[p13l1266t760r1496b821],
4	that	IN	O	that	complm	7	SENT_177	[p13l1525t760r1666b821],
5	tamoxifen	NN	O	tamoxifen	nsubj	7	SENT_177	[p13l1695t760r2056b821],
6	is	VBZ	O	be	cop	7	SENT_177	[p13l2086t760r2137b821],
7	effective	JJ	O	effective	ccomp	3	SENT_177	[p13l11t853r305b914],
8	in	IN	O	in	_	0	SENT_177	[p13l347t854r415b913],
9	both	CC	O	both	preconj	10	SENT_177	[p13l455t853r621b914],
10	BRCA1	NN	O	brca1	prep_in	7	SENT_177	[p13l660t854r936b914],
11	and	CC	O	and	_	0	SENT_177	[p13l984t853r1116b914],
12	BRCA2	NN	O	brca2	nn	14	SENT_177	[p13l1156t854r1438b914],
13	mutation	NN	O	mutation	nn	14	SENT_177	[p13l1478t853r1808b914],
14	carriers	NNS	O	carrier	prep_in	7	SENT_177	[p13l1851t854r2133b914],
15	.	.	O	.	_	0	SENT_177	[p13l1851t854r2133b914],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_178	[p13l10t947r496b1019],
2	,	,	O	,	_	0	SENT_178	[p13l10t947r496b1019],
3	in	IN	O	in	_	0	SENT_178	[p13l564t947r632b1006],
4	a	DT	O	a	det	5	SENT_178	[p13l699t966r734b1007],
5	subset	NN	O	subset	prep_in	10	SENT_178	[p13l801t947r1026b1007],
6	of	IN	O	of	_	0	SENT_178	[p13l1092t947r1169b1007],
7	the	DT	O	the	det	8	SENT_178	[p13l1224t947r1335b1007],
8	data	NNS	O	datum	prep_of	5	SENT_178	[p13l1402t947r1553b1007],
9	we	PRP	O	we	nsubj	10	SENT_178	[p13l1618t966r1716b1007],
10	noted	VBD	O	note	_	0	SENT_178	[p13l1782t947r1988b1007],
11	an	DT	O	a	det	12	SENT_178	[p13l2055t966r2139b1007],
12	association	NN	O	association	dobj	10	SENT_178	[p13l11t1038r404b1099],
13	between	IN	O	between	_	0	SENT_178	[p13l476t1038r777b1099],
14	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	15	SENT_178	[p13l852t1052r1531b1114],
15	status	NN	O	status	prep_between	12	SENT_178	[p13l1605t1052r1809b1099],
16	of	IN	O	of	_	0	SENT_178	[p13l1886t1038r1963b1099],
17	the	DT	O	the	det	20	SENT_178	[p13l2027t1038r2137b1099],
18	contralateral	JJ	O	contralateral	amod	20	SENT_178	[p13l11t1131r461b1192],
19	breast	NN	O	breast	nn	20	SENT_178	[p13l516t1131r733b1192],
20	cancer	NN	O	cancer	prep_of	15	SENT_178	[p13l790t1151r1025b1192],
21	and	CC	O	and	_	0	SENT_178	[p13l1080t1131r1211b1192],
22	past	JJ	DATE	past	amod	24	SENT_178	[p13l1266t1146r1413b1207],
23	tamoxifen	NN	O	tamoxifen	nn	24	SENT_178	[p13l1467t1131r1828b1192],
24	use	NN	O	use	conj_and	20	SENT_178	[p13l1883t1151r2020b1192],
25	.	.	O	.	_	0	SENT_178	[p13l1883t1151r2020b1192],

1	A	DT	O	a	det	3	SENT_179	[p13l2079t1132r2140b1191],
2	greater	JJR	O	greater	amod	3	SENT_179	[p13l9t1239r259b1301],
3	proportion	NN	O	proportion	nsubj	19	SENT_179	[p13l286t1225r676b1301],
4	of	IN	O	of	_	0	SENT_179	[p13l707t1225r784b1285],
5	the	DT	O	the	det	8	SENT_179	[p13l803t1225r914b1285],
6	contralateral	JJ	O	contralateral	amod	8	SENT_179	[p13l947t1225r1397b1285],
7	breast	NN	O	breast	nn	8	SENT_179	[p13l1426t1225r1643b1285],
8	cancers	NNS	O	cancer	prep_of	3	SENT_179	[p13l1675t1244r1939b1285],
9	were	VBD	O	be	cop	19	SENT_179	[p13l1969t1244r2137b1285],
10	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	19	SENT_179	[p13l11t1331r690b1393],
11	positive	JJ	O	positive	amod	19	SENT_179	[p13l736t1317r1010b1393],
12	in	IN	O	in	_	0	SENT_179	[p13l1060t1317r1128b1377],
13	women	NNS	O	woman	prep_in	11	SENT_179	[p13l1174t1337r1440b1378],
14	with	IN	O	with	_	0	SENT_179	[p13l1486t1317r1644b1378],
15	a	DT	O	a	det	16	SENT_179	[p13l1694t1337r1729b1378],
16	history	NN	O	history	prep_with	13	SENT_179	[p13l1776t1317r2023b1393],
17	of	IN	O	of	_	0	SENT_179	[p13l2072t1317r2148b1378],
18	tamoxifen	NN	O	tamoxifen	prep_of	16	SENT_179	[p13l9t1410r370b1471],
19	use	NN	O	use	_	0	SENT_179	[p13l416t1430r534b1471],
20	than	IN	O	than	dep	19	SENT_179	[p13l581t1410r742b1471],
21	in	IN	O	in	_	0	SENT_179	[p13l789t1411r857b1470],
22	those	DT	O	those	prep_in	19	SENT_179	[p13l903t1410r1092b1471],
23	with	IN	O	with	_	0	SENT_179	[p13l1138t1410r1296b1471],
24	no	DT	O	no	det	26	SENT_179	[p13l1342t1430r1431b1471],
25	past	JJ	DATE	past	amod	26	SENT_179	[p13l1478t1425r1625b1486],
26	use	NN	O	use	prep_with	22	SENT_179	[p13l1671t1430r1810b1483],
27	,	,	O	,	_	0	SENT_179	[p13l1671t1430r1810b1483],
28	but	CC	O	but	_	0	SENT_179	[p13l1859t1410r1981b1471],
29	the	DT	O	the	det	31	SENT_179	[p13l2027t1410r2137b1471],
30	samples	NNS	O	sample	nn	31	SENT_179	[p13l11t1504r293b1580],
31	sizes	NNS	O	size	nsubj	33	SENT_179	[p13l340t1504r498b1564],
32	were	VBD	O	be	cop	33	SENT_179	[p13l542t1523r710b1564],
33	small	JJ	O	small	conj_but	19	SENT_179	[p13l756t1504r962b1564],
34	.	.	O	.	_	0	SENT_179	[p13l756t1504r962b1564],

1	The	DT	O	the	det	4	SENT_180	[p13l1010t1504r1157b1564],
2	NSABP	NNP	ORGANIZATION	NSABP	nn	4	SENT_180	[p13l1201t1504r1491b1564],
3	P1	NN	O	p1	nn	4	SENT_180	[p13l1536t1505r1622b1563],
4	trial	NN	O	trial	nsubj	7	SENT_180	[p13l1675t1504r1816b1564],
5	did	VBD	O	do	aux	7	SENT_180	[p13l1862t1504r1976b1564],
6	not	RB	O	not	neg	7	SENT_180	[p13l2020t1518r2139b1564],
7	provide	VB	O	provide	_	0	SENT_180	[p13l8t1596r279b1672],
8	data	NNS	O	datum	dobj	7	SENT_180	[p13l346t1596r498b1657],
9	on	IN	O	on	_	0	SENT_180	[p13l564t1616r654b1657],
10	the	DT	O	the	det	11	SENT_180	[p13l718t1596r829b1657],
11	subset	NN	O	subset	prep_on	7	SENT_180	[p13l896t1596r1120b1657],
12	of	IN	O	of	_	0	SENT_180	[p13l1186t1596r1263b1657],
13	BRCA1	NN	O	brca1	nn	17	SENT_180	[p13l1316t1596r1591b1657],
14	and	CC	O	and	_	0	SENT_180	[p13l1663t1596r1795b1657],
15	BRCA2	NN	O	brca2	nn	17	SENT_180	[p13l1858t1596r2140b1657],
16	mutation	NN	O	mutation	nn	17	SENT_180	[p13l9t1690r339b1750],
17	carriers	NNS	O	carrier	prep_of	11	SENT_180	[p13l386t1690r670b1762],
18	,	,	O	,	_	0	SENT_180	[p13l386t1690r670b1762],
19	and	CC	O	and	cc	7	SENT_180	[p13l721t1689r852b1750],
20	perhaps	RB	O	perhaps	advmod	7	SENT_180	[p13l897t1689r1178b1765],
21	only	RB	O	only	advmod	24	SENT_180	[p13l1227t1689r1380b1765],
22	a	DT	O	a	det	24	SENT_180	[p13l1426t1709r1461b1750],
23	small	JJ	O	small	amod	24	SENT_180	[p13l1509t1689r1695b1750],
24	number	NN	O	number	nsubj	32	SENT_180	[p13l1740t1689r2026b1750],
25	of	IN	O	of	_	0	SENT_180	[p13l2072t1689r2148b1750],
26	participants	NNS	O	participant	prep_of	24	SENT_180	[p13l8t1783r431b1859],
27	in	IN	O	in	_	0	SENT_180	[p13l458t1783r526b1842],
28	that	DT	O	that	det	29	SENT_180	[p13l552t1783r692b1843],
29	study	NN	O	study	prep_in	26	SENT_180	[p13l719t1783r913b1859],
30	were	VBD	O	be	cop	32	SENT_180	[p13l936t1803r1105b1843],
31	mutation	NN	O	mutation	nn	32	SENT_180	[p13l1131t1783r1461b1843],
32	carriers	NNS	O	carrier	ccomp	7	SENT_180	[p13l1488t1783r1770b1843],
33	.	.	O	.	_	0	SENT_180	[p13l1488t1783r1770b1843],

1	There	EX	O	there	expl	2	SENT_181	[p13l92t1875r311b1936],
2	are	VBP	O	be	_	0	SENT_181	[p13l351t1895r457b1936],
3	several	JJ	O	several	amod	4	SENT_181	[p13l497t1875r738b1936],
4	reasons	NNS	O	reason	nsubj	2	SENT_181	[p13l776t1895r1043b1936],
5	to	TO	O	to	aux	6	SENT_181	[p13l1082t1889r1151b1936],
6	believe	VB	O	believe	infmod	4	SENT_181	[p13l1190t1875r1438b1936],
7	that	IN	O	that	complm	20	SENT_181	[p13l1476t1875r1618b1936],
8	breast	NN	O	breast	nn	10	SENT_181	[p13l1653t1875r1871b1936],
9	cancer	NN	O	cancer	nn	10	SENT_181	[p13l1910t1895r2146b1936],
10	risk	NN	O	risk	nsubjpass	20	SENT_181	[p13l8t1968r137b2029],
11	in	IN	O	in	_	0	SENT_181	[p13l161t1969r229b2028],
12	women	NNS	O	woman	prep_in	10	SENT_181	[p13l253t1988r519b2029],
13	with	IN	O	with	_	0	SENT_181	[p13l543t1968r701b2029],
14	BRCAI	NN	O	brcaus	nn	17	SENT_181	[p13l724t1969r1001b2029],
15	or	CC	O	or	_	0	SENT_181	[p13l1032t1988r1107b2029],
16	BRCA2	NN	O	brca2	conj_or	14	SENT_181	[p13l1129t1969r1411b2029],
17	mutations	NNS	O	mutation	prep_with	12	SENT_181	[p13l1435t1969r1797b2029],
18	might	MD	O	might	aux	20	SENT_181	[p13l1824t1968r2035b2044],
19	be	VB	O	be	auxpass	20	SENT_181	[p13l2059t1968r2143b2029],
20	reduced	VBN	O	reduce	ccomp	6	SENT_181	[p13l8t2062r299b2122],
21	by	IN	O	by	_	0	SENT_181	[p13l323t2062r410b2138],
22	blocking	VBG	O	block	agent	20	SENT_181	[p13l432t2062r742b2138],
23	the	DT	O	the	det	24	SENT_181	[p13l765t2062r875b2122],
24	activity	NN	O	activity	dobj	22	SENT_181	[p13l903t2062r1161b2138],
25	of	IN	O	of	_	0	SENT_181	[p13l1185t2062r1262b2122],
26	endogenous	JJ	O	endogenous	amod	27	SENT_181	[p13l1279t2062r1710b2138],
27	oestrogens	NNS	O	oestrogen	prep_of	24	SENT_181	[p13l1738t2076r2138b2138],
28	.	.	O	.	_	0	SENT_181	[p13l1738t2076r2138b2138],

1	The	DT	O	the	det	2	SENT_182	[p13l7t2154r155b2215],
2	incidence	NN	O	incidence	nsubj	10	SENT_182	[p13l220t2154r563b2215],
3	of	IN	O	of	_	0	SENT_182	[p13l629t2154r706b2215],
4	breast	NN	O	breast	nn	5	SENT_182	[p13l758t2154r977b2215],
5	cancer	NN	O	cancer	prep_of	2	SENT_182	[p13l1041t2174r1277b2215],
6	in	IN	O	in	_	0	SENT_182	[p13l1338t2154r1406b2214],
7	BRCAI	NN	O	brcaus	nn	9	SENT_182	[p13l1468t2154r1744b2215],
8	mutation	NN	O	mutation	nn	9	SENT_182	[p13l1813t2154r2144b2215],
9	carriers	NNS	O	carrier	prep_in	5	SENT_182	[p13l10t2247r272b2308],
10	declines	VBZ	O	decline	_	0	SENT_182	[p13l379t2247r666b2308],
11	after	IN	O	after	_	0	SENT_182	[p13l774t2247r936b2308],
12	age	NN	O	age	prep_after	10	SENT_182	[p13l1040t2267r1156b2323],
13	50.18	CD	NUMBER	50.18	number	14	SENT_182	[p13l1264t2248r1480b2308],
14	”	CD	NUMBER	”	num	16	SENT_182	[p13l1264t2248r1480b2308],
15	Premenopausal	JJ	O	premenopausal	amod	16	SENT_182	[p13l1586t2248r2143b2324],
16	oophorectomy	NN	O	oophorectomy	nsubj	22	SENT_182	[p13l10t2341r535b2417],
17	in	IN	O	in	_	0	SENT_182	[p13l576t2341r644b2400],
18	BRCAI	NN	O	brcaus	nn	20	SENT_182	[p13l685t2341r962b2401],
19	mutation	NN	O	mutation	nn	20	SENT_182	[p13l1010t2341r1341b2401],
20	carriers	NNS	O	carrier	prep_in	16	SENT_182	[p13l1385t2341r1648b2401],
21	substantially	RB	O	substantially	advmod	22	SENT_182	[p13l1694t2341r2145b2417],
22	reduces	VBZ	O	reduce	rcmod	12	SENT_182	[p13l8t2433r282b2494],
23	the	DT	O	the	det	24	SENT_182	[p13l314t2433r425b2494],
24	risk	NN	O	risk	dobj	22	SENT_182	[p13l456t2433r586b2494],
25	of	IN	O	of	_	0	SENT_182	[p13l616t2433r693b2494],
26	subsequent	JJ	O	subsequent	amod	28	SENT_182	[p13l715t2433r1123b2509],
27	breast	NN	O	breast	nn	28	SENT_182	[p13l1151t2433r1370b2494],
28	cancer	NN	O	cancer	prep_of	24	SENT_182	[p13l1401t2434r1705b2494],
29	.	.	O	.	_	0	SENT_182	[p13l1401t2434r1705b2494],

1	”	NN	O	”	nsubj	5	SENT_183	[p13l1401t2434r1705b2494],
2	Circulating	VBG	O	circulate	partmod	1	SENT_183	[p13l1739t2433r2145b2509],
3	oestrogen	NN	O	oestrogen	nn	4	SENT_183	[p13l10t2541r358b2602],
4	concentrations	NNS	O	concentration	dobj	2	SENT_183	[p13l411t2527r941b2587],
5	increase	VBP	O	increase	_	0	SENT_183	[p13l995t2527r1284b2587],
6	during	IN	O	during	_	0	SENT_183	[p13l1338t2526r1576b2602],
7	pregnancy	NN	O	pregnancy	prep_during	5	SENT_183	[p13l1625t2546r2020b2602],
8	;	:	O	;	_	0	SENT_183	[p13l1625t2546r2020b2602],
9	in	IN	O	in	_	0	SENT_183	[p13l2076t2526r2144b2586],
10	BRCA1	NN	O	brca1	nn	14	SENT_183	[p13l6t2620r283b2680],
11	and	CC	O	and	_	0	SENT_183	[p13l379t2620r511b2680],
12	BRCA2	NN	O	brca2	conj_and	10	SENT_183	[p13l599t2620r882b2680],
13	mutation	NN	O	mutation	nn	14	SENT_183	[p13l970t2620r1301b2680],
14	carriers	NNS	O	carrier	prep_in	17	SENT_183	[p13l1392t2620r1678b2693],
15	,	,	O	,	_	0	SENT_183	[p13l1392t2620r1678b2693],
16	pregnancy	NN	O	pregnancy	nsubj	17	SENT_183	[p13l1769t2639r2145b2696],
17	increases	VBZ	O	increase	parataxis	5	SENT_183	[p13l8t2712r330b2773],
18	the	DT	O	the	det	19	SENT_183	[p13l363t2712r474b2773],
19	risk	NN	O	risk	dobj	17	SENT_183	[p13l506t2712r635b2773],
20	of	IN	O	of	_	0	SENT_183	[p13l666t2712r743b2773],
21	early-onset	JJ	O	early-onset	amod	24	SENT_183	[p13l766t2712r1161b2788],
22	breast	NN	O	breast	nn	24	SENT_183	[p13l1190t2712r1408b2773],
23	cancer	NN	O	cancer	nn	24	SENT_183	[p13l1441t2732r1676b2773],
24	(	NN	O	(	prep_of	19	SENT_183	[p13l1711t2712r1824b2788],
25	by	IN	O	by	_	0	SENT_183	[p13l1711t2712r1824b2788],
26	contrast	NN	O	contrast	prep_by	17	SENT_183	[p13l1855t2726r2144b2773],
27	with	IN	O	with	_	0	SENT_183	[p13l7t2805r165b2866],
28	non-carriers	NNS	O	non-carrier	prep_with	26	SENT_183	[p13l215t2806r653b2866],
29	for	IN	O	for	_	0	SENT_183	[p13l706t2805r808b2866],
30	whom	WP	O	whom	dobj	37	SENT_183	[p13l857t2805r1082b2866],
31	the	DT	O	the	det	32	SENT_183	[p13l1134t2805r1245b2866],
32	effect	NN	O	effect	nsubj	37	SENT_183	[p13l1300t2805r1493b2866],
33	of	IN	O	of	_	0	SENT_183	[p13l1546t2805r1624b2866],
34	pregnancy	NN	O	pregnancy	prep_of	32	SENT_183	[p13l1665t2825r2040b2881],
35	is	VBZ	O	be	cop	37	SENT_183	[p13l2091t2806r2142b2866],
36	protective	JJ	O	protective	amod	37	SENT_183	[p13l7t2899r464b2975],
37	)	NN	O	)	prepc_for	28	SENT_183	[p13l7t2899r464b2975],
38	?	.	O	?	_	0	SENT_183	[p13l7t2899r464b2975],

1	‘	NNP	O	‘	nn	2	SENT_184	[p13l7t2899r464b2975],
2	Brunet	NNP	PERSON	Brunet	nsubj	6	SENT_184	[p13l555t2900r805b2959],
3	and	CC	O	and	_	0	SENT_184	[p13l892t2899r1024b2959],
4	colleagues	NNS	O	colleague	conj_and	2	SENT_184	[p13l1111t2899r1524b2975],
5	”	RB	O	”	advmod	6	SENT_184	[p13l1111t2899r1524b2975],
6	reported	VBD	O	report	_	0	SENT_184	[p13l1610t2899r1918b2975],
7	that	IN	O	that	complm	9	SENT_184	[p13l2003t2899r2144b2959],
8	smoking	NN	O	smoking	nsubj	9	SENT_184	[p13l9t2991r314b3067],
9	protected	VBN	O	protect	ccomp	6	SENT_184	[p13l355t2991r699b3067],
10	against	IN	O	against	_	0	SENT_184	[p13l744t2991r994b3067],
11	breast	NN	O	breast	nn	12	SENT_184	[p13l1036t2991r1254b3052],
12	cancer	NN	O	cancer	prep_against	9	SENT_184	[p13l1298t3011r1534b3052],
13	in	IN	O	in	_	0	SENT_184	[p13l1575t2991r1644b3051],
14	BRCAI	NNP	ORGANIZATION	BRCAI	prep_in	12	SENT_184	[p13l1685t2991r1961b3052],
15	and	CC	O	and	_	0	SENT_184	[p13l2011t2991r2144b3052],
16	BRCA2	NN	O	brca2	nn	18	SENT_184	[p13l6t3085r289b3145],
17	mutation	NN	O	mutation	nn	18	SENT_184	[p13l348t3085r678b3145],
18	carriers	NNS	O	carrier	conj_and	14	SENT_184	[p13l739t3085r1023b3145],
19	.	.	O	.	_	0	SENT_184	[p13l739t3085r1023b3145],

1	This	DT	O	this	det	2	SENT_185	[p13l1087t3084r1250b3145],
2	effect	NN	O	effect	nsubj	7	SENT_185	[p13l1313t3084r1508b3145],
3	is	VBZ	O	be	cop	7	SENT_185	[p13l1567t3085r1618b3145],
4	probably	RB	O	probably	advmod	7	SENT_185	[p13l1678t3084r2000b3160],
5	an	DT	O	a	det	7	SENT_185	[p13l2060t3104r2144b3145],
6	antioestrogenic	JJ	O	antioestrogenic	amod	7	SENT_185	[p13l10t3178r557b3254],
7	mechanism	NN	O	mechanism	_	0	SENT_185	[p13l600t3178r1033b3238],
8	.	.	O	.	_	0	SENT_185	[p13l600t3178r1033b3238],

1	One	CD	NUMBER	one	nsubjpass	11	SENT_186	[p13l1083t3178r1233b3238],
2	of	IN	O	of	_	0	SENT_186	[p13l1278t3178r1355b3238],
3	the	DT	O	the	det	4	SENT_186	[p13l1388t3178r1499b3238],
4	functions	NNS	O	function	prep_of	1	SENT_186	[p13l1542t3178r1877b3238],
5	of	IN	O	of	_	0	SENT_186	[p13l1922t3178r1999b3238],
6	the	DT	O	the	det	9	SENT_186	[p13l2032t3178r2143b3238],
7	normal	JJ	O	normal	amod	9	SENT_186	[p13l7t3270r265b3331],
8	BRCAI	NN	O	brcaus	nn	9	SENT_186	[p13l294t3270r571b3331],
9	protein	NN	O	protein	prep_of	4	SENT_186	[p13l604t3270r865b3346],
10	is	VBZ	O	be	auxpass	11	SENT_186	[p13l894t3270r946b3331],
11	proposed	VBN	O	propose	_	0	SENT_186	[p13l976t3270r1312b3346],
12	to	TO	O	to	aux	15	SENT_186	[p13l1341t3284r1411b3331],
13	be	VB	O	be	cop	15	SENT_186	[p13l1441t3270r1525b3331],
14	the	DT	O	the	det	15	SENT_186	[p13l1555t3270r1666b3331],
15	reduction	NN	O	reduction	xcomp	11	SENT_186	[p13l1697t3270r2045b3331],
16	of	IN	O	of	_	0	SENT_186	[p13l2077t3270r2154b3331],
17	the	DT	O	the	det	19	SENT_186	[p13l8t3363r119b3424],
18	proliferative	JJ	O	proliferative	amod	19	SENT_186	[p13l155t3363r588b3439],
19	response	NN	O	response	prep_of	15	SENT_186	[p13l625t3383r939b3439],
20	of	IN	O	of	_	0	SENT_186	[p13l978t3363r1055b3424],
21	the	DT	O	the	det	23	SENT_186	[p13l1081t3363r1192b3424],
22	breast	NN	O	breast	nn	23	SENT_186	[p13l1228t3363r1447b3424],
23	epithelium	NN	O	epithelium	prep_of	19	SENT_186	[p13l1484t3363r1869b3439],
24	during	IN	O	during	_	0	SENT_186	[p13l1907t3363r2145b3439],
25	periods	NNS	O	period	prep_during	15	SENT_186	[p13l7t3457r271b3533],
26	of	IN	O	of	_	0	SENT_186	[p13l305t3457r382b3517],
27	oestrogen	NN	O	oestrogen	nn	28	SENT_186	[p13l405t3471r753b3533],
28	exposure	NN	O	exposure	prep_of	25	SENT_186	[p13l785t3458r1176b3533],
29	.	.	O	.	_	0	SENT_186	[p13l785t3458r1176b3533],

1	”	NN	O	”	ccomp	6	SENT_187	[p13l785t3458r1176b3533],
2	Further	RB	O	further	advmod	1	SENT_187	[p13l1209t3457r1507b3530],
3	,	,	O	,	_	0	SENT_187	[p13l1209t3457r1507b3530],
4	tamoxifen	NN	O	tamoxifen	nsubj	6	SENT_187	[p13l1541t3457r1903b3517],
5	might	MD	O	might	aux	6	SENT_187	[p13l1934t3457r2144b3533],
6	reduce	VB	O	reduce	_	0	SENT_187	[p13l8t3549r250b3610],
7	breast	NN	O	breast	nn	9	SENT_187	[p13l283t3549r501b3610],
8	cancer	NN	O	cancer	nn	9	SENT_187	[p13l535t3569r771b3610],
9	risk	NN	O	risk	dobj	6	SENT_187	[p13l802t3549r931b3610],
10	through	IN	O	through	_	0	SENT_187	[p13l962t3549r1249b3625],
11	mechanisms	NNS	O	mechanism	prep_through	6	SENT_187	[p13l1282t3549r1726b3610],
12	other	JJ	O	other	dep	11	SENT_187	[p13l1763t3549r1952b3610],
13	than	IN	O	than	_	0	SENT_187	[p13l1983t3549r2144b3610],
14	receptor-mediated	JJ	O	receptor-mediated	amod	16	SENT_187	[p13l8t3642r675b3718],
15	oestrogen	NN	O	oestrogen	nn	16	SENT_187	[p13l712t3657r1060b3718],
16	blockade	NN	O	blockade	prep_than	11	SENT_187	[p13l1093t3642r1436b3703],
17	.	.	O	.	_	0	SENT_187	[p13l1093t3642r1436b3703],

1	This	DT	O	this	det	2	SENT_188	[p13l1475t3642r1639b3703],
2	hypothesis	NN	O	hypothesis	nsubj	4	SENT_188	[p13l1674t3642r2054b3718],
3	is	VBZ	O	be	cop	4	SENT_188	[p13l2090t3643r2142b3703],
4	consistent	JJ	O	consistent	_	0	SENT_188	[p13l10t3736r371b3796],
5	with	IN	O	with	_	0	SENT_188	[p13l415t3736r573b3796],
6	our	PRP$	O	we	poss	7	SENT_188	[p13l620t3755r743b3796],
7	ﬁnding	VBG	O	ﬁnding	prep_with	4	SENT_188	[p13l787t3736r1043b3812],
8	that	IN	O	that	complm	10	SENT_188	[p13l1088t3736r1229b3796],
9	tamoxifen	NN	O	tamoxifen	nsubj	10	SENT_188	[p13l1273t3736r1636b3796],
10	seems	VBZ	O	seem	ccomp	4	SENT_188	[p13l1683t3756r1895b3796],
11	to	TO	O	to	aux	13	SENT_188	[p13l1943t3750r2012b3796],
12	be	VB	O	be	cop	13	SENT_188	[p13l2058t3736r2143b3796],
13	protective	JJ	O	protective	xcomp	10	SENT_188	[p14l7t15r365b91],
14	in	IN	O	in	_	0	SENT_188	[p14l475t15r544b75],
15	women	NNS	O	woman	prep_in	13	SENT_188	[p14l651t35r917b76],
16	who	WP	O	who	nsubj	18	SENT_188	[p14l1025t15r1176b76],
17	have	VBP	O	have	aux	18	SENT_188	[p14l1286t15r1450b76],
18	undergone	VBN	O	undergo	rcmod	15	SENT_188	[p14l1561t15r1948b91],
19	an	DT	O	a	det	20	SENT_188	[p14l2060t35r2144b76],
20	oophorectomy	NN	O	oophorectomy	dobj	18	SENT_188	[p14l10t108r535b184],
21	and	CC	O	and	_	0	SENT_188	[p14l566t108r698b169],
22	the	DT	O	the	det	24	SENT_188	[p14l728t108r839b169],
23	protective	JJ	O	protective	amod	24	SENT_188	[p14l870t109r1228b184],
24	effects	NNS	O	effect	nsubj	29	SENT_188	[p14l1262t108r1486b169],
25	of	IN	O	of	_	0	SENT_188	[p14l1521t108r1598b169],
26	oophorectomy	NN	O	oophorectomy	prep_of	24	SENT_188	[p14l1621t108r2145b184],
27	and	CC	O	and	_	0	SENT_188	[p14l10t202r142b262],
28	tamoxifen	NN	O	tamoxifen	conj_and	26	SENT_188	[p14l167t202r530b262],
29	seem	VBP	O	seem	conj_and	4	SENT_188	[p14l557t221r737b262],
30	to	TO	O	to	aux	32	SENT_188	[p14l763t216r832b262],
31	be	VB	O	be	cop	32	SENT_188	[p14l858t202r942b262],
32	independent	JJ	O	independent	xcomp	29	SENT_188	[p14l969t202r1423b278],
33	and	CC	O	and	_	0	SENT_188	[p14l1450t202r1582b262],
34	additive	JJ	O	additive	conj_and	32	SENT_188	[p14l1610t202r1913b262],
35	.	.	O	.	_	0	SENT_188	[p14l1610t202r1913b262],

1	We	PRP	O	we	nsubj	2	SENT_189	[p14l91t295r213b355],
2	believe	VBP	O	believe	_	0	SENT_189	[p14l260t294r508b355],
3	that	IN	O	that	complm	10	SENT_189	[p14l556t294r698b355],
4	our	PRP$	O	we	poss	6	SENT_189	[p14l746t314r869b355],
5	study	NN	O	study	nn	6	SENT_189	[p14l916t294r1111b370],
6	design	NN	O	design	nsubj	10	SENT_189	[p14l1158t294r1388b370],
7	is	VBZ	O	be	cop	10	SENT_189	[p14l1435t294r1486b355],
8	the	DT	O	the	det	10	SENT_189	[p14l1535t294r1646b355],
9	best	JJS	O	best	amod	10	SENT_189	[p14l1693t294r1840b355],
10	way	NN	O	way	ccomp	2	SENT_189	[p14l1885t314r2027b370],
11	to	TO	O	to	aux	12	SENT_189	[p14l2073t308r2142b355],
12	address	VB	O	address	infmod	10	SENT_189	[p14l10t387r277b448],
13	this	DT	O	this	det	14	SENT_189	[p14l312t387r438b448],
14	issue	NN	O	issue	dobj	12	SENT_189	[p14l473t388r666b448],
15	.	.	O	.	_	0	SENT_189	[p14l473t388r666b448],

1	We	PRP	O	we	nsubjpass	30	SENT_190	[p14l703t388r825b448],
2	could	MD	O	could	aux	4	SENT_190	[p14l861t387r1060b448],
3	not	RB	O	not	neg	4	SENT_190	[p14l1092t402r1213b448],
4	analyse	VB	O	analyse	_	0	SENT_190	[p14l1247t387r1506b463],
5	this	DT	O	this	det	6	SENT_190	[p14l1539t387r1666b448],
6	dataset	NN	O	dataset	dobj	4	SENT_190	[p14l1702t387r1956b448],
7	by	IN	O	by	_	0	SENT_190	[p14l1987t387r2075b463],
8	a	DT	O	a	det	11	SENT_190	[p14l2108t407r2143b448],
9	historical	JJ	O	historical	amod	11	SENT_190	[p14l7t481r337b541],
10	cohort	NN	O	cohort	nn	11	SENT_190	[p14l390t481r623b541],
11	approach	NN	O	approach	prep_by	4	SENT_190	[p14l674t481r1029b557],
12	,	,	O	,	_	0	SENT_190	[p14l674t481r1029b557],
13	because	IN	O	because	mark	17	SENT_190	[p14l1081t481r1365b541],
14	genetic	JJ	O	genetic	amod	15	SENT_190	[p14l1417t481r1672b557],
15	testing	NN	O	testing	nsubjpass	17	SENT_190	[p14l1723t481r1963b557],
16	was	VBD	O	be	auxpass	17	SENT_190	[p14l2010t500r2142b541],
17	offered	VBN	O	offer	dep	11	SENT_190	[p14l10t573r261b634],
18	only	RB	O	only	advmod	17	SENT_190	[p14l292t573r446b649],
19	to	TO	O	to	_	0	SENT_190	[p14l473t587r542b634],
20	living	VBG	O	live	amod	21	SENT_190	[p14l573t573r770b649],
21	women	NNS	O	woman	prep_to	17	SENT_190	[p14l796t593r1084b646],
22	,	,	O	,	_	0	SENT_190	[p14l796t593r1084b646],
23	and	CC	O	and	_	0	SENT_190	[p14l1118t573r1271b646],
24	,	,	O	,	_	0	SENT_190	[p14l1118t573r1271b646],
25	in	IN	O	in	dep	4	SENT_190	[p14l1304t573r1372b633],
26	many	JJ	O	many	amod	27	SENT_190	[p14l1400t593r1601b649],
27	instances	NNS	O	instance	pobj	25	SENT_190	[p14l1629t573r1979b646],
28	,	,	O	,	_	0	SENT_190	[p14l1629t573r1979b646],
29	was	VBD	O	be	auxpass	30	SENT_190	[p14l2010t593r2142b634],
30	offered	VBN	O	offer	conj_and	4	SENT_190	[p14l10t666r261b727],
31	a	DT	O	a	det	33	SENT_190	[p14l303t686r338b727],
32	considerable	JJ	O	considerable	amod	33	SENT_190	[p14l381t666r832b727],
33	time	NN	O	time	dobj	30	SENT_190	[p14l873t667r1033b727],
34	after	IN	O	after	_	0	SENT_190	[p14l1075t666r1237b727],
35	diagnosis	NN	O	diagnosis	prep_after	30	SENT_190	[p14l1277t666r1627b742],
36	.	.	O	.	_	0	SENT_190	[p14l1277t666r1627b742],

1	Additionally	RB	O	additionally	advmod	9	SENT_191	[p14l1672t666r2140b742],
2	,	,	O	,	_	0	SENT_191	[p14l1672t666r2140b742],
3	women	NNS	O	woman	nsubj	9	SENT_191	[p14l7t779r273b820],
4	with	IN	O	with	_	0	SENT_191	[p14l298t760r456b820],
5	bilateral	JJ	O	bilateral	amod	6	SENT_191	[p14l481t760r772b820],
6	cancer	NN	O	cancer	prep_with	3	SENT_191	[p14l801t779r1037b820],
7	were	VBD	O	be	cop	9	SENT_191	[p14l1060t779r1230b820],
8	more	RBR	O	more	advmod	9	SENT_191	[p14l1257t779r1442b820],
9	likely	JJ	O	likely	_	0	SENT_191	[p14l1470t760r1659b836],
10	to	TO	O	to	aux	13	SENT_191	[p14l1684t774r1753b820],
11	have	VB	O	have	aux	13	SENT_191	[p14l1780t760r1945b820],
12	been	VBN	O	be	auxpass	13	SENT_191	[p14l1971t760r2144b820],
13	offered	VBN	O	offer	xcomp	9	SENT_191	[p14l10t852r261b913],
14	genetic	JJ	O	genetic	amod	15	SENT_191	[p14l346t852r601b928],
15	testing	NN	O	testing	dobj	13	SENT_191	[p14l687t852r927b928],
16	than	IN	O	than	mark	19	SENT_191	[p14l1011t852r1172b913],
17	were	VBD	O	be	cop	19	SENT_191	[p14l1256t872r1425b913],
18	unilateral	JJ	O	unilateral	amod	19	SENT_191	[p14l1511t852r1851b913],
19	cases	NNS	O	case	advcl	13	SENT_191	[p14l1939t872r2138b913],
20	.	.	O	.	_	0	SENT_191	[p14l1939t872r2138b913],

1	Therefore	RB	O	therefore	advmod	7	SENT_192	[p14l7t945r368b1006],
2	a	DT	O	a	det	4	SENT_192	[p14l418t965r453b1006],
3	cohort	NN	O	cohort	nn	4	SENT_192	[p14l503t945r735b1006],
4	study	NN	O	study	nsubjpass	7	SENT_192	[p14l783t945r978b1021],
5	would	MD	O	would	aux	7	SENT_192	[p14l1022t945r1247b1006],
6	be	VB	O	be	auxpass	7	SENT_192	[p14l1293t945r1377b1006],
7	biased	VBN	O	bias	_	0	SENT_192	[p14l1424t945r1653b1006],
8	towards	IN	O	towards	_	0	SENT_192	[p14l1700t945r1983b1006],
9	the	DT	O	the	det	10	SENT_192	[p14l2032t945r2143b1006],
10	inclusion	NN	O	inclusion	prep_towards	7	SENT_192	[p14l8t1039r336b1099],
11	of	IN	O	of	_	0	SENT_192	[p14l375t1039r452b1099],
12	both	CC	O	both	preconj	14	SENT_192	[p14l478t1039r645b1099],
13	long-term	JJ	O	long-term	amod	14	SENT_192	[p14l682t1039r1039b1115],
14	survivors	NNS	O	survivor	prep_of	10	SENT_192	[p14l1078t1039r1398b1099],
15	and	CC	O	and	_	0	SENT_192	[p14l1439t1039r1571b1099],
16	bilateral	JJ	O	bilateral	amod	17	SENT_192	[p14l1607t1039r1898b1099],
17	cases	NNS	O	case	prep_of	10	SENT_192	[p14l1939t1059r2138b1099],
18	.	.	O	.	_	0	SENT_192	[p14l1939t1059r2138b1099],

1	We	PRP	O	we	nsubj	3	SENT_193	[p14l6t1132r128b1192],
2	have	VBP	O	have	aux	3	SENT_193	[p14l155t1131r320b1192],
3	kept	VBN	O	keep	_	0	SENT_193	[p14l350t1131r504b1207],
4	to	TO	O	to	_	0	SENT_193	[p14l531t1145r599b1192],
5	a	DT	O	a	det	6	SENT_193	[p14l631t1151r666b1192],
6	minimum	NN	O	minimum	prep_to	3	SENT_193	[p14l694t1131r1052b1192],
7	the	DT	O	the	det	9	SENT_193	[p14l1080t1131r1190b1192],
8	possible	JJ	O	possible	amod	9	SENT_193	[p14l1218t1131r1506b1207],
9	effect	NN	O	effect	dobj	3	SENT_193	[p14l1536t1131r1731b1192],
10	of	IN	O	of	_	0	SENT_193	[p14l1759t1131r1836b1192],
11	survivor	NN	O	survivor	nn	12	SENT_193	[p14l1855t1131r2146b1192],
12	bias	NN	O	bias	prep_of	9	SENT_193	[p14l7t1224r169b1297],
13	,	,	O	,	_	0	SENT_193	[p14l7t1224r169b1297],
14	because	IN	O	because	mark	17	SENT_193	[p14l237t1224r521b1285],
15	our	PRP$	O	we	poss	16	SENT_193	[p14l589t1244r712b1285],
16	design	NN	O	design	nsubj	17	SENT_193	[p14l777t1224r1007b1300],
17	required	VBD	O	require	dep	12	SENT_193	[p14l1071t1224r1376b1300],
18	the	DT	O	the	det	19	SENT_193	[p14l1441t1224r1552b1285],
19	controls	NNS	O	control	nsubjpass	21	SENT_193	[p14l1620t1224r1907b1285],
20	were	VBD	O	be	auxpass	21	SENT_193	[p14l1974t1244r2143b1285],
21	followed	VBN	O	follow	ccomp	17	SENT_193	[p14l8t1318r316b1378],
22	up	RP	O	up	prt	21	SENT_193	[p14l358t1337r449b1394],
23	for	IN	O	for	prep	21	SENT_193	[p14l492t1318r595b1378],
24	at	IN	O	at	pcomp	23	SENT_193	[p14l636t1332r701b1378],
25	least	JJS	O	least	pobj	24	SENT_193	[p14l742t1318r903b1378],
26	as	RB	O	as	advmod	24	SENT_193	[p14l946t1338r1013b1378],
27	long	RB	O	long	advmod	24	SENT_193	[p14l1057t1318r1213b1394],
28	as	IN	O	as	_	0	SENT_193	[p14l1255t1338r1322b1378],
29	the	DT	O	the	det	31	SENT_193	[p14l1366t1318r1477b1378],
30	matched	VBN	O	match	amod	31	SENT_193	[p14l1519t1318r1832b1378],
31	case	NN	O	case	prep_as	21	SENT_193	[p14l1875t1338r2042b1378],
32	.	.	O	.	_	0	SENT_193	[p14l1875t1338r2042b1378],

1	If	IN	O	if	mark	5	SENT_194	[p14l2089t1318r2154b1377],
2	genetic	JJ	O	genetic	amod	3	SENT_194	[p14l8t1410r263b1486],
3	testing	NN	O	testing	nsubj	5	SENT_194	[p14l294t1410r534b1486],
4	becomes	VBZ	O	become	cop	5	SENT_194	[p14l562t1410r876b1471],
5	widespread	JJ	O	widespread	advcl	10	SENT_194	[p14l907t1410r1317b1486],
6	our	PRP$	O	we	poss	7	SENT_194	[p14l1349t1430r1472b1471],
7	ﬁndings	NNS	O	ﬁndings	nsubjpass	10	SENT_194	[p14l1500t1410r1787b1486],
8	might	MD	O	might	aux	10	SENT_194	[p14l1819t1410r2030b1486],
9	be	VB	O	be	auxpass	10	SENT_194	[p14l2058t1410r2143b1471],
10	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_194	[p14l10t1503r378b1564],
11	by	IN	O	by	_	0	SENT_194	[p14l403t1503r490b1579],
12	a	DT	O	a	det	13	SENT_194	[p14l516t1523r551b1564],
13	cohort	NN	O	cohort	agent	10	SENT_194	[p14l579t1503r812b1564],
14	of	IN	O	of	_	0	SENT_194	[p14l839t1503r916b1564],
15	incident	NN	O	incident	nn	16	SENT_194	[p14l932t1503r1225b1564],
16	cases	NNS	O	case	prep_of	13	SENT_194	[p14l1252t1523r1454b1576],
17	,	,	O	,	_	0	SENT_194	[p14l1252t1523r1454b1576],
18	but	CC	O	but	_	0	SENT_194	[p14l1481t1503r1603b1564],
19	these	DT	O	these	det	20	SENT_194	[p14l1628t1503r1811b1564],
20	data	NNS	O	datum	nsubj	24	SENT_194	[p14l1839t1503r1991b1564],
21	will	MD	O	will	aux	24	SENT_194	[p14l2016t1503r2143b1564],
22	not	RB	O	not	neg	24	SENT_194	[p14l7t1611r127b1657],
23	be	VB	O	be	cop	24	SENT_194	[p14l151t1597r235b1657],
24	available	JJ	O	available	conj_but	10	SENT_194	[p14l263t1597r572b1657],
25	for	IN	O	for	_	0	SENT_194	[p14l599t1597r701b1657],
26	many	JJ	O	many	amod	27	SENT_194	[p14l724t1616r924b1673],
27	years	NNS	DURATION	year	prep_for	24	SENT_194	[p14l946t1616r1148b1673],
28	.	.	O	.	_	0	SENT_194	[p14l946t1616r1148b1673],

1	Because	IN	O	because	_	0	SENT_195	[p14l1180t1598r1473b1657],
2	of	IN	O	of	_	0	SENT_195	[p14l1501t1597r1578b1657],
3	the	DT	O	the	det	4	SENT_195	[p14l1593t1597r1704b1657],
4	difﬁculty	NN	O	difﬁculty	prep_because_of	17	SENT_195	[p14l1732t1597r2052b1673],
5	in	IN	O	in	_	0	SENT_195	[p14l2076t1597r2144b1656],
6	establishing	VBG	O	establish	prepc_in	4	SENT_195	[p14l10t1689r432b1765],
7	carrier	NN	O	carrier	nn	8	SENT_195	[p14l505t1689r738b1750],
8	status	NN	O	status	dobj	6	SENT_195	[p14l811t1703r1015b1750],
9	for	IN	O	for	_	0	SENT_195	[p14l1089t1689r1192b1750],
10	deceased	JJ	O	deceased	amod	11	SENT_195	[p14l1264t1689r1587b1750],
11	women	NNS	O	woman	prep_for	6	SENT_195	[p14l1658t1709r1945b1762],
12	,	,	O	,	_	0	SENT_195	[p14l1658t1709r1945b1762],
13	our	PRP$	O	we	poss	15	SENT_195	[p14l2023t1709r2146b1750],
14	case-control	JJ	O	case-control	amod	15	SENT_195	[p14l10t1782r448b1843],
15	study	NN	O	study	nsubj	17	SENT_195	[p14l496t1782r691b1858],
16	was	VBD	O	be	cop	17	SENT_195	[p14l735t1802r866b1843],
17	restricted	JJ	O	restricted	_	0	SENT_195	[p14l915t1782r1252b1843],
18	to	TO	O	to	_	0	SENT_195	[p14l1298t1796r1367b1843],
19	living	VBG	O	live	prepc_to	17	SENT_195	[p14l1416t1782r1612b1858],
20	patients	NNS	O	patient	dobj	19	SENT_195	[p14l1656t1783r1939b1858],
21	with	IN	O	with	_	0	SENT_195	[p14l1986t1782r2144b1843],
22	breast	NN	O	breast	nn	23	SENT_195	[p14l7t1858r225b1918],
23	cancer	NN	O	cancer	prep_with	19	SENT_195	[p14l252t1877r504b1918],
24	.	.	O	.	_	0	SENT_195	[p14l252t1877r504b1918],

1	Generally	RB	O	generally	advmod	5	SENT_196	[p14l95t1950r465b2026],
2	,	,	O	,	_	0	SENT_196	[p14l95t1950r465b2026],
3	the	DT	O	the	det	4	SENT_196	[p14l525t1950r636b2011],
4	women	NNS	O	woman	nsubj	5	SENT_196	[p14l693t1970r959b2011],
5	completed	VBD	O	complete	_	0	SENT_196	[p14l1017t1950r1395b2026],
6	the	DT	O	the	det	7	SENT_196	[p14l1451t1950r1562b2011],
7	questionnaires	NNS	O	questionnaire	dobj	5	SENT_196	[p14l1621t1950r2142b2026],
8	10	CD	DURATION	10	num	9	SENT_196	[p14l17t2046r96b2104],
9	years	NNS	NUMBER	year	npadvmod	5	SENT_196	[p14l132t2063r314b2119],
10	after	IN	O	after	_	0	SENT_196	[p14l353t2043r515b2104],
11	their	PRP$	O	they	poss	13	SENT_196	[p14l548t2043r717b2104],
12	initial	JJ	O	initial	amod	13	SENT_196	[p14l750t2043r953b2104],
13	diagnosis	NN	O	diagnosis	prep_after	5	SENT_196	[p14l991t2043r1320b2119],
14	of	IN	O	of	_	0	SENT_196	[p14l1360t2043r1437b2104],
15	breast	NN	O	breast	nn	16	SENT_196	[p14l1461t2043r1680b2104],
16	cancer	NN	O	cancer	prep_of	13	SENT_196	[p14l1717t2063r1971b2116],
17	,	,	O	,	_	0	SENT_196	[p14l1717t2063r1971b2116],
18	and	CC	O	and	_	0	SENT_196	[p14l2012t2043r2144b2104],
19	because	IN	O	because	_	0	SENT_196	[p14l7t2137r291b2197],
20	of	IN	O	of	prepc_because_of	37	SENT_196	[p14l341t2137r418b2197],
21	this	DT	O	this	det	23	SENT_196	[p14l455t2137r582b2197],
22	time	NN	O	time	nn	23	SENT_196	[p14l631t2137r790b2197],
23	difference	NN	O	difference	pobj	37	SENT_196	[p14l840t2137r1195b2197],
24	our	PRP$	O	we	poss	25	SENT_196	[p14l1245t2156r1368b2197],
25	ﬁndings	NNS	O	ﬁndings	nsubj	37	SENT_196	[p14l1413t2137r1722b2213],
26	,	,	O	,	_	0	SENT_196	[p14l1413t2137r1722b2213],
27	which	WDT	O	which	nsubjpass	29	SENT_196	[p14l1771t2137r1988b2197],
28	are	VBP	O	be	auxpass	29	SENT_196	[p14l2037t2156r2143b2197],
29	based	VBN	O	base	rcmod	25	SENT_196	[p14l7t2229r213b2290],
30	on	IN	O	on	_	0	SENT_196	[p14l248t2249r338b2290],
31	breast	NN	O	breast	nn	33	SENT_196	[p14l369t2229r588b2290],
32	cancer	NN	O	cancer	nn	33	SENT_196	[p14l622t2249r857b2290],
33	survivors	NNS	O	survivor	prep_on	29	SENT_196	[p14l891t2229r1233b2302],
34	,	,	O	,	_	0	SENT_196	[p14l891t2229r1233b2302],
35	might	MD	O	might	aux	37	SENT_196	[p14l1269t2229r1480b2305],
36	not	RB	O	not	neg	37	SENT_196	[p14l1512t2243r1632b2290],
37	represent	VB	O	represent	conj_and	5	SENT_196	[p14l1664t2243r1999b2305],
38	the	DT	O	the	det	39	SENT_196	[p14l2032t2229r2143b2290],
39	population	NN	O	population	dobj	37	SENT_196	[p14l7t2322r400b2398],
40	of	IN	O	of	_	0	SENT_196	[p14l436t2322r513b2383],
41	patients	NNS	O	patient	prep_of	39	SENT_196	[p14l536t2323r819b2398],
42	in	IN	O	in	_	0	SENT_196	[p14l855t2323r923b2382],
43	general	JJ	O	general	prep_in	41	SENT_196	[p14l957t2322r1236b2398],
44	.	.	O	.	_	0	SENT_196	[p14l957t2322r1236b2398],

1	For	IN	O	for	_	0	SENT_197	[p14l1276t2323r1407b2383],
2	example	NN	O	example	prep_for	43	SENT_197	[p14l1441t2322r1761b2398],
3	,	,	O	,	_	0	SENT_197	[p14l1441t2322r1761b2398],
4	if	IN	O	if	mark	14	SENT_197	[p14l1799t2322r1854b2382],
5	women	NNS	O	woman	nsubj	14	SENT_197	[p14l1878t2342r2144b2383],
6	who	WP	O	who	nsubj	7	SENT_197	[p14l7t2416r158b2476],
7	develop	VBP	O	develop	rcmod	5	SENT_197	[p14l235t2416r511b2492],
8	contralateral	JJ	O	contralateral	amod	10	SENT_197	[p14l590t2416r1041b2476],
9	breast	NN	O	breast	nn	10	SENT_197	[p14l1115t2416r1333b2476],
10	cancer	NN	O	cancer	dobj	7	SENT_197	[p14l1408t2436r1644b2476],
11	after	IN	O	after	_	0	SENT_197	[p14l1718t2416r1880b2476],
12	using	VBG	O	use	prepc_after	7	SENT_197	[p14l1952t2416r2145b2492],
13	tamoxifen	NN	O	tamoxifen	dobj	12	SENT_197	[p14l8t2508r370b2569],
14	have	VBP	O	have	advcl	43	SENT_197	[p14l425t2508r590b2569],
15	a	DT	O	a	det	17	SENT_197	[p14l649t2528r684b2569],
16	poor	JJ	O	poor	amod	17	SENT_197	[p14l740t2528r910b2584],
17	survival	NN	O	survival	dobj	14	SENT_197	[p14l966t2508r1239b2569],
18	relative	JJ	O	relative	advmod	17	SENT_197	[p14l1296t2508r1556b2569],
19	to	TO	O	to	_	0	SENT_197	[p14l1613t2522r1682b2569],
20	those	DT	O	those	prep_to	18	SENT_197	[p14l1741t2508r1930b2569],
21	with	IN	O	with	_	0	SENT_197	[p14l1986t2508r2144b2569],
22	bilateral	JJ	O	bilateral	amod	24	SENT_197	[p14l7t2601r298b2662],
23	breast	NN	O	breast	nn	24	SENT_197	[p14l333t2601r552b2662],
24	cancer	NN	O	cancer	prep_with	20	SENT_197	[p14l589t2621r824b2662],
25	who	WP	O	who	nsubj	28	SENT_197	[p14l856t2601r1007b2662],
26	have	VBP	O	have	aux	28	SENT_197	[p14l1044t2601r1208b2662],
27	not	RB	O	not	neg	28	SENT_197	[p14l1244t2616r1364b2662],
28	taken	VBN	O	take	rcmod	17	SENT_197	[p14l1399t2601r1595b2662],
29	this	DT	O	this	det	30	SENT_197	[p14l1630t2601r1757b2662],
30	drug	NN	O	drug	dobj	28	SENT_197	[p14l1795t2601r1982b2677],
31	,	,	O	,	_	0	SENT_197	[p14l1795t2601r1982b2677],
32	our	PRP$	O	we	poss	33	SENT_197	[p14l2023t2621r2145b2662],
33	estimate	NN	O	estimate	nsubj	43	SENT_197	[p14l10t2695r307b2755],
34	of	IN	O	of	_	0	SENT_197	[p14l338t2695r415b2755],
35	the	DT	O	the	det	37	SENT_197	[p14l432t2695r543b2755],
36	protective	JJ	O	protective	amod	37	SENT_197	[p14l571t2695r928b2771],
37	effect	NN	O	effect	prep_of	33	SENT_197	[p14l959t2695r1153b2755],
38	of	IN	O	of	_	0	SENT_197	[p14l1181t2695r1258b2755],
39	tamoxifen	NN	O	tamoxifen	prep_of	37	SENT_197	[p14l1276t2695r1638b2755],
40	would	MD	O	would	aux	43	SENT_197	[p14l1664t2695r1888b2755],
41	be	VB	O	be	cop	43	SENT_197	[p14l1915t2695r1999b2755],
42	too	RB	O	too	advmod	43	SENT_197	[p14l2027t2709r2142b2755],
43	large	JJ	O	large	_	0	SENT_197	[p14l8t2787r200b2863],
44	.	.	O	.	_	0	SENT_197	[p14l8t2787r200b2863],

1	However	RB	O	however	advmod	42	SENT_198	[p14l275t2788r622b2860],
2	,	,	O	,	_	0	SENT_198	[p14l275t2788r622b2860],
3	if	IN	O	if	mark	7	SENT_198	[p14l695t2787r751b2847],
4	tamoxifen	NN	O	tamoxifen	nn	5	SENT_198	[p14l810t2787r1172b2848],
5	use	NN	O	use	nsubjpass	7	SENT_198	[p14l1241t2807r1358b2848],
6	is	VBZ	O	be	auxpass	7	SENT_198	[p14l1429t2787r1480b2848],
7	associated	VBN	O	associate	advcl	42	SENT_198	[p14l1553t2787r1918b2848],
8	with	IN	O	with	_	0	SENT_198	[p14l1986t2787r2144b2848],
9	improved	JJ	O	improved	amod	10	SENT_198	[p14l8t2880r352b2956],
10	survival	NN	O	survival	prep_with	7	SENT_198	[p14l435t2880r708b2941],
11	in	IN	O	in	_	0	SENT_198	[p14l790t2881r858b2940],
12	this	DT	O	this	det	13	SENT_198	[p14l938t2880r1064b2941],
13	population	NN	O	population	prep_in	10	SENT_198	[p14l1146t2880r1540b2956],
14	(	CD	NUMBER	(	num	13	SENT_198	[p14l1626t2881r1752b2956],
15	eg	FW	O	eg	tmod	7	SENT_198	[p14l1626t2881r1752b2956],
16	,	,	O	,	_	0	SENT_198	[p14l1626t2881r1752b2956],
17	if	IN	O	if	mark	21	SENT_198	[p14l1836t2880r1892b2940],
18	it	PRP	O	it	nsubjpass	21	SENT_198	[p14l1962t2881r2010b2941],
19	is	VBZ	O	be	auxpass	21	SENT_198	[p14l2090t2881r2142b2941],
20	preferentially	RB	O	preferentially	advmod	21	SENT_198	[p14l7t2974r485b3050],
21	given	VBN	O	give	dep	15	SENT_198	[p14l507t2974r696b3050],
22	to	TO	O	to	_	0	SENT_198	[p14l719t2988r788b3034],
23	women	NNS	O	woman	prep_to	21	SENT_198	[p14l813t2993r1079b3034],
24	with	IN	O	with	_	0	SENT_198	[p14l1101t2974r1259b3034],
25	less	JJR	O	less	amod	27	SENT_198	[p14l1282t2974r1406b3034],
26	aggressive	JJ	O	aggressive	amod	27	SENT_198	[p14l1433t2974r1790b3050],
27	tumours	NNS	O	tumour	prep_with	23	SENT_198	[p14l1814t2988r2140b3047],
28	,	,	O	,	_	0	SENT_198	[p14l1814t2988r2140b3047],
29	or	CC	O	or	_	0	SENT_198	[p14l10t3086r84b3126],
30	if	IN	O	if	mark	33	SENT_198	[p14l108t3066r164b3126],
31	the	DT	O	the	det	32	SENT_198	[p14l179t3066r290b3126],
32	drug	NN	O	drug	nsubj	33	SENT_198	[p14l318t3066r486b3142],
33	confers	VBZ	O	confer	dep	15	SENT_198	[p14l512t3066r768b3126],
34	a	DT	O	a	det	37	SENT_198	[p14l797t3086r832b3126],
35	survival	NN	O	survival	nn	37	SENT_198	[p14l860t3066r1134b3127],
36	advantage	NN	O	advantage	nn	37	SENT_198	[p14l1162t3066r1577b3142],
37	)	NN	O	)	dobj	33	SENT_198	[p14l1162t3066r1577b3142],
38	,	,	O	,	_	0	SENT_198	[p14l1162t3066r1577b3142],
39	we	PRP	O	we	nsubj	42	SENT_198	[p14l1605t3086r1703b3127],
40	would	MD	O	would	aux	42	SENT_198	[p14l1728t3066r1953b3127],
41	have	VB	O	have	aux	42	SENT_198	[p14l1977t3066r2142b3127],
42	underestimated	VBN	O	underestimate	_	0	SENT_198	[p14l8t3159r572b3220],
43	the	DT	O	the	det	46	SENT_198	[p14l597t3159r708b3220],
44	true	JJ	O	true	amod	45	SENT_198	[p14l735t3174r878b3220],
45	positive	JJ	O	positive	amod	46	SENT_198	[p14l903t3160r1179b3235],
46	effect	NN	O	effect	dobj	42	SENT_198	[p14l1208t3159r1402b3220],
47	of	IN	O	of	_	0	SENT_198	[p14l1428t3159r1506b3220],
48	tamoxifen	NN	O	tamoxifen	prep_of	46	SENT_198	[p14l1521t3159r1902b3220],
49	.	.	O	.	_	0	SENT_198	[p14l1521t3159r1902b3220],

1	We	PRP	O	we	nsubj	2	SENT_199	[p14l91t3254r213b3313],
2	believe	VBP	O	believe	_	0	SENT_199	[p14l247t3253r495b3313],
3	that	IN	O	that	complm	13	SENT_199	[p14l530t3253r671b3313],
4	the	DT	O	the	det	6	SENT_199	[p14l704t3253r815b3313],
5	observed	VBN	O	observe	amod	6	SENT_199	[p14l852t3253r1172b3313],
6	reduction	NN	O	reduction	nsubj	13	SENT_199	[p14l1206t3253r1554b3313],
7	in	IN	O	in	_	0	SENT_199	[p14l1588t3253r1656b3312],
8	contralateral	JJ	O	contralateral	amod	11	SENT_199	[p14l1692t3253r2143b3313],
9	breast	NN	O	breast	nn	11	SENT_199	[p14l7t3345r225b3405],
10	cancer	NN	O	cancer	nn	11	SENT_199	[p14l257t3365r493b3405],
11	risk	NN	O	risk	prep_in	6	SENT_199	[p14l522t3345r651b3405],
12	is	VBZ	O	be	cop	13	SENT_199	[p14l680t3345r732b3405],
13	attributable	JJ	O	attributable	ccomp	2	SENT_199	[p14l766t3345r1183b3405],
14	to	TO	O	to	prep	13	SENT_199	[p14l1215t3359r1284b3405],
15	tamoxifen	NN	O	tamoxifen	nn	16	SENT_199	[p14l1317t3345r1679b3405],
16	use	NN	O	use	pobj	14	SENT_199	[p14l1710t3365r1827b3405],
17	and	CC	O	and	_	0	SENT_199	[p14l1862t3345r1993b3405],
18	not	RB	O	not	conj_and	14	SENT_199	[p14l2024t3359r2144b3405],
19	to	TO	O	to	dep	14	SENT_199	[p15l8t38r77b84],
20	systemic	JJ	O	systemic	amod	21	SENT_199	[p15l128t24r432b99],
21	differences	NNS	O	difference	pobj	19	SENT_199	[p15l482t23r869b84],
22	in	IN	O	in	_	0	SENT_199	[p15l919t24r987b83],
23	the	DT	O	the	det	25	SENT_199	[p15l1035t23r1146b84],
24	risk	NN	O	risk	nn	25	SENT_199	[p15l1195t23r1325b84],
25	proﬁles	NNS	O	proﬁles	prep_in	21	SENT_199	[p15l1369t23r1634b99],
26	between	IN	O	between	_	0	SENT_199	[p15l1683t23r1984b84],
27	the	DT	O	the	det	28	SENT_199	[p15l2032t23r2143b84],
28	cases	NNS	O	case	prep_between	25	SENT_199	[p15l10t137r189b177],
29	with	IN	O	with	_	0	SENT_199	[p15l215t117r373b177],
30	bilateral	JJ	O	bilateral	amod	31	SENT_199	[p15l397t117r689b177],
31	disease	NN	O	disease	prep_with	28	SENT_199	[p15l717t117r967b177],
32	and	CC	O	and	_	0	SENT_199	[p15l996t117r1128b177],
33	controls	NNS	O	control	conj_and	31	SENT_199	[p15l1155t117r1463b177],
34	.	.	O	.	_	0	SENT_199	[p15l1155t117r1463b177],

1	These	DT	O	these	det	3	SENT_200	[p15l1494t117r1714b177],
2	two	CD	NUMBER	two	num	3	SENT_200	[p15l1740t131r1870b177],
3	groups	NNS	O	group	nsubj	5	SENT_200	[p15l1898t136r2141b193],
4	were	VBD	O	be	cop	5	SENT_200	[p15l7t229r176b270],
5	similar	JJ	O	similar	_	0	SENT_200	[p15l218t209r461b269],
6	in	IN	O	in	_	0	SENT_200	[p15l499t209r568b269],
7	terms	NNS	O	term	prep_in	5	SENT_200	[p15l607t223r807b269],
8	of	IN	O	of	_	0	SENT_200	[p15l850t209r927b269],
9	year	NN	DURATION	year	prep_of	7	SENT_200	[p15l955t229r1108b285],
10	of	IN	O	of	_	0	SENT_200	[p15l1148t209r1225b269],
11	birth	NN	O	birth	prep_of	9	SENT_200	[p15l1253t209r1428b269],
12	and	CC	O	and	_	0	SENT_200	[p15l1469t209r1601b270],
13	age	NN	O	age	conj_and	11	SENT_200	[p15l1643t229r1759b285],
14	of	IN	O	of	_	0	SENT_200	[p15l1802t209r1879b269],
15	cancer	NN	O	cancer	nn	16	SENT_200	[p15l1910t229r2146b269],
16	onset	NN	O	onset	prep_of	11	SENT_200	[p15l10t317r218b363],
17	.	.	O	.	_	0	SENT_200	[p15l10t317r218b363],

1	Women	NNS	O	woman	nsubj	12	SENT_201	[p15l282t303r572b363],
2	with	IN	O	with	_	0	SENT_201	[p15l630t302r788b363],
3	primary	JJ	O	primary	amod	5	SENT_201	[p15l847t303r1133b378],
4	breast	NN	O	breast	nn	5	SENT_201	[p15l1190t302r1408b363],
5	cancer	NN	O	cancer	prep_with	1	SENT_201	[p15l1470t322r1705b363],
6	who	WP	O	who	nsubj	9	SENT_201	[p15l1762t302r1913b363],
7	were	VBD	O	be	cop	9	SENT_201	[p15l1974t322r2143b363],
8	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	9	SENT_201	[p15l10t410r691b472],
9	positive	JJ	O	positive	rcmod	5	SENT_201	[p15l721t396r996b472],
10	were	VBD	O	be	cop	12	SENT_201	[p15l1029t415r1198b456],
11	more	RBR	O	more	advmod	12	SENT_201	[p15l1232t415r1418b456],
12	likely	JJ	O	likely	_	0	SENT_201	[p15l1452t396r1640b472],
13	to	TO	O	to	aux	16	SENT_201	[p15l1671t410r1740b456],
14	have	VB	O	have	aux	16	SENT_201	[p15l1774t396r1938b456],
15	been	VBN	O	be	auxpass	16	SENT_201	[p15l1971t396r2144b456],
16	prescribed	VBN	O	prescribe	xcomp	12	SENT_201	[p15l7t488r384b564],
17	tamoxifen	NN	O	tamoxifen	dobj	16	SENT_201	[p15l529t488r891b548],
18	than	IN	O	than	_	0	SENT_201	[p15l1036t488r1198b548],
19	those	DT	O	those	prep_than	16	SENT_201	[p15l1342t488r1532b548],
20	who	WP	O	who	nsubj	23	SENT_201	[p15l1677t488r1828b549],
21	were	VBD	O	be	cop	23	SENT_201	[p15l1974t508r2143b549],
22	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	23	SENT_201	[p15l10t596r691b657],
23	negative	JJ	O	negative	rcmod	19	SENT_201	[p15l761t582r1078b657],
24	.	.	O	.	_	0	SENT_201	[p15l761t582r1078b657],

1	However	RB	O	however	advmod	12	SENT_202	[p15l1157t582r1503b654],
2	,	,	O	,	_	0	SENT_202	[p15l1157t582r1503b654],
3	the	DT	O	the	det	5	SENT_202	[p15l1579t581r1690b642],
4	prognostic	JJ	O	prognostic	amod	5	SENT_202	[p15l1762t581r2143b657],
5	features	NNS	O	feature	nsubj	12	SENT_202	[p15l8t675r289b735],
6	of	IN	O	of	_	0	SENT_202	[p15l336t675r413b735],
7	the	DT	O	the	det	9	SENT_202	[p15l446t675r557b735],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_202	[p15l601t675r741b735],
9	cancer	NN	O	cancer	prep_of	5	SENT_202	[p15l785t694r1020b735],
10	should	MD	O	should	aux	12	SENT_202	[p15l1063t675r1304b735],
11	not	RB	O	not	neg	12	SENT_202	[p15l1347t689r1467b735],
12	affect	VB	O	affect	_	0	SENT_202	[p15l1511t675r1706b735],
13	the	DT	O	the	det	14	SENT_202	[p15l1749t675r1860b735],
14	risk	NN	O	risk	dobj	12	SENT_202	[p15l1904t675r2033b735],
15	of	IN	O	of	_	0	SENT_202	[p15l2077t675r2154b735],
16	contralateral	JJ	O	contralateral	amod	18	SENT_202	[p15l10t767r461b827],
17	breast	NN	O	breast	nn	18	SENT_202	[p15l528t767r746b827],
18	cancer	NN	O	cancer	prep_of	14	SENT_202	[p15l815t787r1067b827],
19	.	.	O	.	_	0	SENT_202	[p15l815t787r1067b827],

1	In	IN	O	in	_	0	SENT_203	[p15l1141t768r1218b827],
2	a	DT	O	a	det	4	SENT_203	[p15l1287t787r1322b827],
3	large	JJ	O	large	amod	4	SENT_203	[p15l1391t767r1562b843],
4	meta-analysis	NN	O	meta-analysis	prep_in	9	SENT_203	[p15l1631t767r2140b843],
5	,	,	O	,	_	0	SENT_203	[p15l1631t767r2140b843],
6	tamoxifen	NN	O	tamoxifen	nsubj	9	SENT_203	[p15l8t860r370b921],
7	was	VBD	O	be	cop	9	SENT_203	[p15l462t880r594b921],
8	equally	RB	O	equally	advmod	9	SENT_203	[p15l691t860r949b936],
9	effective	JJ	O	effective	_	0	SENT_203	[p15l1043t860r1337b921],
10	in	IN	O	in	_	0	SENT_203	[p15l1432t861r1500b920],
11	prevention	NN	O	prevention	prep_in	9	SENT_203	[p15l1593t861r1981b936],
12	of	IN	O	of	_	0	SENT_203	[p15l2077t860r2154b921],
13	contralateral	JJ	O	contralateral	amod	15	SENT_203	[p15l10t954r461b1014],
14	breast	NN	O	breast	nn	15	SENT_203	[p15l609t954r827b1014],
15	cancer	NN	O	cancer	prep_of	11	SENT_203	[p15l977t973r1212b1014],
16	in	IN	O	in	_	0	SENT_203	[p15l1358t954r1426b1013],
17	women	NNS	O	woman	prep_in	15	SENT_203	[p15l1573t973r1839b1014],
18	with	IN	O	with	prep	9	SENT_203	[p15l1986t954r2144b1014],

1	THE	DT	O	the	det	2	SENT_204	[p15l92t1122r158b1142],
2	LANCET	NN	O	lancet	_	0	SENT_204	[p15l167t1122r297b1143],
3	-	:	O	-	_	0	SENT_204	[p15l306t1129r314b1136],
4	Vol	NN	O	vol	dep	2	SENT_204	[p15l323t1122r367b1143],
5	356	CD	NUMBER	356	num	4	SENT_204	[p15l377t1123r423b1143],
6	-	:	O	-	_	0	SENT_204	[p15l433t1129r441b1136],
7	December	NNP	DATE	December	dep	4	SENT_204	[p15l451t1122r583b1143],
8	2	CD	DATE	2	num	7	SENT_204	[p15l592t1123r614b1146],
9	,	,	DATE	,	_	0	SENT_204	[p15l592t1123r614b1146],
10	2000	CD	DATE	2000	num	7	SENT_204	[p15l624t1123r686b1143],
11	1879	NNS	NUMBER	1879	nn	12	SENT_204	[p15l1986t1117r2062b1143],
12	ARTICLES	NNS	O	article	dep	7	SENT_204	[p15l91t1165r244b1186],

1	oestrogen-receptor	NN	O	oestrogen-receptor	dep	2	SENT_205	[p15l9t1371r691b1433],
2	positive	JJ	O	positive	_	0	SENT_205	[p15l809t1357r1085b1433],
3	and	CC	O	and	_	0	SENT_205	[p15l1209t1357r1341b1418],
4	oestrogen-receptor	JJ	O	oestrogen-receptor	amod	6	SENT_205	[p15l1464t1371r2145b1433],
5	negative	JJ	O	negative	amod	6	SENT_205	[p15l7t1451r304b1526],
6	ﬁrst	NN	O	ﬁrst	conj_and	2	SENT_205	[p15l378t1450r517b1511],
7	primary	JJ	O	primary	amod	8	SENT_205	[p15l589t1451r874b1526],
8	tumours	NNS	O	tumour	dep	2	SENT_205	[p15l945t1452r1320b1511],
9	.	.	O	.	_	0	SENT_205	[p15l945t1452r1320b1511],

1	”	NN	O	”	nsubjpass	24	SENT_206	[p15l945t1452r1320b1511],
2	Whether	IN	O	whether	complm	5	SENT_206	[p15l1392t1451r1711b1511],
3	a	DT	O	a	det	4	SENT_206	[p15l1784t1470r1819b1511],
4	patient	NN	O	patient	nsubj	5	SENT_206	[p15l1891t1451r2144b1527],
5	survives	VBZ	O	survive	dep	1	SENT_206	[p15l9t1544r291b1604],
6	or	CC	O	or	_	0	SENT_206	[p15l326t1563r401b1604],
7	not	RB	O	not	conj_or	5	SENT_206	[p15l430t1558r550b1604],
8	might	MD	O	might	aux	9	SENT_206	[p15l581t1544r792b1620],
9	depend	VB	O	depend	dep	5	SENT_206	[p15l824t1544r1090b1620],
10	on	IN	O	on	_	0	SENT_206	[p15l1123t1564r1213b1604],
11	the	DT	O	the	det	12	SENT_206	[p15l1244t1544r1355b1604],
12	characteristics	NNS	O	characteristic	prep_on	9	SENT_206	[p15l1389t1544r1898b1604],
13	of	IN	O	of	_	0	SENT_206	[p15l1933t1544r2010b1604],
14	the	DT	O	the	det	16	SENT_206	[p15l2031t1544r2142b1604],
15	ﬁrst	NN	O	ﬁrst	nn	16	SENT_206	[p15l7t1636r146b1697],
16	cancer	NN	O	cancer	prep_of	12	SENT_206	[p15l174t1656r429b1709],
17	,	,	O	,	_	0	SENT_206	[p15l174t1656r429b1709],
18	but	CC	O	but	_	0	SENT_206	[p15l458t1636r580b1697],
19	in	IN	O	in	dep	1	SENT_206	[p15l607t1636r675b1696],
20	our	PRP$	O	we	poss	22	SENT_206	[p15l704t1656r827b1697],
21	study	NN	O	study	nn	22	SENT_206	[p15l853t1636r1048b1712],
22	controls	NNS	O	control	pobj	19	SENT_206	[p15l1075t1636r1363b1697],
23	were	VBD	O	be	auxpass	24	SENT_206	[p15l1390t1656r1559b1697],
24	followed	VBN	O	follow	_	0	SENT_206	[p15l1588t1636r1896b1697],
25	up	RP	O	up	prt	24	SENT_206	[p15l1923t1656r2014b1712],
26	for	IN	O	for	prep	24	SENT_206	[p15l2043t1636r2145b1697],
27	at	IN	O	at	pcomp	26	SENT_206	[p15l9t1744r74b1790],
28	least	JJS	O	least	pobj	27	SENT_206	[p15l99t1729r260b1790],
29	as	RB	O	as	advmod	27	SENT_206	[p15l287t1749r354b1790],
30	long	RB	O	long	advmod	27	SENT_206	[p15l382t1729r538b1805],
31	as	IN	O	as	_	0	SENT_206	[p15l564t1749r631b1790],
32	bilateral	JJ	O	bilateral	amod	34	SENT_206	[p15l658t1729r949b1790],
33	disease	NN	O	disease	nn	34	SENT_206	[p15l977t1729r1228b1790],
34	cases	NNS	O	case	prep_as	24	SENT_206	[p15l1256t1749r1456b1790],
35	.	.	O	.	_	0	SENT_206	[p15l1256t1749r1456b1790],

1	Why	WRB	O	why	advmod	2	SENT_207	[p15l91t1823r263b1899],
2	was	VBD	O	be	_	0	SENT_207	[p15l302t1843r434b1883],
3	the	DT	O	the	det	5	SENT_207	[p15l478t1823r589b1883],
4	protective	JJ	O	protective	amod	5	SENT_207	[p15l631t1823r989b1899],
5	effect	NN	O	effect	nsubj	2	SENT_207	[p15l1034t1823r1227b1883],
6	of	IN	O	of	_	0	SENT_207	[p15l1271t1823r1348b1883],
7	tamoxifen	NN	O	tamoxifen	prep_of	5	SENT_207	[p15l1380t1823r1742b1883],
8	greater	JJR	O	greater	amod	7	SENT_207	[p15l1785t1837r2035b1899],
9	in	IN	O	in	_	0	SENT_207	[p15l2075t1823r2144b1882],
10	North	NNP	LOCATION	North	nn	11	SENT_207	[p15l6t1915r228b1976],
11	America	NNP	LOCATION	America	prep_in	8	SENT_207	[p15l265t1915r570b1976],
12	than	IN	O	than	prep	8	SENT_207	[p15l608t1915r770b1976],
13	in	IN	O	in	pcomp	12	SENT_207	[p15l808t1915r877b1975],
14	Europe	NNP	LOCATION	Europe	pobj	13	SENT_207	[p15l915t1915r1212b1991],
15	?	.	O	?	_	0	SENT_207	[p15l915t1915r1212b1991],

1	A	DT	O	a	det	3	SENT_208	[p15l1250t1916r1311b1975],
2	similar	JJ	O	similar	amod	3	SENT_208	[p15l1350t1915r1593b1976],
3	difference	NN	O	difference	nsubjpass	6	SENT_208	[p15l1631t1915r1986b1976],
4	has	VBZ	O	have	aux	6	SENT_208	[p15l2024t1915r2142b1976],
5	been	VBN	O	be	auxpass	6	SENT_208	[p15l6t2008r179b2069],
6	reported	VBN	O	report	dep	16	SENT_208	[p15l231t2008r538b2084],
7	in	IN	O	in	_	0	SENT_208	[p15l590t2009r658b2068],
8	the	DT	O	the	det	10	SENT_208	[p15l710t2008r821b2069],
9	prevention	NN	O	prevention	nn	10	SENT_208	[p15l873t2009r1261b2084],
10	trials	NNS	O	trial	prep_in	6	SENT_208	[p15l1312t2008r1650b2069],
11	.9	CD	NUMBER	.9	number	12	SENT_208	[p15l1312t2008r1650b2069],
12	’	CD	NUMBER	’	num	14	SENT_208	[p15l1312t2008r1650b2069],
13	24	CD	NUMBER	24	number	14	SENT_208	[p15l1312t2008r1650b2069],
14	’25	CD	NUMBER	’25	dep	6	SENT_208	[p15l1312t2008r1650b2069],
15	There	EX	O	there	expl	16	SENT_208	[p15l1703t2009r1921b2069],
16	were	VBD	O	be	_	0	SENT_208	[p15l1973t2028r2142b2069],
17	fewer	JJR	O	fewer	amod	19	SENT_208	[p15l7t2102r204b2162],
18	European	JJ	LOCATION	european	amod	19	SENT_208	[p15l230t2103r584b2178],
19	women	NNS	O	woman	nsubj	16	SENT_208	[p15l609t2121r876b2162],
20	than	IN	O	than	mark	33	SENT_208	[p15l902t2102r1064b2162],
21	North	JJ	LOCATION	north	amod	23	SENT_208	[p15l1089t2102r1312b2162],
22	American	JJ	LOCATION	american	amod	23	SENT_208	[p15l1337t2102r1690b2162],
23	women	NNS	O	woman	nsubj	33	SENT_208	[p15l1716t2121r1982b2162],
24	and	CC	O	and	_	0	SENT_208	[p15l2011t2102r2143b2162],
25	the	DT	O	the	det	26	SENT_208	[p15l7t2194r118b2255],
26	difference	NN	O	difference	nsubj	33	SENT_208	[p15l150t2194r504b2255],
27	in	IN	O	in	_	0	SENT_208	[p15l533t2194r602b2254],
28	the	DT	O	the	det	30	SENT_208	[p15l630t2194r741b2255],
29	odds	NNS	O	odds	nn	30	SENT_208	[p15l773t2194r941b2255],
30	ratios	NNS	O	ratio	prep_in	26	SENT_208	[p15l972t2194r1168b2255],
31	did	VBD	O	do	aux	33	SENT_208	[p15l1200t2194r1315b2255],
32	not	RB	O	not	neg	33	SENT_208	[p15l1343t2208r1463b2255],
33	differ	VB	O	differ	advcl	16	SENT_208	[p15l1493t2194r1684b2255],
34	signiﬁcantly	RB	O	signiﬁcantly	advmod	33	SENT_208	[p15l1712t2194r2145b2270],
35	between	IN	O	between	_	0	SENT_208	[p15l6t2287r307b2348],
36	the	DT	O	the	det	38	SENT_208	[p15l343t2287r454b2348],
37	two	CD	NUMBER	two	num	38	SENT_208	[p15l491t2302r621b2348],
38	groups	NNS	O	group	prep_between	33	SENT_208	[p15l659t2307r923b2363],
39	.	.	O	.	_	0	SENT_208	[p15l659t2307r923b2363],

1	European	JJ	MISC	european	amod	2	SENT_209	[p15l964t2288r1319b2363],
2	patients	NNS	O	patient	nsubj	3	SENT_209	[p15l1354t2288r1636b2363],
3	had	VBD	O	have	_	0	SENT_209	[p15l1673t2287r1807b2348],
4	a	DT	O	a	det	6	SENT_209	[p15l1845t2307r1880b2348],
5	higher	JJR	O	higher	amod	6	SENT_209	[p15l1915t2287r2145b2363],
6	proportion	NN	O	proportion	dobj	3	SENT_209	[p15l6t2381r398b2457],
7	of	IN	O	of	_	0	SENT_209	[p15l443t2381r520b2441],
8	BRCA1	NN	O	brca1	nn	9	SENT_209	[p15l554t2381r830b2441],
9	mutations	NNS	O	mutation	prep_of	6	SENT_209	[p15l880t2381r1265b2454],
10	,	,	O	,	_	0	SENT_209	[p15l880t2381r1265b2454],
11	a	DT	O	a	det	13	SENT_209	[p15l1314t2401r1350b2441],
12	younger	JJR	O	younger	amod	13	SENT_209	[p15l1393t2401r1689b2457],
13	age	NN	O	age	dobj	3	SENT_209	[p15l1733t2401r1849b2457],
14	at	IN	O	at	_	0	SENT_209	[p15l1897t2395r1961b2441],
15	ﬁrst	JJ	O	ﬁrst	amod	16	SENT_209	[p15l2005t2381r2144b2441],
16	diagnosis	NN	O	diagnosis	prep_at	13	SENT_209	[p15l9t2473r339b2549],
17	of	IN	O	of	_	0	SENT_209	[p15l403t2473r480b2534],
18	cancer	NN	O	cancer	prep_of	16	SENT_209	[p15l534t2493r788b2546],
19	,	,	O	,	_	0	SENT_209	[p15l534t2493r788b2546],
20	and	CC	O	and	_	0	SENT_209	[p15l855t2473r987b2534],
21	a	DT	O	a	det	24	SENT_209	[p15l1050t2493r1086b2534],
22	more	RBR	O	more	advmod	23	SENT_209	[p15l1148t2493r1333b2534],
23	recent	JJ	O	recent	amod	24	SENT_209	[p15l1396t2487r1619b2534],
24	diagnosis	NN	O	diagnosis	dobj	3	SENT_209	[p15l1681t2473r2011b2549],
25	of	IN	O	of	_	0	SENT_209	[p15l2076t2473r2153b2534],
26	primary	JJ	O	primary	amod	28	SENT_209	[p15l6t2567r292b2642],
27	breast	NN	O	breast	nn	28	SENT_209	[p15l349t2566r568b2627],
28	cancer	NN	O	cancer	prep_of	24	SENT_209	[p15l629t2586r864b2627],
29	than	IN	O	than	_	0	SENT_209	[p15l922t2566r1083b2627],
30	North	JJ	MISC	north	amod	32	SENT_209	[p15l1142t2566r1364b2627],
31	American	JJ	MISC	american	amod	32	SENT_209	[p15l1422t2567r1775b2627],
32	patients	NNS	O	patient	prep_than	3	SENT_209	[p15l1835t2567r2138b2642],
33	.	.	O	.	_	0	SENT_209	[p15l1835t2567r2138b2642],

1	However	RB	O	however	advmod	8	SENT_210	[p15l8t2661r355b2733],
2	,	,	O	,	_	0	SENT_210	[p15l8t2661r355b2733],
3	these	DT	O	these	det	5	SENT_210	[p15l417t2660r600b2720],
4	minor	JJ	O	minor	amod	5	SENT_210	[p15l660t2660r880b2720],
5	differences	NNS	O	difference	nsubj	8	SENT_210	[p15l938t2660r1325b2720],
6	do	VBP	O	do	aux	8	SENT_210	[p15l1387t2660r1475b2720],
7	not	RB	O	not	neg	8	SENT_210	[p15l1535t2674r1655b2720],
8	explain	VB	O	explain	_	0	SENT_210	[p15l1715t2660r1973b2736],
9	the	DT	O	the	det	11	SENT_210	[p15l2031t2660r2142b2720],
10	recorded	VBN	O	record	amod	11	SENT_210	[p15l7t2752r328b2813],
11	differences	NNS	O	difference	dobj	8	SENT_210	[p15l421t2752r808b2813],
12	in	IN	O	in	_	0	SENT_210	[p15l902t2752r971b2812],
13	protection	NN	O	protection	prep_in	8	SENT_210	[p15l1062t2752r1436b2828],
14	associated	VBN	O	associate	partmod	13	SENT_210	[p15l1529t2752r1894b2813],
15	with	IN	O	with	_	0	SENT_210	[p15l1985t2752r2143b2813],
16	tamoxifen	NN	O	tamoxifen	prep_with	14	SENT_210	[p15l7t2845r388b2906],
17	.	.	O	.	_	0	SENT_210	[p15l7t2845r388b2906],

1	Side-effects	NNS	O	side-effect	nsubj	4	SENT_211	[p15l95t2939r509b2999],
2	of	IN	O	of	_	0	SENT_211	[p15l556t2939r633b2999],
3	tamoxifen	NN	O	tamoxifen	prep_of	1	SENT_211	[p15l667t2939r1029b2999],
4	include	VBP	O	include	_	0	SENT_211	[p15l1073t2939r1337b2999],
5	endometrial	JJ	O	endometrial	amod	6	SENT_211	[p15l1383t2939r1817b2999],
6	cancer	NN	O	cancer	dobj	4	SENT_211	[p15l1863t2940r2142b2999],
7	?	.	O	?	_	0	SENT_211	[p15l1863t2940r2142b2999],

1	This	DT	O	this	det	2	SENT_212	[p15l7t3031r170b3092],
2	cancer	NN	O	cancer	nsubj	7	SENT_212	[p15l206t3051r441b3092],
3	is	VBZ	O	be	cop	7	SENT_212	[p15l472t3031r523b3092],
4	not	RB	O	not	neg	7	SENT_212	[p15l557t3045r677b3092],
5	a	DT	O	a	det	7	SENT_212	[p15l711t3051r746b3092],
6	proven	JJ	O	proven	amod	7	SENT_212	[p15l778t3051r1028b3107],
7	feature	NN	O	feature	ccomp	26	SENT_212	[p15l1061t3031r1309b3092],
8	of	IN	O	of	_	0	SENT_212	[p15l1345t3031r1422b3092],
9	BRCA1	NN	O	brca1	prep_of	7	SENT_212	[p15l1442t3031r1719b3092],
10	or	CC	O	or	_	0	SENT_212	[p15l1758t3051r1833b3092],
11	BRCA2	NN	O	brca2	nn	12	SENT_212	[p15l1862t3031r2144b3092],
12	mutation	NN	O	mutation	ccomp	26	SENT_212	[p15l7t3125r338b3185],
13	.26	CD	NUMBER	.26	number	14	SENT_212	[p15l375t3125r495b3185],
14	”	CD	NUMBER	”	dep	12	SENT_212	[p15l375t3125r495b3185],
15	However	RB	O	however	advmod	7	SENT_212	[p15l529t3126r875b3197],
16	,	,	O	,	_	0	SENT_212	[p15l529t3126r875b3197],
17	in	IN	O	in	_	0	SENT_212	[p15l911t3125r979b3184],
18	one	CD	NUMBER	one	num	19	SENT_212	[p15l1012t3144r1140b3185],
19	report	NN	O	report	prep_in	7	SENT_212	[p15l1172t3139r1413b3201],
20	,	,	O	,	_	0	SENT_212	[p15l1172t3139r1413b3201],
21	risk	NN	O	risk	nsubj	26	SENT_212	[p15l1448t3125r1578b3185],
22	of	IN	O	of	_	0	SENT_212	[p15l1609t3124r1686b3185],
23	endometrial	JJ	O	endometrial	amod	24	SENT_212	[p15l1709t3125r2143b3185],
24	cancer	NN	O	cancer	prep_of	21	SENT_212	[p15l9t3237r245b3278],
25	was	VBD	O	be	cop	26	SENT_212	[p15l267t3238r399b3278],
26	higher	JJR	O	higher	_	0	SENT_212	[p15l425t3218r656b3294],
27	in	IN	O	in	_	0	SENT_212	[p15l679t3218r748b3277],
28	ﬁrst	NN	O	ﬁrst	nn	31	SENT_212	[p15l773t3218r1181b3294],
29	—	NN	O	—	nn	31	SENT_212	[p15l773t3218r1181b3294],
30	degree	NN	O	degree	nn	31	SENT_212	[p15l773t3218r1181b3294],
31	relatives	NNS	O	relative	prep_in	26	SENT_212	[p15l1207t3218r1500b3278],
32	of	IN	O	of	_	0	SENT_212	[p15l1529t3218r1606b3278],
33	Jewish	JJ	MISC	jewish	amod	34	SENT_212	[p15l1617t3218r1853b3292],
34	women	NNS	O	woman	prep_of	31	SENT_212	[p15l1877t3237r2143b3278],
35	with	IN	O	with	_	0	SENT_212	[p15l6t3310r164b3371],
36	ovarian	JJ	O	ovarian	amod	37	SENT_212	[p15l199t3310r463b3371],
37	cancer	NN	O	cancer	prep_with	26	SENT_212	[p15l498t3330r734b3371],
38	who	WP	O	who	nsubj	39	SENT_212	[p15l764t3310r915b3371],
39	carried	VBD	O	carry	rcmod	37	SENT_212	[p15l952t3310r1200b3371],
40	a	DT	O	a	det	42	SENT_212	[p15l1236t3330r1271b3371],
41	BRCA1	NN	O	brca1	nn	42	SENT_212	[p15l1303t3310r1579b3371],
42	mutation	NN	O	mutation	dobj	39	SENT_212	[p15l1618t3310r1949b3371],
43	than	IN	O	than	dep	39	SENT_212	[p15l1982t3310r2143b3371],
44	in	IN	O	in	_	0	SENT_212	[p15l8t3404r76b3463],
45	relatives	NNS	O	relative	prep_in	39	SENT_212	[p15l109t3403r401b3464],
46	of	IN	O	of	_	0	SENT_212	[p15l438t3403r515b3464],
47	women	NNS	O	woman	prep_of	45	SENT_212	[p15l538t3423r804b3464],
48	who	WP	O	who	nsubj	49	SENT_212	[p15l836t3403r987b3464],
49	did	VBD	O	do	rcmod	47	SENT_212	[p15l1024t3403r1139b3464],
50	not	RB	O	not	neg	49	SENT_212	[p15l1172t3405r1361b3464],
51	.	.	O	.	_	0	SENT_212	[p15l1172t3405r1361b3464],

1	”	NN	O	”	nn	2	SENT_213	[p15l1172t3405r1361b3464],
2	Tamoxifen	NN	O	tamoxifen	nsubj	5	SENT_213	[p15l1395t3403r1794b3464],
3	does	VBZ	O	do	aux	5	SENT_213	[p15l1828t3404r1989b3464],
4	not	RB	O	not	neg	5	SENT_213	[p15l2024t3418r2144b3464],
5	increase	VB	O	increase	_	0	SENT_213	[p15l8t3497r297b3557],
6	risk	NN	O	risk	dobj	5	SENT_213	[p15l354t3497r484b3557],
7	of	IN	O	of	_	0	SENT_213	[p15l539t3497r616b3557],
8	ovarian	JJ	O	ovarian	amod	9	SENT_213	[p15l663t3497r927b3557],
9	cancer	NN	O	cancer	prep_of	6	SENT_213	[p15l985t3516r1220b3557],
10	in	IN	O	in	_	0	SENT_213	[p15l1274t3497r1342b3556],
11	BRCA1	NN	O	brca1	prep_in	5	SENT_213	[p15l1396t3497r1672b3557],
12	or	CC	O	or	_	0	SENT_213	[p15l1735t3516r1810b3557],
13	BRCA2	NN	O	brca2	prep_in	5	SENT_213	[p15l1862t3497r2144b3557],

1	mutation	NN	O	mutation	_	0	SENT_214	[p16l7t23r338b84],
2	carriers	NNS	O	carrier	dep	1	SENT_214	[p16l400t23r662b84],
3	or	CC	O	or	_	0	SENT_214	[p16l725t43r800b84],
4	the	DT	O	the	det	6	SENT_214	[p16l857t23r968b84],
5	general	JJ	O	general	amod	6	SENT_214	[p16l1029t23r1289b99],
6	population	NN	O	population	conj_or	2	SENT_214	[p16l1348t23r1760b99],
7	.	.	O	.	_	0	SENT_214	[p16l1348t23r1760b99],

1	Selective	JJ	O	selective	amod	3	SENT_215	[p16l1828t23r2142b84],
2	oestrogen-receptor	NN	O	oestrogen-receptor	nn	3	SENT_215	[p16l9t130r691b192],
3	modulators	NNS	O	modulator	nsubj	18	SENT_215	[p16l762t116r1173b177],
4	might	MD	O	might	aux	8	SENT_215	[p16l1247t116r1458b192],
5	be	VB	O	be	cop	8	SENT_215	[p16l1529t116r1613b177],
6	an	DT	O	a	det	8	SENT_215	[p16l1689t136r1773b177],
7	effective	JJ	O	effective	amod	8	SENT_215	[p16l1848t116r2142b177],
8	alternative	NN	O	alternative	_	0	SENT_215	[p16l9t210r384b270],
9	to	TO	O	to	_	0	SENT_215	[p16l410t224r479b270],
10	tamoxifen	NN	O	tamoxifen	prep_to	8	SENT_215	[p16l506t210r869b270],
11	in	IN	O	in	_	0	SENT_215	[p16l894t210r963b269],
12	genetically	RB	O	genetically	amod	14	SENT_215	[p16l988t210r1371b286],
13	predisposed	VBN	O	predispose	dep	12	SENT_215	[p16l1395t210r1828b286],
14	women	NNS	O	woman	prep_in	10	SENT_215	[p16l1853t229r2140b283],
15	,	,	O	,	_	0	SENT_215	[p16l1853t229r2140b283],
16	and	CC	O	and	_	0	SENT_215	[p16l9t302r142b363],
17	might	MD	O	might	aux	18	SENT_215	[p16l169t302r379b378],
18	have	VB	O	have	conj_and	8	SENT_215	[p16l404t302r569b363],
19	fewer	JJR	O	fewer	amod	20	SENT_215	[p16l597t302r794b363],
20	side-effects	NNS	O	side-effect	dobj	18	SENT_215	[p16l820t302r1239b363],
21	.	.	O	.	_	0	SENT_215	[p16l820t302r1239b363],

1	Raloxifene	NN	MISC	raloxifene	nsubjpass	12	SENT_216	[p16l1273t302r1654b363],
2	is	VBZ	O	be	auxpass	3	SENT_216	[p16l1682t302r1733b363],
3	thought	VBN	O	think	_	0	SENT_216	[p16l1762t302r2046b378],
4	to	TO	O	to	aux	5	SENT_216	[p16l2072t316r2141b363],
5	protect	VB	O	protect	xcomp	3	SENT_216	[p16l6t410r264b471],
6	against	IN	O	against	_	0	SENT_216	[p16l294t396r545b471],
7	breast	NN	O	breast	nn	8	SENT_216	[p16l572t395r790b456],
8	cancer	NN	O	cancer	prep_against	5	SENT_216	[p16l820t415r1055b456],
9	and	CC	O	and	_	0	SENT_216	[p16l1084t395r1217b456],
10	is	VBZ	O	be	auxpass	12	SENT_216	[p16l1246t396r1297b456],
11	not	RB	O	not	neg	12	SENT_216	[p16l1328t410r1448b456],
12	associated	VBN	O	associate	conj_and	3	SENT_216	[p16l1478t395r1843b456],
13	with	IN	O	with	_	0	SENT_216	[p16l1871t395r2029b456],
14	an	DT	O	a	det	16	SENT_216	[p16l2059t415r2143b456],
15	increased	VBN	O	increase	amod	16	SENT_216	[p16l8t489r346b549],
16	risk	NN	O	risk	prep_with	12	SENT_216	[p16l374t489r503b549],
17	of	IN	O	of	_	0	SENT_216	[p16l530t489r607b549],
18	endometrial	JJ	O	endometrial	amod	19	SENT_216	[p16l626t489r1059b549],
19	cancer	NN	O	cancer	prep_of	16	SENT_216	[p16l1088t490r1391b549],
20	.	.	O	.	_	0	SENT_216	[p16l1088t490r1391b549],

1	”	NN	O	”	ccomp	9	SENT_217	[p16l1088t490r1391b549],
2	However	RB	O	however	advmod	1	SENT_217	[p16l1420t490r1767b561],
3	,	,	O	,	_	0	SENT_217	[p16l1420t490r1767b561],
4	studies	NNS	O	study	nsubjpass	9	SENT_217	[p16l1799t489r2045b549],
5	of	IN	O	of	_	0	SENT_217	[p16l2076t489r2153b549],
6	raloxifene	NN	O	raloxifene	prep_of	4	SENT_217	[p16l7t580r361b641],
7	have	VBP	O	have	aux	9	SENT_217	[p16l385t580r549b641],
8	been	VBN	O	be	auxpass	9	SENT_217	[p16l573t580r745b641],
9	done	VBN	O	do	_	0	SENT_217	[p16l771t580r947b641],
10	only	RB	O	only	advmod	9	SENT_217	[p16l974t580r1128b656],
11	in	IN	O	in	_	0	SENT_217	[p16l1150t580r1218b640],
12	postmenopausal	JJ	O	postmenopausal	amod	13	SENT_217	[p16l1241t580r1829b656],
13	women	NNS	O	woman	prep_in	9	SENT_217	[p16l1853t600r2137b641],
14	.	.	O	.	_	0	SENT_217	[p16l1853t600r2137b641],

1	The	DT	O	the	det	5	SENT_218	[p16l7t673r154b734],
2	large	JJ	O	large	amod	5	SENT_218	[p16l188t673r359b749],
3	randomised	JJ	O	randomised	amod	5	SENT_218	[p16l393t673r820b734],
4	STAR	NN	O	star	nn	5	SENT_218	[p16l855t674r1088b734],
5	trial	NN	O	trial	nsubjpass	7	SENT_218	[p16l1116t673r1258b734],
6	is	VBZ	O	be	auxpass	7	SENT_218	[p16l1291t674r1342b734],
7	designed	VBN	O	design	_	0	SENT_218	[p16l1378t673r1695b749],
8	to	TO	O	to	aux	9	SENT_218	[p16l1726t688r1796b734],
9	compare	VB	O	compare	xcomp	7	SENT_218	[p16l1831t693r2142b749],
10	tamoxifen	NN	O	tamoxifen	dobj	9	SENT_218	[p16l7t767r369b827],
11	and	CC	O	and	_	0	SENT_218	[p16l434t767r565b827],
12	raloxifene	NN	O	raloxifene	conj_and	10	SENT_218	[p16l628t767r982b827],
13	in	IN	O	in	_	0	SENT_218	[p16l1045t767r1113b826],
14	high-risk	JJ	O	high-risk	amod	16	SENT_218	[p16l1174t767r1494b843],
15	postmenopausal	JJ	O	postmenopausal	amod	16	SENT_218	[p16l1554t767r2143b843],
16	women	NNS	O	woman	prep_in	9	SENT_218	[p16l6t879r272b920],
17	for	IN	O	for	_	0	SENT_218	[p16l306t859r409b920],
18	whom	WP	O	whom	dobj	23	SENT_218	[p16l439t859r665b920],
19	mutation	NN	O	mutation	nn	20	SENT_218	[p16l699t859r1030b920],
20	status	NN	O	status	nsubjpass	23	SENT_218	[p16l1066t873r1270b920],
21	is	VBZ	O	be	auxpass	23	SENT_218	[p16l1306t859r1357b920],
22	not	RB	O	not	neg	23	SENT_218	[p16l1392t873r1513b920],
23	known	VBN	O	know	prepc_for	16	SENT_218	[p16l1547t859r1809b920],
24	.	.	O	.	_	0	SENT_218	[p16l1547t859r1809b920],

1	Because	IN	O	because	mark	13	SENT_219	[p16l1849t860r2142b920],
2	most	JJS	O	most	amod	4	SENT_219	[p16l7t967r185b1013],
3	breast	NN	O	breast	nn	4	SENT_219	[p16l224t952r442b1013],
4	cancers	NNS	O	cancer	nsubj	13	SENT_219	[p16l485t972r749b1013],
5	in	IN	O	in	_	0	SENT_219	[p16l792t953r860b1012],
6	BRCA1	NN	O	brca1	nn	8	SENT_219	[p16l899t953r1175b1013],
7	mutation	NN	O	mutation	nn	8	SENT_219	[p16l1222t953r1552b1013],
8	carriers	NNS	O	carrier	prep_in	4	SENT_219	[p16l1595t953r1858b1013],
9	appear	VBP	O	appear	cop	13	SENT_219	[p16l1902t972r2145b1028],
10	before	IN	O	before	_	0	SENT_219	[p16l6t1046r232b1106],
11	age	NN	O	age	prep_before	13	SENT_219	[p16l265t1066r381b1122],
12	50	CD	DURATION	50	num	13	SENT_219	[p16l415t1048r500b1106],
13	years	NNS	NUMBER	year	advcl	17	SENT_219	[p16l530t1066r735b1122],
14	,	,	O	,	_	0	SENT_219	[p16l530t1066r735b1122],
15	it	PRP	O	it	nsubjpass	17	SENT_219	[p16l768t1046r816b1106],
16	is	VBZ	O	be	auxpass	17	SENT_219	[p16l846t1046r896b1106],
17	difﬁcult	VBN	O	difﬁcult	_	0	SENT_219	[p16l929t1046r1209b1106],
18	to	TO	O	to	aux	19	SENT_219	[p16l1238t1060r1307b1106],
19	extrapolate	VB	O	extrapolate	xcomp	17	SENT_219	[p16l1340t1046r1738b1122],
20	the	DT	O	the	det	21	SENT_219	[p16l1769t1046r1879b1106],
21	results	NNS	O	result	dobj	19	SENT_219	[p16l1910t1046r2142b1106],
22	of	IN	O	of	_	0	SENT_219	[p16l9t1138r86b1199],
23	the	DT	O	the	det	25	SENT_219	[p16l137t1138r248b1199],
24	STAR	NN	O	star	nn	25	SENT_219	[p16l313t1138r546b1199],
25	trial	NN	O	trial	prep_of	21	SENT_219	[p16l602t1138r744b1199],
26	to	TO	O	to	_	0	SENT_219	[p16l805t1152r874b1199],
27	BRCA1	NN	O	brca1	nn	31	SENT_219	[p16l935t1138r1211b1199],
28	and	CC	O	and	_	0	SENT_219	[p16l1279t1138r1411b1199],
29	BRCA2	NN	O	brca2	conj_and	27	SENT_219	[p16l1470t1138r1753b1199],
30	mutation	NN	O	mutation	nn	31	SENT_219	[p16l1812t1138r2143b1199],
31	carriers	NNS	O	carrier	prep_to	19	SENT_219	[p16l9t1232r295b1304],
32	,	,	O	,	_	0	SENT_219	[p16l9t1232r295b1304],
33	who	WP	O	who	nsubj	34	SENT_219	[p16l323t1231r474b1292],
34	begin	VBP	O	begin	rcmod	31	SENT_219	[p16l502t1231r700b1307],
35	surveillance	NN	O	surveillance	dobj	34	SENT_219	[p16l728t1231r1149b1292],
36	as	RB	O	as	advmod	37	SENT_219	[p16l1179t1251r1247b1292],
37	early	RB	O	early	advmod	35	SENT_219	[p16l1277t1231r1448b1307],
38	as	IN	O	as	_	0	SENT_219	[p16l1475t1251r1542b1292],
39	age	NN	O	age	prep_as	37	SENT_219	[p16l1572t1251r1689b1307],
40	25	CD	DURATION	25	num	41	SENT_219	[p16l1718t1234r1802b1292],
41	years	NNS	NUMBER	year	tmod	35	SENT_219	[p16l1831t1251r2034b1307],
42	.	.	O	.	_	0	SENT_219	[p16l1831t1251r2034b1307],

1	In	IN	O	in	_	0	SENT_220	[p16l2067t1232r2143b1291],
2	our	PRP$	O	we	poss	4	SENT_220	[p16l9t1344r132b1385],
3	study	NN	O	study	nn	4	SENT_220	[p16l174t1325r369b1401],
4	population	NN	O	population	prep_in	17	SENT_220	[p16l409t1325r803b1401],
5	very	RB	O	very	advmod	6	SENT_220	[p16l843t1345r995b1401],
6	few	JJ	O	few	amod	4	SENT_220	[p16l1036t1325r1161b1385],
7	(	CD	PERCENT	(	num	9	SENT_220	[p16l1209t1325r1428b1400],
8	12	CD	PERCENT	12	num	9	SENT_220	[p16l1209t1325r1428b1400],
9	%	NN	PERCENT	%	nsubj	17	SENT_220	[p16l1209t1325r1428b1400],
10	)	CD	NUMBER	)	num	11	SENT_220	[p16l1209t1325r1428b1400],
11	patients	NNS	O	patient	nsubj	12	SENT_220	[p16l1475t1325r1758b1401],
12	had	VBD	O	have	rcmod	9	SENT_220	[p16l1801t1325r1935b1385],
13	their	PRP$	O	they	poss	16	SENT_220	[p16l1977t1325r2145b1385],
14	first	JJ	ORDINAL	first	amod	16	SENT_220	[p16l7t1417r146b1478],
15	breast	NN	O	breast	nn	16	SENT_220	[p16l179t1417r397b1478],
16	cancer	NN	O	cancer	dobj	12	SENT_220	[p16l433t1437r668b1478],
17	diagnosed	VBD	O	diagnose	_	0	SENT_220	[p16l702t1417r1065b1493],
18	before	IN	O	before	_	0	SENT_220	[p16l1098t1417r1325b1478],
19	age	NN	O	age	prep_before	17	SENT_220	[p16l1362t1437r1478b1493],
20	30	CD	DURATION	30	num	21	SENT_220	[p16l1516t1420r1601b1478],
21	years	NNS	NUMBER	year	dep	28	SENT_220	[p16l1636t1437r1818b1493],
22	whereas	IN	O	whereas	dep	28	SENT_220	[p16l1853t1417r2142b1478],
23	(	NN	O	(	nsubjpass	28	SENT_220	[p16l14t1511r232b1586],
24	88	CD	PERCENT	88	num	25	SENT_220	[p16l14t1511r232b1586],
25	%	NN	PERCENT	%	dep	23	SENT_220	[p16l14t1511r232b1586],
26	)	CD	NUMBER	)	dep	23	SENT_220	[p16l14t1511r232b1586],
27	were	VBD	O	be	auxpass	28	SENT_220	[p16l263t1530r432b1571],
28	diagnosed	VBN	O	diagnose	ccomp	17	SENT_220	[p16l460t1510r823b1586],
29	before	IN	O	before	_	0	SENT_220	[p16l848t1510r1074b1571],
30	age	NN	O	age	prep_before	28	SENT_220	[p16l1103t1530r1218b1586],
31	50	CD	DURATION	50	num	32	SENT_220	[p16l1249t1513r1333b1571],
32	years	NNS	NUMBER	year	tmod	28	SENT_220	[p16l1359t1530r1561b1586],
33	.	.	O	.	_	0	SENT_220	[p16l1359t1530r1561b1586],

1	We	PRP	O	we	nsubj	3	SENT_221	[p16l91t1605r212b1664],
2	have	VBP	O	have	aux	3	SENT_221	[p16l305t1604r469b1664],
3	shown	VBN	O	show	_	0	SENT_221	[p16l565t1604r796b1664],
4	a	DT	O	a	det	7	SENT_221	[p16l890t1624r925b1664],
5	strong	JJ	O	strong	amod	7	SENT_221	[p16l1020t1618r1245b1680],
6	protective	JJ	O	protective	amod	7	SENT_221	[p16l1335t1604r1693b1680],
7	effect	NN	O	effect	dobj	3	SENT_221	[p16l1788t1604r1982b1664],
8	of	IN	O	of	_	0	SENT_221	[p16l2076t1604r2153b1664],
9	chemotherapy	NN	O	chemotherapy	prep_of	7	SENT_221	[p16l9t1696r524b1772],
10	for	IN	O	for	_	0	SENT_221	[p16l588t1696r690b1757],
11	risk	NN	O	risk	prep_for	3	SENT_221	[p16l754t1696r883b1757],
12	of	IN	O	of	_	0	SENT_221	[p16l949t1696r1026b1757],
13	contralateral	JJ	O	contralateral	amod	15	SENT_221	[p16l1084t1696r1535b1757],
14	breast	NN	O	breast	nn	15	SENT_221	[p16l1600t1696r1818b1757],
15	cancer	NN	O	cancer	prep_of	11	SENT_221	[p16l1886t1716r2138b1757],
16	.	.	O	.	_	0	SENT_221	[p16l1886t1716r2138b1757],

1	Chemotherapy	NN	O	chemotherapy	nsubj	4	SENT_222	[p16l11t1789r551b1865],
2	might	MD	O	might	aux	4	SENT_222	[p16l607t1789r817b1865],
3	be	VB	O	be	cop	4	SENT_222	[p16l873t1789r958b1850],
4	effective	JJ	O	effective	_	0	SENT_222	[p16l1018t1789r1312b1850],
5	in	IN	O	in	_	0	SENT_222	[p16l1372t1790r1440b1849],
6	eradicating	VBG	O	eradicate	prepc_in	4	SENT_222	[p16l1499t1789r1898b1865],
7	small	JJ	O	small	amod	9	SENT_222	[p16l1956t1789r2143b1850],
8	breast	NN	O	breast	nn	9	SENT_222	[p16l6t1883r225b1943],
9	tumours	NNS	O	tumour	dobj	6	SENT_222	[p16l265t1897r569b1943],
10	before	IN	O	before	mark	13	SENT_222	[p16l611t1883r837b1943],
11	they	PRP	O	they	nsubj	13	SENT_222	[p16l880t1883r1034b1959],
12	become	VBP	O	become	cop	13	SENT_222	[p16l1072t1883r1354b1943],
13	noticeable	JJ	O	noticeable	advcl	4	SENT_222	[p16l1396t1883r1784b1943],
14	.	.	O	.	_	0	SENT_222	[p16l1396t1883r1784b1943],

1	Previous	JJ	O	previous	amod	2	SENT_223	[p16l1833t1883r2141b1943],
2	studies	NNS	O	study	nsubj	5	SENT_223	[p16l9t1975r255b2036],
3	have	VBP	O	have	aux	5	SENT_223	[p16l286t1975r451b2036],
4	also	RB	O	also	advmod	5	SENT_223	[p16l484t1975r619b2036],
5	noted	VBN	O	note	_	0	SENT_223	[p16l651t1975r857b2036],
6	a	DT	O	a	det	7	SENT_223	[p16l890t1995r925b2036],
7	reduction	NN	O	reduction	dobj	5	SENT_223	[p16l956t1975r1304b2036],
8	in	IN	O	in	_	0	SENT_223	[p16l1334t1975r1403b2035],
9	risk	NN	O	risk	prep_in	7	SENT_223	[p16l1432t1975r1562b2036],
10	of	IN	O	of	_	0	SENT_223	[p16l1592t1975r1669b2036],
11	contralateral	JJ	O	contralateral	amod	13	SENT_223	[p16l1691t1975r2143b2036],
12	breast	NN	O	breast	nn	13	SENT_223	[p16l6t2068r225b2129],
13	cancer	NN	O	cancer	prep_of	9	SENT_223	[p16l321t2088r556b2129],
14	with	IN	O	with	_	0	SENT_223	[p16l649t2068r806b2129],
15	chemotherapy	NN	O	chemotherapy	prep_with	5	SENT_223	[p16l903t2068r1419b2144],
16	in	IN	O	in	_	0	SENT_223	[p16l1512t2069r1580b2128],
17	the	DT	O	the	det	19	SENT_223	[p16l1675t2068r1786b2129],
18	general	JJ	O	general	amod	19	SENT_223	[p16l1883t2068r2143b2144],
19	population	NN	O	population	prep_in	5	SENT_223	[p16l6t2162r470b2238],
20	.	.	O	.	_	0	SENT_223	[p16l6t2162r470b2238],

1	”	NN	O	”	nn	5	SENT_224	[p16l6t2162r470b2238],
2	BRCA1	NN	O	brca1	nn	5	SENT_224	[p16l504t2162r780b2222],
3	mutation-associated	JJ	O	mutation-associated	amod	5	SENT_224	[p16l821t2162r1551b2222],
4	breast	NN	O	breast	nn	5	SENT_224	[p16l1586t2162r1804b2222],
5	tumours	NNS	O	tumour	nsubj	16	SENT_224	[p16l1838t2176r2142b2222],
6	are	VBP	O	be	cop	16	SENT_224	[p16l9t2274r115b2315],
7	commonly	RB	O	commonly	advmod	16	SENT_224	[p16l160t2254r544b2330],
8	high	JJ	O	high	amod	9	SENT_224	[p16l583t2254r741b2330],
9	grade	NN	O	grade	npadvmod	16	SENT_224	[p16l782t2254r980b2330],
10	and	CC	O	and	_	0	SENT_224	[p16l1024t2254r1156b2315],
11	p53	NN	O	p53	nn	12	SENT_224	[p16l1191t2256r1325b2330],
12	mutation	NN	O	mutation	npadvmod	16	SENT_224	[p16l1366t2254r1697b2315],
13	positive	JJ	O	positive	amod	9	SENT_224	[p16l1737t2254r2143b2330],
14	,3	CD	NUMBER	,3	number	15	SENT_224	[p16l1737t2254r2143b2330],
15	‘	CD	NUMBER	‘	dep	13	SENT_224	[p16l1737t2254r2143b2330],
16	>	JJR	O	>	_	0	SENT_224	[p16l1737t2254r2143b2330],
17	32	CD	NUMBER	32	nsubj	22	SENT_224	[p16l1737t2254r2143b2330],
18	and	CC	O	and	_	0	SENT_224	[p16l9t2348r141b2408],
19	these	DT	O	these	det	20	SENT_224	[p16l176t2348r359b2408],
20	characteristics	NNS	O	characteristic	nsubj	22	SENT_224	[p16l397t2348r905b2408],
21	might	MD	O	might	aux	22	SENT_224	[p16l942t2348r1152b2424],
22	enhance	VB	O	enhance	ccomp	16	SENT_224	[p16l1188t2348r1484b2408],
23	chemosensitivity	NN	O	chemosensitivity	dobj	22	SENT_224	[p16l1522t2348r2138b2423],
24	.	.	O	.	_	0	SENT_224	[p16l1522t2348r2138b2423],

1	A	DT	O	a	det	4	SENT_225	[p16l6t2442r67b2500],
2	strong	JJ	O	strong	amod	4	SENT_225	[p16l110t2455r336b2517],
3	protective	JJ	O	protective	amod	4	SENT_225	[p16l376t2441r734b2517],
4	effect	NN	O	effect	nsubjpass	11	SENT_225	[p16l780t2441r974b2501],
5	on	IN	O	on	_	0	SENT_225	[p16l1019t2460r1108b2501],
6	contralateral	JJ	O	contralateral	amod	8	SENT_225	[p16l1153t2441r1604b2501],
7	breast	NN	O	breast	nn	8	SENT_225	[p16l1647t2441r1866b2501],
8	cancer	NN	O	cancer	prep_on	4	SENT_225	[p16l1910t2460r2145b2501],
9	was	VBD	O	be	auxpass	11	SENT_225	[p16l6t2553r138b2594],
10	also	RB	O	also	advmod	11	SENT_225	[p16l180t2533r315b2594],
11	seen	VBN	O	see	_	0	SENT_225	[p16l358t2553r514b2594],
12	with	IN	O	with	_	0	SENT_225	[p16l551t2533r710b2594],
13	oophorectomy	NN	O	oophorectomy	prep_with	11	SENT_225	[p16l750t2533r1294b2609],
14	,	,	O	,	_	0	SENT_225	[p16l750t2533r1294b2609],
15	similar	JJ	O	similar	advmod	11	SENT_225	[p16l1338t2533r1581b2594],
16	in	IN	O	in	_	0	SENT_225	[p16l1618t2533r1687b2593],
17	size	NN	O	size	prep_in	15	SENT_225	[p16l1727t2533r1853b2594],
18	to	TO	O	to	_	0	SENT_225	[p16l1893t2547r1962b2594],
19	that	DT	O	that	prep_to	15	SENT_225	[p16l2002t2533r2144b2594],
20	recorded	VBN	O	record	partmod	19	SENT_225	[p16l7t2626r328b2687],
21	with	IN	O	with	_	0	SENT_225	[p16l360t2626r519b2687],
22	tamoxifen	NN	O	tamoxifen	prep_with	20	SENT_225	[p16l552t2626r914b2687],
23	and	CC	O	and	_	0	SENT_225	[p16l950t2626r1082b2687],
24	chemotherapy	NN	O	chemotherapy	conj_and	22	SENT_225	[p16l1118t2626r1650b2702],
25	.	.	O	.	_	0	SENT_225	[p16l1118t2626r1650b2702],

1	This	DT	O	this	det	2	SENT_226	[p16l1689t2626r1852b2687],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_226	[p16l1888t2626r2145b2702],
3	is	VBZ	O	be	_	0	SENT_226	[p16l8t2720r59b2780],
4	in	IN	O	in	_	0	SENT_226	[p16l105t2720r174b2779],
5	keeping	VBG	O	keep	prepc_in	3	SENT_226	[p16l219t2720r499b2796],
6	with	IN	O	with	_	0	SENT_226	[p16l541t2720r699b2780],
7	a	DT	O	a	det	8	SENT_226	[p16l745t2740r780b2780],
8	report	NN	O	report	prep_with	5	SENT_226	[p16l826t2734r1046b2796],
9	showing	VBG	O	show	partmod	8	SENT_226	[p16l1092t2720r1389b2796],
10	that	IN	O	that	complm	12	SENT_226	[p16l1433t2720r1574b2780],
11	oophorectomy	NN	O	oophorectomy	nsubj	12	SENT_226	[p16l1620t2720r2145b2796],
12	reduces	VBZ	O	reduce	ccomp	9	SENT_226	[p16l7t2812r282b2873],
13	the	DT	O	the	det	14	SENT_226	[p16l342t2812r453b2873],
14	risk	NN	O	risk	dobj	12	SENT_226	[p16l513t2812r642b2873],
15	of	IN	O	of	_	0	SENT_226	[p16l700t2812r778b2873],
16	primary	JJ	O	primary	amod	18	SENT_226	[p16l825t2812r1111b2888],
17	breast	NN	O	breast	nn	18	SENT_226	[p16l1167t2812r1385b2873],
18	cancer	NN	O	cancer	prep_of	14	SENT_226	[p16l1445t2832r1680b2873],
19	in	IN	O	in	_	0	SENT_226	[p16l1737t2812r1805b2872],
20	BRCA1	NN	O	brca1	nn	22	SENT_226	[p16l1862t2812r2138b2873],
21	mutation	NN	O	mutation	nn	22	SENT_226	[p16l7t2906r338b2966],
22	carriers	NNS	O	carrier	prep_in	18	SENT_226	[p16l429t2906r763b2966],
23	.	.	O	.	_	0	SENT_226	[p16l429t2906r763b2966],

1	”	NN	O	”	nn	3	SENT_227	[p16l429t2906r763b2966],
2	Ovarian	JJ	O	ovarian	amod	3	SENT_227	[p16l856t2906r1142b2966],
3	ablation	NN	O	ablation	nsubj	5	SENT_227	[p16l1233t2906r1523b2966],
4	also	RB	O	also	advmod	5	SENT_227	[p16l1613t2906r1748b2966],
5	prevents	VBZ	O	prevent	_	0	SENT_227	[p16l1838t2920r2142b2982],
6	contralateral	JJ	O	contralateral	amod	8	SENT_227	[p16l9t2999r460b3059],
7	breast	NN	O	breast	nn	8	SENT_227	[p16l486t2999r704b3059],
8	cancer	NN	O	cancer	dobj	5	SENT_227	[p16l731t3018r966b3059],
9	in	IN	O	in	_	0	SENT_227	[p16l990t2999r1058b3058],
10	the	DT	O	the	det	12	SENT_227	[p16l1083t2999r1194b3059],
11	general	JJ	O	general	amod	12	SENT_227	[p16l1221t2999r1481b3075],
12	population	NN	O	population	prep_in	8	SENT_227	[p16l1506t2999r1969b3075],
13	.	.	O	.	_	0	SENT_227	[p16l1506t2999r1969b3075],

1	”	NN	O	”	_	0	SENT_228	[p16l1506t2999r1969b3075],

1	Our	PRP$	O	we	poss	2	SENT_229	[p16l95t3091r240b3152],
2	study	NN	O	study	nsubj	5	SENT_229	[p16l307t3091r502b3167],
3	does	VBZ	O	do	aux	5	SENT_229	[p16l570t3091r730b3152],
4	not	RB	O	not	neg	5	SENT_229	[p16l799t3105r920b3152],
5	allow	VB	O	allow	_	0	SENT_229	[p16l988t3091r1177b3152],
6	us	PRP	O	we	nsubj	8	SENT_229	[p16l1244t3111r1321b3152],
7	to	TO	O	to	aux	8	SENT_229	[p16l1390t3105r1459b3152],
8	recommend	VB	O	recommend	xcomp	5	SENT_229	[p16l1529t3091r1964b3152],
9	the	DT	O	the	det	11	SENT_229	[p16l2031t3091r2142b3152],
10	optimum	JJ	O	optimum	amod	11	SENT_229	[p16l9t3185r342b3260],
11	duration	NN	O	duration	dobj	8	SENT_229	[p16l404t3184r712b3245],
12	of	IN	O	of	_	0	SENT_229	[p16l775t3184r852b3245],
13	tamoxifen	NN	O	tamoxifen	prep_of	11	SENT_229	[p16l903t3184r1266b3245],
14	for	IN	O	for	_	0	SENT_229	[p16l1326t3184r1429b3245],
15	chemoprevention	NN	O	chemoprevention	prep_for	13	SENT_229	[p16l1490t3184r2140b3260],
16	,	,	O	,	_	0	SENT_229	[p16l1490t3184r2140b3260],
17	because	IN	O	because	_	0	SENT_229	[p16l6t3278r290b3338],
18	of	IN	O	of	_	0	SENT_229	[p16l325t3278r402b3338],
19	its	PRP$	O	its	poss	20	SENT_229	[p16l424t3278r503b3338],
20	design	NN	O	design	prep_because_of	13	SENT_229	[p16l539t3278r768b3354],
21	and	CC	O	and	_	0	SENT_229	[p16l801t3278r933b3338],
22	the	DT	O	the	det	24	SENT_229	[p16l965t3278r1076b3338],
23	small	JJ	O	small	amod	24	SENT_229	[p16l1111t3278r1297b3338],
24	size	NN	O	size	conj_and	13	SENT_229	[p16l1331t3278r1458b3338],
25	of	IN	O	of	_	0	SENT_229	[p16l1492t3278r1569b3338],
26	our	PRP$	O	we	poss	27	SENT_229	[p16l1593t3297r1715b3338],
27	subgroups	NNS	O	subgroup	prep_of	24	SENT_229	[p16l1747t3278r2137b3354],
28	.	.	O	.	_	0	SENT_229	[p16l1747t3278r2137b3354],

1	However	RB	O	however	advmod	6	SENT_230	[p16l8t3371r355b3443],
2	,	,	O	,	_	0	SENT_230	[p16l8t3371r355b3443],
3	we	PRP	O	we	nsubj	6	SENT_230	[p16l389t3390r487b3431],
4	did	VBD	O	do	aux	6	SENT_230	[p16l522t3370r637b3431],
5	not	RB	O	not	neg	6	SENT_230	[p16l668t3384r788b3431],
6	ﬁnd	VB	O	ﬁnd	_	0	SENT_230	[p16l820t3370r962b3431],
7	that	IN	O	that	complm	18	SENT_230	[p16l994t3370r1135b3431],
8	tamoxifen	NN	O	tamoxifen	nn	9	SENT_230	[p16l1166t3370r1528b3431],
9	use	NN	O	use	nsubjpass	18	SENT_230	[p16l1560t3390r1677b3431],
10	for	IN	O	for	prep	9	SENT_230	[p16l1710t3370r1812b3431],
11	a	DT	O	a	det	12	SENT_230	[p16l1844t3390r1879b3431],
12	period	NN	O	period	npadvmod	13	SENT_230	[p16l1911t3370r2143b3446],
13	longer	RBR	O	longer	advmod	14	SENT_230	[p16l8t3463r236b3539],
14	than	IN	O	than	pcomp	10	SENT_230	[p16l264t3463r425b3524],
15	4	CD	DURATION	4	num	16	SENT_230	[p16l456t3466r497b3523],
16	years	NNS	NUMBER	year	pobj	14	SENT_230	[p16l528t3483r710b3539],
17	was	VBD	O	be	auxpass	18	SENT_230	[p16l740t3483r872b3524],
18	associated	VBN	O	associate	ccomp	6	SENT_230	[p16l907t3463r1271b3524],
19	with	IN	O	with	_	0	SENT_230	[p16l1301t3463r1458b3524],
20	a	DT	O	a	det	22	SENT_230	[p16l1491t3483r1525b3524],
21	further	JJ	O	further	amod	22	SENT_230	[p16l1556t3463r1807b3524],
22	decrease	NN	O	decrease	prep_with	18	SENT_230	[p16l1837t3463r2142b3524],
23	in	IN	O	in	_	0	SENT_230	[p16l8t3557r76b3616],
24	risk	NN	O	risk	prep_in	22	SENT_230	[p16l116t3557r245b3617],
25	of	IN	O	of	_	0	SENT_230	[p16l286t3557r363b3617],
26	contralateral	JJ	O	contralateral	amod	28	SENT_230	[p16l395t3557r847b3617],
27	breast	NN	O	breast	nn	28	SENT_230	[p16l887t3557r1105b3617],
28	cancer	NN	O	cancer	prep_of	24	SENT_230	[p16l1147t3576r1399b3617],
29	.	.	O	.	_	0	SENT_230	[p16l1147t3576r1399b3617],

1	Tamoxifen	NN	O	tamoxifen	nn	2	SENT_231	[p16l1445t3557r1844b3617],
2	use	NN	O	use	_	0	SENT_231	[p16l1884t3577r2001b3617],
3	for	IN	O	for	dep	2	SENT_231	[p16l2043t3557r2145b3617],

1	3	CD	DURATION	3	num	2	SENT_232	[p17l9t26r48b84],
2	years	NNS	DURATION	year	nsubj	5	SENT_232	[p17l79t43r261b99],
3	on	IN	O	on	_	0	SENT_232	[p17l294t43r384b84],
4	average	JJ	O	average	prep_on	2	SENT_232	[p17l415t43r682b99],
5	provided	VBN	O	provide	_	0	SENT_232	[p17l712t23r1033b99],
6	protection	NN	O	protection	dobj	5	SENT_232	[p17l1062t23r1435b99],
7	for	IN	O	for	_	0	SENT_232	[p17l1465t23r1567b84],
8	up	RB	DURATION	up	quantmod	10	SENT_232	[p17l1594t43r1685b99],
9	to	TO	DURATION	to	dep	10	SENT_232	[p17l1716t37r1786b84],
10	10	CD	DURATION	10	num	11	SENT_232	[p17l1827t26r1905b84],
11	years	NNS	NUMBER	year	prep_for	6	SENT_232	[p17l1936t43r2140b99],
12	,	,	O	,	_	0	SENT_232	[p17l1936t43r2140b99],
13	after	IN	O	after	_	0	SENT_232	[p17l9t116r171b177],
14	which	WDT	O	which	rel	19	SENT_232	[p17l192t116r409b177],
15	the	DT	O	the	det	17	SENT_232	[p17l432t116r543b177],
16	risk	NN	O	risk	nn	17	SENT_232	[p17l568t116r697b177],
17	ratio	NN	O	ratio	nsubj	19	SENT_232	[p17l719t117r882b177],
18	was	VBD	O	be	cop	19	SENT_232	[p17l907t136r1038b177],
19	unity	NN	O	unity	rcmod	11	SENT_232	[p17l1063t117r1267b192],
20	.	.	O	.	_	0	SENT_232	[p17l1063t117r1267b192],

1	In	IN	O	in	_	0	SENT_233	[p17l1296t117r1373b176],
2	a	DT	O	a	det	4	SENT_233	[p17l1399t136r1434b177],
3	large	JJ	O	large	amod	4	SENT_233	[p17l1459t116r1630b192],
4	meta-analysis	NN	O	meta-analysis	prep_in	21	SENT_233	[p17l1655t116r2142b192],
5	of	IN	O	of	_	0	SENT_233	[p17l9t210r86b270],
6	tamoxifen	NN	O	tamoxifen	nn	8	SENT_233	[p17l110t210r472b270],
7	treatment	NN	O	treatment	nn	8	SENT_233	[p17l505t224r858b270],
8	trials	NNS	O	trial	prep_of	4	SENT_233	[p17l891t210r1088b283],
9	,	,	O	,	_	0	SENT_233	[p17l891t210r1088b283],
10	the	DT	O	the	det	12	SENT_233	[p17l1125t210r1235b270],
11	protective	JJ	O	protective	amod	12	SENT_233	[p17l1269t210r1627b286],
12	effect	NN	O	effect	nsubj	21	SENT_233	[p17l1664t210r1858b270],
13	on	IN	O	on	_	0	SENT_233	[p17l1893t229r1982b270],
14	risk	NN	O	risk	prep_on	12	SENT_233	[p17l2016t210r2145b270],
15	of	IN	O	of	_	0	SENT_233	[p17l9t302r86b363],
16	contralateral	JJ	O	contralateral	amod	18	SENT_233	[p17l114t302r565b363],
17	breast	NN	O	breast	nn	18	SENT_233	[p17l600t302r819b363],
18	cancer	NN	O	cancer	prep_of	14	SENT_233	[p17l856t322r1091b363],
19	did	VBD	O	do	aux	21	SENT_233	[p17l1126t302r1241b363],
20	not	RB	O	not	neg	21	SENT_233	[p17l1277t316r1397b363],
21	decline	VB	O	decline	_	0	SENT_233	[p17l1433t302r1688b363],
22	with	IN	O	with	_	0	SENT_233	[p17l1724t302r1881b363],
23	longer	JJR	O	longer	amod	24	SENT_233	[p17l1917t302r2145b378],
24	duration	NN	O	duration	prep_with	21	SENT_233	[p17l9t395r317b456],
25	of	IN	O	of	_	0	SENT_233	[p17l349t395r426b456],
26	tamoxifen	NN	O	tamoxifen	nn	27	SENT_233	[p17l445t395r808b456],
27	use	NN	O	use	prep_of	24	SENT_233	[p17l837t415r976b468],
28	,	,	O	,	_	0	SENT_233	[p17l837t415r976b468],
29	but	CC	O	but	_	0	SENT_233	[p17l1008t395r1131b456],
30	few	JJ	O	few	nsubj	35	SENT_233	[p17l1160t395r1285b456],
31	of	IN	O	of	_	0	SENT_233	[p17l1315t395r1393b456],
32	the	DT	O	the	det	34	SENT_233	[p17l1413t395r1523b456],
33	analysed	JJ	O	analysed	amod	34	SENT_233	[p17l1556t395r1863b471],
34	studies	NNS	O	study	prep_of	30	SENT_233	[p17l1895t395r2142b456],
35	used	VBN	O	use	conj_but	21	SENT_233	[p17l7t489r174b549],
36	tamoxifen	NN	O	tamoxifen	dobj	35	SENT_233	[p17l228t489r590b549],
37	for	IN	O	for	_	0	SENT_233	[p17l645t489r747b549],
38	longer	JJR	O	longer	prepc_for	35	SENT_233	[p17l800t489r1028b565],
39	than	IN	O	than	_	0	SENT_233	[p17l1081t489r1242b549],
40	5	CD	DURATION	5	num	41	SENT_233	[p17l1300t491r1336b549],
41	years	NNS	NUMBER	year	prep_than	35	SENT_233	[p17l1393t490r1647b565],
42	.	.	O	.	_	0	SENT_233	[p17l1393t490r1647b565],

1	”	NN	O	”	npadvmod	13	SENT_234	[p17l1393t490r1647b565],
2	By	IN	O	by	_	0	SENT_234	[p17l1703t490r1799b565],
3	contrast	NN	O	contrast	prep_by	13	SENT_234	[p17l1854t503r2144b549],
4	with	IN	O	with	_	0	SENT_234	[p17l10t582r169b643],
5	tamoxifen	NN	O	tamoxifen	prep_with	3	SENT_234	[p17l248t582r632b655],
6	,	,	O	,	_	0	SENT_234	[p17l248t582r632b655],
7	the	DT	O	the	det	9	SENT_234	[p17l715t582r827b643],
8	risk	NN	O	risk	nn	9	SENT_234	[p17l909t582r1038b643],
9	reduction	NN	O	reduction	nsubj	13	SENT_234	[p17l1116t582r1465b643],
10	associated	VBN	O	associate	partmod	9	SENT_234	[p17l1548t582r1913b643],
11	with	IN	O	with	_	0	SENT_234	[p17l1992t582r2150b643],
12	oophorectomy	NN	O	oophorectomy	prep_with	10	SENT_234	[p17l13t675r539b751],
13	persisted	VBD	O	persist	_	0	SENT_234	[p17l568t675r889b751],
14	beyond	IN	O	beyond	_	0	SENT_234	[p17l920t675r1187b751],
15	10	CD	DURATION	10	num	16	SENT_234	[p17l1228t678r1307b736],
16	years	NNS	NUMBER	year	prep_beyond	13	SENT_234	[p17l1340t695r1542b751],
17	.	.	O	.	_	0	SENT_234	[p17l1340t695r1542b751],

1	We	PRP	O	we	nsubj	2	SENT_235	[p17l1578t676r1700b736],
2	showed	VBD	O	show	_	0	SENT_235	[p17l1735t675r2006b736],
3	the	DT	O	the	det	4	SENT_235	[p17l2038t675r2149b736],
4	effects	NNS	O	effect	dobj	2	SENT_235	[p17l13t769r238b829],
5	of	IN	O	of	_	0	SENT_235	[p17l272t769r349b829],
6	tamoxifen	NN	O	tamoxifen	prep_of	4	SENT_235	[p17l368t769r731b829],
7	and	CC	O	and	_	0	SENT_235	[p17l763t769r895b829],
8	oophorectomy	NN	O	oophorectomy	prep_of	4	SENT_235	[p17l927t769r1452b845],
9	to	TO	O	to	aux	11	SENT_235	[p17l1480t783r1550b829],
10	be	VB	O	be	cop	11	SENT_235	[p17l1580t769r1665b829],
11	independent	JJ	O	independent	xcomp	2	SENT_235	[p17l1696t769r2151b845],
12	in	IN	O	in	_	0	SENT_235	[p17l12t861r80b921],
13	reducing	VBG	O	reduce	prepc_in	11	SENT_235	[p17l146t861r465b937],
14	risk	NN	O	risk	dobj	13	SENT_235	[p17l530t861r660b922],
15	of	IN	O	of	_	0	SENT_235	[p17l726t861r804b922],
16	contralateral	JJ	O	contralateral	amod	18	SENT_235	[p17l862t861r1314b922],
17	breast	NN	O	breast	nn	18	SENT_235	[p17l1380t861r1599b922],
18	cancer	NN	O	cancer	prep_of	14	SENT_235	[p17l1667t881r1921b934],
19	,	,	O	,	_	0	SENT_235	[p17l1667t881r1921b934],
20	and	CC	O	and	cc	2	SENT_235	[p17l1993t861r2146b934],
21	,	,	O	,	_	0	SENT_235	[p17l1993t861r2146b934],
22	ultimately	RB	O	ultimately	dep	2	SENT_235	[p17l11t954r395b1030],
23	,	,	O	,	_	0	SENT_235	[p17l11t954r395b1030],
24	the	DT	O	the	det	26	SENT_235	[p17l471t954r582b1015],
25	greatest	JJS	O	greatest	amod	26	SENT_235	[p17l656t969r935b1030],
26	protection	NN	O	protection	nsubjpass	29	SENT_235	[p17l1007t955r1381b1030],
27	may	MD	O	may	aux	29	SENT_235	[p17l1454t974r1607b1030],
28	be	VB	O	be	auxpass	29	SENT_235	[p17l1677t954r1761b1015],
29	achieved	VBN	O	achieve	ccomp	2	SENT_235	[p17l1838t954r2150b1015],
30	through	IN	O	through	_	0	SENT_235	[p17l11t1048r299b1124],
31	the	DT	O	the	det	32	SENT_235	[p17l324t1048r435b1108],
32	combination	NN	O	combination	prep_through	29	SENT_235	[p17l463t1048r920b1108],
33	of	IN	O	of	prep	29	SENT_235	[p17l947t1048r1024b1108],
34	both	CC	O	both	dep	33	SENT_235	[p17l1039t1048r1206b1108],
35	therapies	NNS	O	therapy	conj	33	SENT_235	[p17l1231t1048r1575b1124],
36	.	.	O	.	_	0	SENT_235	[p17l1231t1048r1575b1124],

1	We	PRP	O	we	nsubj	2	SENT_236	[p17l95t1141r217b1201],
2	believe	VBP	O	believe	_	0	SENT_236	[p17l249t1140r498b1201],
3	that	IN	O	that	complm	8	SENT_236	[p17l531t1140r673b1201],
4	tamoxifen	NN	O	tamoxifen	nsubjpass	8	SENT_236	[p17l705t1140r1068b1201],
5	can	MD	O	can	aux	8	SENT_236	[p17l1102t1160r1225b1201],
6	reasonably	RB	O	reasonably	advmod	8	SENT_236	[p17l1258t1140r1645b1216],
7	be	VB	O	be	auxpass	8	SENT_236	[p17l1675t1140r1759b1201],
8	offered	VBN	O	offer	ccomp	2	SENT_236	[p17l1795t1140r2046b1201],
9	to	TO	O	to	_	0	SENT_236	[p17l2079t1154r2148b1201],
10	women	NNS	O	woman	prep_to	8	SENT_236	[p17l10t1253r277b1294],
11	with	IN	O	with	_	0	SENT_236	[p17l328t1233r486b1294],
12	BRCA1	NN	O	brca1	nn	15	SENT_236	[p17l536t1234r813b1294],
13	or	CC	O	or	_	0	SENT_236	[p17l873t1253r947b1294],
14	BRCA2	NN	O	brca2	nn	15	SENT_236	[p17l996t1234r1279b1294],
15	mutations	NNS	O	mutation	prep_with	10	SENT_236	[p17l1330t1234r1692b1294],
16	and	CC	O	and	_	0	SENT_236	[p17l1748t1233r1881b1294],
17	breast	NN	O	breast	nn	18	SENT_236	[p17l1932t1233r2151b1294],
18	cancer	NN	O	cancer	conj_and	10	SENT_236	[p17l14t1346r249b1387],
19	for	IN	O	for	_	0	SENT_236	[p17l290t1327r393b1387],
20	the	DT	O	the	det	21	SENT_236	[p17l434t1327r545b1387],
21	prevention	NN	O	prevention	prep_for	18	SENT_236	[p17l588t1327r977b1403],
22	of	IN	O	of	_	0	SENT_236	[p17l1022t1327r1099b1387],
23	contralateral	JJ	O	contralateral	amod	25	SENT_236	[p17l1134t1327r1586b1387],
24	breast	NN	O	breast	nn	25	SENT_236	[p17l1629t1327r1847b1387],
25	cancer	NN	O	cancer	prep_of	21	SENT_236	[p17l1892t1346r2144b1387],
26	.	.	O	.	_	0	SENT_236	[p17l1892t1346r2144b1387],

1	The	DT	O	the	det	2	SENT_237	[p17l11t1419r159b1480],
2	effect	NN	O	effect	nsubjpass	14	SENT_237	[p17l193t1419r387b1480],
3	of	IN	O	of	_	0	SENT_237	[p17l419t1419r497b1480],
4	tamoxifen	NN	O	tamoxifen	prep_of	2	SENT_237	[p17l518t1419r881b1480],
5	on	IN	O	on	_	0	SENT_237	[p17l913t1439r1003b1480],
6	reduction	NN	O	reduction	prep_on	4	SENT_237	[p17l1034t1419r1383b1480],
7	of	IN	O	of	_	0	SENT_237	[p17l1415t1419r1493b1480],
8	cancer-associated	JJ	O	cancer-associated	amod	9	SENT_237	[p17l1516t1419r2150b1480],
9	mortality	NN	O	mortality	prep_of	6	SENT_237	[p17l11t1512r342b1588],
10	has	VBZ	O	have	aux	14	SENT_237	[p17l365t1512r482b1573],
11	not	RB	O	not	neg	14	SENT_237	[p17l508t1527r628b1573],
12	yet	RB	O	yet	advmod	14	SENT_237	[p17l651t1527r758b1588],
13	been	VBN	O	be	auxpass	14	SENT_237	[p17l782t1512r955b1573],
14	established	VBN	O	establish	_	0	SENT_237	[p17l981t1512r1400b1585],
15	,	,	O	,	_	0	SENT_237	[p17l981t1512r1400b1585],
16	and	CC	O	and	_	0	SENT_237	[p17l1430t1512r1562b1573],
17	our	PRP$	O	we	poss	18	SENT_237	[p17l1589t1532r1712b1573],
18	data	NNS	O	datum	nsubj	21	SENT_237	[p17l1736t1512r1888b1573],
19	do	VBP	O	do	aux	21	SENT_237	[p17l1916t1512r2004b1573],
20	not	RB	O	not	neg	21	SENT_237	[p17l2030t1527r2151b1573],
21	allow	VB	O	allow	conj_and	14	SENT_237	[p17l14t1606r202b1666],
22	us	PRP	O	we	nsubj	24	SENT_237	[p17l229t1626r306b1666],
23	to	TO	O	to	aux	24	SENT_237	[p17l335t1620r404b1666],
24	determine	VB	O	determine	xcomp	21	SENT_237	[p17l435t1606r799b1666],
25	whether	IN	O	whether	complm	27	SENT_237	[p17l827t1606r1121b1666],
26	tamoxifen	NN	O	tamoxifen	nsubj	27	SENT_237	[p17l1147t1606r1510b1666],
27	slows	VBZ	O	slow	ccomp	24	SENT_237	[p17l1538t1606r1728b1666],
28	the	DT	O	the	det	29	SENT_237	[p17l1757t1606r1868b1666],
29	growth	NN	O	growth	dobj	27	SENT_237	[p17l1897t1606r2150b1682],
30	of	IN	O	of	_	0	SENT_237	[p17l13t1698r90b1759],
31	existing	VBG	O	exist	amod	32	SENT_237	[p17l125t1698r400b1774],
32	tumours	NNS	O	tumour	prep_of	29	SENT_237	[p17l441t1712r745b1759],
33	or	CC	O	or	_	0	SENT_237	[p17l791t1718r865b1759],
34	reduces	VBZ	O	reduce	conj_or	27	SENT_237	[p17l906t1698r1181b1759],
35	the	DT	O	the	det	36	SENT_237	[p17l1225t1698r1336b1759],
36	development	NN	O	development	dobj	34	SENT_237	[p17l1381t1698r1850b1774],
37	of	IN	O	of	_	0	SENT_237	[p17l1893t1698r1970b1759],
38	new	JJ	O	new	amod	39	SENT_237	[p17l2002t1718r2151b1759],
39	ones	NNS	O	one	prep_of	36	SENT_237	[p17l13t1811r194b1852],
40	.	.	O	.	_	0	SENT_237	[p17l13t1811r194b1852],

1	We	PRP	O	we	nsubj	2	SENT_238	[p17l255t1792r377b1852],
2	believe	VBP	O	believe	_	0	SENT_238	[p17l434t1791r683b1852],
3	that	IN	O	that	complm	7	SENT_238	[p17l740t1791r882b1852],
4	tamoxifen	NN	O	tamoxifen	nsubj	7	SENT_238	[p17l938t1791r1301b1852],
5	will	MD	O	will	aux	7	SENT_238	[p17l1356t1791r1484b1852],
6	also	RB	O	also	advmod	7	SENT_238	[p17l1543t1791r1678b1852],
7	reduce	VB	O	reduce	ccomp	2	SENT_238	[p17l1737t1791r1980b1852],
8	the	DT	O	the	det	9	SENT_238	[p17l2038t1791r2149b1852],
9	occurrence	NN	O	occurrence	dobj	7	SENT_238	[p17l13t1904r410b1945],
10	of	IN	O	of	_	0	SENT_238	[p17l463t1885r540b1945],
11	primary	JJ	O	primary	amod	12	SENT_238	[p17l580t1885r866b1961],
12	cancers	NNS	O	cancer	prep_of	9	SENT_238	[p17l917t1904r1182b1945],
13	in	IN	O	in	_	0	SENT_238	[p17l1235t1885r1303b1944],
14	BRCAI	NNP	O	BRCAI	prep_in	7	SENT_238	[p17l1352t1885r1629b1945],
15	and	CC	O	and	_	0	SENT_238	[p17l1686t1885r1819b1945],
16	BRCA2	NN	O	brca2	nn	18	SENT_238	[p17l1868t1885r2151b1945],
17	mutation	NN	O	mutation	nn	18	SENT_238	[p17l11t1977r343b2038],
18	carriers	NNS	O	carrier	prep_in	7	SENT_238	[p17l425t1977r711b2050],
19	,	,	O	,	_	0	SENT_238	[p17l425t1977r711b2050],
20	and	CC	O	and	_	0	SENT_238	[p17l758t1977r890b2038],
21	that	IN	O	that	complm	29	SENT_238	[p17l931t1977r1073b2038],
22	tamoxifen	NN	O	tamoxifen	nn	23	SENT_238	[p17l1114t1977r1477b2038],
23	chemoprevention	NN	O	chemoprevention	nsubjpass	29	SENT_238	[p17l1520t1977r2150b2053],
24	and	CC	O	and	_	0	SENT_238	[p17l14t2070r145b2131],
25	other	JJ	O	other	amod	26	SENT_238	[p17l172t2070r361b2131],
26	options	NNS	O	option	conj_and	23	SENT_238	[p17l385t2071r649b2146],
27	should	MD	O	should	aux	29	SENT_238	[p17l677t2070r917b2131],
28	be	VB	O	be	auxpass	29	SENT_238	[p17l941t2070r1025b2131],
29	discussed	VBN	O	discuss	ccomp	2	SENT_238	[p17l1052t2070r1393b2131],
30	with	IN	O	with	_	0	SENT_238	[p17l1416t2070r1574b2131],
31	healthy	JJ	O	healthy	amod	32	SENT_238	[p17l1597t2070r1862b2146],
32	women	NNS	O	woman	prep_with	29	SENT_238	[p17l1883t2090r2150b2131],
33	who	WP	O	who	nsubj	34	SENT_238	[p17l10t2164r161b2224],
34	carry	VBP	O	carry	rcmod	32	SENT_238	[p17l201t2183r381b2240],
35	BRCA1	NN	O	brca1	nn	38	SENT_238	[p17l413t2164r690b2224],
36	or	CC	O	or	_	0	SENT_238	[p17l732t2183r807b2224],
37	BRCA2	NN	O	brca2	nn	38	SENT_238	[p17l839t2164r1122b2224],
38	mutations	NNS	O	mutation	dobj	34	SENT_238	[p17l1156t2164r1539b2224],
39	.	.	O	.	_	0	SENT_238	[p17l1156t2164r1539b2224],

1	Risk	NN	O	risk	nn	2	SENT_239	[p17l1582t2164r1740b2224],
2	factors	NNS	O	factor	nsubj	6	SENT_239	[p17l1773t2164r2012b2224],
3	for	IN	O	for	_	0	SENT_239	[p17l2049t2164r2152b2224],
4	second	JJ	ORDINAL	second	amod	5	SENT_239	[p17l13t2256r263b2317],
5	cancers	NNS	O	cancer	prep_for	2	SENT_239	[p17l303t2276r568b2317],
6	differ	VBP	O	differ	_	0	SENT_239	[p17l610t2256r801b2317],
7	from	IN	O	from	_	0	SENT_239	[p17l838t2256r1011b2317],
8	those	DT	O	those	prep_from	6	SENT_239	[p17l1049t2256r1239b2317],
9	for	IN	O	for	_	0	SENT_239	[p17l1279t2256r1381b2317],
10	the	DT	O	the	det	12	SENT_239	[p17l1418t2256r1529b2317],
11	primary	JJ	O	primary	amod	12	SENT_239	[p17l1567t2256r1853b2332],
12	cancer	NN	O	cancer	prep_for	8	SENT_239	[p17l1892t2276r2146b2329],
13	,	,	O	,	_	0	SENT_239	[p17l1892t2276r2146b2329],
14	but	CC	O	but	_	0	SENT_239	[p17l10t2349r133b2410],
15	it	PRP	O	it	nsubj	17	SENT_239	[p17l179t2350r227b2410],
16	is	VBZ	O	be	cop	17	SENT_239	[p17l273t2350r324b2410],
17	notable	JJ	O	notable	conj_but	6	SENT_239	[p17l372t2349r640b2410],
18	that	IN	O	that	complm	36	SENT_239	[p17l687t2349r828b2410],
19	the	DT	O	the	det	20	SENT_239	[p17l874t2349r985b2410],
20	size	NN	O	size	nsubj	36	SENT_239	[p17l1034t2350r1161b2410],
21	of	IN	O	of	_	0	SENT_239	[p17l1209t2349r1286b2410],
22	the	DT	O	the	det	24	SENT_239	[p17l1323t2349r1434b2410],
23	risk	NN	O	risk	nn	24	SENT_239	[p17l1481t2349r1611b2410],
24	reduction	NN	O	reduction	prep_of	20	SENT_239	[p17l1654t2349r2004b2410],
25	for	IN	O	for	_	0	SENT_239	[p17l2050t2349r2152b2410],
26	primary	JJ	O	primary	amod	27	SENT_239	[p17l10t2443r296b2519],
27	cancer	NN	O	cancer	prep_for	24	SENT_239	[p17l340t2463r575b2503],
28	seen	VBN	O	see	partmod	27	SENT_239	[p17l617t2462r773b2503],
29	in	IN	O	in	_	0	SENT_239	[p17l816t2443r884b2502],
30	the	DT	O	the	det	34	SENT_239	[p17l927t2443r1038b2503],
31	NSABP	NNP	ORGANIZATION	NSABP	nn	34	SENT_239	[p17l1080t2443r1372b2503],
32	Pl	NN	O	pl	nn	34	SENT_239	[p17l1415t2444r1503b2502],
33	prevention	NN	O	prevention	nn	34	SENT_239	[p17l1554t2443r1943b2519],
34	trial9	NN	O	trial9	prep_in	28	SENT_239	[p17l1984t2443r2149b2503],
35	was	VBD	O	be	cop	36	SENT_239	[p17l10t2555r142b2596],
36	similar	JJ	O	similar	ccomp	17	SENT_239	[p17l218t2535r461b2596],
37	to	TO	O	to	_	0	SENT_239	[p17l532t2549r601b2596],
38	that	DT	O	that	prep_to	36	SENT_239	[p17l675t2535r816b2596],
39	predicted	VBN	O	predict	partmod	38	SENT_239	[p17l887t2535r1229b2611],
40	on	IN	O	on	_	0	SENT_239	[p17l1304t2555r1393b2596],
41	the	DT	O	the	det	42	SENT_239	[p17l1465t2535r1577b2596],
42	basis	NN	O	basis	prep_on	39	SENT_239	[p17l1649t2535r1822b2596],
43	of	IN	O	of	_	0	SENT_239	[p17l1898t2535r1975b2596],
44	the	DT	O	the	det	47	SENT_239	[p17l2038t2535r2149b2596],
45	contralateral	JJ	O	contralateral	amod	47	SENT_239	[p17l14t2628r465b2689],
46	breast	NN	O	breast	nn	47	SENT_239	[p17l490t2628r709b2689],
47	cancers	NNS	O	cancer	prep_of	42	SENT_239	[p17l736t2648r1001b2689],
48	in	IN	O	in	_	0	SENT_239	[p17l1029t2629r1096b2688],
49	previous	JJ	O	previous	amod	50	SENT_239	[p17l1121t2629r1426b2704],
50	trials	NNS	O	trial	prep_in	47	SENT_239	[p17l1453t2628r1699b2689],
51	.	.	O	.	_	0	SENT_239	[p17l1453t2628r1699b2689],

1	“	NN	O	“	_	0	SENT_240	[p17l1453t2628r1699b2689],

1	Hereditary	JJ	O	hereditary	dep	194	SENT_241	[p17l13t2798r341b2862],
2	Breast	NN	O	breast	dep	194	SENT_241	[p17l363t2798r568b2850],
3	Cancer	NN	O	cancer	dep	194	SENT_241	[p17l592t2796r814b2850],
4	Clinical	JJ	O	clinical	dep	194	SENT_241	[p17l836t2796r1060b2850],
5	Study	NNP	O	Study	dep	194	SENT_241	[p17l1081t2796r1262b2862],
6	Group	NNP	O	Group	dep	194	SENT_241	[p17l1284t2796r1472b2862],
7	W	NNP	O	W	dep	194	SENT_241	[p17l10t2878r76b2925],
8	Foulkes	NNPS	PERSON	Foulkes	dep	194	SENT_241	[p17l95t2877r333b2934],
9	,	,	O	,	_	0	SENT_241	[p17l95t2877r333b2934],
10	P	NN	O	p	dep	194	SENT_241	[p17l356t2878r395b2924],
11	Tonin	NN	O	tonin	dep	194	SENT_241	[p17l414t2877r591b2924],
12	(	NN	O	(	dep	194	SENT_241	[p17l615t2877r838b2935],
13	McGill	NNP	ORGANIZATION	McGill	dep	194	SENT_241	[p17l615t2877r838b2935],
14	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l858t2877r1190b2936],
15	)	NN	O	)	dep	194	SENT_241	[p17l858t2877r1190b2936],
16	,	,	O	,	_	0	SENT_241	[p17l858t2877r1190b2936],
17	C	NN	O	c	dep	194	SENT_241	[p17l1215t2877r1259b2925],
18	Perret	NNP	PERSON	Perret	dep	194	SENT_241	[p17l1282t2878r1470b2934],
19	,	,	O	,	_	0	SENT_241	[p17l1282t2878r1470b2934],
20	A-M	NNP	O	A-M	dep	194	SENT_241	[p17l1490t2878r1628b2924],
21	Mes-Masson	NNP	O	Mes-Masson	dep	194	SENT_241	[p17l1647t2878r2031b2934],
22	,	,	O	,	_	0	SENT_241	[p17l1647t2878r2031b2934],
23	D	NNP	O	D	dep	194	SENT_241	[p17l11t2952r63b2998],
24	Provencher	NNP	PERSON	Provencher	dep	194	SENT_241	[p17l85t2952r407b2999],
25	(	NNP	O	(	dep	194	SENT_241	[p17l431t2952r743b3011],
26	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l431t2952r743b3011],
27	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l763t2951r823b2999],
28	Montreal	NNP	ORGANIZATION	Montreal	dep	194	SENT_241	[p17l835t2952r1139b3010],
29	)	NNP	O	)	dep	194	SENT_241	[p17l835t2952r1139b3010],
30	,	,	O	,	_	0	SENT_241	[p17l835t2952r1139b3010],
31	B	NNP	PERSON	B	dep	194	SENT_241	[p17l1163t2952r1203b2998],
32	Rosen	NNP	PERSON	Rosen	dep	194	SENT_241	[p17l1226t2952r1416b3008],
33	,	,	O	,	_	0	SENT_241	[p17l1226t2952r1416b3008],
34	E	NNP	ORGANIZATION	E	dep	194	SENT_241	[p17l1439t2952r1481b2998],
35	Warner	NNP	ORGANIZATION	Warner	dep	194	SENT_241	[p17l1499t2952r1729b3008],
36	,	,	O	,	_	0	SENT_241	[p17l1499t2952r1729b3008],
37	R	NNP	PERSON	R	dep	194	SENT_241	[p17l1753t2952r1800b2998],
38	Nedelcu	NNP	PERSON	Nedelcu	dep	194	SENT_241	[p17l1816t2952r2071b3008],
39	,	,	O	,	_	0	SENT_241	[p17l1816t2952r2071b3008],
40	E	NNP	O	E	dep	194	SENT_241	[p17l11t3028r54b3074],
41	Hoodfar	NNP	O	Hoodfar	dep	194	SENT_241	[p17l74t3027r328b3084],
42	,	,	O	,	_	0	SENT_241	[p17l74t3027r328b3084],
43	D	NNP	O	D	dep	194	SENT_241	[p17l351t3028r403b3074],
44	Hannah	NNP	PERSON	Hannah	dep	194	SENT_241	[p17l425t3027r669b3084],
45	,	,	O	,	_	0	SENT_241	[p17l425t3027r669b3084],
46	A	NNP	O	A	dep	194	SENT_241	[p17l690t3028r738b3074],
47	Finch	NNP	O	Finch	dep	194	SENT_241	[p17l757t3027r936b3084],
48	,	,	O	,	_	0	SENT_241	[p17l757t3027r936b3084],
49	H	NNP	O	H	dep	194	SENT_241	[p17l960t3028r1012b3074],
50	Jernstrom	NNP	O	Jernstrom	dep	194	SENT_241	[p17l1029t3028r1327b3085],
51	,	,	O	,	_	0	SENT_241	[p17l1029t3028r1327b3085],
52	J	NNP	O	J	dep	194	SENT_241	[p17l1346t3028r1373b3085],
53	McLaughlin	NNP	PERSON	McLaughlin	dep	194	SENT_241	[p17l1391t3027r1758b3087],
54	,	,	O	,	_	0	SENT_241	[p17l1391t3027r1758b3087],
55	K	NNP	O	K	dep	194	SENT_241	[p17l11t3103r64b3149],
56	Metcalfe	NNP	PERSON	Metcalfe	dep	194	SENT_241	[p17l82t3102r345b3159],
57	,	,	O	,	_	0	SENT_241	[p17l82t3102r345b3159],
58	A	NNP	O	A	dep	194	SENT_241	[p17l366t3103r414b3149],
59	Liede	NNP	O	Liede	dep	194	SENT_241	[p17l433t3102r591b3150],
60	(	NNP	O	(	dep	194	SENT_241	[p17l616t3102r928b3161],
61	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l616t3102r928b3161],
62	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l948t3102r1009b3149],
63	Toronto	NNP	ORGANIZATION	Toronto	dep	194	SENT_241	[p17l1020t3102r1300b3160],
64	)	NNP	O	)	dep	194	SENT_241	[p17l1020t3102r1300b3160],
65	,	,	O	,	_	0	SENT_241	[p17l1020t3102r1300b3160],
66	K	NNP	PERSON	K	dep	194	SENT_241	[p17l1323t3103r1376b3149],
67	Panabaker	NNP	PERSON	Panabaker	dep	194	SENT_241	[p17l1394t3102r1706b3159],
68	,	,	O	,	_	0	SENT_241	[p17l1394t3102r1706b3159],
69	C	NNP	O	C	dep	194	SENT_241	[p17l1730t3102r1775b3150],
70	Kim-Sing	NNP	O	Kim-Sing	dep	194	SENT_241	[p17l1798t3102r2089b3161],
71	,	,	O	,	_	0	SENT_241	[p17l1798t3102r2089b3161],
72	D	NNP	O	D	dep	194	SENT_241	[p17l11t3178r63b3224],
73	Horsman	NNP	PERSON	Horsman	dep	194	SENT_241	[p17l85t3178r366b3234],
74	,	,	O	,	_	0	SENT_241	[p17l85t3178r366b3234],
75	C	NNP	O	C	dep	194	SENT_241	[p17l391t3177r436b3224],
76	Trevisan	NNP	PERSON	Trevisan	dep	194	SENT_241	[p17l458t3177r721b3234],
77	,	,	O	,	_	0	SENT_241	[p17l458t3177r721b3234],
78	I	PRP	O	I	dep	194	SENT_241	[p17l743t3178r765b3224],
79	Olivotto	NNP	PERSON	Olivotto	dep	194	SENT_241	[p17l788t3177r1017b3224],
80	(	NNP	O	(	dep	194	SENT_241	[p17l1043t3177r1250b3235],
81	British	NNP	O	British	dep	194	SENT_241	[p17l1043t3177r1250b3235],
82	Columbia	NNP	ORGANIZATION	Columbia	dep	194	SENT_241	[p17l1272t3177r1552b3224],
83	Cancer	NNP	ORGANIZATION	Cancer	dep	194	SENT_241	[p17l1574t3177r1777b3224],
84	Agency	NNP	ORGANIZATION	Agency	dep	194	SENT_241	[p17l1794t3177r2045b3236],
85	)	NNP	O	)	dep	194	SENT_241	[p17l1794t3177r2045b3236],
86	,	,	O	,	_	0	SENT_241	[p17l1794t3177r2045b3236],
87	D	NNP	PERSON	D	dep	194	SENT_241	[p17l11t3253r63b3299],
88	Gilchrist	NNP	PERSON	Gilchrist	dep	194	SENT_241	[p17l86t3252r330b3300],
89	(	NNP	O	(	dep	194	SENT_241	[p17l354t3252r666b3311],
90	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l354t3252r666b3311],
91	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l686t3252r746b3300],
92	Alberta	NNP	ORGANIZATION	Alberta	dep	194	SENT_241	[p17l757t3252r1007b3311],
93	)	NN	O	)	dep	194	SENT_241	[p17l757t3252r1007b3311],
94	,	,	O	,	_	0	SENT_241	[p17l757t3252r1007b3311],
95	P	NN	O	p	dep	194	SENT_241	[p17l1030t3253r1069b3299],
96	Ainsworth	NNP	PERSON	Ainsworth	dep	194	SENT_241	[p17l1088t3252r1398b3309],
97	,	,	O	,	_	0	SENT_241	[p17l1088t3252r1398b3309],
98	G	NNP	PERSON	G	dep	194	SENT_241	[p17l1421t3253r1474b3300],
99	Sheridan	NNP	PERSON	Sheridan	dep	194	SENT_241	[p17l1495t3252r1746b3300],
100	(	NNP	O	(	dep	194	SENT_241	[p17l1770t3253r2082b3312],
101	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l1770t3253r2082b3312],
102	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l13t3327r73b3374],
103	Western	NNP	ORGANIZATION	Western	dep	194	SENT_241	[p17l83t3328r320b3375],
104	Ontario/LRCC	NN	ORGANIZATION	ontario/lrcc	dep	194	SENT_241	[p17l341t3327r812b3386],
105	)	NN	O	)	dep	194	SENT_241	[p17l341t3327r812b3386],
106	,	,	O	,	_	0	SENT_241	[p17l341t3327r812b3386],
107	T	NN	O	t	dep	194	SENT_241	[p17l834t3328r883b3374],
108	Rebbeck	NN	O	rebbeck	dep	194	SENT_241	[p17l903t3327r1163b3384],
109	,	,	O	,	_	0	SENT_241	[p17l903t3327r1163b3384],
110	A	DT	O	a	dep	194	SENT_241	[p17l1184t3328r1232b3374],
111	Eisen	NNP	PERSON	Eisen	dep	194	SENT_241	[p17l1250t3327r1404b3374],
112	(	NNP	O	(	dep	194	SENT_241	[p17l1429t3327r1741b3386],
113	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l1429t3327r1741b3386],
114	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l1761t3327r1821b3374],
115	Pennsylvania	NNP	ORGANIZATION	Pennsylvania	dep	194	SENT_241	[p17l12t3402r422b3461],
116	)	NN	O	)	dep	194	SENT_241	[p17l12t3402r422b3461],
117	,	,	O	,	_	0	SENT_241	[p17l12t3402r422b3461],
118	M	NN	O	m	dep	194	SENT_241	[p17l444t3403r509b3449],
119	Daly	NNP	PERSON	Daly	dep	194	SENT_241	[p17l529t3402r678b3461],
120	,	,	O	,	_	0	SENT_241	[p17l529t3402r678b3461],
121	A	NNP	O	A	dep	194	SENT_241	[p17l699t3403r747b3449],
122	Godwin	NNP	O	Godwin	dep	194	SENT_241	[p17l767t3402r1011b3459],
123	,	,	O	,	_	0	SENT_241	[p17l767t3402r1011b3459],
124	J	NNP	O	J	dep	194	SENT_241	[p17l1030t3403r1056b3460],
125	Wagner-Costalos	NNP	O	Wagner-Costalos	dep	194	SENT_241	[p17l1073t3402r1562b3461],
126	(	NNP	O	(	dep	194	SENT_241	[p17l1588t3402r1718b3460],
127	Fox	NNP	O	Fox	dep	194	SENT_241	[p17l1588t3402r1718b3460],
128	Chase	NNP	O	Chase	dep	194	SENT_241	[p17l1739t3402r1910b3449],
129	Cancer	NNP	O	Cancer	dep	194	SENT_241	[p17l1933t3402r2136b3449],
130	Center	NNP	O	Center	dep	194	SENT_241	[p17l14t3478r247b3536],
131	)	NN	O	)	dep	194	SENT_241	[p17l14t3478r247b3536],
132	,	,	O	,	_	0	SENT_241	[p17l14t3478r247b3536],
133	C	NN	O	c	dep	194	SENT_241	[p17l272t3478r316b3525],
134	Lerman	NNP	PERSON	Lerman	dep	194	SENT_241	[p17l338t3478r578b3534],
135	,	,	O	,	_	0	SENT_241	[p17l338t3478r578b3534],
136	B	NNP	PERSON	B	dep	194	SENT_241	[p17l601t3478r642b3524],
137	Peshkin	NNP	PERSON	Peshkin	dep	194	SENT_241	[p17l664t3477r885b3525],
138	(	NNP	O	(	dep	194	SENT_241	[p17l910t3477r1212b3536],
139	Lombardi	NNP	LOCATION	Lombardi	dep	194	SENT_241	[p17l910t3477r1212b3536],
140	Cancer	NNP	LOCATION	Cancer	dep	194	SENT_241	[p17l1234t3478r1437b3525],
141	Centre	NNP	LOCATION	Centre	dep	194	SENT_241	[p17l1458t3478r1691b3536],
142	)	NN	O	)	dep	194	SENT_241	[p17l1458t3478r1691b3536],
143	,	,	O	,	_	0	SENT_241	[p17l1458t3478r1691b3536],
144	o	NN	O	o	dep	194	SENT_241	[p17l1716t3478r1763b3525],
145	Olopade	NNP	PERSON	Olopade	dep	194	SENT_241	[p17l1787t3477r2042b3537],
146	,	,	O	,	_	0	SENT_241	[p17l1787t3477r2042b3537],
147	S	NNP	O	S	dep	194	SENT_241	[p17l14t3552r46b3600],
148	Cummings	NNP	PERSON	Cummings	dep	194	SENT_241	[p17l70t3552r381b3611],
149	(	NNP	O	(	dep	194	SENT_241	[p17l407t3552r719b3611],
150	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l407t3552r719b3611],
151	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l739t3552r799b3599],
152	Chicago	NNP	ORGANIZATION	Chicago	dep	194	SENT_241	[p17l814t3552r1086b3611],
153	)	NNP	O	)	dep	194	SENT_241	[p17l814t3552r1086b3611],
154	,	,	O	,	_	0	SENT_241	[p17l814t3552r1086b3611],
155	L	NNP	O	L	dep	194	SENT_241	[p17l1108t3553r1154b3599],
156	Cannon-Albright	NNP	O	Cannon-Albright	dep	194	SENT_241	[p17l1174t3552r1674b3611],
157	,	,	O	,	_	0	SENT_241	[p17l1174t3552r1674b3611],
158	L	NNP	PERSON	L	dep	194	SENT_241	[p17l1696t3553r1742b3599],
159	Steele	NNP	PERSON	Steele	dep	194	SENT_241	[p17l1761t3552r1926b3600],
160	(	NNP	O	(	dep	194	SENT_241	[p17l16t3627r328b3686],
161	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l16t3627r328b3686],
162	of	IN	ORGANIZATION	of	dep	194	SENT_241	[p17l348t3627r408b3674],
163	Utah	NNP	ORGANIZATION	Utah	dep	194	SENT_241	[p17l420t3627r604b3685],
164	)	NNP	O	)	dep	194	SENT_241	[p17l420t3627r604b3685],
165	,	,	O	,	_	0	SENT_241	[p17l420t3627r604b3685],
166	J	NNP	PERSON	J	dep	194	SENT_241	[p17l623t3628r649b3685],
167	Garber	NNP	PERSON	Garber	dep	194	SENT_241	[p17l669t3627r869b3674],
168	(	NNP	O	(	dep	194	SENT_241	[p17l893t3627r1066b3685],
169	Dana	NNP	PERSON	Dana	dep	194	SENT_241	[p17l893t3627r1066b3685],
170	Farber	NNP	PERSON	Farber	dep	194	SENT_241	[p17l1087t3627r1276b3674],
171	Cancer	NNP	O	Cancer	dep	194	SENT_241	[p17l1297t3627r1500b3674],
172	Center	NNP	O	Center	dep	194	SENT_241	[p17l1521t3627r1754b3685],
173	)	NN	O	)	dep	194	SENT_241	[p17l1521t3627r1754b3685],
174	,	,	O	,	_	0	SENT_241	[p17l1521t3627r1754b3685],
175	H	NNP	O	H	dep	194	SENT_241	[p17l1777t3628r1830b3674],
176	Lynch	NNP	PERSON	Lynch	dep	194	SENT_241	[p17l1850t3627r2046b3686],
177	,	,	O	,	_	0	SENT_241	[p17l1850t3627r2046b3686],
178	JLynch	NNP	O	JLynch	dep	194	SENT_241	[p17l7t3702r247b3762],
179	,	,	O	,	_	0	SENT_241	[p17l7t3702r247b3762],
180	C	NNP	O	C	dep	194	SENT_241	[p17l272t3703r317b3750],
181	Snyder	NNP	O	Snyder	dep	194	SENT_241	[p17l341t3702r553b3761],
182	,	,	O	,	_	0	SENT_241	[p17l341t3702r553b3761],
183	C	NNP	O	C	dep	194	SENT_241	[p17l579t3703r623b3750],
184	Durham	NNP	LOCATION	Durham	dep	194	SENT_241	[p17l646t3702r885b3750],
185	(	NNP	O	(	dep	194	SENT_241	[p17l910t3702r1217b3762],
186	Creighton	NNP	ORGANIZATION	Creighton	dep	194	SENT_241	[p17l910t3702r1217b3762],
187	University	NNP	ORGANIZATION	University	dep	194	SENT_241	[p17l1236t3703r1568b3761],
188	)	NN	O	)	dep	194	SENT_241	[p17l1236t3703r1568b3761],
189	,	,	O	,	_	0	SENT_241	[p17l1236t3703r1568b3761],
190	N	NN	O	n	dep	194	SENT_241	[p17l1590t3703r1645b3750],
191	Tung	NNP	PERSON	Tung	dep	194	SENT_241	[p17l1663t3703r1836b3762],
192	,	,	O	,	_	0	SENT_241	[p17l1663t3703r1836b3762],
193	S	NNP	O	S	dep	194	SENT_241	[p17l1861t3703r1894b3750],
194	Come	VB	O	come	_	0	SENT_241	[p17l1918t3703r2087b3750],

1	(	NNP	O	(	dep	244	SENT_242	[p18l16t14r169b73],
2	Beth	NNP	ORGANIZATION	Beth	dep	244	SENT_242	[p18l16t14r169b73],
3	Israel	NNP	ORGANIZATION	Israel	dep	244	SENT_242	[p18l188t14r340b61],
4	Hospital	NNP	ORGANIZATION	Hospital	dep	244	SENT_242	[p18l361t14r600b73],
5	Deaconness	NNP	ORGANIZATION	Deaconness	dep	244	SENT_242	[p18l621t15r958b61],
6	Hospital	NNP	ORGANIZATION	Hospital	dep	244	SENT_242	[p18l979t14r1236b73],
7	,	,	O	,	_	0	SENT_242	[p18l979t14r1236b73],
8	Boston	NNP	LOCATION	Boston	dep	244	SENT_242	[p18l1259t14r1499b73],
9	)	NNP	O	)	dep	244	SENT_242	[p18l1259t14r1499b73],
10	,	,	O	,	_	0	SENT_242	[p18l1259t14r1499b73],
11	B	NNP	PERSON	B	dep	244	SENT_242	[p18l1522t15r1563b61],
12	Karlan	NNP	PERSON	Karlan	dep	244	SENT_242	[p18l1585t14r1777b61],
13	(	NNP	O	(	dep	244	SENT_242	[p18l16t89r402b147],
14	Cedars-Sinai	NNP	ORGANIZATION	Cedars-Sinai	dep	244	SENT_242	[p18l16t89r402b147],
15	Medical	NNP	ORGANIZATION	Medical	dep	244	SENT_242	[p18l422t89r651b136],
16	Center	NNP	ORGANIZATION	Center	dep	244	SENT_242	[p18l674t89r907b147],
17	)	NN	O	)	dep	244	SENT_242	[p18l674t89r907b147],
18	,	,	O	,	_	0	SENT_242	[p18l674t89r907b147],
19	M	NN	O	m	dep	244	SENT_242	[p18l929t90r994b136],
20	Osborne	NNP	PERSON	Osborne	dep	244	SENT_242	[p18l1016t89r1272b146],
21	,	,	O	,	_	0	SENT_242	[p18l1016t89r1272b146],
22	N	NNP	O	N	dep	244	SENT_242	[p18l1293t90r1349b136],
23	Singer	NNP	O	Singer	dep	244	SENT_242	[p18l1371t89r1565b148],
24	,	,	O	,	_	0	SENT_242	[p18l1371t89r1565b148],
25	G	NNP	O	G	dep	244	SENT_242	[p18l1589t89r1641b136],
26	Rosenthal	NNP	PERSON	Rosenthal	dep	244	SENT_242	[p18l1661t89r1958b146],
27	,	,	O	,	_	0	SENT_242	[p18l1661t89r1958b146],
28	F	NN	O	f	dep	244	SENT_242	[p18l11t165r52b211],
29	Gilbert	NNP	PERSON	Gilbert	dep	244	SENT_242	[p18l74t164r274b212],
30	(	NNP	O	(	dep	244	SENT_242	[p18l298t165r504b224],
31	Strang	NNP	ORGANIZATION	Strang	dep	244	SENT_242	[p18l298t165r504b224],
32	Cancer	NNP	ORGANIZATION	Cancer	dep	244	SENT_242	[p18l526t164r728b212],
33	Prevention	NNP	ORGANIZATION	Prevention	dep	244	SENT_242	[p18l747t165r1053b212],
34	Center	NNP	ORGANIZATION	Center	dep	244	SENT_242	[p18l1075t165r1308b223],
35	)	NN	O	)	dep	244	SENT_242	[p18l1075t165r1308b223],
36	,	,	O	,	_	0	SENT_242	[p18l1075t165r1308b223],
37	K	NNP	PERSON	K	dep	244	SENT_242	[p18l1331t165r1384b211],
38	Huelsman	NNP	PERSON	Huelsman	dep	244	SENT_242	[p18l1402t164r1709b221],
39	,	,	O	,	_	0	SENT_242	[p18l1402t164r1709b221],
40	H	NNP	O	H	dep	244	SENT_242	[p18l1732t165r1785b211],
41	Saal	NNP	PERSON	Saal	dep	244	SENT_242	[p18l1808t164r1922b212],
42	(	NNP	O	(	dep	244	SENT_242	[p18l16t239r328b298],
43	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l16t239r328b298],
44	Cincinnati	NNP	ORGANIZATION	Cincinnati	dep	244	SENT_242	[p18l349t239r644b287],
45	College	NNP	ORGANIZATION	College	dep	244	SENT_242	[p18l667t239r877b298],
46	of	IN	ORGANIZATION	of	dep	244	SENT_242	[p18l900t239r960b286],
47	Medicine	NNP	ORGANIZATION	Medicine	dep	244	SENT_242	[p18l972t239r1280b298],
48	)	NNP	O	)	dep	244	SENT_242	[p18l972t239r1280b298],
49	,	,	O	,	_	0	SENT_242	[p18l972t239r1280b298],
50	D	NNP	PERSON	D	dep	244	SENT_242	[p18l1302t240r1354b286],
51	Fishman	NNP	PERSON	Fishman	dep	244	SENT_242	[p18l1376t239r1623b286],
52	(	NNP	O	(	dep	244	SENT_242	[p18l1647t239r2058b297],
53	Northwestern	NNP	ORGANIZATION	Northwestern	dep	244	SENT_242	[p18l1647t239r2058b297],
54	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l11t314r343b373],
55	)	NN	O	)	dep	244	SENT_242	[p18l11t314r343b373],
56	,	,	O	,	_	0	SENT_242	[p18l11t314r343b373],
57	K	NNP	O	K	dep	244	SENT_242	[p18l366t315r419b361],
58	Ofﬁt	NNP	O	Ofﬁt	dep	244	SENT_242	[p18l438t314r584b371],
59	,	,	O	,	_	0	SENT_242	[p18l438t314r584b371],
60	Deborah	NNP	PERSON	Deborah	dep	244	SENT_242	[p18l606t314r855b361],
61	Levin	NNP	PERSON	Levin	dep	244	SENT_242	[p18l875t314r1051b371],
62	,	,	O	,	_	0	SENT_242	[p18l875t314r1051b371],
63	M	NN	O	m	dep	244	SENT_242	[p18l1073t315r1138b361],
64	D	NN	O	d	dep	244	SENT_242	[p18l1158t315r1209b361],
65	Anderson	NNP	PERSON	Anderson	dep	244	SENT_242	[p18l1229t314r1521b371],
66	,	,	O	,	_	0	SENT_242	[p18l1229t314r1521b371],
67	G	NNP	O	G	dep	244	SENT_242	[p18l1545t314r1597b361],
68	Mills	NNP	O	Mills	dep	244	SENT_242	[p18l1616t314r1758b361],
69	(	NNP	O	(	dep	244	SENT_242	[p18l16t389r499b448],
70	Memorial-Sloan	NNP	O	Memorial-Sloan	dep	244	SENT_242	[p18l16t389r499b448],
71	Kettering	NNP	ORGANIZATION	Kettering	dep	244	SENT_242	[p18l519t390r787b449],
72	Cancer	NNP	ORGANIZATION	Cancer	dep	244	SENT_242	[p18l809t390r1011b437],
73	Center	NNP	ORGANIZATION	Center	dep	244	SENT_242	[p18l1032t390r1266b448],
74	)	NN	O	)	dep	244	SENT_242	[p18l1032t390r1266b448],
75	,	,	O	,	_	0	SENT_242	[p18l1032t390r1266b448],
76	S	NN	O	s	dep	244	SENT_242	[p18l1290t390r1323b437],
77	Merajver	NN	O	merajver	dep	244	SENT_242	[p18l1345t389r1600b448],
78	(	CD	NUMBER	(	dep	244	SENT_242	[p18l1624t390r1936b448],
79	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l1624t390r1936b448],
80	Michigan	NNP	ORGANIZATION	Michigan	dep	244	SENT_242	[p18l11t464r280b523],
81	Comprehensive	NNP	ORGANIZATION	Comprehensive	dep	244	SENT_242	[p18l302t464r742b523],
82	Cancer	NNP	ORGANIZATION	Cancer	dep	244	SENT_242	[p18l765t464r968b512],
83	Center	NNP	ORGANIZATION	Center	dep	244	SENT_242	[p18l989t464r1222b522],
84	)	NN	O	)	dep	244	SENT_242	[p18l989t464r1222b522],
85	,	,	O	,	_	0	SENT_242	[p18l989t464r1222b522],
86	H	NN	O	h	dep	244	SENT_242	[p18l1245t465r1298b511],
87	Risch	NNP	PERSON	Risch	dep	244	SENT_242	[p18l1320t464r1475b511],
88	(	CD	NUMBER	(	dep	244	SENT_242	[p18l1499t464r1643b523],
89	Yale	NNP	ORGANIZATION	Yale	dep	244	SENT_242	[p18l1499t464r1643b523],
90	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l1664t464r1996b523],
91	)	NN	O	)	dep	244	SENT_242	[p18l1664t464r1996b523],
92	,	,	O	,	_	0	SENT_242	[p18l1664t464r1996b523],
93	]	CD	NUMBER	]	dep	244	SENT_242	[p18l7t539r262b597],
94	Weitzel	NNP	PERSON	Weitzel	dep	244	SENT_242	[p18l7t539r262b597],
95	(	NNP	O	(	dep	244	SENT_242	[p18l287t539r429b598],
96	City	NNP	ORGANIZATION	City	dep	244	SENT_242	[p18l287t539r429b598],
97	of	IN	ORGANIZATION	of	dep	244	SENT_242	[p18l449t539r509b586],
98	Hope	NNP	ORGANIZATION	Hope	dep	244	SENT_242	[p18l521t540r677b598],
99	Hospital	NNP	ORGANIZATION	Hospital	dep	244	SENT_242	[p18l698t539r979b598],
100	)	NNP	O	)	dep	244	SENT_242	[p18l698t539r979b598],
101	,	,	O	,	_	0	SENT_242	[p18l698t539r979b598],
102	N	NNP	PERSON	N	dep	244	SENT_242	[p18l1001t540r1056b586],
103	Lindor	NNP	PERSON	Lindor	dep	244	SENT_242	[p18l1075t539r1272b586],
104	(	VBD	O	(	dep	244	SENT_242	[p18l1295t539r1476b598],
105	Mayo	NNP	ORGANIZATION	Mayo	dep	244	SENT_242	[p18l1295t539r1476b598],
106	Clinic	NNP	ORGANIZATION	Clinic	dep	244	SENT_242	[p18l1500t539r1709b597],
107	)	NNP	O	)	dep	244	SENT_242	[p18l1500t539r1709b597],
108	,	,	O	,	_	0	SENT_242	[p18l1500t539r1709b597],
109	K	NNP	PERSON	K	dep	244	SENT_242	[p18l1732t540r1785b586],
110	Hughes	NNP	PERSON	Hughes	dep	244	SENT_242	[p18l1803t539r2018b598],
111	(	NNP	O	(	dep	244	SENT_242	[p18l16t614r210b674],
112	Lahey	NNP	ORGANIZATION	Lahey	dep	244	SENT_242	[p18l16t614r210b674],
113	Clinic	NNP	ORGANIZATION	Clinic	dep	244	SENT_242	[p18l231t614r440b673],
114	)	NNP	O	)	dep	244	SENT_242	[p18l231t614r440b673],
115	,	,	O	,	_	0	SENT_242	[p18l231t614r440b673],
116	W	NNP	O	W	dep	244	SENT_242	[p18l461t615r528b662],
117	McKinnon	NNP	PERSON	McKinnon	dep	244	SENT_242	[p18l546t615r876b671],
118	,	,	O	,	_	0	SENT_242	[p18l546t615r876b671],
119	M	NNP	O	M	dep	244	SENT_242	[p18l898t615r964b661],
120	Wood	NNP	O	Wood	dep	244	SENT_242	[p18l981t614r1155b662],
121	(	NNP	O	(	dep	244	SENT_242	[p18l1180t615r1452b673],
122	Vermont	NNP	LOCATION	Vermont	dep	244	SENT_242	[p18l1180t615r1452b673],
123	Familial	NNP	O	Familial	dep	244	SENT_242	[p18l1471t614r1701b662],
124	Cancer	NNP	O	Cancer	dep	244	SENT_242	[p18l1724t615r1927b662],
125	Program	NNP	O	Program	dep	244	SENT_242	[p18l12t690r297b748],
126	)	NNP	O	)	dep	244	SENT_242	[p18l12t690r297b748],
127	,	,	O	,	_	0	SENT_242	[p18l12t690r297b748],
128	G	NNP	PERSON	G	dep	244	SENT_242	[p18l321t689r373b737],
129	Lenoir	NNP	PERSON	Lenoir	dep	244	SENT_242	[p18l392t689r597b746],
130	,	,	O	,	_	0	SENT_242	[p18l392t689r597b746],
131	O	NNP	PERSON	O	dep	244	SENT_242	[p18l621t689r669b737],
132	Serova	NNP	PERSON	Serova	dep	244	SENT_242	[p18l693t689r897b746],
133	,	,	O	,	_	0	SENT_242	[p18l693t689r897b746],
134	S	NNP	O	S	dep	244	SENT_242	[p18l922t689r954b737],
135	Mazoyer	NNP	O	Mazoyer	dep	244	SENT_242	[p18l977t690r1224b748],
136	(	NNP	O	(	dep	244	SENT_242	[p18l1247t689r1633b748],
137	International	NNP	ORGANIZATION	International	dep	244	SENT_242	[p18l1247t689r1633b748],
138	Agency	NNP	ORGANIZATION	Agency	dep	244	SENT_242	[p18l1652t690r1863b748],
139	for	IN	ORGANIZATION	for	dep	244	SENT_242	[p18l1882t689r1962b737],
140	Research	NNP	ORGANIZATION	Research	dep	244	SENT_242	[p18l12t764r267b811],
141	on	IN	ORGANIZATION	on	dep	244	SENT_242	[p18l288t779r357b811],
142	Cancer	NNP	ORGANIZATION	Cancer	dep	244	SENT_242	[p18l380t764r598b821],
143	,	,	O	,	_	0	SENT_242	[p18l380t764r598b821],
144	Lyon	NNP	LOCATION	Lyon	dep	244	SENT_242	[p18l620t765r783b823],
145	,	,	O	,	_	0	SENT_242	[p18l620t765r783b823],
146	France	NNP	LOCATION	France	dep	244	SENT_242	[p18l806t764r1043b822],
147	)	NNP	O	)	dep	244	SENT_242	[p18l806t764r1043b822],
148	,	,	O	,	_	0	SENT_242	[p18l806t764r1043b822],
149	G	NNP	PERSON	G	dep	244	SENT_242	[p18l1066t764r1119b811],
150	Evans	NNP	PERSON	Evans	dep	244	SENT_242	[p18l1138t765r1323b821],
151	,	,	O	,	_	0	SENT_242	[p18l1138t765r1323b821],
152	F	NN	O	f	dep	244	SENT_242	[p18l1345t765r1386b811],
153	Lalloo	NN	O	lalloo	dep	244	SENT_242	[p18l1406t764r1584b811],
154	(	CD	NUMBER	(	dep	244	SENT_242	[p18l1610t764r1878b823],
155	Regional	NNP	ORGANIZATION	Regional	dep	244	SENT_242	[p18l1610t764r1878b823],
156	Genetics	NNP	ORGANIZATION	Genetics	dep	244	SENT_242	[p18l1900t764r2144b811],
157	Service	NNP	ORGANIZATION	Service	dep	244	SENT_242	[p18l14t839r229b896],
158	,	,	O	,	_	0	SENT_242	[p18l14t839r229b896],
159	St	NNP	ORGANIZATION	St	dep	244	SENT_242	[p18l254t840r311b887],
160	Mary	NNP	ORGANIZATION	Mary	dep	244	SENT_242	[p18l331t839r525b898],
161	’s	POS	ORGANIZATION	’s	dep	244	SENT_242	[p18l331t839r525b898],
162	Hospital	NNP	ORGANIZATION	Hospital	dep	244	SENT_242	[p18l547t839r804b899],
163	,	,	O	,	_	0	SENT_242	[p18l547t839r804b899],
164	Manchester	NNP	LOCATION	Manchester	dep	244	SENT_242	[p18l826t839r1176b896],
165	,	,	O	,	_	0	SENT_242	[p18l826t839r1176b896],
166	UK	NNP	LOCATION	UK	dep	244	SENT_242	[p18l1198t840r1345b898],
167	)	NNP	O	)	dep	244	SENT_242	[p18l1198t840r1345b898],
168	,	,	O	,	_	0	SENT_242	[p18l1198t840r1345b898],
169	N	NNP	O	N	dep	244	SENT_242	[p18l1367t840r1421b887],
170	Haites	NNP	O	Haites	dep	244	SENT_242	[p18l1441t840r1621b887],
171	(	NNP	O	(	dep	244	SENT_242	[p18l1647t840r1959b898],
172	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l1647t840r1959b898],
173	of	IN	ORGANIZATION	of	dep	244	SENT_242	[p18l1979t839r2039b887],
174	Aberdeen	NNP	ORGANIZATION	Aberdeen	dep	244	SENT_242	[p18l10t914r326b973],
175	)	NNP	O	)	dep	244	SENT_242	[p18l10t914r326b973],
176	,	,	O	,	_	0	SENT_242	[p18l10t914r326b973],
177	H	NNP	O	H	dep	244	SENT_242	[p18l349t915r402b961],
178	Olsson	NNP	PERSON	Olsson	dep	244	SENT_242	[p18l425t914r632b971],
179	,	,	O	,	_	0	SENT_242	[p18l425t914r632b971],
180	O	NNP	PERSON	O	dep	244	SENT_242	[p18l657t914r704b962],
181	Johannson	NNP	PERSON	Johannson	dep	244	SENT_242	[p18l722t914r1041b972],
182	,	,	O	,	_	0	SENT_242	[p18l722t914r1041b972],
183	A	DT	O	a	dep	244	SENT_242	[p18l1062t915r1110b961],
184	Borg	NNP	PERSON	Borg	dep	244	SENT_242	[p18l1129t915r1266b973],
185	(	NNP	O	(	dep	244	SENT_242	[p18l1289t914r1464b973],
186	Lund	NNP	ORGANIZATION	Lund	dep	244	SENT_242	[p18l1289t914r1464b973],
187	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l1484t914r1791b973],
188	,	,	O	,	_	0	SENT_242	[p18l1484t914r1791b973],
189	Lund	NNP	PERSON	Lund	dep	244	SENT_242	[p18l1813t914r1985b971],
190	,	,	O	,	_	0	SENT_242	[p18l1813t914r1985b971],
191	Sweden	NNP	LOCATION	Sweden	dep	244	SENT_242	[p18l14t989r274b1047],
192	)	NNP	O	)	dep	244	SENT_242	[p18l14t989r274b1047],
193	,	,	O	,	_	0	SENT_242	[p18l14t989r274b1047],
194	P	NN	PERSON	p	dep	244	SENT_242	[p18l297t990r336b1036],
195	Moller	NNP	PERSON	Moller	dep	244	SENT_242	[p18l356t989r548b1036],
196	(	NNP	O	(	dep	244	SENT_242	[p18l570t989r902b1048],
197	Norwegian	NNP	O	Norwegian	dep	244	SENT_242	[p18l570t989r902b1048],
198	Radium	NNP	ORGANIZATION	Radium	dep	244	SENT_242	[p18l922t989r1147b1036],
199	Hospital	NNP	ORGANIZATION	Hospital	dep	244	SENT_242	[p18l1168t989r1424b1048],
200	,	,	O	,	_	0	SENT_242	[p18l1168t989r1424b1048],
201	Oslo	NNP	LOCATION	Oslo	dep	244	SENT_242	[p18l1448t989r1593b1046],
202	,	,	O	,	_	0	SENT_242	[p18l1448t989r1593b1046],
203	Norway	NNP	LOCATION	Norway	dep	244	SENT_242	[p18l1614t989r1881b1048],
204	)	NNP	O	)	dep	244	SENT_242	[p18l1614t989r1881b1048],
205	,	,	O	,	_	0	SENT_242	[p18l1614t989r1881b1048],
206	P	NN	O	p	dep	244	SENT_242	[p18l12t1065r50b1111],
207	Radice	NN	O	radice	dep	244	SENT_242	[p18l71t1064r280b1121],
208	,	,	O	,	_	0	SENT_242	[p18l71t1064r280b1121],
209	G	NN	O	g	dep	244	SENT_242	[p18l304t1065r356b1112],
210	Spatti	NNS	O	spattus	dep	244	SENT_242	[p18l377t1064r557b1124],
211	,	,	O	,	_	0	SENT_242	[p18l377t1064r557b1124],
212	A	DT	O	a	dep	244	SENT_242	[p18l578t1065r626b1111],
213	Conti	NNP	O	Conti	dep	244	SENT_242	[p18l647t1064r823b1121],
214	,	,	O	,	_	0	SENT_242	[p18l647t1064r823b1121],
215	V	NNP	O	V	dep	244	SENT_242	[p18l844t1065r891b1112],
216	Pensotti	NNP	O	Pensotti	dep	244	SENT_242	[p18l910t1064r1156b1121],
217	,	,	O	,	_	0	SENT_242	[p18l910t1064r1156b1121],
218	S	NNP	O	S	dep	244	SENT_242	[p18l1181t1065r1213b1112],
219	Manoukian	NNP	PERSON	Manoukian	dep	244	SENT_242	[p18l1235t1064r1578b1121],
220	,	,	O	,	_	0	SENT_242	[p18l1235t1064r1578b1121],
221	M	NNP	O	M	dep	244	SENT_242	[p18l1600t1065r1665b1111],
222	Pierotti	NNP	PERSON	Pierotti	dep	244	SENT_242	[p18l1685t1065r1893b1112],
223	(	NNP	O	(	dep	244	SENT_242	[p18l1918t1065r2141b1123],
224	Istituto	NNP	PERSON	Istituto	dep	244	SENT_242	[p18l1918t1065r2141b1123],
225	Tumori	NNP	PERSON	Tumori	dep	244	SENT_242	[p18l10t1139r230b1187],
226	Nazionale	NNP	PERSON	Nazionale	dep	244	SENT_242	[p18l249t1139r550b1196],
227	,	,	O	,	_	0	SENT_242	[p18l249t1139r550b1196],
228	Milan	NNP	LOCATION	Milan	dep	244	SENT_242	[p18l572t1139r757b1196],
229	,	,	O	,	_	0	SENT_242	[p18l572t1139r757b1196],
230	Italy	NNP	LOCATION	Italy	dep	244	SENT_242	[p18l780t1139r946b1198],
231	)	NNP	O	)	dep	244	SENT_242	[p18l780t1139r946b1198],
232	,	,	O	,	_	0	SENT_242	[p18l780t1139r946b1198],
233	and	CC	O	and	dep	244	SENT_242	[p18l970t1139r1115b1197],
234	]	NNP	O	]	dep	244	SENT_242	[p18l970t1139r1115b1197],
235	Lubinski	NNP	PERSON	Lubinski	dep	244	SENT_242	[p18l1133t1139r1382b1187],
236	(	NNP	O	(	dep	244	SENT_242	[p18l1407t1139r1769b1198],
237	Pomeranian	NNP	ORGANIZATION	Pomeranian	dep	244	SENT_242	[p18l1407t1139r1769b1198],
238	Medical	NNP	ORGANIZATION	Medical	dep	244	SENT_242	[p18l1789t1139r2018b1187],
239	University	NNP	ORGANIZATION	University	dep	244	SENT_242	[p18l11t1214r318b1273],
240	,	,	O	,	_	0	SENT_242	[p18l11t1214r318b1273],
241	Szczecin	NNP	LOCATION	Szczecin	dep	244	SENT_242	[p18l343t1214r598b1271],
242	,	,	O	,	_	0	SENT_242	[p18l343t1214r598b1271],
243	Poland	NNP	LOCATION	Poland	dep	244	SENT_242	[p18l621t1214r859b1272],
244	)	CD	NUMBER	)	_	0	SENT_242	[p18l621t1214r859b1272],
245	.	.	O	.	_	0	SENT_242	[p18l621t1214r859b1272],

1	Contributors	NNS	O	contributor	nsubj	13	SENT_243	[p18l14t1369r397b1422],
2	Steven	NNP	PERSON	Steven	nn	3	SENT_243	[p18l14t1450r200b1497],
3	Narod	NNP	PERSON	Narod	dep	1	SENT_243	[p18l219t1450r402b1497],
4	was	VBD	O	be	cop	7	SENT_243	[p18l421t1465r524b1497],
5	the	DT	O	the	det	7	SENT_243	[p18l545t1450r631b1497],
6	principal	JJ	O	principal	amod	7	SENT_243	[p18l651t1450r899b1509],
7	investigator	NN	O	investigator	_	0	SENT_243	[p18l920t1450r1247b1509],
8	and	CC	O	and	_	0	SENT_243	[p18l1267t1450r1369b1497],
9	study	NN	O	study	nn	10	SENT_243	[p18l1391t1450r1543b1509],
10	coordinator	NN	O	coordinator	conj_and	7	SENT_243	[p18l1563t1450r1907b1506],
11	,	,	O	,	_	0	SENT_243	[p18l1563t1450r1907b1506],
12	and	CC	O	and	_	0	SENT_243	[p18l1931t1450r2034b1497],
13	prepared	VBD	O	prepare	conj_and	7	SENT_243	[p18l10t1525r262b1584],
14	the	DT	O	the	det	15	SENT_243	[p18l281t1525r368b1573],
15	manuscript	NN	O	manuscript	dobj	13	SENT_243	[p18l389t1525r721b1584],
16	.	.	O	.	_	0	SENT_243	[p18l389t1525r721b1584],

1	Jean	NNP	PERSON	Jean	_	0	SENT_244	[p18l741t1525r1161b1583],
2	.	.	O	.	_	0	SENT_244	[p18l741t1525r1161b1583],

1	—	NN	O	—	_	0	SENT_245	[p18l741t1525r1161b1583],
2	.	.	O	.	_	0	SENT_245	[p18l741t1525r1161b1583],

1	Sebastien	NNP	PERSON	Sebastien	nn	2	SENT_246	[p18l741t1525r1161b1583],
2	Bunet	NNP	PERSON	Bunet	nsubj	3	SENT_246	[p18l1181t1526r1351b1573],
3	did	VBD	O	do	_	0	SENT_246	[p18l1371t1525r1461b1573],
4	the	DT	O	the	det	6	SENT_246	[p18l1481t1525r1567b1573],
5	statistical	JJ	O	statistical	amod	6	SENT_246	[p18l1589t1525r1848b1573],
6	analysis	NN	O	analysis	dobj	3	SENT_246	[p18l1870t1525r2099b1584],
7	.	.	O	.	_	0	SENT_246	[p18l1870t1525r2099b1584],

1	Study	NNP	O	Study	nn	2	SENT_247	[p18l14t1600r177b1659],
2	activities	NNS	O	activity	nsubjpass	4	SENT_247	[p18l197t1600r438b1647],
3	were	VBD	O	be	auxpass	4	SENT_247	[p18l459t1616r590b1648],
4	supervised	VBN	O	supervise	_	0	SENT_247	[p18l612t1600r907b1659],
5	by	IN	O	by	_	0	SENT_247	[p18l926t1600r1008b1659],
6	:	:	O	:	_	0	SENT_247	[p18l926t1600r1008b1659],
7	Parvis	NNP	PERSON	Parvis	nn	8	SENT_247	[p18l1032t1600r1200b1647],
8	Ghadirian	NNP	PERSON	Ghadirian	agent	4	SENT_247	[p18l1223t1600r1509b1648],
9	at	IN	O	at	_	0	SENT_247	[p18l1530t1611r1580b1647],
10	the	DT	O	the	det	11	SENT_247	[p18l1599t1600r1685b1647],
11	University	NNP	ORGANIZATION	University	prep_at	8	SENT_247	[p18l1706t1600r1998b1659],
12	of	IN	ORGANIZATION	of	_	0	SENT_247	[p18l2018t1600r2078b1647],
13	Montreal	NNP	ORGANIZATION	Montreal	nn	14	SENT_247	[p18l11t1675r273b1722],
14	hospitals	NNS	O	hospital	prep_of	11	SENT_247	[p18l293t1675r557b1734],
15	;	:	O	;	_	0	SENT_247	[p18l293t1675r557b1734],
16	Mark	NNP	PERSON	Mark	nn	17	SENT_247	[p18l579t1675r735b1722],
17	Robson	NNP	PERSON	Robson	dep	8	SENT_247	[p18l754t1675r969b1722],
18	a	DT	O	a	det	20	SENT_247	[p18l990t1690r1018b1722],
19	Memorial	NN	O	memorial	nn	20	SENT_247	[p18l1038t1675r1316b1722],
20	Sloan-Kettering	NN	O	sloan-kettering	dep	17	SENT_247	[p18l1339t1675r1804b1734],
21	;	:	O	;	_	0	SENT_247	[p18l1339t1675r1804b1734],
22	Ketil	NNP	PERSON	Ketil	nn	23	SENT_247	[p18l11t1750r149b1798],
23	Heimdal	NNP	PERSON	Heimdal	dep	8	SENT_247	[p18l170t1750r414b1798],
24	at	IN	O	at	_	0	SENT_247	[p18l436t1761r486b1798],
25	the	DT	O	the	det	28	SENT_247	[p18l505t1750r592b1798],
26	Norwegian	JJ	O	norwegian	amod	28	SENT_247	[p18l611t1750r924b1809],
27	Radium	NN	ORGANIZATION	radium	nn	28	SENT_247	[p18l944t1750r1169b1798],
28	Hospital	NN	ORGANIZATION	hospital	prep_at	23	SENT_247	[p18l1190t1750r1446b1809],
29	;	:	O	;	_	0	SENT_247	[p18l1190t1750r1446b1809],
30	Susan	NNP	PERSON	Susan	nn	31	SENT_247	[p18l1471t1750r1638b1798],
31	Neuhausen	NNP	PERSON	Neuhausen	dep	8	SENT_247	[p18l1656t1750r1978b1798],
32	at	IN	O	at	_	0	SENT_247	[p18l1999t1761r2049b1798],
33	the	DT	O	the	det	39	SENT_247	[p18l11t1825r97b1872],
34	University	NNP	ORGANIZATION	University	dep	39	SENT_247	[p18l118t1825r410b1884],
35	of	IN	ORGANIZATION	of	_	0	SENT_247	[p18l430t1825r490b1872],
36	Utah	NNP	ORGANIZATION	Utah	prep_of	34	SENT_247	[p18l502t1825r661b1882],
37	;	:	O	;	_	0	SENT_247	[p18l502t1825r661b1882],
38	Dominique	NNP	PERSON	Dominique	nn	39	SENT_247	[p18l683t1825r1006b1884],
39	Stoppa	NNP	PERSON	Stoppa	prep_at	31	SENT_247	[p18l1029t1825r1488b1884],
40	.	.	O	.	_	0	SENT_247	[p18l1029t1825r1488b1884],

1	—	NN	O	—	_	0	SENT_248	[p18l1029t1825r1488b1884],
2	.	.	O	.	_	0	SENT_248	[p18l1029t1825r1488b1884],

1	Lyonnet	NNP	PERSON	Lyonnet	_	0	SENT_249	[p18l1029t1825r1488b1884],
2	at	IN	O	at	_	0	SENT_249	[p18l1509t1836r1559b1872],
3	the	DT	O	the	det	5	SENT_249	[p18l1578t1825r1665b1873],
4	Institut	NNP	ORGANIZATION	Institut	nn	5	SENT_249	[p18l1685t1825r1892b1873],
5	Curie	NNP	ORGANIZATION	Curie	prep_at	1	SENT_249	[p18l1914t1825r2087b1882],
6	;	:	O	;	_	0	SENT_249	[p18l1914t1825r2087b1882],
7	Caryn	NNP	PERSON	Caryn	nn	8	SENT_249	[p18l14t1900r185b1959],
8	Lerman	NNP	PERSON	Lerman	dep	1	SENT_249	[p18l205t1900r428b1947],
9	at	IN	O	at	_	0	SENT_249	[p18l449t1910r499b1947],
10	the	DT	O	the	det	13	SENT_249	[p18l519t1900r605b1947],
11	Lombardi	NNP	ORGANIZATION	Lombardi	nn	13	SENT_249	[p18l626t1900r908b1947],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_249	[p18l930t1900r1133b1947],
13	Center	NNP	ORGANIZATION	Center	prep_at	8	SENT_249	[p18l1155t1900r1362b1956],
14	;	:	O	;	_	0	SENT_249	[p18l1155t1900r1362b1956],
15	Barbra	NNP	PERSON	Barbra	nn	16	SENT_249	[p18l1386t1900r1576b1947],
16	Pasini	NNP	PERSON	Pasini	dep	1	SENT_249	[p18l1597t1900r1765b1947],
17	at	IN	O	at	_	0	SENT_249	[p18l1787t1910r1837b1947],
18	Istituto	NNP	ORGANIZATION	Istituto	nn	20	SENT_249	[p18l1856t1900r2058b1947],
19	Nazionale	NNP	ORGANIZATION	Nazionale	nn	20	SENT_249	[p18l10t1975r294b2023],
20	Tumori	NNP	ORGANIZATION	Tumori	prep_at	16	SENT_249	[p18l314t1975r550b2032],
21	;	:	O	;	_	0	SENT_249	[p18l314t1975r550b2032],
22	Barbara	NNP	PERSON	Barbara	nn	23	SENT_249	[p18l573t1975r795b2023],
23	Weber	NNP	PERSON	Weber	dep	1	SENT_249	[p18l814t1975r1003b2023],
24	at	IN	O	at	_	0	SENT_249	[p18l1023t1986r1073b2023],
25	the	DT	O	the	det	26	SENT_249	[p18l1092t1975r1179b2023],
26	University	NNP	ORGANIZATION	University	prep_at	23	SENT_249	[p18l1199t1976r1491b2034],
27	of	IN	ORGANIZATION	of	_	0	SENT_249	[p18l1511t1975r1571b2023],
28	Pennsulvaniag	NNP	ORGANIZATION	Pennsulvaniag	prep_of	26	SENT_249	[p18l1584t1975r1975b2032],
29	and	CC	O	and	_	0	SENT_249	[p18l1999t1975r2102b2023],
30	Henry	NNP	PERSON	Henry	nn	31	SENT_249	[p18l11t2051r191b2109],
31	Lynch	NNP	PERSON	Lynch	prep_at	23	SENT_249	[p18l209t2050r388b2109],
32	at	IN	O	at	_	0	SENT_249	[p18l409t2061r459b2097],
33	Creighton	NNP	ORGANIZATION	Creighton	nn	34	SENT_249	[p18l481t2050r765b2109],
34	University	NNP	ORGANIZATION	University	prep_at	31	SENT_249	[p18l784t2050r1089b2109],
35	.	.	O	.	_	0	SENT_249	[p18l784t2050r1089b2109],

1	Patricia	NNP	PERSON	Patricia	nn	4	SENT_250	[p18l1114t2050r1327b2097],
2	de	NNP	PERSON	de	nn	4	SENT_250	[p18l1349t2050r1413b2098],
3	los	NNP	PERSON	los	nn	4	SENT_250	[p18l1434t2050r1509b2097],
4	Rios	NNP	PERSON	Rios	nsubj	5	SENT_250	[p18l1532t2050r1653b2097],
5	organised	VBD	O	organise	_	0	SENT_250	[p18l1676t2050r1945b2109],
6	data	NNS	O	datum	nn	7	SENT_250	[p18l1966t2050r2085b2098],
7	submission	NN	O	submission	dobj	5	SENT_250	[p18l12t2125r326b2172],
8	from	IN	O	from	_	0	SENT_250	[p18l346t2124r481b2172],
9	the	DT	O	the	det	11	SENT_250	[p18l500t2125r587b2172],
10	individual	JJ	O	individual	amod	11	SENT_250	[p18l607t2125r888b2172],
11	centers	NNS	O	center	prep_from	5	SENT_250	[p18l910t2135r1106b2172],
12	and	CC	O	and	_	0	SENT_250	[p18l1129t2125r1232b2172],
13	ensured	JJ	O	ensured	amod	14	SENT_250	[p18l1253t2125r1474b2172],
14	completeness	NN	O	completeness	prep_from	5	SENT_250	[p18l1495t2125r1870b2184],
15	and	CC	O	and	_	0	SENT_250	[p18l1893t2125r1996b2172],
16	accuracy	NN	O	accuracy	conj_and	11	SENT_250	[p18l13t2216r259b2259],
17	of	IN	O	of	_	0	SENT_250	[p18l278t2200r338b2248],
18	the	DT	O	the	det	20	SENT_250	[p18l350t2200r437b2248],
19	submitted	VBN	O	submit	amod	20	SENT_250	[p18l459t2200r741b2248],
20	data	NNS	O	datum	prep_of	14	SENT_250	[p18l763t2200r896b2248],
21	.	.	O	.	_	0	SENT_250	[p18l763t2200r896b2248],

1	Acknowledgments	NNS	O	acknowledgment	nsubjpass	5	SENT_251	[p18l8t2359r583b2424],
2	This	DT	O	this	det	3	SENT_251	[p18l10t2439r138b2486],
3	study	NN	O	study	dep	1	SENT_251	[p18l160t2439r312b2498],
4	was	VBD	O	be	auxpass	5	SENT_251	[p18l330t2455r432b2487],
5	supported	VBN	O	support	_	0	SENT_251	[p18l455t2439r738b2498],
6	by	IN	O	by	_	0	SENT_251	[p18l757t2439r825b2498],
7	the	DT	O	the	det	14	SENT_251	[p18l844t2439r931b2486],
8	US	NNP	ORGANIZATION	US	nn	14	SENT_251	[p18l951t2439r1041b2487],
9	National	NNP	ORGANIZATION	National	dep	14	SENT_251	[p18l1062t2439r1308b2486],
10	Institutes	NNPS	ORGANIZATION	Institutes	dep	9	SENT_251	[p18l1328t2439r1589b2486],
11	of	IN	ORGANIZATION	of	_	0	SENT_251	[p18l1612t2439r1672b2486],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_251	[p18l1685t2439r1877b2486],
13	grants	NNS	O	grant	prep_of	9	SENT_251	[p18l1896t2450r2066b2498],
14	1R01	NN	O	1r01	agent	5	SENT_251	[p18l18t2513r157b2560],
15	CA63682	NN	O	ca63682	nn	21	SENT_251	[p18l187t2513r478b2569],
16	,	,	O	,	_	0	SENT_251	[p18l187t2513r478b2569],
17	CA63678	NN	O	ca63678	dep	21	SENT_251	[p18l503t2513r794b2569],
18	,	,	O	,	_	0	SENT_251	[p18l503t2513r794b2569],
19	CA57601	NN	O	ca57601	dep	21	SENT_251	[p18l819t2513r1110b2569],
20	,	,	O	,	_	0	SENT_251	[p18l819t2513r1110b2569],
21	CA61231	NN	O	ca61231	dep	14	SENT_251	[p18l1135t2513r1426b2570],
22	,	,	O	,	_	0	SENT_251	[p18l1135t2513r1426b2570],
23	and	CC	O	and	_	0	SENT_251	[p18l1449t2513r1553b2560],
24	CA74415	NN	O	ca74415	conj_and	21	SENT_251	[p18l1575t2513r1866b2569],
25	,	,	O	,	_	0	SENT_251	[p18l1575t2513r1866b2569],
26	the	DT	O	the	det	29	SENT_251	[p18l1888t2513r1974b2560],
27	National	NNP	ORGANIZATION	National	nn	29	SENT_251	[p18l10t2588r256b2636],
28	Cancer	NNP	ORGANIZATION	Cancer	nn	29	SENT_251	[p18l279t2588r482b2636],
29	Institute	NNP	ORGANIZATION	Institute	dep	14	SENT_251	[p18l501t2588r736b2636],
30	of	IN	ORGANIZATION	of	_	0	SENT_251	[p18l758t2588r818b2636],
31	Canada	NNP	ORGANIZATION	Canada	nn	34	SENT_251	[p18l833t2588r1048b2636],
32	Breast	NN	ORGANIZATION	breast	nn	34	SENT_251	[p18l1069t2589r1246b2636],
33	Cancer	NN	ORGANIZATION	cancer	nn	34	SENT_251	[p18l1268t2588r1471b2636],
34	Initiative	NNP	ORGANIZATION	Initiative	prep_of	29	SENT_251	[p18l1489t2588r1755b2645],
35	,	,	O	,	_	0	SENT_251	[p18l1489t2588r1755b2645],
36	the	DT	O	the	det	44	SENT_251	[p18l1777t2588r1863b2636],
37	Department	NNP	ORGANIZATION	Department	dep	44	SENT_251	[p18l11t2665r356b2723],
38	of	IN	ORGANIZATION	of	_	0	SENT_251	[p18l377t2664r438b2711],
39	the	DT	ORGANIZATION	the	det	42	SENT_251	[p18l449t2664r536b2711],
40	Army	NNP	ORGANIZATION	Army	nn	42	SENT_251	[p18l555t2665r715b2723],
41	grants	NNS	O	grant	nn	42	SENT_251	[p18l734t2675r904b2723],
42	DAMD17-94	NN	O	damd17-94	prep_of	37	SENT_251	[p18l926t2665r1548b2722],
43	-	:	O	-	_	0	SENT_251	[p18l926t2665r1548b2722],
44	]	NN	O	]	appos	14	SENT_251	[p18l926t2665r1548b2722],
45	.	.	O	.	_	0	SENT_251	[p18l926t2665r1548b2722],

1	—	NN	O	—	_	0	SENT_252	[p18l926t2665r1548b2722],
2	.	.	O	.	_	0	SENT_252	[p18l926t2665r1548b2722],

1	4299	CD	NUMBER	4299	_	0	SENT_253	[p18l926t2665r1548b2722],
2	,	,	O	,	_	0	SENT_253	[p18l926t2665r1548b2722],
3	DAMD	NN	O	damd	nn	4	SENT_253	[p18l1570t2665r1791b2711],
4	1794J4260	NN	O	1794j4260	conj_and	1	SENT_253	[p18l1820t2665r2049b2722, p18l12t2740r170b2795],
5	,	,	O	,	_	0	SENT_253	[p18l1820t2665r2049b2722, p18l12t2740r170b2795],
6	and	CC	O	and	_	0	SENT_253	[p18l194t2739r297b2786],
7	DAMD	NNP	O	DAMD	conj_and	1	SENT_253	[p18l317t2739r537b2786],
8	17	CD	NUMBER	17	number	9	SENT_253	[p18l567t2739r774b2797],
9	—	CD	NUMBER	—	dep	1	SENT_253	[p18l567t2739r774b2797],
10	97	CD	NUMBER	97	dep	9	SENT_253	[p18l567t2739r774b2797],
11	-	:	O	-	_	0	SENT_253	[p18l567t2739r774b2797],
12	]	CD	NUMBER	]	num	13	SENT_253	[p18l567t2739r774b2797],
13	4340	CD	NUMBER	4340	dep	9	SENT_253	[p18l793t2740r951b2795],
14	,	,	O	,	_	0	SENT_253	[p18l793t2740r951b2795],
15	the	DT	O	the	det	19	SENT_253	[p18l973t2739r1060b2786],
16	Canadian	JJ	ORGANIZATION	canadian	amod	19	SENT_253	[p18l1083t2739r1354b2786],
17	Genetics	NNP	ORGANIZATION	Genetics	nn	19	SENT_253	[p18l1375t2739r1620b2786],
18	Diseases	NNP	ORGANIZATION	Diseases	nn	19	SENT_253	[p18l1641t2739r1880b2786],
19	Network	NNP	ORGANIZATION	Network	appos	13	SENT_253	[p18l10t2814r274b2871],
20	,	,	O	,	_	0	SENT_253	[p18l10t2814r274b2871],
21	the	DT	O	the	det	24	SENT_253	[p18l297t2814r383b2862],
22	Canadian	JJ	O	canadian	amod	24	SENT_253	[p18l406t2814r677b2862],
23	Breast	NN	ORGANIZATION	breast	nn	24	SENT_253	[p18l698t2815r874b2862],
24	Cancer	NN	ORGANIZATION	cancer	appos	13	SENT_253	[p18l896t2814r1099b2862],
25	Foundation	NNP	ORGANIZATION	Foundation	nn	29	SENT_253	[p18l1118t2814r1450b2862],
26	(	NNP	O	(	nn	29	SENT_253	[p18l1475t2814r1713b2873],
27	Ontario	NNP	LOCATION	Ontario	nn	29	SENT_253	[p18l1475t2814r1713b2873],
28	Chapter	NNP	O	Chapter	nn	29	SENT_253	[p18l1737t2814r2007b2873],
29	)	NNP	O	)	dep	24	SENT_253	[p18l1737t2814r2007b2873],
30	,	,	O	,	_	0	SENT_253	[p18l1737t2814r2007b2873],
31	the	DT	O	the	det	35	SENT_253	[p18l2029t2814r2115b2862],
32	Fonds	NNP	O	Fonds	nn	35	SENT_253	[p18l11t2889r187b2937],
33	de	IN	O	de	amod	35	SENT_253	[p18l210t2889r274b2937],
34	La	NNP	O	La	nn	35	SENT_253	[p18l295t2890r368b2936],
35	Recherche	NNP	O	Recherche	appos	13	SENT_253	[p18l389t2889r684b2936],
36	en	IN	O	en	_	0	SENT_253	[p18l706t2905r771b2936],
37	Sante	NNP	LOCATION	Sante	nn	39	SENT_253	[p18l793t2889r948b2937],
38	du	NNP	O	du	nn	39	SENT_253	[p18l970t2889r1042b2937],
39	Quebec	NNP	LOCATION	Quebec	prep_en	35	SENT_253	[p18l1064t2889r1295b2948],
40	,	,	O	,	_	0	SENT_253	[p18l1064t2889r1295b2948],
41	the	DT	O	the	det	45	SENT_253	[p18l1318t2889r1404b2936],
42	Ontario	NNP	ORGANIZATION	Ontario	nn	45	SENT_253	[p18l1427t2889r1643b2937],
43	Cancer	NNP	ORGANIZATION	Cancer	nn	45	SENT_253	[p18l1667t2889r1869b2937],
44	Genetics	NNP	ORGANIZATION	Genetics	nn	45	SENT_253	[p18l1889t2889r2134b2937],
45	Network	NNP	ORGANIZATION	Network	conj_and	39	SENT_253	[p18l10t2964r274b3020],
46	,	,	O	,	_	0	SENT_253	[p18l10t2964r274b3020],
47	the	DT	O	the	det	48	SENT_253	[p18l297t2964r383b3011],
48	Women	NNS	MISC	woman	poss	51	SENT_253	[p18l402t2964r671b3011],
49	’s	POS	MISC	’s	_	0	SENT_253	[p18l402t2964r671b3011],
50	Cancer	NN	MISC	cancer	nn	51	SENT_253	[p18l695t2964r898b3011],
51	Program	NN	MISC	program	prep_en	35	SENT_253	[p18l917t2964r1161b3023],
52	of	IN	O	of	_	0	SENT_253	[p18l1182t2963r1242b3011],
53	the	DT	O	the	det	57	SENT_253	[p18l1254t2964r1341b3011],
54	Dana	NNP	ORGANIZATION	Dana	nn	57	SENT_253	[p18l1362t2964r1515b3011],
55	Farber	NNP	ORGANIZATION	Farber	nn	57	SENT_253	[p18l1535t2964r1725b3011],
56	Cancer	NNP	ORGANIZATION	Cancer	nn	57	SENT_253	[p18l1746t2964r1949b3011],
57	Institute	NNP	ORGANIZATION	Institute	prep_of	51	SENT_253	[p18l11t3039r264b3096],
58	,	,	O	,	_	0	SENT_253	[p18l11t3039r264b3096],
59	the	DT	O	the	det	62	SENT_253	[p18l286t3039r373b3087],
60	Norwegian	JJ	O	norwegian	amod	62	SENT_253	[p18l392t3039r704b3098],
61	Cancer	NN	ORGANIZATION	cancer	nn	62	SENT_253	[p18l727t3039r929b3087],
62	Society	NNP	ORGANIZATION	Society	prep_en	35	SENT_253	[p18l950t3039r1169b3098],
63	,	,	O	,	_	0	SENT_253	[p18l950t3039r1169b3098],
64	the	DT	O	the	det	66	SENT_253	[p18l1191t3039r1277b3087],
65	Italian	JJ	ORGANIZATION	italian	amod	66	SENT_253	[p18l1298t3039r1478b3087],
66	Association	NN	ORGANIZATION	association	prep_en	35	SENT_253	[p18l1496t3039r1821b3087],
67	and	CC	ORGANIZATION	and	_	0	SENT_253	[p18l1842t3039r1946b3087],
68	Foundation	NNP	ORGANIZATION	Foundation	prep_en	35	SENT_253	[p18l11t3114r344b3162],
69	for	IN	ORGANIZATION	for	_	0	SENT_253	[p18l364t3114r443b3161],
70	Cancer	NNP	ORGANIZATION	Cancer	nn	74	SENT_253	[p18l464t3114r667b3162],
71	Research	NNP	ORGANIZATION	Research	nn	74	SENT_253	[p18l686t3114r941b3161],
72	(	NNP	O	(	nn	74	SENT_253	[p18l965t3114r1187b3173],
73	Special	JJ	O	special	amod	74	SENT_253	[p18l965t3114r1187b3173],
74	Project	NN	O	project	prep_for	35	SENT_253	[p18l1208t3114r1421b3173],
75	:	:	O	:	_	0	SENT_253	[p18l1208t3114r1421b3173],
76	Hereditary	JJ	O	hereditary	amod	78	SENT_253	[p18l1446t3114r1750b3173],
77	Tumours	JJ	O	tumours	amod	78	SENT_253	[p18l1768t3114r2075b3172],
78	)	NN	O	)	dep	9	SENT_253	[p18l1768t3114r2075b3172],
79	,	,	O	,	_	0	SENT_253	[p18l1768t3114r2075b3172],
80	the	DT	O	the	det	81	SENT_253	[p18l11t3189r98b3236],
81	Society	NNP	MISC	Society	appos	78	SENT_253	[p18l120t3189r323b3248],
82	of	IN	MISC	of	_	0	SENT_253	[p18l343t3188r404b3236],
83	Memorial	NNP	MISC	Memorial	nn	86	SENT_253	[p18l416t3189r694b3236],
84	Sloan-Kettering	NNP	MISC	Sloan-Kettering	nn	86	SENT_253	[p18l716t3189r1167b3248],
85	Cancer	NNP	MISC	Cancer	nn	86	SENT_253	[p18l1189t3189r1391b3236],
86	Center	NNP	MISC	Center	prep_of	81	SENT_253	[p18l1412t3189r1620b3245],
87	,	,	O	,	_	0	SENT_253	[p18l1412t3189r1620b3245],
88	the	DT	O	the	det	90	SENT_253	[p18l1642t3189r1729b3236],
89	Utah	NNP	O	Utah	nn	90	SENT_253	[p18l1749t3189r1892b3236],
90	Cancer	NNP	O	Cancer	appos	86	SENT_253	[p18l1914t3189r2117b3236],

1	1880	NNP	DATE	1880	_	0	SENT_254	[p18l96t3346r172b3372],
2	THE	DT	O	the	det	3	SENT_254	[p18l1468t3351r1534b3371],
3	LANCET	NN	O	lancet	dep	1	SENT_254	[p18l1544t3351r1673b3372],
4	-	:	O	-	_	0	SENT_254	[p18l1683t3358r1690b3365],
5	Vol	NN	O	vol	dep	1	SENT_254	[p18l1700t3351r1744b3372],
6	356	CD	NUMBER	356	num	5	SENT_254	[p18l1754t3352r1799b3372],
7	-	:	O	-	_	0	SENT_254	[p18l1810t3358r1818b3365],
8	December	NNP	DATE	December	dep	5	SENT_254	[p18l1828t3351r1959b3372],
9	2	CD	DATE	2	num	8	SENT_254	[p18l1968t3352r1990b3375],
10	,	,	DATE	,	_	0	SENT_254	[p18l1968t3352r1990b3375],
11	2000	CD	DATE	2000	num	8	SENT_254	[p18l2001t3352r2063b3372],
12	ARTICLES	NNS	O	article	dep	8	SENT_254	[p18l1913t3394r2067b3415],

1	Registry	NN	O	registry	_	0	SENT_255	[p18l10t3599r255b3658],
2	,	,	O	,	_	0	SENT_255	[p18l10t3599r255b3658],
3	and	CC	O	and	_	0	SENT_255	[p18l279t3599r382b3646],
4	the	DT	O	the	det	6	SENT_255	[p18l402t3599r488b3646],
5	Utah	NNP	ORGANIZATION	Utah	nn	6	SENT_255	[p18l509t3599r652b3646],
6	Department	NNP	ORGANIZATION	Department	conj_and	1	SENT_255	[p18l672t3600r1017b3658],
7	of	IN	ORGANIZATION	of	_	0	SENT_255	[p18l1038t3599r1099b3646],
8	Health	NNP	ORGANIZATION	Health	prep_of	6	SENT_255	[p18l1111t3599r1318b3646],
9	.	.	O	.	_	0	SENT_255	[p18l1111t3599r1318b3646],

1	MR	NN	PERSON	mr	nsubj	4	SENT_256	[p18l1342t3600r1456b3646],
2	is	VBZ	O	be	cop	4	SENT_256	[p18l1474t3599r1514b3646],
3	the	DT	O	the	det	4	SENT_256	[p18l1535t3599r1621b3646],
4	recipient	JJ	O	recipient	_	0	SENT_256	[p18l1642t3599r1889b3658],
5	of	IN	O	of	_	0	SENT_256	[p18l1909t3599r1969b3646],
6	an	DT	O	a	det	13	SENT_256	[p18l1983t3614r2049b3646],
7	American	JJ	ORGANIZATION	american	amod	13	SENT_256	[p18l8t3674r284b3721],
8	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_256	[p18l306t3674r509b3721],
9	Society	NNP	ORGANIZATION	Society	nn	13	SENT_256	[p18l530t3674r733b3733],
10	Physicians	NNP	O	Physicians	nn	13	SENT_256	[p18l752t3674r1044b3733],
11	Training	NNP	O	Training	nn	13	SENT_256	[p18l1066t3674r1314b3733],
12	Award	NN	O	award	nn	13	SENT_256	[p18l1331t3674r1519b3721],
13	PRTA-38	NN	O	prta-38	prep_of	4	SENT_256	[p18l1540t3675r1834b3721],
14	.	.	O	.	_	0	SENT_256	[p18l1540t3675r1834b3721],

1	References	NNS	O	reference	_	0	SENT_257	[p19l12t122r359b172],

1	Narod	NNP	PERSON	Narod	nn	2	SENT_258	[p19l112t227r295b275],
2	SA	NNP	O	SA	_	0	SENT_258	[p19l318t227r416b284],
3	,	,	O	,	_	0	SENT_258	[p19l318t227r416b284],
4	Ford	NNP	ORGANIZATION	Ford	nn	5	SENT_258	[p19l439t227r577b275],
5	D	NNP	ORGANIZATION	D	appos	2	SENT_258	[p19l597t228r667b284],
6	,	,	O	,	_	0	SENT_258	[p19l597t228r667b284],
7	Devilee	JJ	O	devilee	amod	8	SENT_258	[p19l690t227r901b275],
8	P	NN	O	p	appos	2	SENT_258	[p19l922t228r978b284],
9	,	,	O	,	_	0	SENT_258	[p19l922t228r978b284],
10	et	FW	O	et	nn	11	SENT_258	[p19l1002t238r1051b274],
11	al.	FW	O	al.	appos	2	SENT_258	[p19l1072t227r1133b274],
12	.	.	O	.	_	0	SENT_258	[p19l1072t227r1133b274],

1	An	DT	O	a	det	2	SENT_259	[p19l1155t228r1240b274],
2	evaluation	NN	O	evaluation	_	0	SENT_259	[p19l1261t227r1550b275],
3	of	IN	O	of	_	0	SENT_259	[p19l1571t227r1631b274],
4	genetic	JJ	O	genetic	amod	5	SENT_259	[p19l1643t227r1842b286],
5	heterogeneity	NN	O	heterogeneity	prep_of	2	SENT_259	[p19l112t302r494b361],
6	in	IN	O	in	_	0	SENT_259	[p19l513t302r566b349],
7	145	CD	NUMBER	145	num	10	SENT_259	[p19l594t304r689b349],
8	breast-ovarian	JJ	O	breast-ovarian	amod	10	SENT_259	[p19l712t302r1115b349],
9	cancer	NN	O	cancer	nn	10	SENT_259	[p19l1136t317r1319b349],
10	families	NNS	O	family	prep_in	2	SENT_259	[p19l1338t302r1568b349],
11	.	.	O	.	_	0	SENT_259	[p19l1338t302r1568b349],

1	Am	VBP	O	be	dep	2	SENT_260	[p19l1588t302r1688b349],
2	_	NN	O	_	_	0	SENT_260	[p19l1702t302r1744b361],
3	7	CD	NUMBER	7	num	2	SENT_260	[p19l1702t302r1744b361],
4	Hum	NNP	O	Hum	nn	5	SENT_260	[p19l1757t303r1896b349],
5	Genet	NNP	O	Genet	dep	2	SENT_260	[p19l1920t302r2074b349],
6	1995	CD	DATE	1995	dep	5	SENT_260	[p19l120t379r272b434],
7	;	:	O	;	_	0	SENT_260	[p19l120t379r272b434],
8	56	CD	NUMBER	56	dep	6	SENT_260	[p19l297t378r379b424],
9	:	:	O	:	_	0	SENT_260	[p19l297t378r379b424],
10	254-64	CD	NUMBER	254-64	dep	8	SENT_260	[p19l405t379r630b424],
11	.	.	O	.	_	0	SENT_260	[p19l405t379r630b424],

1	Ford	NNP	ORGANIZATION	Ford	nn	2	SENT_261	[p19l113t462r251b510],
2	D	NNP	ORGANIZATION	D	_	0	SENT_261	[p19l272t463r342b519],
3	,	,	O	,	_	0	SENT_261	[p19l272t463r342b519],
4	Easton	NNP	ORGANIZATION	Easton	nn	5	SENT_261	[p19l364t463r559b509],
5	DF	NNP	ORGANIZATION	DF	appos	2	SENT_261	[p19l579t463r692b519],
6	,	,	O	,	_	0	SENT_261	[p19l579t463r692b519],
7	Stratton	NNP	LOCATION	Stratton	nn	8	SENT_261	[p19l716t462r945b510],
8	M	NNP	O	M	appos	2	SENT_261	[p19l965t463r1046b519],
9	,	,	O	,	_	0	SENT_261	[p19l965t463r1046b519],
10	et	FW	O	et	nn	11	SENT_261	[p19l1070t473r1119b509],
11	al.	FW	O	al.	appos	2	SENT_261	[p19l1140t462r1200b509],
12	.	.	O	.	_	0	SENT_261	[p19l1140t462r1200b509],

1	Genetic	JJ	O	genetic	amod	2	SENT_262	[p19l1226t462r1445b510],
2	heterogeneity	NN	O	heterogeneity	_	0	SENT_262	[p19l1465t462r1848b521],
3	and	CC	O	and	_	0	SENT_262	[p19l1868t462r1971b510],
4	penetrance	NN	O	penetrance	nn	5	SENT_262	[p19l112t548r422b596],
5	analysis	NN	O	analysis	conj_and	2	SENT_262	[p19l445t537r658b596],
6	of	IN	O	of	_	0	SENT_262	[p19l681t537r741b584],
7	the	DT	O	the	det	11	SENT_262	[p19l753t537r840b584],
8	BRCA1	NN	O	brca1	nn	11	SENT_262	[p19l859t537r1075b584],
9	and	CC	O	and	_	0	SENT_262	[p19l1100t537r1203b584],
10	BRCA2	NN	O	brca2	nn	11	SENT_262	[p19l1222t537r1442b584],
11	genes	NNS	O	gene	prep_of	2	SENT_262	[p19l1462t552r1616b596],
12	in	IN	O	in	_	0	SENT_262	[p19l1637t537r1690b584],
13	breast	NN	O	breast	nn	15	SENT_262	[p19l1709t537r1880b584],
14	cancer	NN	O	cancer	nn	15	SENT_262	[p19l1900t552r2084b584],
15	families	NNS	O	family	prep_in	2	SENT_262	[p19l113t611r343b659],
16	.	.	O	.	_	0	SENT_262	[p19l113t611r343b659],

1	Amj	NN	O	amj	nn	4	SENT_263	[p19l363t612r671b671],
2	‘	CD	NUMBER	‘	num	4	SENT_263	[p19l363t612r671b671],
3	Hum	NNP	O	Hum	nn	4	SENT_263	[p19l363t612r671b671],
4	Genet	NNP	O	Genet	_	0	SENT_263	[p19l695t612r849b659],
5	1998	CD	DATE	1998	dep	4	SENT_263	[p19l873t614r1025b668],
6	;	:	O	;	_	0	SENT_263	[p19l873t614r1025b668],
7	62	CD	NUMBER	62	num	9	SENT_263	[p19l1048t614r1132b659],
8	:	:	O	:	_	0	SENT_263	[p19l1048t614r1132b659],
9	676-89	CD	NUMBER	676-89	dep	4	SENT_263	[p19l1159t614r1382b659],
10	.	.	O	.	_	0	SENT_263	[p19l1159t614r1382b659],

1	Struewing	VBG	PERSON	struew	_	0	SENT_264	[p19l115t696r401b755],
2	JP	NNP	O	JP	dobj	1	SENT_264	[p19l416t697r500b754],
3	,	,	O	,	_	0	SENT_264	[p19l416t697r500b754],
4	Hartge	NNP	PERSON	Hartge	nn	5	SENT_264	[p19l522t697r716b755],
5	P	NN	PERSON	p	appos	2	SENT_264	[p19l738t697r793b753],
6	,	,	O	,	_	0	SENT_264	[p19l738t697r793b753],
7	Wacholder	NNP	PERSON	Wacholder	nn	8	SENT_264	[p19l814t696r1125b743],
8	S	NNP	O	S	appos	2	SENT_264	[p19l1146t696r1197b753],
9	,	,	O	,	_	0	SENT_264	[p19l1146t696r1197b753],
10	et	FW	O	et	nn	11	SENT_264	[p19l1221t706r1271b743],
11	al.	FW	O	al.	appos	2	SENT_264	[p19l1292t696r1352b743],
12	.	.	O	.	_	0	SENT_264	[p19l1292t696r1352b743],

1	The	DT	O	the	det	2	SENT_265	[p19l1375t696r1491b743],
2	risk	NN	O	risk	nsubj	5	SENT_265	[p19l1512t696r1612b743],
3	of	IN	O	of	_	0	SENT_265	[p19l1632t696r1692b743],
4	cancer	NN	O	cancer	prep_of	2	SENT_265	[p19l1706t711r1890b743],
5	associated	VBN	O	associate	_	0	SENT_265	[p19l114t771r399b818],
6	with	IN	O	with	_	0	SENT_265	[p19l418t771r542b818],
7	speciﬁc	NN	O	speciﬁc	nn	8	SENT_265	[p19l562t770r768b830],
8	mutations	NNS	O	mutation	prep_with	5	SENT_265	[p19l789t771r1071b818],
9	of	IN	O	of	_	0	SENT_265	[p19l1094t770r1154b818],
10	BRCA1	NN	O	brca1	prep_of	8	SENT_265	[p19l1165t771r1381b818],
11	and	CC	O	and	_	0	SENT_265	[p19l1406t771r1509b818],
12	BRCA2	NN	O	brca2	prep_of	8	SENT_265	[p19l1528t771r1748b818],
13	among	IN	O	among	_	0	SENT_265	[p19l1769t786r1961b830],
14	Ashkenazi	NNP	MISC	Ashkenazi	nn	15	SENT_265	[p19l111t846r400b893],
15	Jews	NNPS	MISC	Jews	prep_among	5	SENT_265	[p19l416t846r560b903],
16	.	.	O	.	_	0	SENT_265	[p19l416t846r560b903],

1	N	NN	O	n	nn	2	SENT_266	[p19l583t846r642b892],
2	Eng	NN	O	eng	_	0	SENT_266	[p19l655t846r781b905],
3	!	.	O	!	_	0	SENT_266	[p19l655t846r781b905],

1	3	CD	NUMBER	3	num	2	SENT_267	[p19l790t846r831b905],
2	’	NN	O	’	nsubj	3	SENT_267	[p19l790t846r831b905],
3	Med	VBD	O	med	_	0	SENT_267	[p19l843t846r971b893],
4	1997	CD	DATE	1997	dobj	3	SENT_267	[p19l993t847r1145b902],
5	;	:	O	;	_	0	SENT_267	[p19l993t847r1145b902],
6	336	CD	NUMBER	336	num	8	SENT_267	[p19l1169t848r1287b893],
7	:	:	O	:	_	0	SENT_267	[p19l1169t848r1287b893],
8	1401-08	CD	DATE	1401-08	dep	4	SENT_267	[p19l1318t847r1573b893],
9	.	.	O	.	_	0	SENT_267	[p19l1318t847r1573b893],

1	Thorlacius	NNP	O	Thorlacius	nn	2	SENT_268	[p19l112t930r417b977],
2	S	NNP	O	S	_	0	SENT_268	[p19l440t930r492b987],
3	,	,	O	,	_	0	SENT_268	[p19l440t930r492b987],
4	Struewing	NNP	PERSON	Struewing	nn	5	SENT_268	[p19l516t930r803b989],
5	JP	NNP	O	JP	appos	2	SENT_268	[p19l817t931r900b988],
6	,	,	O	,	_	0	SENT_268	[p19l817t931r900b988],
7	Hartge	NNP	PERSON	Hartge	nn	8	SENT_268	[p19l924t931r1117b989],
8	P	NN	PERSON	p	appos	2	SENT_268	[p19l1138t931r1194b987],
9	,	,	O	,	_	0	SENT_268	[p19l1138t931r1194b987],
10	et	FW	O	et	nn	11	SENT_268	[p19l1218t941r1268b977],
11	al.	FW	O	al.	appos	2	SENT_268	[p19l1288t930r1349b977],
12	.	.	O	.	_	0	SENT_268	[p19l1288t930r1349b977],

1	Population-based	JJ	O	population-based	amod	2	SENT_269	[p19l1373t930r1870b989],
2	study	NN	O	study	_	0	SENT_269	[p19l1891t930r2043b989],
3	of	IN	O	of	_	0	SENT_269	[p19l2063t930r2123b977],
4	risk	NN	O	risk	prep_of	2	SENT_269	[p19l113t1004r214b1051],
5	of	IN	O	of	_	0	SENT_269	[p19l234t1003r294b1051],
6	breast	NN	O	breast	nn	7	SENT_269	[p19l305t1004r476b1051],
7	cancer	NN	O	cancer	prep_of	2	SENT_269	[p19l496t1019r680b1051],
8	in	IN	O	in	_	0	SENT_269	[p19l698t1004r752b1051],
9	carriers	NNS	O	carrier	prep_in	2	SENT_269	[p19l773t1004r977b1051],
10	of	IN	O	of	_	0	SENT_269	[p19l1000t1003r1060b1051],
11	BRCA2	NN	O	brca2	nn	12	SENT_269	[p19l1071t1004r1292b1051],
12	mutation	NN	O	mutation	prep_of	9	SENT_269	[p19l1311t1004r1583b1051],
13	.	.	O	.	_	0	SENT_269	[p19l1311t1004r1583b1051],

1	Lancet	NNP	O	Lancet	_	0	SENT_270	[p19l1607t1004r1790b1051],
2	1998	CD	DATE	1998	num	1	SENT_270	[p19l1814t1006r1966b1060],
3	;	:	O	;	_	0	SENT_270	[p19l1814t1006r1966b1060],
4	352	CD	NUMBER	352	num	6	SENT_270	[p19l1989t1005r2107b1051],
5	:	:	O	:	_	0	SENT_270	[p19l1989t1005r2107b1051],
6	1337-39	CD	NUMBER	1337-39	dep	1	SENT_270	[p19l120t1081r376b1126],
7	.	.	O	.	_	0	SENT_270	[p19l120t1081r376b1126],

1	Verhoog	NNP	O	Verhoog	nn	2	SENT_271	[p19l111t1163r354b1222],
2	LC	NNP	O	LC	_	0	SENT_271	[p19l373t1163r484b1219],
3	,	,	O	,	_	0	SENT_271	[p19l373t1163r484b1219],
4	Brekelmans	NNP	ORGANIZATION	Brekelmans	nn	5	SENT_271	[p19l506t1163r836b1210],
5	CTM	NNP	ORGANIZATION	CTM	appos	2	SENT_271	[p19l860t1163r1040b1219],
6	,	,	O	,	_	0	SENT_271	[p19l860t1163r1040b1219],
7	Seynaeve	NNP	O	Seynaeve	nn	8	SENT_271	[p19l1065t1163r1322b1222],
8	C	NNP	O	C	appos	2	SENT_271	[p19l1345t1163r1409b1219],
9	,	,	O	,	_	0	SENT_271	[p19l1345t1163r1409b1219],
10	et	FW	O	et	nn	11	SENT_271	[p19l1432t1173r1482b1210],
11	al.	FW	O	al.	appos	2	SENT_271	[p19l1503t1163r1563b1210],
12	.	.	O	.	_	0	SENT_271	[p19l1503t1163r1563b1210],

1	Survival	NN	O	survival	nn	4	SENT_272	[p19l1590t1163r1815b1210],
2	and	CC	O	and	_	0	SENT_272	[p19l1837t1163r1940b1210],
3	tumour	NN	O	tumour	nn	4	SENT_272	[p19l112t1249r326b1286],
4	characteristics	NNS	O	characteristic	_	0	SENT_272	[p19l346t1238r743b1286],
5	of	IN	O	of	_	0	SENT_272	[p19l765t1238r825b1286],
6	breast	NN	O	breast	nn	9	SENT_272	[p19l837t1238r1217b1286],
7	—	NN	O	—	nn	9	SENT_272	[p19l837t1238r1217b1286],
8	cancer	NN	O	cancer	nn	9	SENT_272	[p19l837t1238r1217b1286],
9	patients	NNS	O	patient	prep_of	4	SENT_272	[p19l1235t1239r1455b1298],
10	with	IN	O	with	_	0	SENT_272	[p19l1475t1238r1599b1286],
11	germline	NN	O	germline	nn	12	SENT_272	[p19l1619t1238r1864b1298],
12	mutations	NNS	O	mutation	prep_with	4	SENT_272	[p19l113t1312r395b1360],
13	of	IN	O	of	_	0	SENT_272	[p19l418t1312r478b1360],
14	BRCA1	NN	O	brca1	prep_of	4	SENT_272	[p19l489t1312r723b1360],
15	.	.	O	.	_	0	SENT_272	[p19l489t1312r723b1360],

1	Lancet	NNP	O	Lancet	_	0	SENT_273	[p19l747t1313r930b1360],
2	1998	CD	DATE	1998	num	1	SENT_273	[p19l953t1314r1106b1369],
3	;	:	O	;	_	0	SENT_273	[p19l953t1314r1106b1369],
4	251	CD	NUMBER	251	num	6	SENT_273	[p19l1128t1314r1247b1360],
5	:	:	O	:	_	0	SENT_273	[p19l1128t1314r1247b1360],
6	316-21	CD	NUMBER	316-21	dep	1	SENT_273	[p19l1273t1314r1497b1360],
7	.	.	O	.	_	0	SENT_273	[p19l1273t1314r1497b1360],

1	Robson	NNP	PERSON	Robson	nn	2	SENT_274	[p19l114t1396r330b1444],
2	M	NNP	O	M	_	0	SENT_274	[p19l349t1397r430b1453],
3	,	,	O	,	_	0	SENT_274	[p19l349t1397r430b1453],
4	Gilewki	NNP	PERSON	Gilewki	nn	5	SENT_274	[p19l454t1396r670b1444],
5	T	NN	PERSON	t	appos	2	SENT_274	[p19l690t1397r755b1453],
6	,	,	O	,	_	0	SENT_274	[p19l690t1397r755b1453],
7	Haas	NNP	PERSON	Haas	nn	8	SENT_274	[p19l777t1397r919b1444],
8	B	NNP	O	B	appos	2	SENT_274	[p19l941t1397r1000b1453],
9	,	,	O	,	_	0	SENT_274	[p19l941t1397r1000b1453],
10	et	FW	O	et	nn	11	SENT_274	[p19l1024t1407r1073b1444],
11	al.	FW	O	al.	appos	2	SENT_274	[p19l1094t1396r1154b1444],
12	.	.	O	.	_	0	SENT_274	[p19l1094t1396r1154b1444],

1	BRCA	NNP	O	BRCA	nn	2	SENT_275	[p19l1177t1396r1674b1444],
2	—	NN	O	—	nsubj	3	SENT_275	[p19l1177t1396r1674b1444],
3	associated	VBN	O	associate	_	0	SENT_275	[p19l1177t1396r1674b1444],
4	breast	NN	O	breast	nn	5	SENT_275	[p19l1693t1396r1864b1444],
5	cancer	NN	O	cancer	dobj	3	SENT_275	[p19l1885t1412r2068b1444],
6	in	IN	O	in	_	0	SENT_275	[p19l2087t1396r2140b1443],
7	young	JJ	O	young	amod	8	SENT_275	[p19l111t1488r287b1532],
8	women	NNS	O	woman	prep_in	5	SENT_275	[p19l305t1488r527b1520],
9	.	.	O	.	_	0	SENT_275	[p19l305t1488r527b1520],

1	3	CD	NUMBER	3	num	4	SENT_276	[p19l544t1473r586b1532],
2	’	NN	O	’	nn	4	SENT_276	[p19l544t1473r586b1532],
3	Clin	NN	O	clin	nn	4	SENT_276	[p19l603t1473r713b1520],
4	Oncol	NN	O	oncol	_	0	SENT_276	[p19l738t1473r893b1520],
5	1998	CD	DATE	1998	dep	4	SENT_276	[p19l915t1474r1067b1529],
6	;	:	O	;	_	0	SENT_276	[p19l915t1474r1067b1529],
7	16	CD	NUMBER	16	num	9	SENT_276	[p19l1094t1474r1174b1520],
8	:	:	O	:	_	0	SENT_276	[p19l1094t1474r1174b1520],
9	1642-49	CD	NUMBER	1642-49	dep	4	SENT_276	[p19l1206t1474r1461b1520],
10	.	.	O	.	_	0	SENT_276	[p19l1206t1474r1461b1520],

1	Hartmann	NNP	PERSON	Hartmann	nn	2	SENT_277	[p19l113t1556r408b1603],
2	LC	NNP	O	LC	_	0	SENT_277	[p19l428t1556r538b1612],
3	,	,	O	,	_	0	SENT_277	[p19l428t1556r538b1612],
4	Schaid	NNP	O	Schaid	nn	5	SENT_277	[p19l563t1556r752b1603],
5	DJ	NNP	O	DJ	appos	2	SENT_277	[p19l772t1556r865b1614],
6	,	,	O	,	_	0	SENT_277	[p19l772t1556r865b1614],
7	Woods	NNP	PERSON	Woods	nn	8	SENT_277	[p19l886t1556r1084b1603],
8	JE	NNP	O	JE	appos	2	SENT_277	[p19l1102t1556r1187b1613],
9	,	,	O	,	_	0	SENT_277	[p19l1102t1556r1187b1613],
10	et	FW	O	et	nn	11	SENT_277	[p19l1211t1566r1261b1603],
11	al.	FW	O	al.	appos	2	SENT_277	[p19l1282t1556r1342b1603],
12	.	.	O	.	_	0	SENT_277	[p19l1282t1556r1342b1603],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_278	[p19l1366t1555r1592b1615],
2	of	IN	O	of	_	0	SENT_278	[p19l1612t1555r1672b1603],
3	bilateral	JJ	O	bilateral	amod	5	SENT_278	[p19l1683t1556r1911b1603],
4	prophylactic	NN	O	prophylactic	nn	5	SENT_278	[p19l112t1631r461b1691],
5	mastectomy	NN	O	mastectomy	prep_of	1	SENT_278	[p19l482t1642r824b1690],
6	in	IN	O	in	_	0	SENT_278	[p19l843t1632r896b1678],
7	women	NNS	O	woman	prep_in	5	SENT_278	[p19l915t1647r1123b1679],
8	with	IN	O	with	_	0	SENT_278	[p19l1141t1631r1265b1679],
9	a	DT	O	a	det	11	SENT_278	[p19l1286t1647r1313b1679],
10	family	NN	O	family	nn	11	SENT_278	[p19l1333t1631r1508b1690],
11	history	NN	O	history	prep_with	7	SENT_278	[p19l1526t1631r1720b1690],
12	of	IN	O	of	_	0	SENT_278	[p19l1739t1631r1799b1679],
13	breast	NN	O	breast	nn	14	SENT_278	[p19l1810t1631r1981b1679],
14	cancer	NN	O	cancer	prep_of	1	SENT_278	[p19l114t1722r311b1754],
15	.	.	O	.	_	0	SENT_278	[p19l114t1722r311b1754],

1	N	NN	O	n	nn	3	SENT_279	[p19l334t1707r393b1753],
2	Engl	NN	ORGANIZATION	engl	nn	3	SENT_279	[p19l405t1706r532b1765],
3	j	NN	O	j	nsubj	5	SENT_279	[p19l540t1706r582b1765],
4	‘	CD	NUMBER	‘	dep	3	SENT_279	[p19l540t1706r582b1765],
5	Med	VBD	O	med	_	0	SENT_279	[p19l595t1706r722b1754],
6	1998	CD	DATE	1998	dobj	5	SENT_279	[p19l745t1708r897b1763],
7	;	:	O	;	_	0	SENT_279	[p19l745t1708r897b1763],
8	340	CD	NUMBER	340	num	10	SENT_279	[p19l920t1708r1038b1754],
9	:	:	O	:	_	0	SENT_279	[p19l920t1708r1038b1754],
10	77-84	CD	NUMBER	77-84	dep	6	SENT_279	[p19l1064t1708r1252b1754],
11	.	.	O	.	_	0	SENT_279	[p19l1064t1708r1252b1754],

1	Burke	NNP	PERSON	Burke	nn	2	SENT_280	[p19l113t1790r282b1838],
2	W	NNP	O	W	_	0	SENT_280	[p19l301t1791r383b1847],
3	,	,	O	,	_	0	SENT_280	[p19l301t1791r383b1847],
4	Daly	NNP	PERSON	Daly	nn	5	SENT_280	[p19l405t1790r540b1849],
5	M	NNP	O	M	appos	2	SENT_280	[p19l559t1791r640b1847],
6	,	,	O	,	_	0	SENT_280	[p19l559t1791r640b1847],
7	Garber	NNP	PERSON	Garber	nn	8	SENT_280	[p19l664t1790r864b1838],
8	J	NNP	PERSON	J	appos	2	SENT_280	[p19l879t1791r921b1848],
9	,	,	O	,	_	0	SENT_280	[p19l879t1791r921b1848],
10	et	FW	O	et	nn	11	SENT_280	[p19l944t1801r994b1838],
11	al.	FW	O	al.	appos	2	SENT_280	[p19l1015t1790r1075b1838],
12	.	.	O	.	_	0	SENT_280	[p19l1015t1790r1075b1838],

1	Recommendations	NNS	O	recommendation	_	0	SENT_281	[p19l1100t1790r1629b1838],
2	for	IN	O	for	_	0	SENT_281	[p19l1650t1790r1730b1838],
3	follow-up	JJ	O	follow-up	amod	4	SENT_281	[p19l1749t1790r2017b1850],
4	care	NN	O	care	prep_for	1	SENT_281	[p19l114t1881r227b1913],
5	of	IN	O	of	_	0	SENT_281	[p19l250t1865r310b1913],
6	individuals	NNS	O	individual	prep_of	4	SENT_281	[p19l322t1865r628b1913],
7	with	IN	O	with	_	0	SENT_281	[p19l648t1865r771b1913],
8	an	DT	O	a	det	10	SENT_281	[p19l792t1881r858b1913],
9	inherited	VBN	O	inherit	amod	10	SENT_281	[p19l878t1865r1131b1913],
10	predisposition	NN	O	predisposition	prep_with	6	SENT_281	[p19l1150t1865r1549b1924],
11	to	TO	O	to	_	0	SENT_281	[p19l1569t1876r1623b1913],
12	cancer	NN	O	cancer	prep_to	10	SENT_281	[p19l1646t1881r1842b1913],
13	:	:	O	:	_	0	SENT_281	[p19l1646t1881r1842b1913],
14	BRCA1	NN	O	brca1	dep	1	SENT_281	[p19l1866t1865r2081b1913],
15	and	CC	O	and	_	0	SENT_281	[p19l114t1940r217b1988],
16	BRCA2	NN	O	brca2	dep	1	SENT_281	[p19l236t1940r470b1988],
17	.	.	O	.	_	0	SENT_281	[p19l236t1940r470b1988],

1	j	NN	O	j	_	0	SENT_282	[p19l488t1940r682b1999],
2	‘	CD	NUMBER	‘	num	1	SENT_282	[p19l488t1940r682b1999],
3	A1l/IA	NN	O	a1l/ia	dep	1	SENT_282	[p19l488t1940r682b1999],
4	1997	CD	DATE	1997	num	3	SENT_282	[p19l712t1942r863b1997],
5	;	:	O	;	_	0	SENT_282	[p19l712t1942r863b1997],
6	277	CD	NUMBER	277	num	8	SENT_282	[p19l886t1942r1005b1988],
7	:	:	O	:	_	0	SENT_282	[p19l886t1942r1005b1988],
8	997-1003	CD	NUMBER	997-1003	dep	1	SENT_282	[p19l1031t1942r1328b1988],
9	.	.	O	.	_	0	SENT_282	[p19l1031t1942r1328b1988],

1	Fisher	NNP	PERSON	Fisher	nn	2	SENT_283	[p19l113t2024r285b2072],
2	B	NNP	PERSON	B	_	0	SENT_283	[p19l304t2025r361b2081],
3	,	,	O	,	_	0	SENT_283	[p19l304t2025r361b2081],
4	Constantino	NNP	O	Constantino	nn	5	SENT_283	[p19l386t2024r722b2072],
5	JP	NNP	O	JP	appos	2	SENT_283	[p19l739t2025r820b2082],
6	,	,	O	,	_	0	SENT_283	[p19l739t2025r820b2082],
7	Wickerham	NNP	PERSON	Wickerham	nn	8	SENT_283	[p19l840t2024r1158b2072],
8	DL	NNP	O	DL	appos	2	SENT_283	[p19l1177t2025r1288b2081],
9	,	,	O	,	_	0	SENT_283	[p19l1177t2025r1288b2081],
10	et	FW	O	et	nn	11	SENT_283	[p19l1311t2035r1359b2072],
11	a1	FW	O	a1	appos	2	SENT_283	[p19l1380t2024r1438b2072],
12	.	.	O	.	_	0	SENT_283	[p19l1380t2024r1438b2072],

1	Tamoxifen	NN	O	tamoxifen	_	0	SENT_284	[p19l1461t2024r1763b2072],
2	for	IN	O	for	_	0	SENT_284	[p19l1782t2024r1859b2072],
3	prevention	NN	O	prevention	prep_for	1	SENT_284	[p19l112t2099r406b2158],
4	of	IN	O	of	_	0	SENT_284	[p19l427t2099r485b2147],
5	breast	NN	O	breast	nn	6	SENT_284	[p19l496t2099r661b2147],
6	cancer	NN	O	cancer	prep_of	3	SENT_284	[p19l681t2115r874b2156],
7	;	:	O	;	_	0	SENT_284	[p19l681t2115r874b2156],
8	report	NN	O	report	dep	1	SENT_284	[p19l895t2110r1063b2158],
9	of	IN	O	of	_	0	SENT_284	[p19l1083t2099r1141b2147],
10	the	DT	O	the	det	14	SENT_284	[p19l1153t2099r1236b2147],
11	National	NNP	O	National	nn	14	SENT_284	[p19l1255t2099r1495b2147],
12	Surgical	NNP	O	Surgical	nn	14	SENT_284	[p19l1517t2099r1737b2158],
13	Adjuvant	JJ	O	adjuvant	amod	14	SENT_284	[p19l1755t2099r2008b2158],
14	Breast	NN	O	breast	prep_of	8	SENT_284	[p19l113t2175r285b2221],
15	and	CC	O	and	_	0	SENT_284	[p19l305t2174r406b2222],
16	Bowel	NNP	O	Bowel	nn	19	SENT_284	[p19l426t2174r594b2222],
17	Project	NNP	O	Project	nn	19	SENT_284	[p19l614t2174r808b2233],
18	PI	NN	O	pi	nn	19	SENT_284	[p19l827t2175r889b2221],
19	study	NN	O	study	prep_of	8	SENT_284	[p19l910t2174r1070b2233],
20	.	.	O	.	_	0	SENT_284	[p19l910t2174r1070b2233],

1	_	NN	O	_	nn	5	SENT_285	[p19l1087t2174r1127b2233],
2	7	CD	NUMBER	7	num	5	SENT_285	[p19l1087t2174r1127b2233],
3	Natl	NNP	O	Natl	nn	5	SENT_285	[p19l1140t2174r1262b2221],
4	Cancer	NNP	O	Cancer	nn	5	SENT_285	[p19l1279t2174r1462b2221],
5	Inst	NNP	O	Inst	_	0	SENT_285	[p19l1476t2175r1576b2221],
6	1998	CD	DATE	1998	dep	5	SENT_285	[p19l1599t2176r1747b2231],
7	;	:	O	;	_	0	SENT_285	[p19l1599t2176r1747b2231],
8	90	CD	NUMBER	90	num	10	SENT_285	[p19l1769t2176r1850b2222],
9	:	:	O	:	_	0	SENT_285	[p19l1769t2176r1850b2222],
10	1371-88	CD	NUMBER	1371-88	dep	5	SENT_285	[p19l1881t2176r2128b2222],
11	.	.	O	.	_	0	SENT_285	[p19l1881t2176r2128b2222],

1	Early	RB	O	early	advmod	5	SENT_286	[p19l113t2258r261b2317],
2	Breast	NN	O	breast	nn	4	SENT_286	[p19l281t2259r458b2306],
3	Cancer	NN	O	cancer	nn	4	SENT_286	[p19l480t2258r683b2306],
4	Trialists	NNS	O	trialist	nsubj	5	SENT_286	[p19l701t2258r947b2306],
5	’	VBP	O	’	_	0	SENT_286	[p19l701t2258r947b2306],
6	Collaborative	NNP	O	Collaborative	nn	7	SENT_286	[p19l973t2258r1350b2306],
7	Group	NNP	O	Group	dobj	5	SENT_286	[p19l1372t2258r1573b2317],
8	.	.	O	.	_	0	SENT_286	[p19l1372t2258r1573b2317],

1	Tamoxifen	NN	O	tamoxifen	_	0	SENT_287	[p19l1597t2258r1908b2306],
2	for	IN	O	for	_	0	SENT_287	[p19l1927t2258r2007b2306],
3	early	JJ	O	early	amod	5	SENT_287	[p19l114t2333r248b2392],
4	breast	NN	O	breast	nn	5	SENT_287	[p19l265t2333r436b2380],
5	cancer	NN	O	cancer	prep_for	1	SENT_287	[p19l456t2349r653b2380],
6	:	:	O	:	_	0	SENT_287	[p19l456t2349r653b2380],
7	an	DT	O	a	det	8	SENT_287	[p19l679t2349r745b2380],
8	overview	NN	O	overview	dep	1	SENT_287	[p19l766t2333r1013b2381],
9	of	IN	O	of	_	0	SENT_287	[p19l1033t2333r1093b2380],
10	the	DT	O	the	det	12	SENT_287	[p19l1105t2333r1192b2380],
11	randomised	JJ	O	randomised	amod	12	SENT_287	[p19l1213t2333r1546b2381],
12	trials	NNS	O	trial	prep_of	8	SENT_287	[p19l1566t2333r1717b2380],
13	.	.	O	.	_	0	SENT_287	[p19l1566t2333r1717b2380],

1	Lancet	NNP	O	Lancet	_	0	SENT_288	[p19l1741t2334r1924b2380],
2	1998	CD	DATE	1998	num	1	SENT_288	[p19l1947t2335r2099b2390],
3	,	,	O	,	_	0	SENT_288	[p19l1947t2335r2099b2390],
4	351	CD	NUMBER	351	num	1	SENT_288	[p19l114t2409r232b2456],
5	:	:	O	:	_	0	SENT_288	[p19l114t2409r232b2456],
6	1451-67	CD	NUMBER	1451-67	dep	1	SENT_288	[p19l263t2410r518b2456],
7	.	.	O	.	_	0	SENT_288	[p19l263t2410r518b2456],

1	Hogervorst	NNP	O	Hogervorst	nn	2	SENT_289	[p19l113t2494r430b2552],
2	FB	NNP	O	FB	_	0	SENT_289	[p19l449t2494r552b2550],
3	,	,	O	,	_	0	SENT_289	[p19l449t2494r552b2550],
4	Cornelis	NNP	ORGANIZATION	Cornelis	nn	5	SENT_289	[p19l577t2493r812b2541],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_289	[p19l834t2493r934b2550],
6	,	,	O	,	_	0	SENT_289	[p19l834t2493r934b2550],
7	Bout	NN	O	bout	nn	8	SENT_289	[p19l957t2494r1095b2540],
8	M	NN	O	m	appos	2	SENT_289	[p19l1114t2494r1195b2550],
9	,	,	O	,	_	0	SENT_289	[p19l1114t2494r1195b2550],
10	et	FW	O	et	nn	11	SENT_289	[p19l1219t2504r1269b2540],
11	al.	FW	O	al.	appos	2	SENT_289	[p19l1289t2493r1350b2540],
12	.	.	O	.	_	0	SENT_289	[p19l1289t2493r1350b2540],

1	Rapid	JJ	O	rapid	amod	2	SENT_290	[p19l1375t2493r1543b2552],
2	detection	NN	O	detection	_	0	SENT_290	[p19l1564t2493r1824b2541],
3	of	IN	O	of	_	0	SENT_290	[p19l1845t2493r1906b2540],
4	BRCA1	NN	O	brca1	nn	5	SENT_290	[p19l1917t2493r2132b2540],
5	mutations	NNS	O	mutation	prep_of	2	SENT_290	[p19l113t2568r395b2615],
6	by	IN	O	by	_	0	SENT_290	[p19l415t2568r484b2627],
7	the	DT	O	the	det	10	SENT_290	[p19l503t2568r589b2615],
8	protein	NN	O	protein	nn	10	SENT_290	[p19l609t2568r812b2627],
9	truncation	NN	O	truncation	nn	10	SENT_290	[p19l832t2568r1126b2615],
10	test	NN	O	test	prep_by	2	SENT_290	[p19l1145t2579r1259b2615],
11	.	.	O	.	_	0	SENT_290	[p19l1145t2579r1259b2615],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_291	[p19l1281t2569r1391b2615],
2	Genet	NNP	PERSON	Genet	_	0	SENT_291	[p19l1412t2568r1565b2615],
3	1995	CD	DATE	1995	num	2	SENT_291	[p19l1589t2570r1740b2625],
4	;	:	O	;	_	0	SENT_291	[p19l1589t2570r1740b2625],
5	10	CD	NUMBER	10	num	7	SENT_291	[p19l1768t2570r1848b2616],
6	:	:	O	:	_	0	SENT_291	[p19l1768t2570r1848b2616],
7	208-12	CD	NUMBER	208-12	dep	2	SENT_291	[p19l1874t2570r2098b2616],
8	.	.	O	.	_	0	SENT_291	[p19l1874t2570r2098b2616],

1	Tonin	NNP	O	Tonin	nn	2	SENT_292	[p19l112t2652r290b2700],
2	P	NN	O	p	_	0	SENT_292	[p19l310t2653r365b2709],
3	,	,	O	,	_	0	SENT_292	[p19l310t2653r365b2709],
4	Weber	NNP	PERSON	Weber	nn	5	SENT_292	[p19l386t2652r576b2700],
5	B	NNP	PERSON	B	appos	2	SENT_292	[p19l595t2653r654b2709],
6	,	,	O	,	_	0	SENT_292	[p19l595t2653r654b2709],
7	Ofﬁt	NNP	O	Ofﬁt	nn	8	SENT_292	[p19l679t2652r808b2700],
8	K	NNP	O	K	appos	2	SENT_292	[p19l828t2653r895b2709],
9	,	,	O	,	_	0	SENT_292	[p19l828t2653r895b2709],
10	et	FW	O	et	nn	11	SENT_292	[p19l918t2663r968b2700],
11	al.	FW	O	al.	appos	2	SENT_292	[p19l989t2652r1049b2700],
12	.	.	O	.	_	0	SENT_292	[p19l989t2652r1049b2700],

1	Frequency	NN	O	frequency	_	0	SENT_293	[p19l1074t2653r1376b2711],
2	of	IN	O	of	_	0	SENT_293	[p19l1396t2652r1456b2700],
3	recurrent	JJ	O	recurrent	amod	4	SENT_293	[p19l1468t2663r1729b2700],
4	BRCA1	NN	O	brca1	prep_of	1	SENT_293	[p19l1747t2652r1963b2700],
5	and	CC	O	and	_	0	SENT_293	[p19l1988t2652r2091b2700],
6	BRCA2	NN	O	brca2	nn	7	SENT_293	[p19l111t2727r332b2774],
7	mutations	NNS	O	mutation	prep_of	1	SENT_293	[p19l351t2727r634b2775],
8	in	IN	O	in	_	0	SENT_293	[p19l655t2727r708b2774],
9	Ashkenazi	NNP	MISC	Ashkenazi	prep_in	1	SENT_293	[p19l726t2727r1015b2775],
10	Jewish	JJ	MISC	jewish	amod	13	SENT_293	[p19l1031t2727r1215b2785],
11	breast	NN	O	breast	nn	13	SENT_293	[p19l1234t2727r1404b2775],
12	cancer	NN	O	cancer	nn	13	SENT_293	[p19l1425t2743r1608b2775],
13	families	NNS	O	family	dep	9	SENT_293	[p19l1627t2727r1857b2775],
14	.	.	O	.	_	0	SENT_293	[p19l1627t2727r1857b2775],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_294	[p19l111t2802r221b2848],
2	Med	NNP	O	Med	_	0	SENT_294	[p19l235t2801r362b2848],
3	1996	CD	DATE	1996	num	2	SENT_294	[p19l385t2803r537b2858],
4	;	:	O	;	_	0	SENT_294	[p19l385t2803r537b2858],
5	11	CD	NUMBER	11	num	7	SENT_294	[p19l564t2803r644b2848],
6	:	:	O	:	_	0	SENT_294	[p19l564t2803r644b2848],
7	1179-83	CD	NUMBER	1179-83	dep	2	SENT_294	[p19l675t2803r931b2848],
8	.	.	O	.	_	0	SENT_294	[p19l675t2803r931b2848],

1	Tonin	NNP	O	Tonin	nn	2	SENT_295	[p19l112t2885r290b2933],
2	P	NN	O	p	_	0	SENT_295	[p19l310t2886r365b2942],
3	,	,	O	,	_	0	SENT_295	[p19l310t2886r365b2942],
4	Mes	NNP	O	Mes	appos	2	SENT_295	[p19l388t2886r755b2933],
5	.	.	O	.	_	0	SENT_295	[p19l388t2886r755b2933],

1	—	NN	O	—	_	0	SENT_296	[p19l388t2886r755b2933],
2	.	.	O	.	_	0	SENT_296	[p19l388t2886r755b2933],

1	Masson	NNP	ORGANIZATION	Masson	nn	2	SENT_297	[p19l388t2886r755b2933],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_297	[p19l774t2886r904b2942],
3	,	,	O	,	_	0	SENT_297	[p19l774t2886r904b2942],
4	Futreal	NNP	PERSON	Futreal	nn	5	SENT_297	[p19l926t2885r1130b2933],
5	A	NNP	O	A	appos	2	SENT_297	[p19l1149t2886r1212b2942],
6	,	,	O	,	_	0	SENT_297	[p19l1149t2886r1212b2942],
7	et	FW	O	et	nn	8	SENT_297	[p19l1236t2896r1285b2933],
8	al.	FW	O	al.	appos	5	SENT_297	[p19l1306t2885r1367b2933],
9	.	.	O	.	_	0	SENT_297	[p19l1306t2885r1367b2933],

1	Founder	NN	O	founder	nn	2	SENT_298	[p19l1391t2885r1637b2933],
2	BRCA1	NN	O	brca1	_	0	SENT_298	[p19l1654t2885r1869b2933],
3	and	CC	O	and	_	0	SENT_298	[p19l1895t2885r1998b2933],
4	BRCA2	NN	O	brca2	nn	5	SENT_298	[p19l111t2961r332b3008],
5	mutations	NNS	O	mutation	conj_and	2	SENT_298	[p19l351t2961r634b3008],
6	in	IN	O	in	_	0	SENT_298	[p19l655t2961r708b3008],
7	French	NNP	MISC	French	prep_in	2	SENT_298	[p19l729t2961r1229b3009],
8	.	.	O	.	_	0	SENT_298	[p19l729t2961r1229b3009],

1	—	NN	O	—	_	0	SENT_299	[p19l729t2961r1229b3009],
2	.	.	O	.	_	0	SENT_299	[p19l729t2961r1229b3009],

1	Canadian	JJ	MISC	canadian	amod	2	SENT_300	[p19l729t2961r1229b3009],
2	breast	NN	O	breast	_	0	SENT_300	[p19l1247t2961r1418b3008],
3	and	CC	O	and	_	0	SENT_300	[p19l1439t2961r1542b3008],
4	ovarian	JJ	O	ovarian	amod	6	SENT_300	[p19l1564t2961r1769b3008],
5	cancer	NN	O	cancer	nn	6	SENT_300	[p19l1791t2976r1974b3008],
6	families	NNS	O	family	conj_and	2	SENT_300	[p19l113t3037r343b3084],
7	.	.	O	.	_	0	SENT_300	[p19l113t3037r343b3084],

1	Am_7Hum	NN	O	am_7hum	_	0	SENT_301	[p19l363t3037r671b3096],
2	Genet	NNP	O	Genet	dep	1	SENT_301	[p19l696t3037r849b3084],
3	1998	CD	DATE	1998	num	2	SENT_301	[p19l873t3039r1025b3094],
4	;	:	O	;	_	0	SENT_301	[p19l873t3039r1025b3094],
5	63	CD	NUMBER	63	num	7	SENT_301	[p19l1048t3039r1132b3084],
6	:	:	O	:	_	0	SENT_301	[p19l1048t3039r1132b3084],
7	1341-51	CD	NUMBER	1341-51	dep	1	SENT_301	[p19l1163t3039r1419b3084],
8	.	.	O	.	_	0	SENT_301	[p19l1163t3039r1419b3084],

1	Karp	NNP	PERSON	Karp	nn	2	SENT_302	[p19l113t3122r255b3180],
2	SE	NN	O	se	_	0	SENT_302	[p19l278t3121r374b3178],
3	,	,	O	,	_	0	SENT_302	[p19l278t3121r374b3178],
4	Tonin	NNP	O	Tonin	nn	5	SENT_302	[p19l396t3121r573b3168],
5	PN	NNP	O	PN	appos	2	SENT_302	[p19l594t3122r705b3178],
6	,	,	O	,	_	0	SENT_302	[p19l594t3122r705b3178],
7	Begin	NNP	O	Begin	nn	8	SENT_302	[p19l727t3121r889b3180],
8	LR	NNP	O	LR	appos	2	SENT_302	[p19l909t3122r1015b3178],
9	,	,	O	,	_	0	SENT_302	[p19l909t3122r1015b3178],
10	et	FW	O	et	nn	11	SENT_302	[p19l1039t3132r1089b3168],
11	al.	FW	O	al.	appos	2	SENT_302	[p19l1109t3121r1169b3168],
12	.	.	O	.	_	0	SENT_302	[p19l1109t3121r1169b3168],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_303	[p19l1194t3121r1458b3169],
2	of	IN	O	of	_	0	SENT_303	[p19l1480t3121r1540b3168],
3	BRCA1	NN	O	brca1	nn	4	SENT_303	[p19l1551t3121r1767b3168],
4	mutations	NNS	O	mutation	prep_of	1	SENT_303	[p19l1791t3121r2073b3168],
5	on	IN	O	on	_	0	SENT_303	[p19l114t3211r184b3243],
6	nuclear	JJ	O	nuclear	amod	7	SENT_303	[p19l203t3196r413b3243],
7	grade	NN	O	grade	prep_on	1	SENT_303	[p19l432t3196r586b3255],
8	and	CC	O	and	_	0	SENT_303	[p19l608t3196r711b3243],
9	estrogen	NN	O	estrogen	nn	11	SENT_303	[p19l732t3206r968b3255],
10	receptor	NN	O	receptor	nn	11	SENT_303	[p19l988t3206r1223b3255],
11	status	NN	O	status	prep_on	1	SENT_303	[p19l1243t3207r1402b3243],
12	in	IN	O	in	_	0	SENT_303	[p19l1423t3196r1477b3243],
13	breast	NN	O	breast	nn	14	SENT_303	[p19l1496t3196r1666b3243],
14	cancers	NNS	O	cancer	prep_in	7	SENT_303	[p19l1687t3211r1893b3243],
15	in	IN	O	in	_	0	SENT_303	[p19l1915t3196r1968b3243],
16	Ashkenazi	NNP	MISC	Ashkenazi	nn	18	SENT_303	[p19l111t3271r400b3318],
17	Jewish	JJ	MISC	jewish	amod	18	SENT_303	[p19l416t3271r600b3329],
18	women	NNS	O	woman	prep_in	1	SENT_303	[p19l619t3286r841b3318],
19	.	.	O	.	_	0	SENT_303	[p19l619t3286r841b3318],

1	Cancer	NN	O	cancer	_	0	SENT_304	[p19l867t3271r1056b3318],
2	1997	CD	DATE	1997	num	1	SENT_304	[p19l1079t3272r1230b3327],
3	;	:	O	;	_	0	SENT_304	[p19l1079t3272r1230b3327],
4	80	CD	NUMBER	80	num	6	SENT_304	[p19l1254t3273r1338b3318],
5	:	:	O	:	_	0	SENT_304	[p19l1254t3273r1338b3318],
6	435-41	CD	NUMBER	435-41	dep	1	SENT_304	[p19l1363t3272r1588b3318],
7	.	.	O	.	_	0	SENT_304	[p19l1363t3272r1588b3318],

1	15	CD	NUMBER	15	num	3	SENT_305	[p19l16t3357r75b3402],
2	Johannsson	NNP	PERSON	Johannsson	nn	3	SENT_305	[p19l109t3355r438b3413],
3	OT	NNP	O	OT	_	0	SENT_305	[p19l460t3355r576b3412],
4	,	,	O	,	_	0	SENT_305	[p19l460t3355r576b3412],
5	Idvall	NNP	O	Idvall	nn	6	SENT_305	[p19l598t3355r755b3402],
6	I	NNP	O	I	appos	3	SENT_305	[p19l776t3356r815b3412],
7	,	,	O	,	_	0	SENT_305	[p19l776t3356r815b3412],
8	Anderson	NNP	PERSON	Anderson	nn	9	SENT_305	[p19l836t3355r1112b3402],
9	C	NNP	O	C	appos	3	SENT_305	[p19l1134t3355r1198b3412],
10	,	,	O	,	_	0	SENT_305	[p19l1134t3355r1198b3412],
11	et	FW	O	et	nn	12	SENT_305	[p19l1221t3365r1271b3402],
12	al.	FW	O	al.	appos	3	SENT_305	[p19l1292t3355r1352b3402],
13	.	.	O	.	_	0	SENT_305	[p19l1292t3355r1352b3402],

1	Tumour	NN	O	tumour	_	0	SENT_306	[p19l1376t3356r1618b3402],
2	biological	JJ	O	biological	amod	3	SENT_306	[p19l1635t3355r1907b3414],
3	features	NNS	O	feature	dep	1	SENT_306	[p19l1927t3355r2146b3402],
4	of	IN	O	of	_	0	SENT_306	[p19l114t3429r175b3477],
5	BRCAI-induced	JJ	O	brcai-induced	amod	6	SENT_306	[p19l185t3430r658b3477],
6	breast	NN	O	breast	prep_of	3	SENT_306	[p19l677t3430r847b3477],
7	and	CC	O	and	_	0	SENT_306	[p19l868t3430r971b3477],
8	ovarian	JJ	O	ovarian	amod	9	SENT_306	[p19l993t3430r1199b3477],
9	cancer	NN	O	cancer	prep_of	3	SENT_306	[p19l1220t3445r1417b3477],
10	.	.	O	.	_	0	SENT_306	[p19l1220t3445r1417b3477],

1	Eur	NNP	O	Eur	nn	3	SENT_307	[p19l1440t3430r1594b3489],
2	}	NNP	O	}	nn	3	SENT_307	[p19l1440t3430r1594b3489],
3	Cancer	NNP	O	Cancer	_	0	SENT_307	[p19l1610t3430r1799b3477],
4	1997	CD	DATE	1997	num	3	SENT_307	[p19l1822t3432r1974b3486],
5	;	:	O	;	_	0	SENT_307	[p19l1822t3432r1974b3486],
6	33	CD	NUMBER	33	dep	3	SENT_307	[p19l1997t3432r2081b3477],
7	:	:	O	:	_	0	SENT_307	[p19l1997t3432r2081b3477],
8	362-7	CD	NUMBER	362-7	number	9	SENT_307	[p19l115t3506r285b3551],
9	1	CD	NUMBER	1	dep	6	SENT_307	[p19l297t3506r339b3551],
10	.	.	O	.	_	0	SENT_307	[p19l297t3506r339b3551],

1	16	CD	NUMBER	16	num	3	SENT_308	[p20l16t27r77b72],
2	Loman	NNP	ORGANIZATION	Loman	nn	3	SENT_308	[p20l113t25r317b72],
3	N	NNP	ORGANIZATION	N	_	0	SENT_308	[p20l336t25r407b81],
4	,	,	O	,	_	0	SENT_308	[p20l336t25r407b81],
5	Johannsson	NNP	PERSON	Johannsson	nn	6	SENT_308	[p20l426t25r754b82],
6	O	NNP	O	O	appos	3	SENT_308	[p20l776t25r842b81],
7	,	,	O	,	_	0	SENT_308	[p20l776t25r842b81],
8	Bendahl	NNP	O	Bendahl	nn	9	SENT_308	[p20l865t25r1099b72],
9	P	NN	O	p	appos	6	SENT_308	[p20l1120t25r1252b81],
10	.	.	O	.	_	0	SENT_308	[p20l1120t25r1252b81],

1	—	NN	O	—	_	0	SENT_309	[p20l1120t25r1252b81],
2	.	.	O	.	_	0	SENT_309	[p20l1120t25r1252b81],

1	O	NN	O	o	_	0	SENT_310	[p20l1120t25r1252b81],
2	,	,	O	,	_	0	SENT_310	[p20l1120t25r1252b81],
3	Borg	NNP	PERSON	Borg	nn	4	SENT_310	[p20l1276t25r1412b84],
4	A	NNP	O	A	dep	1	SENT_310	[p20l1430t25r1493b81],
5	,	,	O	,	_	0	SENT_310	[p20l1430t25r1493b81],
6	Femo	NNP	O	Femo	nn	7	SENT_310	[p20l1515t25r1683b72],
7	M	NNP	O	M	appos	4	SENT_310	[p20l1704t25r1785b81],
8	,	,	O	,	_	0	SENT_310	[p20l1704t25r1785b81],

1	Olsson	NNP	PERSON	Olsson	nn	2	SENT_311	[p20l115t100r307b147],
2	AH	NNP	O	AH	_	0	SENT_311	[p20l325t100r443b147],
3	.	.	O	.	_	0	SENT_311	[p20l325t100r443b147],

1	Steroid	NN	O	steroid	nn	2	SENT_312	[p20l470t100r672b147],
2	receptors	NNS	O	receptor	nsubj	7	SENT_312	[p20l691t110r949b159],
3	in	IN	O	in	_	0	SENT_312	[p20l970t100r1024b146],
4	hereditary	JJ	O	hereditary	amod	6	SENT_312	[p20l1043t100r1329b159],
5	breast	NN	O	breast	nn	6	SENT_312	[p20l1347t100r1518b147],
6	carcinomas	NNS	O	carcinoma	prep_in	2	SENT_312	[p20l1538t100r1856b147],
7	associated	VBN	O	associate	_	0	SENT_312	[p20l114t175r399b223],
8	with	IN	O	with	_	0	SENT_312	[p20l418t175r542b223],
9	BRCA1	NN	O	brca1	nn	12	SENT_312	[p20l560t176r775b223],
10	or	CC	O	or	_	0	SENT_312	[p20l800t191r858b223],
11	BRCAZ	NN	O	brcaz	nn	12	SENT_312	[p20l876t176r1097b223],
12	mutations	NNS	O	mutation	prep_with	7	SENT_312	[p20l1116t176r1398b223],
13	or	CC	O	or	_	0	SENT_312	[p20l1421t191r1479b223],
14	unknown	JJ	O	unknown	amod	16	SENT_312	[p20l1497t175r1763b223],
15	susceptibility	NN	O	susceptibility	nn	16	SENT_312	[p20l1783t175r2151b235],
16	genes	NNS	O	gene	prep_with	7	SENT_312	[p20l113t266r283b309],
17	.	.	O	.	_	0	SENT_312	[p20l113t266r283b309],

1	Cancer	NN	O	cancer	_	0	SENT_313	[p20l309t250r498b298],
2	1998	CD	DATE	1998	num	1	SENT_313	[p20l521t252r673b307],
3	,	,	O	,	_	0	SENT_313	[p20l521t252r673b307],
4	83	CD	NUMBER	83	num	6	SENT_313	[p20l697t252r780b298],
5	:	:	O	:	_	0	SENT_313	[p20l697t252r780b298],
6	310-19	CD	NUMBER	310-19	appos	1	SENT_313	[p20l806t252r1030b298],
7	.	.	O	.	_	0	SENT_313	[p20l806t252r1030b298],

1	17	CD	NUMBER	17	num	3	SENT_314	[p20l13t327r73b372],
2	Eisenger	NN	O	eisenger	nn	3	SENT_314	[p20l110t325r355b384],
3	F	NN	O	f	nsubj	22	SENT_314	[p20l373t326r431b382],
4	,	,	O	,	_	0	SENT_314	[p20l373t326r431b382],
5	Jacquemier	NN	O	jacquemier	nn	17	SENT_314	[p20l450t325r775b384],
6	J	NN	O	j	nn	17	SENT_314	[p20l790t326r831b383],
7	,	,	O	,	_	0	SENT_314	[p20l790t326r831b383],
8	Nogues	NNP	PERSON	Nogues	dep	17	SENT_314	[p20l853t326r1070b384],
9	C	NNP	O	C	nn	17	SENT_314	[p20l1094t325r1158b382],
10	,	,	O	,	_	0	SENT_314	[p20l1094t325r1158b382],
11	Birnbaum	NNP	PERSON	Birnbaum	appos	17	SENT_314	[p20l1181t325r1467b372],
12	D	NNP	O	D	nn	17	SENT_314	[p20l1487t326r1558b382],
13	,	,	O	,	_	0	SENT_314	[p20l1487t326r1558b382],
14	Sobol	NNP	PERSON	Sobol	appos	17	SENT_314	[p20l1583t325r1743b372],
15	H.	NNP	PERSON	H.	nn	17	SENT_314	[p20l1764t326r1833b372],
16	Steroid	NN	PERSON	steroid	nn	17	SENT_314	[p20l1860t325r2063b372],
17	receptors	NNS	O	receptor	nsubj	22	SENT_314	[p20l110t410r369b459],
18	in	IN	O	in	_	0	SENT_314	[p20l390t400r444b447],
19	hereditary	JJ	O	hereditary	amod	21	SENT_314	[p20l463t400r751b459],
20	breast	NN	O	breast	nn	21	SENT_314	[p20l769t400r941b447],
21	carcinomas	NNS	O	carcinoma	prep_in	17	SENT_314	[p20l961t400r1280b447],
22	associated	VBN	O	associate	_	0	SENT_314	[p20l1304t400r1590b447],
23	with	IN	O	with	_	0	SENT_314	[p20l1609t400r1733b447],
24	BRCA1	NN	O	brca1	nn	27	SENT_314	[p20l1751t400r1968b447],
25	or	CC	O	or	_	0	SENT_314	[p20l1993t415r2052b447],
26	BRCA2	NN	O	brca2	nn	27	SENT_314	[p20l109t475r330b522],
27	mutations	NNS	O	mutation	prep_with	22	SENT_314	[p20l349t475r634b522],
28	or	CC	O	or	_	0	SENT_314	[p20l656t490r715b522],
29	unknown	JJ	O	unknown	amod	31	SENT_314	[p20l733t475r1000b522],
30	susceptibility	NN	O	susceptibility	nn	31	SENT_314	[p20l1022t475r1391b534],
31	genes	NNS	O	gene	prep_with	22	SENT_314	[p20l1410t490r1581b534],
32	.	.	O	.	_	0	SENT_314	[p20l1410t490r1581b534],

1	Cancer	NN	O	cancer	_	0	SENT_315	[p20l1607t475r1797b522],
2	1999	CD	DATE	1999	num	1	SENT_315	[p20l1820t477r1973b532],
3	;	:	O	;	_	0	SENT_315	[p20l1820t477r1973b532],
4	85	CD	NUMBER	85	dep	1	SENT_315	[p20l1997t476r2081b522],
5	:	:	O	:	_	0	SENT_315	[p20l1997t476r2081b522],
6	229	CD	NUMBER	229	number	7	SENT_315	[p20l112t552r214b597],
7	1-93	CD	NUMBER	1-93	dep	4	SENT_315	[p20l226t552r374b597],
8	.	.	O	.	_	0	SENT_315	[p20l226t552r374b597],

1	18	CD	NUMBER	18	num	3	SENT_316	[p20l13t636r73b682],
2	Narod	NNP	ORGANIZATION	Narod	nn	3	SENT_316	[p20l109t634r294b681],
3	SA	NNP	ORGANIZATION	SA	_	0	SENT_316	[p20l316t634r415b691],
4	,	,	O	,	_	0	SENT_316	[p20l316t634r415b691],
5	Goldgar	NNP	PERSON	Goldgar	nn	6	SENT_316	[p20l439t634r672b693],
6	D	NNP	O	D	appos	3	SENT_316	[p20l691t635r761b691],
7	,	,	O	,	_	0	SENT_316	[p20l691t635r761b691],
8	Cannon-Albright	NNP	O	Cannon-Albright	appos	3	SENT_316	[p20l786t634r1291b693],
9	,	,	O	,	_	0	SENT_316	[p20l786t634r1291b693],
10	et	FW	O	et	nn	11	SENT_316	[p20l1315t645r1365b681],
11	al.	FW	O	al.	appos	3	SENT_316	[p20l1386t634r1446b681],
12	.	.	O	.	_	0	SENT_316	[p20l1386t634r1446b681],

1	Risk	NN	O	risk	nn	2	SENT_317	[p20l1471t634r1595b681],
2	modiﬁers	NNS	O	modiﬁers	_	0	SENT_317	[p20l1613t634r1878b682],
3	in	IN	O	in	_	0	SENT_317	[p20l1900t634r1953b681],
4	carriers	NNS	O	carrier	prep_in	2	SENT_317	[p20l111t709r317b756],
5	of	IN	O	of	_	0	SENT_317	[p20l340t709r401b756],
6	BRCA1	NN	O	brca1	nn	7	SENT_317	[p20l411t709r628b756],
7	mutations	NNS	O	mutation	prep_of	2	SENT_317	[p20l652t709r953b756],
8	.	.	O	.	_	0	SENT_317	[p20l652t709r953b756],

1	Int_7	NNP	O	Int_7	nn	2	SENT_318	[p20l976t709r1109b768],
2	Cancer	NNP	O	Cancer	_	0	SENT_318	[p20l1126t709r1315b756],
3	1995	CD	DATE	1995	num	2	SENT_318	[p20l1338t711r1491b766],
4	,	,	O	,	_	0	SENT_318	[p20l1338t711r1491b766],
5	64	CD	NUMBER	64	num	2	SENT_318	[p20l1515t711r1599b757],
6	:	:	O	:	_	0	SENT_318	[p20l1515t711r1599b757],
7	394-98	CD	NUMBER	394-98	dep	2	SENT_318	[p20l1625t711r1851b757],
8	.	.	O	.	_	0	SENT_318	[p20l1625t711r1851b757],

1	19	CD	NUMBER	19	num	3	SENT_319	[p20l13t794r73b841],
2	Easton	NNP	ORGANIZATION	Easton	nn	3	SENT_319	[p20l110t793r306b840],
3	DF	NN	O	df	_	0	SENT_319	[p20l326t793r439b850],
4	,	,	O	,	_	0	SENT_319	[p20l326t793r439b850],
5	Ford	NNP	ORGANIZATION	Ford	nn	6	SENT_319	[p20l462t792r602b841],
6	D	NNP	ORGANIZATION	D	appos	3	SENT_319	[p20l622t793r692b850],
7	,	,	O	,	_	0	SENT_319	[p20l622t793r692b850],
8	Bishop	NNP	PERSON	Bishop	nn	9	SENT_319	[p20l715t792r910b853],
9	DT	NNP	O	DT	appos	3	SENT_319	[p20l932t793r1052b850],
10	,	,	O	,	_	0	SENT_319	[p20l932t793r1052b850],
11	et	FW	O	et	nn	12	SENT_319	[p20l1076t803r1126b840],
12	al.	FW	O	al.	appos	3	SENT_319	[p20l1147t792r1208b840],
13	.	.	O	.	_	0	SENT_319	[p20l1147t792r1208b840],

1	Breast	NN	O	breast	nn	5	SENT_320	[p20l1233t793r1411b840],
2	and	CC	O	and	_	0	SENT_320	[p20l1432t792r1536b840],
3	ovarian	JJ	O	ovarian	conj_and	1	SENT_320	[p20l1557t793r1764b841],
4	cancer	NN	O	cancer	nn	5	SENT_320	[p20l1785t808r1970b840],
5	incidence	NN	O	incidence	_	0	SENT_320	[p20l110t868r379b916],
6	in	IN	O	in	_	0	SENT_320	[p20l400t869r454b916],
7	BRCA1	NN	O	brca1	nn	9	SENT_320	[p20l472t869r689b916],
8	mutation	NN	O	mutation	nn	9	SENT_320	[p20l713t869r973b916],
9	carriers	NNS	O	carrier	prep_in	5	SENT_320	[p20l994t868r1216b917],
10	.	.	O	.	_	0	SENT_320	[p20l994t868r1216b917],

1	Amj	NN	O	amj	nn	4	SENT_321	[p20l1236t869r1546b929],
2	‘	CD	NUMBER	‘	num	4	SENT_321	[p20l1236t869r1546b929],
3	Hum	NNP	O	Hum	nn	4	SENT_321	[p20l1236t869r1546b929],
4	Genet	NNP	O	Genet	_	0	SENT_321	[p20l1571t869r1725b916],
5	1995	CD	DATE	1995	dep	4	SENT_321	[p20l1749t870r1902b926],
6	;	:	O	;	_	0	SENT_321	[p20l1749t870r1902b926],
7	56	CD	NUMBER	56	dep	4	SENT_321	[p20l1927t870r2010b917],
8	:	:	O	:	_	0	SENT_321	[p20l1927t870r2010b917],
9	265-7	CD	NUMBER	265-7	number	10	SENT_321	[p20l112t946r283b992],
10	1	CD	NUMBER	1	dep	7	SENT_321	[p20l296t946r315b991],
11	.	.	O	.	_	0	SENT_321	[p20l329t984r337b992],

1	20	CD	NUMBER	20	num	3	SENT_322	[p20l7t1030r74b1075],
2	Rebbeck	NNP	ORGANIZATION	Rebbeck	nn	3	SENT_322	[p20l111t1028r357b1075],
3	TR	NN	ORGANIZATION	tr	_	0	SENT_322	[p20l375t1028r488b1084],
4	,	,	O	,	_	0	SENT_322	[p20l375t1028r488b1084],
5	Levin	NNP	ORGANIZATION	Levin	nn	6	SENT_322	[p20l510t1028r672b1075],
6	AM	NNP	ORGANIZATION	AM	appos	3	SENT_322	[p20l690t1028r820b1084],
7	,	,	O	,	_	0	SENT_322	[p20l690t1028r820b1084],
8	Eisen	NNP	PERSON	Eisen	nn	9	SENT_322	[p20l843t1028r998b1075],
9	A	NNP	O	A	appos	3	SENT_322	[p20l1017t1028r1080b1084],
10	,	,	O	,	_	0	SENT_322	[p20l1017t1028r1080b1084],
11	et	FW	O	et	nn	12	SENT_322	[p20l1104t1038r1154b1075],
12	al.	FW	O	al.	appos	3	SENT_322	[p20l1175t1028r1236b1075],
13	.	.	O	.	_	0	SENT_322	[p20l1175t1028r1236b1075],

1	Reduction	NN	O	reduction	nsubj	5	SENT_323	[p20l1261t1028r1556b1075],
2	in	IN	O	in	_	0	SENT_323	[p20l1576t1028r1629b1075],
3	breast	NN	O	breast	nn	4	SENT_323	[p20l1648t1028r1820b1075],
4	cancer	NN	O	cancer	prep_in	1	SENT_323	[p20l1841t1043r2025b1075],
5	risk	NN	O	risk	_	0	SENT_323	[p20l2044t1028r2145b1075],
6	after	IN	O	after	_	0	SENT_323	[p20l111t1103r239b1152],
7	bilateral	JJ	O	bilateral	amod	9	SENT_323	[p20l256t1104r485b1152],
8	prophylactic	JJ	O	prophylactic	amod	9	SENT_323	[p20l505t1104r856b1164],
9	oophorectomy	NN	O	oophorectomy	prep_after	5	SENT_323	[p20l878t1104r1290b1164],
10	in	IN	O	in	_	0	SENT_323	[p20l1309t1104r1362b1151],
11	BRCA1	NN	O	brca1	nn	13	SENT_323	[p20l1381t1104r1598b1152],
12	mutation	NN	O	mutation	nn	13	SENT_323	[p20l1622t1104r1882b1152],
13	carriers	NNS	O	carrier	prep_in	9	SENT_323	[p20l1903t1104r2125b1152],
14	.	.	O	.	_	0	SENT_323	[p20l1903t1104r2125b1152],

1	j	NN	O	j	nn	5	SENT_324	[p20l103t1180r285b1239],
2	‘	CD	NUMBER	‘	num	5	SENT_324	[p20l103t1180r285b1239],
3	Natl	NNP	O	Natl	nn	5	SENT_324	[p20l103t1180r285b1239],
4	Cancer	NNP	O	Cancer	nn	5	SENT_324	[p20l302t1180r492b1227],
5	Inst	NNP	O	Inst	_	0	SENT_324	[p20l507t1180r610b1227],
6	1999	CD	DATE	1999	dep	5	SENT_324	[p20l634t1181r787b1236],
7	;	:	O	;	_	0	SENT_324	[p20l634t1181r787b1236],
8	91	CD	NUMBER	91	num	10	SENT_324	[p20l810t1182r894b1227],
9	:	:	O	:	_	0	SENT_324	[p20l810t1182r894b1227],
10	1475-79	CD	NUMBER	1475-79	dep	5	SENT_324	[p20l926t1181r1183b1227],
11	.	.	O	.	_	0	SENT_324	[p20l926t1181r1183b1227],

1	21	CD	NUMBER	21	num	3	SENT_325	[p20l7t1265r69b1310],
2	Jernstrom	NN	O	jernstrom	nn	3	SENT_325	[p20l106t1264r390b1321],
3	H	NN	O	h	_	0	SENT_325	[p20l410t1264r481b1320],
4	,	,	O	,	_	0	SENT_325	[p20l410t1264r481b1320],
5	Lerman	NNP	PERSON	Lerman	nn	6	SENT_325	[p20l503t1264r729b1310],
6	C	NNP	O	C	appos	3	SENT_325	[p20l751t1263r814b1320],
7	,	,	O	,	_	0	SENT_325	[p20l751t1263r814b1320],
8	Ghadirian	NNP	MISC	Ghadirian	nn	9	SENT_325	[p20l839t1263r1126b1310],
9	P	NN	O	p	appos	3	SENT_325	[p20l1146t1264r1202b1320],
10	,	,	O	,	_	0	SENT_325	[p20l1146t1264r1202b1320],
11	et	FW	O	et	nn	12	SENT_325	[p20l1226t1274r1277b1310],
12	al.	FW	O	al.	appos	3	SENT_325	[p20l1297t1263r1358b1310],
13	.	.	O	.	_	0	SENT_325	[p20l1297t1263r1358b1310],

1	Pregnancy	NN	O	pregnancy	_	0	SENT_326	[p20l1383t1264r1682b1322],
2	and	CC	O	and	_	0	SENT_326	[p20l1702t1263r1805b1310],
3	risk	NN	O	risk	conj_and	1	SENT_326	[p20l1825t1263r1927b1310],
4	of	IN	O	of	_	0	SENT_326	[p20l1947t1263r2007b1310],
5	early	JJ	O	early	amod	8	SENT_326	[p20l111t1338r246b1397],
6	onset	NN	O	onset	nn	8	SENT_326	[p20l266t1349r415b1385],
7	breast	NN	O	breast	nn	8	SENT_326	[p20l434t1338r605b1385],
8	cancer	NN	O	cancer	prep_of	1	SENT_326	[p20l626t1353r811b1385],
9	in	IN	O	in	_	0	SENT_326	[p20l829t1338r883b1385],
10	carriers	NNS	O	carrier	prep_in	1	SENT_326	[p20l904t1338r1110b1385],
11	of	IN	O	of	_	0	SENT_326	[p20l1133t1338r1193b1385],
12	BRCA1	NN	O	brca1	prep_of	10	SENT_326	[p20l1204t1338r1421b1385],
13	and	CC	O	and	_	0	SENT_326	[p20l1447t1338r1551b1385],
14	BRCA2	NN	O	brca2	conj_and	12	SENT_326	[p20l1569t1338r1803b1385],
15	.	.	O	.	_	0	SENT_326	[p20l1569t1338r1803b1385],

1	Lancet	NNP	O	Lancet	_	0	SENT_327	[p20l110t1414r293b1460],
2	1999	CD	DATE	1999	num	1	SENT_327	[p20l317t1415r470b1470],
3	;	:	O	;	_	0	SENT_327	[p20l317t1415r470b1470],
4	354	CD	NUMBER	354	num	6	SENT_327	[p20l493t1414r612b1461],
5	:	:	O	:	_	0	SENT_327	[p20l493t1414r612b1461],
6	1846-50	CD	NUMBER	1846-50	dep	1	SENT_327	[p20l644t1415r900b1460],
7	.	.	O	.	_	0	SENT_327	[p20l644t1415r900b1460],

1	22	CD	NUMBER	22	num	3	SENT_328	[p20l7t1499r74b1544],
2	Brunet	NNP	ORGANIZATION	Brunet	nn	3	SENT_328	[p20l111t1498r307b1545],
3	JS	NNP	ORGANIZATION	JS	_	0	SENT_328	[p20l322t1497r403b1555],
4	,	,	O	,	_	0	SENT_328	[p20l322t1497r403b1555],
5	Ghadirian	NNP	O	Ghadirian	nn	6	SENT_328	[p20l427t1497r715b1545],
6	P	NN	O	p	appos	3	SENT_328	[p20l735t1498r791b1554],
7	,	,	O	,	_	0	SENT_328	[p20l735t1498r791b1554],
8	Rebbeck	NNP	ORGANIZATION	Rebbeck	nn	9	SENT_328	[p20l815t1497r1061b1545],
9	TR	NN	ORGANIZATION	tr	appos	3	SENT_328	[p20l1079t1498r1192b1554],
10	,	,	O	,	_	0	SENT_328	[p20l1079t1498r1192b1554],
11	et	FW	O	et	nn	12	SENT_328	[p20l1216t1508r1266b1545],
12	al.	FW	O	al.	appos	3	SENT_328	[p20l1287t1497r1347b1545],
13	.	.	O	.	_	0	SENT_328	[p20l1287t1497r1347b1545],

1	The	DT	O	the	det	2	SENT_329	[p20l1371t1497r1487b1545],
2	effect	NN	O	effect	_	0	SENT_329	[p20l1509t1497r1661b1545],
3	of	IN	O	of	_	0	SENT_329	[p20l1683t1497r1743b1545],
4	smoking	NN	O	smoking	prep_of	2	SENT_329	[p20l1757t1497r1996b1556],
5	on	IN	O	on	_	0	SENT_329	[p20l2016t1513r2086b1545],
6	breast	NN	O	breast	nn	8	SENT_329	[p20l109t1572r280b1619],
7	cancer	NN	O	cancer	nn	8	SENT_329	[p20l301t1588r486b1619],
8	incidence	NN	O	incidence	prep_on	2	SENT_329	[p20l505t1572r774b1620],
9	in	IN	O	in	_	0	SENT_329	[p20l795t1572r848b1619],
10	BRCA1	NN	O	brca1	nn	13	SENT_329	[p20l867t1572r1084b1619],
11	and	CC	O	and	_	0	SENT_329	[p20l1110t1572r1213b1619],
12	BRCA2	NN	O	brca2	conj_and	10	SENT_329	[p20l1232t1572r1454b1619],
13	carriers	NNS	O	carrier	prep_in	8	SENT_329	[p20l1474t1572r1697b1619],
14	.	.	O	.	_	0	SENT_329	[p20l1474t1572r1697b1619],

1	3	CD	NUMBER	3	_	0	SENT_330	[p20l1714t1572r1756b1631],
2	'	''	O	'	_	0	SENT_330	[p20l1714t1572r1756b1631],
3	Natl	NNP	O	Natl	nn	4	SENT_330	[p20l1769t1572r1896b1619],
4	Cancer	NNP	O	Cancer	dep	1	SENT_330	[p20l1913t1572r2103b1619],
5	Inst	NNP	O	Inst	dep	1	SENT_330	[p20l109t1648r212b1695],
6	1998	CD	DATE	1998	num	5	SENT_330	[p20l236t1649r388b1704],
7	;	:	O	;	_	0	SENT_330	[p20l236t1649r388b1704],
8	90	CD	NUMBER	90	num	10	SENT_330	[p20l412t1649r497b1695],
9	:	:	O	:	_	0	SENT_330	[p20l412t1649r497b1695],
10	761-65	CD	NUMBER	761-65	dep	1	SENT_330	[p20l523t1649r748b1695],
11	.	.	O	.	_	0	SENT_330	[p20l523t1649r748b1695],

1	23	CD	NUMBER	23	num	3	SENT_331	[p20l7t1733r73b1780],
2	Fan	NN	O	fan	nn	3	SENT_331	[p20l110t1732r221b1779],
3	S	NN	O	s	_	0	SENT_331	[p20l243t1732r295b1789],
4	,	,	O	,	_	0	SENT_331	[p20l243t1732r295b1789],
5	Wang	NNP	PERSON	Wang	nn	6	SENT_331	[p20l316t1732r541b1792],
6	]	NNP	O	]	appos	3	SENT_331	[p20l316t1732r541b1792],
7	,	,	O	,	_	0	SENT_331	[p20l316t1732r541b1792],
8	Yuan	NNP	O	Yuan	nn	9	SENT_331	[p20l563t1732r717b1779],
9	R	NNP	O	R	appos	3	SENT_331	[p20l737t1732r799b1789],
10	,	,	O	,	_	0	SENT_331	[p20l737t1732r799b1789],
11	et	FW	O	et	nn	12	SENT_331	[p20l823t1742r873b1779],
12	al.	FW	O	al.	appos	3	SENT_331	[p20l894t1731r955b1779],
13	.	.	O	.	_	0	SENT_331	[p20l894t1731r955b1779],

1	BRCA1	NN	O	brca1	nn	2	SENT_332	[p20l977t1732r1194b1779],
2	inhibition	NN	O	inhibition	nsubj	8	SENT_332	[p20l1218t1731r1495b1779],
3	of	IN	O	of	_	0	SENT_332	[p20l1516t1731r1576b1779],
4	estrogen	NN	O	estrogen	nn	6	SENT_332	[p20l1590t1742r1827b1792],
5	receptor	NN	O	receptor	nn	6	SENT_332	[p20l1847t1742r2083b1792],
6	signalling	NN	O	signalling	prep_of	2	SENT_332	[p20l111t1807r379b1868],
7	in	IN	O	in	advmod	8	SENT_332	[p20l398t1808r451b1855],
8	transfected	VBN	O	transfect	_	0	SENT_332	[p20l471t1807r784b1856],
9	cells	NNS	O	cell	dobj	8	SENT_332	[p20l805t1807r940b1855],
10	.	.	O	.	_	0	SENT_332	[p20l805t1807r940b1855],

1	Science	NN	O	science	_	0	SENT_333	[p20l965t1808r1157b1855],
2	1999	CD	DATE	1999	num	1	SENT_333	[p20l1183t1809r1336b1865],
3	;	:	O	;	_	0	SENT_333	[p20l1183t1809r1336b1865],
4	284	CD	NUMBER	284	num	6	SENT_333	[p20l1359t1809r1478b1856],
5	:	:	O	:	_	0	SENT_333	[p20l1359t1809r1478b1856],
6	1354-56	CD	NUMBER	1354-56	dep	1	SENT_333	[p20l1509t1809r1766b1856],
7	.	.	O	.	_	0	SENT_333	[p20l1509t1809r1766b1856],

1	24	CD	NUMBER	24	num	3	SENT_334	[p20l7t1892r74b1937],
2	Veronesi	NNP	ORGANIZATION	Veronesi	nn	3	SENT_334	[p20l108t1890r358b1937],
3	U	NNP	ORGANIZATION	U	_	0	SENT_334	[p20l378t1890r448b1946],
4	,	,	O	,	_	0	SENT_334	[p20l378t1890r448b1946],
5	Maisonneuve	NNP	PERSON	Maisonneuve	nn	6	SENT_334	[p20l470t1890r852b1937],
6	P	NN	PERSON	p	appos	3	SENT_334	[p20l873t1890r930b1946],
7	,	,	O	,	_	0	SENT_334	[p20l873t1890r930b1946],
8	Costa	NNP	MISC	Costa	nn	9	SENT_334	[p20l955t1890r1117b1937],
9	A	NNP	MISC	A	appos	3	SENT_334	[p20l1136t1890r1199b1946],
10	,	,	O	,	_	0	SENT_334	[p20l1136t1890r1199b1946],
11	et	FW	O	et	nn	12	SENT_334	[p20l1223t1900r1273b1937],
12	al.	FW	O	al.	appos	3	SENT_334	[p20l1294t1890r1354b1937],
13	.	.	O	.	_	0	SENT_334	[p20l1294t1890r1354b1937],

1	Prevention	NNP	O	Prevention	_	0	SENT_335	[p20l1380t1890r1688b1937],
2	of	IN	O	of	_	0	SENT_335	[p20l1709t1889r1770b1937],
3	breast	NN	O	breast	nn	4	SENT_335	[p20l1781t1890r1952b1937],
4	cancer	NN	O	cancer	prep_of	1	SENT_335	[p20l111t1981r296b2014],
5	with	IN	O	with	_	0	SENT_335	[p20l313t1966r438b2014],
6	tamoxifen	NN	O	tamoxifen	prep_with	4	SENT_335	[p20l457t1965r756b2014],
7	:	:	O	:	_	0	SENT_335	[p20l457t1965r756b2014],
8	preliminary	JJ	O	preliminary	amod	9	SENT_335	[p20l780t1966r1108b2026],
9	ﬁndings	NNS	O	ﬁndings	dep	1	SENT_335	[p20l1127t1965r1351b2026],
10	from	IN	O	from	_	0	SENT_335	[p20l1372t1965r1508b2014],
11	the	DT	O	the	det	14	SENT_335	[p20l1529t1966r1616b2014],
12	Italian	JJ	MISC	italian	amod	14	SENT_335	[p20l1637t1966r1818b2014],
13	randomized	JJ	O	randomized	amod	14	SENT_335	[p20l110t2042r448b2089],
14	trial	NN	O	trial	prep_from	9	SENT_335	[p20l467t2042r579b2089],
15	among	IN	O	among	_	0	SENT_335	[p20l600t2057r794b2101],
16	hysterectomised	JJ	O	hysterectomised	amod	17	SENT_335	[p20l812t2042r1271b2101],
17	women	NNS	O	woman	prep_among	14	SENT_335	[p20l1290t2057r1514b2089],
18	.	.	O	.	_	0	SENT_335	[p20l1290t2057r1514b2089],

1	Lancet	NNP	O	Lancet	_	0	SENT_336	[p20l1538t2042r1722b2089],
2	1998	CD	DATE	1998	num	1	SENT_336	[p20l1745t2043r1898b2098],
3	;	:	O	;	_	0	SENT_336	[p20l1745t2043r1898b2098],
4	352	CD	NUMBER	352	num	6	SENT_336	[p20l111t2118r230b2164],
5	:	:	O	:	_	0	SENT_336	[p20l111t2118r230b2164],
6	93-97	CD	DATE	93-97	dep	1	SENT_336	[p20l256t2118r445b2164],
7	.	.	O	.	_	0	SENT_336	[p20l256t2118r445b2164],

1	25	CD	NUMBER	25	num	2	SENT_337	[p20l7t2203r72b2248],
2	Powles	NNPS	ORGANIZATION	Powles	_	0	SENT_337	[p20l111t2201r307b2248],
3	T	NN	ORGANIZATION	t	dep	2	SENT_337	[p20l328t2202r393b2258],
4	,	,	O	,	_	0	SENT_337	[p20l328t2202r393b2258],
5	Eeles	NNP	PERSON	Eeles	nn	6	SENT_337	[p20l416t2201r563b2248],
6	R	NNP	PERSON	R	appos	3	SENT_337	[p20l585t2202r646b2258],
7	,	,	O	,	_	0	SENT_337	[p20l585t2202r646b2258],
8	Ashley	NNP	PERSON	Ashley	nn	9	SENT_337	[p20l668t2201r859b2260],
9	S	NNP	PERSON	S	appos	3	SENT_337	[p20l880t2201r931b2258],
10	,	,	O	,	_	0	SENT_337	[p20l880t2201r931b2258],
11	et	FW	O	et	nn	12	SENT_337	[p20l955t2212r1005b2248],
12	al.	FW	O	al.	appos	3	SENT_337	[p20l1026t2201r1087b2248],
13	.	.	O	.	_	0	SENT_337	[p20l1026t2201r1087b2248],

1	Interim	JJ	O	interim	amod	2	SENT_338	[p20l1111t2201r1323b2248],
2	analysis	NN	O	analysis	nsubj	15	SENT_338	[p20l1345t2201r1560b2260],
3	of	IN	O	of	_	0	SENT_338	[p20l1583t2201r1644b2248],
4	the	DT	O	the	det	5	SENT_338	[p20l1655t2201r1743b2248],
5	incidence	NN	O	incidence	prep_of	2	SENT_338	[p20l1764t2201r2033b2248],
6	of	IN	O	of	_	0	SENT_338	[p20l2055t2201r2116b2248],
7	breast	NN	O	breast	nn	8	SENT_338	[p20l109t2276r280b2323],
8	cancer	NN	O	cancer	prep_of	5	SENT_338	[p20l301t2291r486b2323],
9	in	IN	O	in	_	0	SENT_338	[p20l505t2276r558b2323],
10	the	DT	O	the	det	14	SENT_338	[p20l578t2276r665b2323],
11	Royal	NNP	LOCATION	Royal	nn	14	SENT_338	[p20l687t2276r847b2335],
12	Marsden	NNP	LOCATION	Marsden	nn	14	SENT_338	[p20l868t2276r1121b2323],
13	Hospital	NNP	LOCATION	Hospital	nn	14	SENT_338	[p20l1142t2276r1383b2335],
14	tamoxifen	NN	O	tamoxifen	prep_in	8	SENT_338	[p20l1403t2276r1688b2323],
15	randomised	VBD	O	randomise	_	0	SENT_338	[p20l1707t2276r2043b2323],
16	chemoprevention	NN	O	chemoprevention	nn	17	SENT_338	[p20l111t2351r605b2410],
17	trial	NN	O	trial	dobj	15	SENT_338	[p20l625t2351r751b2398],
18	.	.	O	.	_	0	SENT_338	[p20l625t2351r751b2398],

1	Lancet	NNP	O	Lancet	_	0	SENT_339	[p20l775t2352r959b2398],
2	1998	CD	DATE	1998	num	1	SENT_339	[p20l983t2353r1136b2408],
3	;	:	O	;	_	0	SENT_339	[p20l983t2353r1136b2408],
4	352	CD	NUMBER	352	num	6	SENT_339	[p20l1160t2352r1278b2398],
5	:	:	O	:	_	0	SENT_339	[p20l1160t2352r1278b2398],
6	98-101	CD	NUMBER	98-101	dep	1	SENT_339	[p20l1304t2353r1530b2398],
7	.	.	O	.	_	0	SENT_339	[p20l1304t2353r1530b2398],

1	26	CD	NUMBER	26	_	0	SENT_340	[p20l7t2436r74b2482],
2	Ford	NNP	ORGANIZATION	Ford	nn	3	SENT_340	[p20l110t2434r249b2482],
3	D	NNP	ORGANIZATION	D	dep	1	SENT_340	[p20l270t2435r340b2491],
4	,	,	O	,	_	0	SENT_340	[p20l270t2435r340b2491],
5	Easton	NNP	ORGANIZATION	Easton	nn	6	SENT_340	[p20l363t2435r558b2482],
6	DF	NNP	ORGANIZATION	DF	appos	3	SENT_340	[p20l579t2435r692b2491],
7	,	,	O	,	_	0	SENT_340	[p20l579t2435r692b2491],
8	Bishop	NNP	PERSON	Bishop	nn	9	SENT_340	[p20l715t2434r910b2493],
9	DT	NNP	O	DT	appos	3	SENT_340	[p20l932t2435r1052b2491],
10	,	,	O	,	_	0	SENT_340	[p20l932t2435r1052b2491],
11	Narod	NNP	ORGANIZATION	Narod	nn	12	SENT_340	[p20l1073t2434r1258b2482],
12	SA	NNP	ORGANIZATION	SA	appos	3	SENT_340	[p20l1281t2434r1379b2491],
13	,	,	O	,	_	0	SENT_340	[p20l1281t2434r1379b2491],
14	Goldgar	NNP	PERSON	Goldgar	nn	15	SENT_340	[p20l1404t2434r1637b2493],
15	DE	NN	O	de	appos	3	SENT_340	[p20l1656t2435r1769b2482],
16	.	.	O	.	_	0	SENT_340	[p20l1656t2435r1769b2482],

1	Risks	NNS	O	risk	_	0	SENT_341	[p20l1794t2434r1941b2482],
2	of	IN	O	of	_	0	SENT_341	[p20l1964t2434r2024b2482],
3	cancer	NN	O	cancer	prep_of	1	SENT_341	[p20l111t2524r296b2556],
4	in	IN	O	in	_	0	SENT_341	[p20l315t2508r368b2555],
5	BRCA1-mutation	NN	O	brca1-mutation	nn	6	SENT_341	[p20l387t2508r893b2556],
6	carriers	NNS	O	carrier	prep_in	1	SENT_341	[p20l914t2508r1136b2556],
7	.	.	O	.	_	0	SENT_341	[p20l914t2508r1136b2556],

1	Lancet	NNP	O	Lancet	_	0	SENT_342	[p20l1161t2509r1344b2556],
2	1994	CD	DATE	1994	num	1	SENT_342	[p20l1368t2510r1521b2565],
3	;	:	O	;	_	0	SENT_342	[p20l1368t2510r1521b2565],
4	343	CD	NUMBER	343	num	6	SENT_342	[p20l1545t2510r1663b2556],
5	:	:	O	:	_	0	SENT_342	[p20l1545t2510r1663b2556],
6	692-95	CD	NUMBER	692-95	dep	1	SENT_342	[p20l1690t2510r1915b2556],
7	.	.	O	.	_	0	SENT_342	[p20l1690t2510r1915b2556],

1	27	CD	NUMBER	27	num	4	SENT_343	[p20l7t2594r73b2640],
2	Breast	NN	O	breast	nn	4	SENT_343	[p20l111t2593r289b2640],
3	Cancer	NN	O	cancer	nn	4	SENT_343	[p20l311t2592r515b2641],
4	Linkage	NN	O	linkage	_	0	SENT_343	[p20l533t2592r760b2653],
5	Consortium	NNP	O	Consortium	dep	4	SENT_343	[p20l783t2592r1140b2641],
6	.	.	O	.	_	0	SENT_343	[p20l783t2592r1140b2641],

1	Cancer	NN	O	cancer	nn	2	SENT_344	[p20l1167t2593r1371b2641],
2	risks	NNS	O	risk	_	0	SENT_344	[p20l1389t2592r1514b2641],
3	in	IN	O	in	_	0	SENT_344	[p20l1535t2593r1589b2640],
4	BRCA2	NN	O	brca2	nn	5	SENT_344	[p20l1607t2593r1829b2640],
5	carriers	NNS	O	carrier	prep_in	2	SENT_344	[p20l1850t2593r2072b2640],
6	.	.	O	.	_	0	SENT_344	[p20l1850t2593r2072b2640],

1	j’	NN	O	j’	_	0	SENT_345	[p20l103t2669r285b2727],
2	Natl	NNP	O	Natl	nn	4	SENT_345	[p20l103t2669r285b2727],
3	Cancer	NNP	O	Cancer	nn	4	SENT_345	[p20l302t2669r492b2716],
4	Inst	NNP	O	Inst	dep	1	SENT_345	[p20l507t2669r610b2716],
5	1999	CD	DATE	1999	num	4	SENT_345	[p20l634t2670r787b2725],
6	;	:	O	;	_	0	SENT_345	[p20l634t2670r787b2725],
7	91	CD	NUMBER	91	num	9	SENT_345	[p20l810t2670r894b2716],
8	:	:	O	:	_	0	SENT_345	[p20l810t2670r894b2716],
9	1310-16	CD	NUMBER	1310-16	dep	1	SENT_345	[p20l926t2670r1183b2716],
10	.	.	O	.	_	0	SENT_345	[p20l926t2670r1183b2716],

1	28	CD	NUMBER	28	num	3	SENT_346	[p20l7t2752r73b2797],
2	Moslehi	NN	O	moslehus	nn	3	SENT_346	[p20l110t2750r339b2797],
3	R	NN	O	r	_	0	SENT_346	[p20l361t2750r422b2806],
4	,	,	O	,	_	0	SENT_346	[p20l361t2750r422b2806],
5	Chu	NNP	O	Chu	nn	6	SENT_346	[p20l447t2750r569b2797],
6	W	NNP	O	W	appos	3	SENT_346	[p20l588t2750r670b2806],
7	,	,	O	,	_	0	SENT_346	[p20l588t2750r670b2806],
8	Karlan	NNP	PERSON	Karlan	nn	9	SENT_346	[p20l693t2750r887b2797],
9	B	NNP	O	B	appos	3	SENT_346	[p20l907t2750r967b2806],
10	,	,	O	,	_	0	SENT_346	[p20l907t2750r967b2806],
11	et	FW	O	et	nn	12	SENT_346	[p20l991t2760r1041b2797],
12	al.	FW	O	al.	appos	3	SENT_346	[p20l1062t2750r1122b2797],
13	.	.	O	.	_	0	SENT_346	[p20l1062t2750r1122b2797],

1	BRCA1	NN	O	brca1	nn	5	SENT_347	[p20l1145t2750r1362b2797],
2	and	CC	O	and	_	0	SENT_347	[p20l1388t2750r1491b2797],
3	BRCA2	NN	O	brca2	conj_and	1	SENT_347	[p20l1510t2750r1732b2797],
4	mutation	NN	O	mutation	nn	5	SENT_347	[p20l1751t2750r2011b2797],
5	analysis	NN	O	analysis	_	0	SENT_347	[p20l111t2826r327b2886],
6	of	IN	O	of	_	0	SENT_347	[p20l349t2825r410b2874],
7	208	CD	NUMBER	208	num	10	SENT_347	[p20l424t2828r527b2874],
8	Ashkenazi	NNP	MISC	Ashkenazi	nn	10	SENT_347	[p20l548t2826r838b2874],
9	Jewish	JJ	MISC	jewish	amod	10	SENT_347	[p20l854t2826r1039b2885],
10	women	NNS	O	woman	prep_of	5	SENT_347	[p20l1058t2841r1267b2874],
11	with	IN	O	with	_	0	SENT_347	[p20l1286t2826r1410b2874],
12	ovarian	JJ	O	ovarian	amod	13	SENT_347	[p20l1431t2826r1638b2874],
13	cancer	NN	O	cancer	prep_with	5	SENT_347	[p20l1660t2841r1858b2874],
14	.	.	O	.	_	0	SENT_347	[p20l1660t2841r1858b2874],

1	Am	VBP	O	be	cop	3	SENT_348	[p20l1877t2826r1978b2874],
2	3	CD	NUMBER	3	number	3	SENT_348	[p20l1992t2826r2034b2886],
3	‘	CD	NUMBER	‘	_	0	SENT_348	[p20l1992t2826r2034b2886],
4	Hum	NNP	O	Hum	nn	5	SENT_348	[p20l109t2901r248b2948],
5	Genet	NNP	O	Genet	dep	3	SENT_348	[p20l273t2901r427b2948],
6	2000	CD	DATE	2000	num	5	SENT_348	[p20l445t2903r604b2957],
7	;	:	O	;	_	0	SENT_348	[p20l445t2903r604b2957],
8	66	CD	NUMBER	66	num	10	SENT_348	[p20l627t2903r712b2948],
9	:	:	O	:	_	0	SENT_348	[p20l627t2903r712b2948],
10	1259-72	CD	NUMBER	1259-72	dep	3	SENT_348	[p20l743t2902r1000b2948],
11	.	.	O	.	_	0	SENT_348	[p20l743t2902r1000b2948],

1	29	CD	NUMBER	29	num	3	SENT_349	[p20l7t2987r73b3033],
2	Cummings	NNP	ORGANIZATION	Cummings	nn	3	SENT_349	[p20l112t2985r425b3044],
3	SR	NN	ORGANIZATION	sr	_	0	SENT_349	[p20l449t2985r547b3042],
4	,	,	O	,	_	0	SENT_349	[p20l449t2985r547b3042],
5	Eckert	NNP	PERSON	Eckert	nn	6	SENT_349	[p20l570t2985r755b3032],
6	S	NNP	O	S	appos	3	SENT_349	[p20l777t2985r829b3042],
7	,	,	O	,	_	0	SENT_349	[p20l777t2985r829b3042],
8	Krueger	NNP	PERSON	Krueger	nn	9	SENT_349	[p20l852t2986r1085b3044],
9	KA	NN	O	ka	appos	3	SENT_349	[p20l1104t2986r1219b3042],
10	,	,	O	,	_	0	SENT_349	[p20l1104t2986r1219b3042],
11	et	FW	O	et	nn	12	SENT_349	[p20l1243t2996r1293b3032],
12	al.	FW	O	al.	appos	3	SENT_349	[p20l1314t2985r1375b3033],
13	.	.	O	.	_	0	SENT_349	[p20l1314t2985r1375b3033],

1	The	DT	O	the	det	2	SENT_350	[p20l1398t2985r1514b3032],
2	effect	NN	O	effect	_	0	SENT_350	[p20l1537t2985r1689b3032],
3	of	IN	O	of	_	0	SENT_350	[p20l1710t2985r1770b3032],
4	raloxifene	NN	O	raloxifene	prep_of	2	SENT_350	[p20l1782t2985r2060b3032],
5	on	IN	O	on	_	0	SENT_350	[p20l2082t3001r2152b3032],
6	risk	NN	O	risk	prep_on	4	SENT_350	[p20l110t3060r211b3107],
7	of	IN	O	of	_	0	SENT_350	[p20l231t3060r292b3107],
8	breast	NN	O	breast	nn	9	SENT_350	[p20l303t3060r474b3107],
9	cancer	NN	O	cancer	prep_of	6	SENT_350	[p20l495t3076r680b3107],
10	in	IN	O	in	_	0	SENT_350	[p20l699t3060r752b3107],
11	postmenopausal	JJ	O	postmenopausal	amod	12	SENT_350	[p20l771t3060r1233b3119],
12	women	NNS	O	woman	prep_in	9	SENT_350	[p20l1253t3076r1476b3108],
13	:	:	O	:	_	0	SENT_350	[p20l1253t3076r1476b3108],
14	results	NNS	O	result	dep	2	SENT_350	[p20l1501t3060r1682b3107],
15	from	IN	O	from	_	0	SENT_350	[p20l1703t3060r1840b3107],
16	the	DT	O	the	det	17	SENT_350	[p20l1860t3060r1947b3107],
17	MORE	JJR	O	more	prep_from	14	SENT_350	[p20l110t3135r321b3182],
18	randomized	VBN	O	randomize	partmod	17	SENT_350	[p20l341t3135r678b3182],
19	trial	NN	O	trial	dobj	18	SENT_350	[p20l699t3135r825b3182],
20	.	.	O	.	_	0	SENT_350	[p20l699t3135r825b3182],

1	_	NN	O	_	_	0	SENT_351	[p20l842t3135r1037b3194],
2	7/1	CD	NUMBER	7/1	dep	1	SENT_351	[p20l842t3135r1037b3194],
3	.	.	O	.	_	0	SENT_351	[p20l842t3135r1037b3194],

1	/	:	O	/	punct	5	SENT_352	[p20l842t3135r1037b3194],
2	VIA	IN	O	via	dep	5	SENT_352	[p20l842t3135r1037b3194],
3	1999	CD	DATE	1999	pobj	2	SENT_352	[p20l1067t3137r1220b3192],
4	;	:	O	;	_	0	SENT_352	[p20l1067t3137r1220b3192],
5	281	CD	NUMBER	281	_	0	SENT_352	[p20l1243t3137r1362b3182],
6	:	:	O	:	_	0	SENT_352	[p20l1243t3137r1362b3182],
7	2189-97	CD	NUMBER	2189-97	dep	5	SENT_352	[p20l1388t3137r1651b3182],
8	.	.	O	.	_	0	SENT_352	[p20l1388t3137r1651b3182],

1	30	CD	NUMBER	30	num	3	SENT_353	[p20l7t3220r74b3266],
2	Chen	NNP	O	Chen	nn	3	SENT_353	[p20l112t3218r265b3266],
3	Y	NN	O	y	_	0	SENT_353	[p20l284t3219r347b3275],
4	,	,	O	,	_	0	SENT_353	[p20l284t3219r347b3275],
5	Thompson	NNP	PERSON	Thompson	nn	6	SENT_353	[p20l370t3218r685b3277],
6	W	NNP	O	W	appos	3	SENT_353	[p20l703t3219r786b3275],
7	,	,	O	,	_	0	SENT_353	[p20l703t3219r786b3275],
8	Semenciw	NNP	O	Semenciw	nn	9	SENT_353	[p20l810t3218r1100b3266],
9	R	NNP	O	R	appos	3	SENT_353	[p20l1120t3219r1181b3275],
10	,	,	O	,	_	0	SENT_353	[p20l1120t3219r1181b3275],
11	Mao	NNP	PERSON	Mao	nn	13	SENT_353	[p20l1203t3219r1335b3266],
12	Y.	NNP	PERSON	Y.	nn	13	SENT_353	[p20l1355t3219r1416b3266],
13	Epidemiology	NNP	PERSON	Epidemiology	appos	3	SENT_353	[p20l1441t3218r1837b3277],
14	of	IN	O	of	_	0	SENT_353	[p20l1856t3218r1917b3266],
15	contralateral	JJ	O	contralateral	amod	17	SENT_353	[p20l111t3293r466b3341],
16	breast	NN	O	breast	nn	17	SENT_353	[p20l485t3293r656b3341],
17	cancer	NN	O	cancer	prep_of	13	SENT_353	[p20l677t3309r875b3341],
18	.	.	O	.	_	0	SENT_353	[p20l677t3309r875b3341],

1	Cancer	NNP	O	Cancer	nn	3	SENT_354	[p20l902t3293r1091b3341],
2	Epidemiol	NNP	O	Epidemiol	nn	3	SENT_354	[p20l1106t3293r1375b3352],
3	Biomarkers	NNS	O	biomarker	_	0	SENT_354	[p20l1389t3293r1694b3341],
4	Prev	NNP	O	Prev	dep	3	SENT_354	[p20l1712t3294r1835b3341],
5	1999	CD	DATE	1999	num	4	SENT_354	[p20l1862t3295r2015b3350],
6	;	:	O	;	_	0	SENT_354	[p20l1862t3295r2015b3350],
7	8	CD	NUMBER	8	num	9	SENT_354	[p20l2039t3295r2088b3341],
8	:	:	O	:	_	0	SENT_354	[p20l2039t3295r2088b3341],
9	855-62	CD	NUMBER	855-62	dep	3	SENT_354	[p20l112t3370r337b3416],
10	.	.	O	.	_	0	SENT_354	[p20l112t3370r337b3416],

1	31	CD	NUMBER	31	num	4	SENT_355	[p20l7t3454r69b3501],
2	Breast	NN	O	breast	nn	4	SENT_355	[p20l111t3453r289b3500],
3	Cancer	NN	O	cancer	nn	4	SENT_355	[p20l311t3452r515b3501],
4	Linkage	NN	O	linkage	_	0	SENT_355	[p20l533t3452r760b3513],
5	Consortium	NNP	O	Consortium	dep	4	SENT_355	[p20l783t3452r1140b3501],
6	.	.	O	.	_	0	SENT_355	[p20l783t3452r1140b3501],

1	Pathology	NN	O	pathology	_	0	SENT_356	[p20l1164t3452r1449b3513],
2	of	IN	O	of	_	0	SENT_356	[p20l1469t3452r1530b3500],
3	familial	JJ	O	familial	amod	5	SENT_356	[p20l1542t3452r1751b3501],
4	breast	NN	O	breast	nn	5	SENT_356	[p20l109t3528r280b3576],
5	cancer	NN	O	cancer	prep_of	1	SENT_356	[p20l301t3544r499b3576],
6	:	:	O	:	_	0	SENT_356	[p20l301t3544r499b3576],
7	differences	NNS	O	difference	dep	1	SENT_356	[p20l525t3528r828b3576],
8	between	IN	O	between	_	0	SENT_356	[p20l848t3528r1085b3576],
9	breast	NN	O	breast	nn	10	SENT_356	[p20l1104t3528r1275b3576],
10	cancers	NNS	O	cancer	prep_between	7	SENT_356	[p20l1297t3544r1504b3576],
11	in	IN	O	in	_	0	SENT_356	[p20l1526t3529r1579b3575],
12	carriers	NNS	O	carrier	prep_in	10	SENT_356	[p20l1600t3529r1806b3576],
13	of	IN	O	of	_	0	SENT_356	[p20l1829t3528r1890b3576],
14	BRCAI	NN	O	brcaus	nn	17	SENT_356	[p20l108t3605r326b3652],
15	or	CC	O	or	_	0	SENT_356	[p20l351t3620r410b3652],
16	BRCA2	NN	O	brca2	conj_or	14	SENT_356	[p20l427t3605r649b3652],
17	mutations	NNS	O	mutation	prep_of	12	SENT_356	[p20l668t3605r952b3652],
18	and	CC	O	and	_	0	SENT_356	[p20l975t3604r1078b3652],
19	sporadic	JJ	O	sporadic	amod	20	SENT_356	[p20l1099t3604r1337b3665],
20	cases	NNS	O	case	conj_and	17	SENT_356	[p20l1359t3620r1516b3652],
21	.	.	O	.	_	0	SENT_356	[p20l1359t3620r1516b3652],

1	Lancet	NNP	O	Lancet	_	0	SENT_357	[p20l1540t3605r1723b3652],
2	1997	CD	DATE	1997	num	1	SENT_357	[p20l1747t3606r1900b3662],
3	;	:	O	;	_	0	SENT_357	[p20l1747t3606r1900b3662],
4	349	CD	NUMBER	349	num	6	SENT_357	[p20l111t3682r230b3728],
5	:	:	O	:	_	0	SENT_357	[p20l111t3682r230b3728],
6	1505-10	CD	DATE	1505-10	dep	1	SENT_357	[p20l261t3682r517b3728],
7	.	.	O	.	_	0	SENT_357	[p20l261t3682r517b3728],

1	32	CD	NUMBER	32	num	3	SENT_358	[p21l7t26r74b72],
2	Crook	NN	O	crook	nn	3	SENT_358	[p21l112t25r291b72],
3	T	NN	O	t	_	0	SENT_358	[p21l309t25r374b81],
4	,	,	O	,	_	0	SENT_358	[p21l309t25r374b81],
5	Crossland	NNP	LOCATION	Crossland	nn	6	SENT_358	[p21l399t25r684b72],
6	S	NNP	LOCATION	S	appos	3	SENT_358	[p21l706t25r757b81],
7	,	,	O	,	_	0	SENT_358	[p21l706t25r757b81],
8	Crompton	NNP	PERSON	Crompton	nn	9	SENT_358	[p21l782t25r1080b84],
9	MR	NN	PERSON	mr	appos	3	SENT_358	[p21l1099t25r1229b81],
10	,	,	O	,	_	0	SENT_358	[p21l1099t25r1229b81],
11	Osin	NN	O	osin	nn	12	SENT_358	[p21l1253t25r1385b72],
12	P	NN	O	p	appos	3	SENT_358	[p21l1405t25r1461b81],
13	,	,	O	,	_	0	SENT_358	[p21l1405t25r1461b81],
14	Gusterson	NNP	PERSON	Gusterson	nn	15	SENT_358	[p21l1485t25r1778b72],
15	BA	NN	O	ba	appos	3	SENT_358	[p21l1798t25r1903b72],
16	.	.	O	.	_	0	SENT_358	[p21l1798t25r1903b72],

1	p53	NN	O	p53	nn	2	SENT_359	[p21l1922t26r2028b84],
2	mutations	NNS	O	mutation	nsubj	6	SENT_359	[p21l110t99r394b146],
3	in	IN	O	in	_	0	SENT_359	[p21l416t99r469b146],
4	BRC/11	NN	O	brc/11	nn	5	SENT_359	[p21l488t99r1022b146],
5	—	NN	O	—	prep_in	2	SENT_359	[p21l488t99r1022b146],
6	associated	VBN	O	associate	_	0	SENT_359	[p21l488t99r1022b146],
7	familial	JJ	O	familial	amod	9	SENT_359	[p21l1042t98r1251b146],
8	breast	NN	O	breast	nn	9	SENT_359	[p21l1271t99r1442b146],
9	cancer	NN	O	cancer	dobj	6	SENT_359	[p21l1463t114r1661b146],
10	.	.	O	.	_	0	SENT_359	[p21l1463t114r1661b146],

1	Lancet	NNP	O	Lancet	_	0	SENT_360	[p21l1685t99r1869b146],
2	1997	CD	DATE	1997	num	1	SENT_360	[p21l1893t100r2026b146],
3	5	CD	NUMBER	5	number	4	SENT_360	[p21l2031t114r2045b155],
4	350	CD	NUMBER	350	dep	1	SENT_360	[p21l111t176r230b222],
5	:	:	O	:	_	0	SENT_360	[p21l111t176r230b222],
6	638-39	CD	NUMBER	638-39	dep	1	SENT_360	[p21l257t176r481b222],
7	.	.	O	.	_	0	SENT_360	[p21l257t176r481b222],

1	33	CD	NUMBER	33	num	3	SENT_361	[p21l7t261r73b307],
2	Meakin	NNP	ORGANIZATION	Meakin	nn	3	SENT_361	[p21l110t259r327b306],
3	JW	NNP	ORGANIZATION	JW	_	0	SENT_361	[p21l342t260r450b317],
4	,	,	O	,	_	0	SENT_361	[p21l342t260r450b317],
5	Hayward	NNP	ORGANIZATION	Hayward	nn	6	SENT_361	[p21l474t259r733b318],
6	JL	NNP	ORGANIZATION	JL	appos	3	SENT_361	[p21l749t260r835b317],
7	,	,	O	,	_	0	SENT_361	[p21l749t260r835b317],
8	Panzarella	NNP	PERSON	Panzarella	nn	9	SENT_361	[p21l858t259r1150b306],
9	T	NN	O	t	appos	3	SENT_361	[p21l1169t260r1234b316],
10	,	,	O	,	_	0	SENT_361	[p21l1169t260r1234b316],
11	et	FW	O	et	nn	12	SENT_361	[p21l1258t270r1309b306],
12	al.	FW	O	al.	appos	3	SENT_361	[p21l1330t259r1390b307],
13	.	.	O	.	_	0	SENT_361	[p21l1330t259r1390b307],

1	Ovarian	JJ	O	ovarian	amod	2	SENT_362	[p21l1417t259r1641b307],
2	irradiation	NN	O	irradiation	_	0	SENT_362	[p21l1661t259r1958b307],
3	and	CC	O	and	_	0	SENT_362	[p21l1979t259r2083b307],
4	prednisone	NN	O	prednisone	conj_and	2	SENT_362	[p21l109t334r423b393],
5	following	VBG	O	follow	_	0	SENT_362	[p21l444t334r707b393],
6	surgery	NN	O	surgery	prep_following	2	SENT_362	[p21l727t349r933b393],
7	and	CC	O	and	_	0	SENT_362	[p21l954t334r1057b381],
8	radiotherapy	NN	O	radiotherapy	prep_following	2	SENT_362	[p21l1077t334r1439b393],
9	for	IN	O	for	_	0	SENT_362	[p21l1457t334r1537b381],
10	carcinoma	NN	O	carcinoma	prep_for	6	SENT_362	[p21l1557t334r1851b381],
11	of	IN	O	of	_	0	SENT_362	[p21l1873t334r1934b381],
12	the	DT	O	the	det	13	SENT_362	[p21l1946t334r2033b381],
13	breast	NN	O	breast	prep_of	10	SENT_362	[p21l109t408r295b455],
14	.	.	O	.	_	0	SENT_362	[p21l109t408r295b455],

1	Breast	NN	O	breast	nn	4	SENT_363	[p21l317t409r490b455],
2	Cancer	NN	O	cancer	nn	4	SENT_363	[p21l508t408r698b455],
3	Res	NNP	O	Res	nn	4	SENT_363	[p21l713t409r806b455],
4	Treat	NNP	O	Treat	_	0	SENT_363	[p21l831t409r972b455],
5	1996	CD	DATE	1996	num	4	SENT_363	[p21l996t410r1149b465],
6	;	:	O	;	_	0	SENT_363	[p21l996t410r1149b465],
7	37	CD	NUMBER	37	num	9	SENT_363	[p21l1172t410r1256b456],
8	:	:	O	:	_	0	SENT_363	[p21l1172t410r1256b456],
9	11-19	CD	DATE	11-19	dep	4	SENT_363	[p21l1288t410r1472b455],
10	.	.	O	.	_	0	SENT_363	[p21l1288t410r1472b455],

1	34	CD	NUMBER	34	num	3	SENT_364	[p21l7t494r74b540],
2	O’Reagan	NN	O	o’reagan	nn	3	SENT_364	[p21l112t492r393b551],
3	R	NN	O	r	_	0	SENT_364	[p21l414t493r475b549],
4	,	,	O	,	_	0	SENT_364	[p21l414t493r475b549],
5	Jordan	NNP	LOCATION	Jordan	nn	6	SENT_364	[p21l494t492r686b550],
6	VC	NNP	LOCATION	VC	appos	3	SENT_364	[p21l705t492r819b549],
7	,	,	O	,	_	0	SENT_364	[p21l705t492r819b549],
8	Gradishar	NNP	PERSON	Gradishar	nn	10	SENT_364	[p21l844t492r1127b540],
9	W	NNP	O	W	nn	10	SENT_364	[p21l1144t493r1248b550],
10	]	NN	O	]	appos	6	SENT_364	[p21l1144t493r1248b550],
11	.	.	O	.	_	0	SENT_364	[p21l1144t493r1248b550],

1	Tamoxifen	NN	O	tamoxifen	_	0	SENT_365	[p21l1272t492r1585b540],
2	and	CC	O	and	_	0	SENT_365	[p21l1606t492r1710b540],
3	contralateral	JJ	O	contralateral	amod	5	SENT_365	[p21l1732t492r2086b540],
4	breast	NN	O	breast	nn	5	SENT_365	[p21l109t567r280b615],
5	cancer	NN	O	cancer	conj_and	1	SENT_365	[p21l301t567r670b626],
6	.	.	O	.	_	0	SENT_365	[p21l301t567r670b626],
7	)	SYM	O	)	dep	1	SENT_365	[p21l301t567r670b626],

1	/	:	O	/	punct	4	SENT_366	[p21l301t567r670b626],
2	1m	NN	O	1m	nn	4	SENT_366	[p21l301t567r670b626],
3	Coll	NNP	O	Coll	nn	4	SENT_366	[p21l692t567r801b615],
4	Surg	NNP	O	Surg	_	0	SENT_366	[p21l816t567r945b626],
5	1999	CD	DATE	1999	dep	4	SENT_366	[p21l968t569r1121b624],
6	;	:	O	;	_	0	SENT_366	[p21l968t569r1121b624],
7	188	CD	NUMBER	188	dep	4	SENT_366	[p21l1148t569r1264b615],
8	:	:	O	:	_	0	SENT_366	[p21l1148t569r1264b615],
9	678-83	CD	NUMBER	678-83	dep	7	SENT_366	[p21l1290t569r1515b615],
10	.	.	O	.	_	0	SENT_366	[p21l1290t569r1515b615],

1	THE	DT	O	the	det	2	SENT_367	[p21l92t753r158b773],
2	LANCET	NN	O	lancet	_	0	SENT_367	[p21l167t753r297b774],
3	-	:	O	-	_	0	SENT_367	[p21l306t760r314b767],
4	Vol	NN	O	vol	dep	2	SENT_367	[p21l323t753r367b774],
5	356	CD	NUMBER	356	num	4	SENT_367	[p21l377t754r423b774],
6	-	:	O	-	_	0	SENT_367	[p21l434t760r441b767],
7	December	NNP	DATE	December	dep	4	SENT_367	[p21l451t753r583b774],
8	2	CD	DATE	2	num	7	SENT_367	[p21l592t754r614b777],
9	,	,	DATE	,	_	0	SENT_367	[p21l592t754r614b777],
10	2000	CD	DATE	2000	num	7	SENT_367	[p21l624t754r686b774],
11	1881	CD	DATE	1881	dep	7	SENT_367	[p21l1986t748r2060b774],

